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In the last decade, environmental concerns arose due to the analytic-chemical demonstration 
of pharmaceuticals and personal care products (PPCPs) in the aquatic environment. 
Residues of numerous PPCPs occur in the ng/L to low μg/L range in surface waters. 
Consequently, aquatic organisms are continually exposed to them at contaminated sites. 
However, these low concentrations remain a cause for concern, since some of these 
compounds are biologically active at low concentrations, and only little is known about their 
effects on the environment. Pharmaceuticals as a major category of PPCPs are mostly 
designed to interact with cellular receptors at low concentrations to elicit specific biological 
effects. Their effects on non-mammalian species might be similar to those occurring in 
mammals, since many target receptors are conserved between vertebrates. Therefore, we 
hypothesize that PPCPs can have similar biological and toxicological effects in non-target 
species as in humans. 
 
The overall goal of this thesis is to investigate the effects of two pharmaceuticals, the 
benzodiazepine diazepam and the antineoplastic agent PKC412 (protein kinase inhibitor) as 
well as the UV-filter 2-ethyl-hexyl-4-trimethoxycinnamate (EHMC) on gene expression 
changes and physiology of fish at concentrations near to those found or expected to occur in 
the environment. For the pharmaceuticals we aimed to link changes on the transcription level 
with effects on the organism level in order to understand their relationship and their 
ecotoxicological significance. The following studies have been performed: 
 
In vitro study: CYP3A assay 
In a first study, an assay for measuring the activity of cytochrome P450 3A (CYP3A) was 
optimized for its use in different fish cell lines. Several CYP3A substrates in fish cells were 
found to be similarly catalyzed to those in human cells. Additionally, the established assay 
allows a high-throughput screening for different CYP3A inducers and inhibitors.  
 
In subsequent studies we investigated the gene expression pattern upon exposure of 
zebrafish eleuthero-embryos to diazepam, and the protein kinase inhibitor PKC412, and of 
adult male fish (diazepam). By applying microarrays the transcription profile of the UV-filter 
EHMC was also studied in adult zebrafish.  
 
The benzodiazepine derivate diazepam  
The treatment of male adult fish with 235 ng/L and 291 μg/L diazepam resulted in expression 
changes of 51 and 103 genes, respectively. In addition, Gene Ontology (GO) analysis was 
performed to identify functional groups of genes of interest. At 235 ng/L diazepam, 
functionally identified genes fell into 57 different categories and at 291 μg/L diazepam into 40 
Summary 
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categories. Among those categories, alteration of genes involved in rhythmic processes, 
especially in the circadian rhythm, is of particular significance. Furthermore, MetaCore 
pathway analysis showed that the circadian rhythm is the most significantly altered pathway. 
In order to confirm microarray results, qRT-PCR was performed for selected genes (arntl2, 
cry2b, cry5, nr1d1, per1, arr3, gabrr1 and hsd17β3). The differential expression of these 
genes upon exposure of adult male zebrafish was confirmed in zebrafish eleuthero-embryos 
exposed to the same nominal concentrations of 273 ng/L and 273 μg/L diazepam.  
 
Subsequently we analysed whether these alterations on mRNA levels are linked to 
physiological effects such as the swimming behaviour. At 273 ug/L diazpam the locomotor 
activity significantly increased in eleuthero-embryos. Additional histological analyses of 
testes did not indicate any significant effects, although alterations in interstitial tissue were 
noted. This study leads to the conclusion that diazepam-induced alterations of genes 
involved in circadian rhythm are paralleled by effects in neurobehaviour at high, but not at 
low diazepam concentrations that may occur in polluted environments. 
 
Protein kinase inhibitor PKC412 
Exposure of zebrafish eleuthero-embryos to PKC412 lead to transcriptional changes of 259 
genes at 1.3 μg/L, and 511 genes at 21 μg/L. Some of the pathways affected by PKC412 
were angiogenesis, apoptosis, DNA damage response and response to oxidative stress. 
Behavioural, developmental and physiological effects were investigated in order to analyze 
for correlations between altered gene-expression profiles with effects on development and 
physiology. The expression of circadian rhythm genes was further investigated, however, no 
effects on the swimming behaviour were observed. In addition, potential effects of PKC412 
exposure to angiogenesis were analyzed in double transgenic zebrafish embryos 
Tg(fli1a:EGFP)y1;Tg(gata1:dsRed)sd2. No interference was noted based on the lack of 
major effects. Furthermore, effects of PKC412 on apoptosis were investigated. Apoptotic 
cells were found in the olfactory placodes of eleuthero-embryos at 31 μg/L PKC412. DNA 
damage was induced at 1.6 μg/L and 31 μg/L, but there were no significant effects on the 
formation of reactive oxygen species. This study leads to the conclusion that PKC412-
induced alterations of gene transcripts are partly paralleled by physiological effects at high, 
but not at the low PKC412 concentrations expected to be of environmental relevance. 
 
UV-filter EHMC 
Adult male zebrafish were exposed to 2.2 μg/L and 890 μg/L EHMC for 14 d. This treatment 
led to the alteration of 1096 and 1137 genes, respectively. 708 of the significantly altered 
genes were regulated at both concentrations always in the same direction (up or down). 
Summary 
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Gene Ontology (GO) analysis was performed to identify functional groups of genes of 
interest. At both concentrations differentially altered genes fell into 1637 different categories. 
Among them cellular processes, development processes and response to different kinds of 
stimuli (endogenous, hormone, steroid hormone) are affected at both EHMC concentrations. 
Additionally, we performed a pathway analysis with MetaCore. The different treatments had 
33 (2.2 μg/L EHMC: 33 maps; 890 μg/L EHMC: 36 maps) maps in common. The most 
relevant maps include pathways involved in tissue remodelling, wound repair, DNA damage 
response, apoptosis and many more. To validate gene expression changes obtained in 
microarrays, the expression of 5 different genes (vtg1, ptgds, igfbp1, rbp2a and gadd45b) 
was analyzed by qRT-PCR in whole body, and additionally, in liver, brain and testis. In 
addition, the effects of EHMC on different genes involved in hormonal pathways (vtg3, esr1, 
esr2b, ar, hsd17β3, cyp19b and cyp19a) were investigated. Different trends in gene 
modulations were observed among whole body and the investigated tissues. Therefore, a 
gene expression in individual tissues varies, and must not be reflected in the whole body 
response. 
 
In conclusion, it is not possible to specify a specific mode of action of EHMC, as it displayed 
multiple hormonal and additional effects in different tissues and the whole body. To obtain a 
more complete toxicological profile of EHMC, further studies are needed to relate the 
transcription profile to physiological effects, and to potential effects on fertility and 
reproduction. 
 
The data obtained in the in vivo experiments demonstrated that microarray analysis could 
reveal new insights into the modes of action of these compounds. Gene expression changes 
are very sensitive and may occur at low concentrations (diazepam, EHMC), which were near 
to environmental relevant ones. However, links to changes in locomotor activity (diazepam, 
PKC412) and other cellular processes (angiogenesis, apoptosis, DNA damage and formation 
of reactive oxygen species; PKC412) mainly occur at concentrations up to 10,000 times 
higher than anticipated in the environment.  
 
In conclusion, the data of this thesis reveals a novel and more detailed pictures of the modes 
of action of diazepam, PKC412 and EHMC. Toxicogenomics is confirmed to be an 
appropriate approach to obtain broad information on the transcriptome. Nevertheless, it was 
only partly feasible to link the obtained gene expression changes to physiological effects in 
fish. Therefore, further effort should be made on research into the link of gene expression 
patterns and physiological effects. Consequently, the question to what extent toxicogenomics 
serves as a valuable tool for the environmental risk assessment should further be evaluated.
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In den letzten Jahrzehnten wuchsen beständig Bedenken über eine mögliche 
Umweltgefährdung durch Rückstände von Arzneimitteln und Körperpflegeprodukten. 
Rückstände zahlreicher Arzneimittel und Körperpflegeprodukte in Oberflächengewässern 
werden regelmässig im Bereich von ng/L bis hin zu μg/L gefunden. Dadurch sind vor allem 
aquatische Organismen diesen Substanzen kontinuierlich an den belasteten Standorten 
ausgesetzt. Obwohl meist tiefe Substanzkonzentrationen vorherrschen, sind diese 
bedenklich, da einige der fraglichen Substanzen schon bei tiefen Konzentrationen biologisch 
aktiv sind. Zudem sind bei vielen Umweltchemikalien die Auswirkungen auf 
Nichtzielorganismen bzw. die Umwelt im Allgemeinen unbekannt. Arzneimittel wurden 
grösstenteils entwickelt, um schon bei tiefen Konzentrationen mit zellulären Rezeptoren zu 
interagieren bzw. um zu einer spezifischen Wirkung zu führen. Ihre Auswirkungen auf höher 
entwickelte Nichtzielorganismen (wie z.B. Fische) können folglich ähnlich zu denen in 
Säugetieren sein, da die meisten Zielrezeptoren auch bei diesen Organismen vorhanden 
sind. Aufgrund dessen wird angenommen, dass Arzneimittel und Körperpflegeprodukte die 
gleichen biologischen sowie toxikologischen oder zumindest vergleichbare Auswirkungen auf 
Fische wie auf den Menschen haben. 
 
Das Ziel dieser Arbeit ist es, die Effekte von zwei Arzneimitteln (Diazepam und der 
antineoplastische Wirkstoff PKC412) und dem UV-Filter 2-Ethylhexyl-4-trimetoxycinnamat 
(EHMC) auf Genexpressionsebene und auf die Physiologie von Zebrafischen nahe 
umweltrelevanter Konzentrationen zu untersuchen. Bei der Exposition gegenüber den 
Arzneimitteln wurde versucht, die erhaltenen Änderungen auf der Transkriptionsebene mit 
Effekten auf der Organismusebene zu verbinden, um ihre umwelttoxikologische Relevanz 
besser zu verstehen. Folgende Studien wurden ausgeführt: 
 
In vitro Studie: CYP3A Assay 
In einer ersten Studie, wurde ein Assay für die Messung der Cytochrom P450 3A (CYP3A) 
Aktivität verschiedener Fischzelllinien optimiert. Es wurde gezeigt, dass CYP3A Substrate 
sowohl in menschlichen Leberzellen als auch in Fischzellen (Zebrafisch Leberzellen, 
Poeciliopsis lucida Leberzellen, Regenbogenforellen Gonadenzellen und Fathead Minnow 
Epithelzellen des Anus) katalysiert werden. Zusätzlich erlaubt dieser Assay, dass mit einer 
hohen Durchsatzrate nach potentiellen CYP3A-Hemmern oder -Induktoren gesucht werden 
kann. 
 
In den nachfolgenden Studien wurden die Genexpressionsänderungen in Zebrafischlarven 
nach der Exposition mit Diazepam und PKC412 untersucht. Zusätzlich zu den Larven 
wurden ebenso die Effekte von Diazepam auf ausgewachsene Zebrafisch-Männchen 
Zusammenfassung 
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untersucht. Ausserdem wurde in einem weiteren Versuch mittels Microarray Analyse das 
Transkriptionsprofil des UV-Filters EHMC in ausgewachsenen Zebrafisch-Männchen 
untersucht. 
 
Das Benzodiazepin-Derivat Diazepam 
Durch die Exposition männlicher Zebrafische mit 235 ng/L und 291 μg/L Diazepam wurde die 
Expression von 51 bzw. 103 Genen signifikant verändert. Damit Gene funktionellen Gruppen 
zugeordnet und diese identifiziert werden konnten, wurde eine Gene Ontologie (GO) Analyse 
durchgeführt. Nach der Behandlung mit 235 ng/L Diazepam wurden 57 funktionelle Gruppen 
identifiziert während nach der Behandlung mit 291 μg/L 40 Gruppen bestimmt wurden. In 
den identifizierten Gruppen sind vor allem Gene relevant, welche zu rhythmischen 
Prozessen insbesondere zum zirkadianen Rhythmus gehören. Zusätzlich zur GO Analyse 
wurde mit Hilfe von MetaCore eine Pathway Analyse durchgeführt. Diese zeigte auf, dass 
der zirkadiane Rhythmus einer der wichtigsten Pathway ist, welcher signifikant verändert 
wurde. 
 
Die erhaltenen Microarray Resultate wurden anschliessend mittels qRT-PCR verifiziert. Dazu 
wurden folgende Gene untersucht: arntl2, cry2b, cry5, nr1d1, per1, arr3, gabrr1 und 
hsd17β3. Ausserdem wurde die Änderung dieser Gene auch in Zebrafisch Larven, welche 
mit 273 ng/L und 273 μg/L Diazepam exponiert wurden, untersucht.  
 
Im Anschluss an diese Experimente wurden die Effekte auf Gen-Ebene mit physiologischen 
Effekten wie z.B. das Schwimmverhalten gekoppelt. So konnte gezeigt werden, dass sich 
Zebrafisch Larven nach einer Exposition mit 273 μg/L Diazepam viel aktiver als 
unbehandelte Larven bewegen. Zusätzlich zum Schwimmverhalten wurden die Hoden der 
Männchen auf Veränderungen hinsichtlich der verschiedenen Entwicklungsstadien der 
Spermien histologisch untersucht. Es traten keine signifikanten Änderungen der 
Entwicklungsstadien auf, jedoch wurde eine Veränderung des interstitiellen Gewebes 
beobachtet. Diese Studie führte zum Fazit, dass die durch Diazepam verursachten 
Genexpressionsänderungen mit neurologischem Verhalten gekoppelt werden können. Dies 
ist aber nur für hohe und nicht für tiefe umweltrelevante Konzentrationen möglich. 
 
Der Proteinkinase Inhibitor PKC412 
Die Exposition von Zebrafisch Larven mit 1.3 und 21 μg/L PKC412 führte zu einer 
signifikanten Änderung von 259 bzw. 511 Genen. Angiogenese, Apoptose, Antwort auf DNA 
Schäden und Antwort auf oxidativen Stress sind einige der durch PKC412 veränderten 
Pathways. Wiederum wurden Verhaltens-, Entwicklungs- und physiologische Effekte bei 
Zusammenfassung 
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diesen exponierten Tieren untersucht, um eine Korrelation zwischen den 
Genexpressionsänderungen und Effekten in der Entwicklung und Physiologie zu 
ermöglichen. Ausserdem wurden die Genexpressionänderungen des zirkadianen Rhythmus 
vertiefend untersucht. Hierbei wurden jedoch keine Effekte auf das Schwimmverhalten 
beobachtet. Zusätzlich wurden mögliche Effekte durch PKC412 auf die Angiogenese mittels 
doppel transgenen Zebrafisch-Embryonen (Tg(fli1a:EGFP)y1; Tg(gata1:dsRed)sd2) 
untersucht. Es konnten keine signifikanten Effekte bei der Blutgefässbildung beobachtet 
werden. Apoptotische Zellen wurden hauptsächlich bei den olfaktorischen Plakoden nach 
einer Exposition mit 31 μg/L PKC412 gefunden. Im Gegensatz dazu, traten DNA Schäden 
bei beiden Konzentrationen (1.6 μg/L und 31 μg/L) von PKC412 auf. Es wurden jedoch nicht 
vermehrt reaktive Sauerstoffspezies gebildet. Fazit dieser Studie ist, dass 
Genexpressionsänderungen, welche durch PKC412 ausgelöst wurden, nur eingeschränkt 
mit physiologischen Effekten gekoppelt werden können. Diese Aussage trifft vor allem für die 
hohen PKC412 Konzentrationen zu. Mit Ausnahme der DNA Schäden war es anderseits 
nicht möglich die Genexpressionsänderungen der tiefen Konzentration von PKC412 mit 
physiologischen Effekten zu koppeln. 
 
UV-Filter EHMC 
Adulte Zebrafisch Männchen wurden mit 2.2 μg/L und 890 μg/L EHMC (nominale 
Konzentrationen) exponiert. Dies führte zu einer Expressionsänderung von 1096 bzw. 1137 
verschiedenen Genen. 708 der signifikant veränderten Gene wurden bei beiden 
Konzentrationen gefunden, wobei diese Gene auch immer in der gleichen Richtung reguliert 
waren. Eine Gen Ontology Analyse wurde durchgeführt, um funktionelle Gruppen von Genen 
zu identifizieren. Bei beiden EHMC Konzentrationen wurden als Resultat dieser Analyse 
1637 verschiedene Kategorien erhalten. Unter diesen Kategorien wurden vor allem zelluläre 
Prozesse, Entwicklungsprozesse und Antworten auf verschiedene Stimuli (endogene wie 
hormonelle) gefunden. Zusätzlich zu dieser Analyse wurde eine Pathway Analyse mittels 
MetaCore durchgeführt. 33 Mappen (33 bei 2.2 μg/L und 36 bei 890 μg/L EHMC) waren bei 
beiden Konzentrationen dieselben. Die wichtigsten Mappen sind: Gewebe Umgestaltungen, 
Wundheilung, Antworten auf DNA Schäden und Apoptose. Fünf verschiedene Gene (vtg1, 
ptgds, igfbp1, rbp2a und gadd45b) wurden mittels qRT-PCR in den Ganzkörperproben und 
zusätzlich in Gehirn, Leber und Hoden untersucht, um die erhaltenen 
Expressionsänderungen zu verifizieren. Um die Effekte von EHMC auf die hormonellen 
Pathways zu untersuchen, wurden 7 zusätzliche Gene (vtg3, esr1, esr2b, ar, hsd17β3, 
cyp19b und cyp19a) mittels qRT-PCR untersucht. Es wurden unterschiedliche Trends in der 
Genexpressionsänderungen der Ganzkörperproben im Vergleich zu den verschiedenen 
Geweben beobachtet. Man kann daher sagen, dass sich die Genexpressionen in den 
Zusammenfassung 
15 
verschiednen Geweben unterscheiden und oft nicht vergleichbar mit Ganzkörper-Antworten 
sind. 
 
Aus diesem Grund war es nicht möglich, eine spezifische Wirkungsweise von EHMC 
aufzuzeigen. EHMC kann demnach unterschiedliche hormonelle Effekte in den 
verschiedenen Organen bzw. im ganzen Körper auslösen. Damit ein kompletteres 
toxikologisches Profil von EHMC skizziert werden kann, müssten zusätzlich physiologische 
Effekte und Effekte auf die Fortpflanzungsfähigkeit und Reproduktion untersucht werden. 
 
Die erhaltenen Daten der in vivo Experimente zeigen, dass mittels einer Microarray Analyse 
neue Erkenntnisse über die Wirkungsweise der untersuchten Substanzen generiert werden. 
Genexpressionsänderungen sind zumeist sehr sensitiv und treten deshalb oft schon bei 
tiefen, nahe umweltrelevanten Konzentrationen auf (Diazepam, EHMC). Korrelationen zu 
Änderungen im Schwimmverhalten (Diazepam, PKC412) oder zu unterschiedlichen 
zellulären Prozessen (Angiogenese, Apoptose, Antwort auf DNA Schäden und Bildung von 
reaktiven Sauerstoffspezies; PKC412) treten jedoch meist erst bei Konzentrationen auf, 
welche bis zu 10'000 mal höher sind als durchschnittliche Umweltkonzentrationen der 
besagten Stoffe. 
 
Zusammenfassend zeigt diese Arbeit ein neueres und detailierteres Bild über die 
Wirkungsweise von Diazepam, PKC412 und EHMC auf. Toxicogenomics war in diesem 
Zusammenhang eine angemessene Methode, um viele Informationen über Änderungen im 
Transkriptom zu erhalten. Nichtsdestotrotz, war es nur teilweise möglich die erhaltenen 
Genexpressionsänderungen mit phyisologischen Veränderungen zu verknüpfen. Aus diesem 
Grund sollten künftig vermehrt Anstrengungen unternommen werden, um diese 
Zusammenhänge besser aufzeigen zu können. Zusätzlich muss der Wert von 
Toxicogenomics für Umweltrisikoanalysen noch genauer untersucht werden. 
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1.1 Pharmaceuticals and personal care products in the 
environment 
In the last decade, steadily increasing data on levels of environmental residues of 
pharmaceuticals and personal care products (PPCPs) have been reported. As a result, 
multiple research efforts have been initiated to scrutinize possible input pathways and fate of 
these newly emerging pollutants.  
 
PPCPs constitute a group of a wide number of largely consumed compounds including 
therapeutic drugs, veterinary drugs, diagnostic agents, fragrances, cosmetics, sunscreen 
products, and nutraceuticals (e.g. vitamins). They are manufactured in large amounts as 
outlined in the following chapters. If they are easily broken down, processed by the human 
body or degraded quickly, only small concentrations of the parent compound occur in the 
environment independent of their production volume. However, PPCPs are still of concern as 
they may be active at extremely low concentrations, they are widespread and continuously 
released, and may have unpredictable biochemical interactions in mixtures or could 
biomagnify in the food chain, and therefore affect aquatic organisms. Some of the known 
effects are delayed development in fish (e.g. Raldúa et al., 2008) or even disruption of fish 
populations (Kidd et al., 2007) and delayed metamorphosis in frogs (Veldhoen et al., 2006), 
to name a few of the implications.  
 
The following chapters focus on the input pathways of PPCPs into the aquatic environment, 
their occurrence and their potential effects on humans and the environment. 
 
1.1.1 Exposure routes 
PPCPs including their metabolites and transformation products can be discharged into the 
environment through different exposure routes. PPCPs mainly enter the sewage treatment 
plants (STPs) as components of domestic, hospital and industrial waste (Figure 1) including 
excretion by humans and animals, leaching from landfills, disposal of expired and unused 
PPCPs in the toilet, release of unabsorbed externally applied PPCPs (e.g. sun-screen) to 
surface waters and use of sewage solids for soil amendment and fertilisation. Once they 
have entered STPs, PPCPs can be removed by several routes (Fent et al., 2006; Suárez et 
al., 2008; Monteiro and Boxall, 2010). These removal mechanisms include sorption to solids, 
volatilization and biological and chemical transformation. Depending on their sorption 
coefficient (Kd, which includes absorption and adsorption), sorption to sludge can occur 
(Daughton and Ternes, 1999; Joss et al., 2005; Suárez et al., 2008). Volatilization is 
negligible for pharmaceuticals due to their physical properties. However, it is an important 
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process for instance for the fragrance celestolide (Suárez et al., 2008), and also for other 
PPCPs. Additionally to sorption and volatilization, PPCPs can be biodegraded into lower 
molecular weight products. Complete mineralization, partial degradation or minor chemical 
modifications can occur (Daughton and Ternes, 1999; Joss et al., 2005). The extent of 
biological transformation may vary greatly from compound to compound. Several studies 
showed that at least 90 % of the analgesic ibuprofen undergoes biotransformation (Buser et 
al., 1999; Joss et al., 2005; Reif et al., 2008). In contrast, only 15 % of the antiepileptic drug 
carbamazepine is lost due to biotransformation (Joss et al., 2005; Reif et al., 2008; Suárez et 
al., 2008).  
 
Despite treatment, residues of most commonly used PPCPs are still present in the effluents 
of STPs, since many of these polar compounds are often incompletely removed due to their 
remarkable persistence; e.g. carbamazepine, which is neither sorbed nor biotransformed 
(Suárez et al., 2008). The treated wastewater is then mostly discharged into surface waters 
or sometimes irrigated onto fields. Additionally, primary and secondary sludge containing 
sorbed PPCPs is deposited on land. It has been reported that PPCPs contained in sewage 
sludge can be leached out, infiltrate into the groundwater (Khan and Ongerth, 2002; Kupper 
et al., 2004; Kinney et al., 2006), and subsequently into drinking water. In addition to 
consumption of contaminated drinking water, there are also other indirect (direct ones are 
drugs, sunscreens, cosmetics etc.) routes of exposure for humans; e.g. consumption of fish 
containing PPCPs, and dermal contact during showering with domestic water as well as 
swimming in PPCPs contaminated surface water. 
 
Figure 1 
Exposure routes of human pharmaceuticals and personal care products into wastewaters and aquatic 
environment (adapted from Ternes, 2006)  
Industry
Drinking water
Hospital Household
Treatment Sewage
Domestic waste
Soil Treatment plant
Landfill
Surface water Groundwater
Disposal
Chapter 1 
19 
1.1.2 Occurrence of PPCPs in the aquatic environment  
PPCPs in STPs have been increasing over the last decade due to their growing number, 
production volumes, and extended use. Furthermore, in recent years lowered limits of 
detection in high performance liquid chromatography-tandem mass spectrometry and gas 
chromatography-tandem mass spectrometry have led to more comprehensive knowledge of 
residues of different pollutants in all kind of liquid media (wastewater, surface water, ground 
water, drinking water) and solid matrices (sewage sludge, soil, sediment) in the ng/L to low 
μg/L range (Figure 2) (Daughton and Ternes, 1999; Fent et al., 2006; Kümmerer, 2008; 
Suárez et al., 2008; Monteiro and Boxall, 2010). However, even these low concentrations 
remain a cause for concern since some of these compounds are biologically active at low 
concentrations, and generally effects on non-target species are mainly unknown. 
 
  
Figure 2  
Concentration ranges of pharmaceuticals in (a) treated wastewater and (b) surface water. According to Fent et al., 
2006  
 
One of the most common classes of pharmaceuticals, a major category of PPCPs, detected 
in the environment are lipid regulators, particularly fibrates. Bezafibrate, gemfibrozil and 
fenofibrate have been detected at μg/L ranges in treated wastewater (Figure 2) (Fent et al., 
2006). Clofibric acid is commonly reported in surface water and STPs effluents in the μg/L 
range and has even been detected in drinking water (Heberer and Stan, 1997). Beta 
blockers, too, are among the most prescribed drugs, so they are also frequently detected in 
STPs effluents and surface waters, where they occur in the range of ng/L to μg/L (Figure 2) 
(Fent et al., 2006).  
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Furthermore, there are many other pharmaceuticals occurring in the effluents of STPs 
(Figure 2). Several pharmaceuticals such as diclofenac, sulfamethoxazole and 
carbamazepine are only partially removed in STPs (Joss et al., 2006). Carbamazepine 
belongs to the most often used antiepileptics and has been frequently detected in STP 
effluents and surface waters. In STP effluents, concentration above 1 μg/L were detected, 
whereas in surface waters the concentrations were mostly in the ng/L range (Figure 2) (Fent 
et al., 2006). This brief overview and the few examples show that surface waters can be 
contaminated by many different PPCPs. 
 
1.1.3 Ecotoxicological effects on non-target species 
Adverse effects on aquatic organisms can occur as PPCPs and potentially also their 
metabolites are biologically active. Drugs as a major part of PPCPs are mostly designed to 
interact with cellular receptors at low concentrations and they elicit specific biological effects. 
The effects of drugs on lower vertebrates could be similar to those occurring in mammals, 
since many target receptors have been conserved during evolution (Fent et al., 2006; Owen 
et al., 2007; Gunnarsson et al., 2008; Christen et al., 2010). However, there are also PPCPs 
such as cosmetic additives which have unexpected effects on lower organisms, due to their 
differences in targets and metabolism (Daughton and Ternes, 1999). 
 
Aquatic organisms are continuously exposed to PPCPs via wastewater at contaminated sites 
and the uptake includes branchial (gills), dermal (skin) and oral (gastrointestinal tract) 
absorption (Kennedy et al., 1995). PPCPs which come into contact with gills mostly 
penetrate the epithelium through the cells (transcellularly), and very rarely through tight 
junctions (paracellularly) (Kennedy et al., 1995).Thus far, there is no evidence of active 
transport through the gills into the blood. Therefore, it is assumed that passive diffusion is the 
main transport mechanism. In addition to the gills, the gut epithelium is an important uptake 
route for PPCPs. There, PPCPs can enter via the same routes as food or water uptake. The 
overall importance of uptake by the skin is unknown. There are studies which showed that 
cutaneous absorption is more important in small fish due to larger ratio between skin surface 
area to gill surface area (Lien and McKim, 1993). However, the uptake is also dependent on 
external physical factors such as dissolved oxygen, water pH and temperature (Kennedy et 
al., 1995). Due to this continuous exposure, multi-generation exposure can occur and 
depending on body size, low-dose effects are also particularly relevant.  
 
In addition, PPCPs are often present in the environment as complex mixtures which could 
result in additive, synergistic or antagonistic effects (Richards et al., 2004). Many polar 
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PPCPs show "pseudopersistence" in the environment, as they are continuously discharged 
via wastewater. This will lead to accumulation of PPCPs in aquatic organisms and potentially 
to biomagnification in the food chain as shown for antidepressants (Brooks et al., 2005). 
Furthermore, there are also PPCPs having endocrine activity, such as synthetic oestrogens 
(Länge et al., 2001) or progestins (Zeilinger et al., 2009; Paulos et al., 2010) commonly used 
in contraceptives. Several studies have shown that reproduction of aquatic organisms is 
affected at even low concentrations of synthetic oestrogens. Observed effects were changes 
in the sperm density, gonad size, reduced viability of eggs and male sex reversal (Länge et 
al., 2001; Zillioux et al., 2001; Schultz et al., 2003; Thorpe et al., 2003; Hogan et al., 2010). 
However, even up to now only little data are available for evaluating potential risks to the 
aquatic environment, except for some endocrine disruptors. As PPCPs remain a challenging 
problem for both humans and aquatic organisms, further effort should be put into 
ecotoxicological research of PPCPs. 
 
1.1.4 Biotransformation in aquatic organisms 
Aquatic organisms are continuously exposed to a number of PPCPs. Due to this, organisms 
have to avoid compound accumulation in their body. An efficient protection via metabolism, 
elimination and adaptation is therefore essential (Livingstone, 1998; Van Leeuwen and 
Vermeire, 2007). There are two classes of elimination reactions, phase-I and phase-II 
reactions (Figure 3). Phase-I reactions usually precede phase-II reactions, though not 
necessarily. During these processes, polar groups are either introduced or unmasked 
resulting in more polar metabolites of parent compounds. In the case of pharmaceuticals, 
phase-I reactions can lead to inactivation but also to activation of a compound generating 
biologically more active or toxic metabolites (Halling-Sorensen, 1998). Phase-I reactions may 
occur by oxidation, reduction and hydrolysis (Livingstone, 1998). Oxidation involves the 
enzymatic addition of oxygen or removal of hydrogen, carried out by cytochrome P450-
dependent monooxygenases (CYP), most often in the liver, the flavin-containing 
monooxygenases (FMO) and the peroxidases (Guengerich, 1992). Oxidative reactions (e.g. 
hydroxylation, N-oxidation, deamination, N-dealkylation) typically involve a cytochrome P450 
hemeprotein, NADPH and oxygen. CYPs play a critical role in catalyzing reactions e.g. 
biosynthesis of steroid hormones, metabolism of xenobiotics to reactive metabolites, 
oxidation of unsaturated fatty acids etc. FMOs catalyze numerous monooxygenase reactions 
using NADPH. FMOs play an important role in the toxicity of various heteroatom-containing 
substances (Schlenk, 1998). In addition, peroxidases are also involved in oxidation 
processes. The peroxidase action involves the use of hydroperoxide as a substrate resulting 
in an oxidation of this substrate (Guengerich, 1992). Examples for pharmaceuticals 
metabolised via oxidative reactions are diazepam (N-dealkylation, deamination), ibuprofen 
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(aliphatic hydroxylation), acetaminophen (N-oxidation) and many more (Monteiro and Boxall, 
2010). Reduction is also an important phase-I reaction, and PPCPs containing functional 
groups such as aldehydes, ketones, and alcohols are reduced through enzymatic reactions 
catalyzed by reductases and different dehydrogenases (Kennedy et al., 1995). Hydrolytic 
reactions can also occur in fish. PPCPs containing esters such as MS-222, amides and 
epoxides mostly undergo such reactions (Kennedy et al., 1995). Aspirin, clofibric acid, 
cocaine, lidocaine etc. were metabolised via hydrolysis reactions (Monteiro and Boxall, 
2010).  
 
If metabolites of phase-I reactions are sufficiently polar, they may be readily excreted at this 
point. However, many phase-I products are not rapidly eliminated and undergo a subsequent 
reaction, which involves conjugation of the compound with either sugars (glucuronidation) or 
peptides to form a more polar conjugate (Daughton and Ternes, 1999; Suárez et al., 2008). 
During phase-II reactions functional groups are linked to polar, negatively charged 
endogenous molecules. Important phase-II reactions are glucuronidation, sulphonation, 
methylation, acetylation and conjugation with amino acids and glutathione. Glucuronidation 
involves the conjugation of UDP-glucuronic acid to PPCPs. Acetaminophen, oxazepam (a 
metabolite of diazepam) and morphine are metabolised by glucuronidation (Monteiro and 
Boxall, 2010). During sulphonation reactions, sulphate is transferred to PPCPs containing 
phenolic groups as for instance in the metabolism of sulphonamides (Monteiro and Boxall, 
2010). Biologic methylation is an important process in the metabolism of norepinephrine, 
serotonin and histamine. In addition, conjugation of PPCPs to various amino acids such as 
taurine and glycine can occur in fish (Kennedy et al., 1995). Glutathione S-transferases 
(GST) catalyze the formation of N-acetylcysteine derivatives of PPCPs resulting in 
metabolites, which were generally less toxic and more water soluble (Kennedy et al., 1995). 
The purpose of these reactions is to convert lipophilic chemical compound into more easily 
excreted polar products. 
 
However, there are also PPCPs such as tetracyclines, penicillins, fluoroquinolones and β-
blockers (with the exception of propanolol and betaxolol) which are excreted unchanged, 
whereas analgesics and anti-inflammatory drugs are extensively metabolised (Monteiro and 
Boxall, 2010). 
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Figure 3 
Metabolic approach to increase the polarity and excretability of drugs. (Adapted from Daughton and Ternes,1999) 
 
In addition to phase I and II detoxification processes, there are also "phase 0 and III" 
processes found to occur in fish (Sturm et al., 2005). Proteins belonging to "phase 0" act as a 
cellular first line of defence by preventing the up-take of compounds by the cell (Glavinas et 
al., 2004; Xia et al., 2007; Szakacs et al., 2008). Multidrug resistance proteins (ABC 
transporters) are of high significance in this process. They form a barrier against drug, 
metabolites and toxicant up-take, and play an important role in distribution and excretion of a 
wide variety of compounds (Brinkmann and Eichelbaum, 2001). In addition, they are 
responsible for the efflux of metabolites, and are therefore, referred to the "phase III" 
detoxification system (Xu et al., 2005; Szakacs et al., 2008; Zaja et al., 2008; Loncar et al., 
2010). However, the action of this detoxification system can be inhibited by certain 
substances such as verapamil that directly binds to the active site of the transporter 
(Caminada et al., 2008; Zaja et al., 2008). This can increase the toxicity of a number of drugs 
as they can not be readily removed from the exposed organism and therefore the exposure 
time is increased. 
 
1.1.4.1 CYPA3  
During the evolution of eukaryotic cells, mechanisms have emerged serving to protect 
animals and also plants against chemicals. The cytochrome family enzyme group (CYPs) is 
a part of this protective mechanism system, representing an important class of phase-I 
enzymes. CYPs are intracellular type III membrane proteins which activate molecular oxygen 
to metabolize a great variety of organic chemicals. They can be found in most organisms, 
organs and tissues such as liver, kidney, breast, prostate, skin, gonads, placenta, brain, lung, 
spleen, pancreas and gastro-intestinal tract. In fish, the site of the major expression is the 
liver and kidney (Stegeman, 1989; Buhler and Wang-Buhler, 1998).  
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In our research (Chapter 2) we focus on the isoenzyme CYP3A. The CYP3A family forms the 
largest subfamily of CYPs found in the liver and small intestine (Hegelund and Celander, 
2003; Lee and Buhler, 2003; Nallani et al., 2004), and plays an important role in the 
metabolism of endogenous substances and xenobiotics. Several drug-drug interactions are 
associated with the induction of this enzyme (Tseng et al., 2005). CYP3A is not only common 
to mammals, but it can also be found in several fish species; e.g. rainbow trout CYP3A27 
and CYP3A45 (Lee et al., 1993; Lee and Buhler, 2003), medaka CYP3A38 (Kullman et al., 
2000) and CYP3A40 (Kullman and Hinton, 2001), killifish CYP3A30 and CYP3A56 (McArthur 
et al., 2003), Danio rerio CYP3A65 (Tseng et al., 2005) and fathead minnow CYP3A126 
(Christen et al., 2010b).  
 
There are remarkable species differences in the response of CYP3A to xenobiotics 
(Roymans et al., 2004). Rifampicin for example is a strong inducer of the human CYP3A4, 
but not in mice, whereas pregnenolone 16α-carbonitrile (PCN) is a strong activator of the 
murine CYP3A, but not in humans (Vignati et al., 2004). Zebrafish seem to elicit the same 
response as in mice. It was shown that PCN is also an inducer of CYP3A65 in zebrafish liver 
(Bresolin et al., 2005). In the same study it was shown that nifedipine and clotrimazole were 
not able to induce CYP3A65 in vivo. However, these compounds induced CYP3A in vitro 
(Moore et al., 2000). Additionally, rifampicin and dexamethasone, which are known human 
CYP3A inducers, also induce CYP3A activity in grass carp (Li et al., 2008). However, in 
zebrafish only rifampicin is a CYP3A inducer, whereas dexamethasone is an inhibitor (Tseng 
et al., 2005). In carp, CYP3A activity was significantly inhibited by antidepressant drugs such 
as paroxetine, fluvoxamine, and fluoxetine (Thibaut et al., 2006). These compounds are also 
well-known inhibitors of human CYP3A4 (Tredger and Stoll, 2002). In addition, significant 
inhibition of carp CYP3A was shown for gemfibrozil, clofibrate and diclofenac (Thibaut et al., 
2006). The antifungal agents ketoconazole, miconazole, and clotrimazole, and EE2 inhibited 
CYP3A-catalyzed activities in different fish species (Miranda et al., 1998; Hegelund et al., 
2004; Hasselberg et al., 2005). Typical mammalian inducers are not able to induce CYP3A in 
the fish cell line PLHC-1 (Celander et al., 1996). Due to this fact, extrapolation from 
mammals to other vertebrates such as fish is not always possible in this respect. 
 
1.2 Pharmaceuticals  
The high consumption of pharmaceuticals, especially in industrialized countries, has led to 
contamination in the environment. There are more than 4000 pharmaceuticals with different 
physico-chemical and biological properties and different modes of action (Beausse, 2004). It 
was estimated that the annual global consumption of drugs by humans is around 100,000 
tons (Ternes, 2006). In Europe approximately 3000 different pharmaceuticals are commonly 
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used. Among them are painkillers, antibiotics, antidiabetics, beta blockers, contraceptives, 
lipid regulators, antidepressants, neuroreactive drugs and cytostatic agents. In 2008, most 
pharmaceuticals consumed in Switzerland belonged to the group of neuro-active compounds 
(16.8%) and around 9% of totally consumed pharmaceuticals were cancer drugs (Figure 4). 
As a consequence, a mixture of pharmaceuticals and their metabolites will enter the STPs. 
Depending on their water solubility, polarity and persistence, pharmaceuticals may not be 
completely eliminated or transformed, and occur in the aquatic environment (Corcoran et al., 
2010). More than 100 different pharmaceuticals have been reported in the high ng/L and low 
μg/L range in STP effluents (Halling-Sorensen, 1998; Daughton and Ternes, 1999; Fent et 
al., 2006). In surface waters, pharmaceuticals rarely exceed concentrations of 100 ng/L 
(Trudeau et al., 2005). In addition, certain pharmaceuticals were detected in the low ng/L 
range in oceans (Weigel et al., 2004), groundwater (Corcoran et al., 2010) and even in 
drinking water (Bruce et al., 2010). Although these concentrations are low, pharmaceuticals 
may pose a risk to aquatic organisms as they were designed to elicit specific biological 
effects at low concentrations. As aquatic organisms are continuously exposed to 
pharmaceuticals, there is a risk for uptake via dermal and gill surfaces, orally through diet, or 
maternally via lipid reserve of eggs (Erickson et al., 2008). Therefore, there is a potential of 
unintended side effects on non-target organisms in the aquatic and terrestrial environment 
(Daughton and Ternes, 1999; Fent et al., 2006; Monteiro and Boxall, 2010).  
 
Several pharmaceuticals are known to induce such effects. A prominent example is the 
synthetic oestrogen 17α-ethynylestradiol (EE2), which is extremely potent in fish. It was 
shown to induce feminisation in fish at environmentally relevant concentrations, including 
induction of vitellogenin in males (Scholz et al., 2004), formation of female reproductive duct 
in testis (Jobling et al., 1998), and induction of inter-sex (Jobling et al., 1998; Länge et al., 
2001; Shved et al., 2008). Additionally to this drug class, there are nonsteroidal anti-
inflammatory drugs (NSAIDS), which are known to affect reproduction in fish. For instance 
indomethacin disrupts the process of oocyte maturation and ovulation in zebrafish (Lister and 
Van Der Kraak, 2008), and ibuprofen is able to alter the spawning pattern in medaka (Flippin 
et al., 2007). Furthermore, lipid lowering agents may also interfere with fertility (Runnalls et 
al., 2007). Although various effects of pharmaceuticals have been documented, evidence of 
these effects on the biochemical and molecular level, as well as on populations is as yet 
missing. However, the decline of vulture populations in the Indian subcontinent is the result 
of the exposure to the anti-inflammatory drug diclofenac (Oaks et al., 2004). 
 
In addition to these effects, bioaccumulation and persistence of pharmaceuticals is also of 
concern (Corcoran et al., 2010). Furthermore, pharmaceuticals are often released as 
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complex mixtures in the environment. The combined effects of these are largely unknown 
(Tixier et al., 2003; Stackelberg et al., 2004), but additive interactions are demonstrated in 
vitro (Fent et al., 2006). Addressing the lack of knowledge concerning the effects of 
pharmaceuticals and the ecotoxicological risks associated with their environmental 
occurrence, this thesis focuses on selected pharmaceuticals. 
 
Figure 4  
Distribution of pharmaceuticals on the Swiss market in 2008. The main group used in Switzerland belongs to 
pharmaceuticals against diseases in the central nervous system followed by pharmaceuticals against 
cardiovascular diseases (source: IMS Health GmbH, Hergiswil). 
 
Our studies mainly focus on two different pharmaceuticals belonging to different compound 
classes. In a first study (Chapter 3), the effects of diazepam on the gene expression pattern 
of adult zebrafish and zebrafish eleuthero-embryo were investigated. This neuro-active 
compound was chosen because of its high usage, its occurrence in the environment and the 
need for more complete effect data for its risk assessment (Straub, 2008). Although 
diazepam is an "old" compound (admission to the market in 1963), there is still the need for 
more knowledge about its effects on non-target species such as fish.  
 
In a second study (Chapter 4), the effects of a novel antineoplastic drug, midostaurin 
(PKC412), on the gene expression pattern of zebrafish eleuthero-embryos were investigated. 
Additionally, we searched for correlations between altered gene expressions and effects on 
the physiological level. This anti-cancer agent that will be on the market only in the future 
was chosen because of its high biological activity and unknown environmental risks. The 
ecotoxicological analysis prior to its introduction into the environment allows a prospective 
risk analysis. 
Central nervous system (16.8%)
Cardiovascular diseases (14.6%)
Infections (10.9%)
Cancer (9%)
Gastrointestinal diseases (8%)
Musculoskeletal disorders (6.6%)
Respiratory diseases (6.5%)
Haematopoiesis (5.1%)
Urogenital system (4.6%)
Skin (3.7%)
Other (14.2%)
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1.2.1 γ-Aminobutyric acid (GABA) signalling: Diazepam 
Diazepam is the active ingredient of Valium® and belongs to the benzodiazepine group, 
which has a widespread application in human medicine (Jouvel et al., 2000). It has anxiolytic, 
sedative, muscle-relaxant, anti-convulsive and anti-epileptic properties (Shader and 
Greenblatt, 1977). Due to its high use and incomplete degradation, concentrations of up to 
0.66 µg/L (van der Hoeven, 2004) were detected in effluents of sewage treatment plants. In 
surface water, concentrations ranged from 0.04 µg/L in Germany (Ternes, 1998) to 0.66 µg/L 
in Belgium (van der Ven et al., 2004). Acute toxicity and additional data are reported (Straub, 
2008). However, it remains unknown whether environmental exposures lead to negative 
effects on aquatic life. Therefore, there is a need to analyze for effects at more 
environmentally realistic concentrations, which is done in this thesis. 
 
Benzodiazepines act through binding to the GABAA receptor resulting in central nervous 
system (CNS) depression. The GABAA receptor consists of five subunits (Carr and 
Chambers, 2001). Binding of benzodiazepines, barbiturates and neuroactive steroids to the 
GABA receptor potentiates GABA action, which results in depression of the CNS. As in 
mammals, three subtypes of GABA target receptors (GABAA, GABAB and GABAC) occur in 
fish, and the binding site for benzodiazepines in the brain is suggested to be highly 
conserved between fish and mammals (Carr and Chambers, 2001). In non-target species 
acute diazepam toxicity lies in the high mg/L range, whereas chronic toxicity is in the low 
mg/L range (Straub, 2008). The measured "no observed effect concentration" (NOEC) of 
diazepam in early life stage tests with D. rerio was found to be 273 μg/L, and the "lowest 
observed effect concentration" (LOEC) was 2.57 mg/L (Straub, 2008). Exposure of fish to 
diazepam may impair locomotion (Zhdanova et al., 2001; Nunes et al., 2008), affect vision 
(Salas et al., 1992) and can produce anxiolytic effects at concentrations ranging from 1.25 to 
5 mg/L, doses that do not cause sedation in fish (Bencan et al., 2009). Nevertheless, there is 
a lack of chronic environmental toxicity studies with focus on the modes of action. 
Furthermore, more specific effects should be investigated as a proper ecological risk 
assessment of diazepam at environmentally realistic concentrations in aquatic organisms is 
missing. 
 
1.2.2 Protein kinase C inhibition: Midostaurin (PKC412) 
Midostaurin (PKC412) is a member of the family of indolocarbazoles and a selective inhibitor 
of several isoforms of protein kinase C (PKC) in humans. PKC412 has a broad kinase 
inhibition spectrum and is therefore not very selective, even at high affinity interaction (Kd < 
100 nM; (Karaman et al., 2008). It is a sugar ring variant of staurosporine, which was 
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originally isolated from Streptomyces staurosporeus (Takahashi et al., 1989). PKC412 is able 
to inhibit a large variety of tyrosine kinases including FLT3 (FMS-like tyrosine kinase), PDGF 
(platelet derived growth factor) receptors and c-kit (stem cell factor) receptor (Fabbro et al., 
2000). PKC412 has been developed as a therapeutic agent against acute myeloid leukaemia 
(AML), because of its ability to inhibit growth, angiogenesis and P-glycoprotein mediated 
multidrug resistance in tumour cells. In addition, PKC412 also affects other cellular 
processes such as immune responses or neuronal functions, such as human T-cell 
activation, proliferation and TNFα production (Si et al., 2005). 
 
Since Midostaurin is in clinical phase III and not yet on the market, there are very few data 
available about its toxicity in aquatic organisms. In non-target species the acute and the 
chronic PKC412 toxicity lies in the lower μg/L range; exposure of zebrafish larvae to 100 nM 
(57 μg/L) PKC412 has resulted in a curved body axis (Chan et al., 2002). The measured "no 
observed effect concentration" (NOEC) of PKC412 in early life stage tests with D. rerio was 
14 μg/L, and the "lowest observed effect concentration" (LOEC) was 43 μg/L (Novartis 
Pharma AG, internal data). The 96h-LC50 in D. rerio was 25 μg/L and the NOEC was 19 μg/L 
(Novartis Pharma AG, internal data). The predicted environmental concentration (PEC) is 
estimated in the range of 1.5 μg/L (Novartis Pharma AG, internal data).  
 
Nevertheless, there is a lack of chronic environmental toxicity studies with focus on the 
modes of action on this pharmaceutical. Furthermore, ecological risk assessments of 
PKC412 at environmentally realistic concentrations in aquatic organisms are lacking. 
 
1.3 Personal care products 
Personal care products (PCPs) are substances mainly used to maintain hygiene and 
general-well being. They include fragrances (i.e. synthetic musks), cosmetics (i.e. skin-care 
cream, lotions, powders, perfumes, lipsticks, nail polish, make-up, hair dyes, hair sprays and 
gel, shampoos deodorants, etc.) sunscreens (UV-filters) and protective products such as 
insect repellents (DEET) and antimicrobials (e.g. triclosan).  
 
There is a high consumption of PCPs in our daily life; e.g in 2000, the annual use of the 
synthetic musk galaxolide (HHCB) was 1473 t in Europe (Berset et al., 2004). These 
products can be released directly into recreational waters or volatilized into the air (e.g. 
musks). Thus they were also found in the environment. HHCB was detected in water at 
concentrations up to 5 μg/L in Germany (Bester, 2005) and up 6.9 μg/L in Switzerland 
(Berset et al., 2004). In addition, ingredients of sunscreens were detected at high levels in 
the aquatic environment (Balmer et al., 2005; Zwiener et al., 2007; Rodil and Moeder, 2008). 
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As a result, aquatic organisms are continuously exposed to them and possibly negatively 
affected. It was shown that commonly used fragrances such as tonalide (AHTN) and HHCB 
are not only oestrogenic (Seinen et al., 1999; Schreurs et al., 2002), but also elicit acute 
toxicity in some aquatic organisms at environmentally relevant concentrations (Breitholtz et 
al., 2003; Gooding et al., 2006). HC Orange No.1, a colour additive, was shown to 
bioaccumulate in goldfish (Sun et al., 2006). The effects of fragrances, in particular synthetic 
musks, and UV-filters, in particular EHMC, were described in detail in the following chapters 
(1.3.1 and 1.3.2).  
 
1.3.1 Fragrances: Synthetic musks 
Synthetic musks are widely used as inexpensive fragrances in personal care products. They 
are structurally similar chemicals which mimic the odour of the expensive, natural Asian 
musk deer and include synthetic nitro musks (e.g. musk ketone, musk xylene etc.) and 
synthetic polycyclic musks (indane and tetraline derivatives). These artificial musks do not 
occur naturally and there is no structural similarity to natural musk compounds. Nowadays, 
mostly polycyclic musks were used as nitro musks are known to be persistent and to induce 
adverse effects (Tas et al., 1997; Chou and Dietrich, 1999). Polycyclic musks are used in 
almost all consumer products, such as perfumes, cosmetics, soaps, shampoos, laundry 
detergents, fabric softeners, household cleaners, air fresheners, and other household 
products. Used in high amounts (tons per year), they are ubiquitous pollutants in aquatic 
environments and have received increasing attention (Rimkus and Wolf, 1996; Kafferlein et 
al., 1998). Although of low toxicity, their persistence and ability to bioaccumulate have raised 
concerns about them as environmental pollutants and also for human health. 
 
Polycyclic musks such as HHCB and AHTN were found in fish in Italy (Draisci et al., 1998) 
and at different sampling sites in Germany (Winkler et al., 1998; Heberer et al., 1999). In 
addition, they were already detected in the 90s in the river Glatt in Switzerland (Muller et al., 
1996) and also recently at different sampling sites in South Korea (Lee et al., 2010). HHCB 
and AHTN bioconcentrate in aquatic biota (Rimkus, 1999) and have been measured in 
human blood (Hutter et al., 2005), adipose tissue (Rimkus and Wolf, 1996), and breast milk 
(Reiner et al., 2007)). Due to the fact that synthetic musks are small compounds, they are 
also able to inhibit ABC transporters in aquatic organisms. Musk ketone, musk xylene, HHCB 
and AHTN were able to inhibit multixenobiotic resistance (MXR) transporter activity in the 
California mussel (Mytilus californianus) (Smital et al., 2004). As a consequence, synthetic 
musks may enhance the toxicity of other MXR substrates and the may accumulate in cells. 
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1.3.2 UV-filters: EHMC 
UV-filters are organic or inorganic ingredients of personal care products whose purpose is to 
filter UV-A and/or UV-B radiation from sunlight in order to protect the human skin from their 
negative effects. UV-filters are increasingly used not only in sunscreen but also in other 
products used daily e.g. cosmetics, body lotion, hair spray, shampoos etc, as well (Balmer et 
al., 2005; Fent et al., 2010). As a result of their various applications, UV-filters may enter the 
aquatic environment either directly via wash-off from skin and clothes or via effluents of STPs 
or swimming pool waters, where rather high levels of different UV-filters were measured 
(Balmer et al., 2005; Zwiener et al., 2007; Rodil and Moeder, 2008). They enter the 
environment either directly or indirectly via wastewater. Further sources of UV-filter residues 
are landfill leachates as well as deposition from building components which are protected 
with coatings (Plagellat et al., 2006). 
 
Many organic UV-filters are lipophilic and photostable. Therefore, they are relatively stable in 
the aquatic environment and maintain the potential of adsorbing into sewage sludge 
(Plagellat et al., 2006). Additionally, they bioaccumulate in fish (Buser et al., 2006; Fent et al., 
2010) and in human breast milk (Schlumpf et al., 2008). Some UV-filters interfere with the 
sex-hormone system and act therefore as endocrine disruptors. Since significant amounts of 
these chemicals are used today, there are major concerns and needs for a better 
understanding of effects on fish and also of their mode of action. For some UV-filters 
hormonal activity was documented in vitro as well as in vivo (Schlumpf et al., 2001; Schlumpf 
et al., 2004; Gomez et al., 2005; Kunz and Fent, 2006b). Organic UV-filters demonstrated 
oestrogenic activity and adverse effects on fertility and reproduction in fish (Kunz et al., 
2006a; Kunz et al., 2006b; Weisbrod et al., 2007). In previous studies 3-benzylidene 
camphor (3-BC), benzophenone-1 (BP-1) and BP-2 led to vitellogenin (Vtg) induction in 
juvenile fathead minnows (Kunz and Fent, 2006b) and benzophenone-3 (BP-3) in medaka 
(Coronado et al., 2008). Vtg induction has been reported for 3-BC in rainbow trout (Holbech 
et al., 2002), and for 4-methyl-benzylidene camphor (4-MBC) and 2-ethyl-hexyl-4-
trimethoxycinnamate (EHMC) at high concentrations in male medaka (Inui et al., 2003).  
 
In this thesis we are mainly interested in the UV-filter EHMC as it is one of the most widely 
used UV-filters in sunscreens (see Chapter 5 and 6). The environmental concentrations of 
EHMC range between 0.01-0.1 µg/L in treated wastewater and up to 19 µg/L in untreated 
municipal wastewater (Balmer et al., 2005). EHMC residues were detected in lakes and 
rivers (Balmer et al., 2005; Fent et al., 2010), and in coastal seawater up to 390 ng/L 
(Langford and Thomas, 2008). This compound was also found at levels of 0.26 to 5.61 μg/L 
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in raw drinking water (Loraine and Pettigrove, 2006), and unexpectedly, even at very remote 
environments such as the Pacific Ocean (Polynesia) (Goksoyr et al., 2009).  
 
EHMC is lipophilic (logP = 5.66; Zenker et al., 2008) and accumulates in aquatic biota (Fent 
et al., 2010). It was found in different trophic levels and tends to bioconcentrate along the 
food-chain (Figure 5). 
Figure 5   
Box-whisker plots of UV-filters residues of EHMC aggregated for three trophic levels (cormorants, fish, 
MZB=macrozoobenthos). ○ = outlier (according to Fent et al., 2010) 
 
Despite its widespread presence in the environment, little is known about the potential risk 
posed by EHMC to aquatic life. In recombinant yeast systems EHMC showed anti-
oestrogenic and antiandrogenic with weak androgenic activity in vitro (Kunz and Fent, 
2006a). Injection of high concentrations of EHMC in male medaka led to induction of Vtg 
(Inui et al., 2003), while no Vtg induction was observed in juvenile fathead minnows exposed 
to lower aqueous concentrations (Kunz and Fent, 2006a). These few studies are not 
conclusive and the potential oestrogenic activity of EHMC in fish needs further investigation. 
Moreover, the modes of action on the hormone system remain to be investigated. 
 
1.4 Small fish models 
Fish find frequent application as model organisms in aquatic toxicology. Small fish species 
commonly used in ecotoxicology are zebrafish (Danio rerio), fathead minnow (Pimephales 
promelas) and Japanese medaka (Oryzias latipes).  
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1.4.1 Zebrafish (Danio rerio) 
Danio rerio (Figure 6) is a small tropical fresh-water fish, which is native to rivers of northern 
India, northern Pakistan, Nepal and Bhutan. It not only is a common aquarium fish, but also 
an interesting model organism in biology. Danio rerio is the most popular model organism in 
embryonic development and often studied in (eco)toxicology (Raldua and Babin, 2007; 
Liedtke et al., 2008; Mehta et al., 2008).  
 
 
Figure 6   
Adult female zebrafish. The characteristic stripes running along the fins gave this species its name. Adult 
zebrafish are only about 3-5 cm in length. (Photo by S. Tinguely) 
 
The unique features of Danio rerio are the short generation time, the large number of 
offspring and the transparency of embryos. Therefore, it is easy to conduct toxicological 
studies over the whole reproduction cycle. The basic body plan is already established in 
zebrafish embryos after 24 hours post fertilisation (hpf) and they hatch approximately after 2-
3 days post fertilisation (dpf) (Figure 7). 
 
At 5 dpf organogenesis of major organs is completed (Rubinstein, 2003). The transparency 
of the chorion eases the observation of different developmental stages (Kimmel et al., 1995). 
Zebrafish are already mature at the age of 3 months. Having such a short reproduction cycle, 
female zebrafish can lay more than a hundred eggs per day, even under laboratory 
conditions. This facilitates the use of zebrafish embryos for ecotoxicological research. 
 
The sequencing of the zebrafish genome (http://zfin.org/) is highly promoted and places this 
freshwater fish in a privileged position for toxicogenomic studies. Due to genetic similarities 
to vertebrates, the zebrafish is also used as a model for human diseases and development, 
to name just a few fields.  
 
Experiments with embryos are considered as alternatives to (adult) animal experiments due 
to animal welfare reasons. The embryo model is a complex, multicellular system, which 
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integrates interactions of various tissues and differentiation processes. This is an advantage 
over all other available systems. 
 
(A) (B) 
 
Figure 7   
Zebrafish eleuthero-embryo. (A) 48 hpf. (B) 72 hpf. 
 
A number of permanent cell lines from Danio rerio have been established. ZFL (Figure 8, 
liver cell line, (Ghosh et al., 1994), ZF4 cell line (24 hpf embryo), ZF13 and ZF 29 (fibroblast 
like cell line, (Collodi et al., 1992) and ZEM2 cell lines (from blastula stage embryo, (Ghosh 
and Collodi, 1994) are only some of the used cell lines for research. These laboratory cell 
lines are able to conserve some of their original in vivo tissue-specific gene expression, even 
though adapted to experimental culture (Ross et al., 2000). Due to the availability of such cell 
lines, it is possible to conduct large scale genomic analysis of drug-induced changes in 
mRNA expression levels of environmentally relevant pharmaceuticals in a hepatic in vitro 
system (Pomati et al., 2007). 
 
 
Figure 8   
Cell morphology of zebrafish liver cell line (ZFL) 
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1.5 Toxicogenomics 
Toxic effects of chemicals can lead to alterations of processes on molecular levels, e.g. gene 
expression, protein expression or metabolomic profiles. Up to now, standard toxicity tests 
provide little information about possible modes of action. The new field of toxicogenomics 
includes transcriptomics (gene expression), proteomics (protein expression) and 
metabolomics (metabolic profile). These novel methods allow a system-wide analysis of 
effects caused by chemical exposure. The advantage of toxicogenomics is that it uses the 
changes in gene and protein expression to detect subtle molecular-level changes in 
organisms that may precede toxic effects or propagate to higher level effects. Additionally, it 
can provide information about molecular changes in an organism before obvious 
manifestations of toxicity are present. Furthermore, microarrays allow studying of different 
endpoints in a single assay and it is possible to obtain characteristic patterns of gene 
expression that may allow identifying the toxic potential. As toxicogenomics has the potential 
to serve as a powerful tool to detect molecular effects and new biomarkers, we focus in this 
thesis on transcriptomics. 
 
1.5.1 Transcriptomics 
Thus far, Northern Blot, in situ hybridisation and quantitative RT-PCR allowed monitoring of 
only a small set of selected genes. In contrast, DNA microarray technologies allow screening 
for a large set of differentially expressed genes. Additionally, they can detect changes in 
gene expression before physiological changes e.g. behaviour, tissue damage, reproduction 
etc. can occur. Therefore, it is a tool for obtaining an early indication of a toxic response. 
 
DNA microarrays basically comprise a glass slide where oligonucleotides were spotted (e.g. 
Agilent, Affymetrix). Depending on the brand, the oligonucleotides consist of 25 bases 
(Affymetrix) or 60 bases (Agilent). The oligonucleotides are either synthesized by 
photolithographic procedures (Affymetrix) or ink-jet principles as used by Agilent. Each gene 
is then represented by different oligonucleotide fragments, which are attached on the glass 
slide on a tiny section (Figure 9). 
 
The principle behind microarrays is the hybridisation between the oligonucleotides on the 
chip and cRNA in the samples. The isolated mRNA is reversed transcribed into cDNA and 
then converted into double stranded cDNA. Thereafter, the cDNA is converted to cRNA using 
fluorescently labelled nucleotides. The labelled cRNA is then hybridised to the microarray. 
Unbound cRNA is washed off and the slides are scanned to obtain the appropriate signal 
intensities. 
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The use of cRNA instead of cDNA has two advantages. Firstly, RNA to DNA hybridisation 
has a higher sensitivity than DNA to DNA. Secondly, the isolated mRNA will be multiplied 
during the conversion from DNA to cRNA, which leads to the detection of signals that are 
based on a very low number of expressed mRNA. 
 
Using Agilent microarrays there is also the possibility of performing one-colour or two-colour 
experiments. In one-colour experiments all probes are labelled with the same fluorescent dye 
and hybridised on separate slides. In contrast, performing two-colour experiments control 
and treated samples are labelled with different dyes and hybridised on the same slide. In this 
thesis we performed one-colour experiments using Agilent 4x44K zebrafish microarray.  
 
(A) (B) 
 
Figure 9  
Basic construction of an Affymetrix chip. (A) Features of a microarray. Each chip consists of 6.5 mio locations 
which were built up by millions of DNA strands. One DNA strand is 25 base pairs in length. (B) Hybridisation and 
detection (source: Affymetrix homepage http://www.affymetrix.com) 
 
Although this method allows the investigation of thousands of gene expression changes, 
there are some major concerns about the toxicological significance. From mRNA level to the 
protein level, several modification processes can take place, not always leading to changes 
in the protein expression. Therefore, effects on gene expression should always be correlated 
to effects on protein level, behavioural changes, physiological effects etc. to validate the 
toxicological relevance.  
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1.5.2 Ecotoxicogenomics 
In response to exposure to PPCPs, changes in gene expression occur and altered patterns 
of mRNA expression can be analyzed by microarrays. Ecotoxicogenomics allows us to 
obtain a better understanding of toxicological mechanisms and to identify gene expression 
patterns that are representative of adverse outcomes (Neumann and Galvez, 2002; Snell et 
al., 2003; Coverdale et al., 2004). 
 
In this study we used the ecotoxicogenomic approach to investigate the possible mode of 
action of some selected PPCPs, and to link these gene expression changes with 
physiological changes. Additionally we wanted to elucidate whether gene expression 
changes at low, environmentally realistic concentrations are a sensitive endpoint, and 
whether they can thus serve as early warnings of effects on the organism level. 
 
1.6 Research goals 
The aim of this thesis is to determine and assess effects and possible modes of action of 
selected human pharmaceuticals in in vitro systems with different fish cell lines (CYP3A, 
Chapter 2). Environmentally important PPCPs with interesting mode of actions, and of which 
only little is known about effects on aquatic organisms are focused on in this thesis. Two 
selected pharmaceuticals and the UV-filter EHMC were investigated in vivo in different 
developmental stages of zebrafish (Chapter 3 -5). The following research goals are thereby 
highlighted: 
 
Optimisation. CYP3A alteration can serve as a biomarker of xenobiotic exposure. There are 
many microsome-based assays available to measure its enzyme activity in vitro and in vivo. 
However, these assays are quite time-consuming, as microsomes have to be initially 
prepared. Therefore, one goal of this thesis is to optimise an already available human whole 
cell assay for its use in fish. CYP3A enzyme activity was determined using the human 
CYP3A substrate 7-benzyloxy-4-trifluoromethylcoumarin (BFC) which is metabolized into a 
fluorescent product measurable by a plate reader (Chapter 2). 
 
Investigation. External influences such as exposure to PPCPs can alter gene expression 
profiles in different developmental stages of organisms. These alterations can be measured 
using Agilent zebrafish whole genome oligonucleotide microarrays and qRT-PCR analysis. 
Therefore, we investigated the effects of diazepam (Chapter 3), PKC412 (Chapter 4) and 
EHMC (Chapter 5) on the gene expression to study their modes of action. 
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Validation. PPCPs mainly occur in the environment in the higher ng/L and lower μg/L range. 
As adverse effects at environmentally relevant concentrations are of concern, an additional 
goal of this thesis is to validate these effects on gene expression. Therefore, all studies were 
also conducted at low concentrations (Chapter 3-5). 
 
Linkage and analysis. Alterations in gene expression do not always result in physiological 
effects. As there are many modification steps on the route from the gene to the protein, gene 
expression changes do not often result in protein alterations. Therefore, gene expression 
changes should be always linked to physiological and morphological parameters (Chapter 3, 
4). To obtain these linkages, we performed additional experiments on several parameters 
including locomotor activity, gonad histology, angiogenesis, apoptosis, DNA damage and 
formation of reactive oxygen species. 
 
Through this approach the hypothesis was tested that changes in gene expression may be 
more sensitive than behavioural, histological or other toxicological effects. Additionally, we 
addressed the question of whether gene expression changes propagate to toxico-
physiological relevant measures such as development, behaviour (reduction of the ability to 
find food or to escape from predators), fertility and reproduction. 
 
1.7 Outline of the thesis 
The thesis is presented in 6 chapters, whereof chapter 2 to 5 contain the results obtained in 
different studies during this thesis. 
 
Chapter 1: General introduction 
In this chapter a general introduction to the topic and the thesis is given. 
 
Chapter 2: A microtitre-plate based cytochrome P450 3A activity assay in fish cell 
lines 
Alteration of CYP3A expression and activity in organisms can be an indication for exposure 
to xenobiotics. Therefore, these changes may serve as a biomarker of xenobiotic exposure. 
As no assays exist for measuring CYP3A activity in fish cells, we improved an existing 
human whole cell assay for its use in fish. This fluorescent CYP3A high-throughput assay 
uses 7-benzyloxy-4-trifluoromethylcoumarin (BFC) as a substrate, which is then metabolized 
into a fluorescent product and can be measured. We show that this assay is suitable to 
analyse for induction as well as inhibition of CYP3A caused by pharmaceuticals. 
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Chapter 3: Effects of diazepam on gene expression and link to physiological effects in 
different life stages in zebrafish Danio rerio  
In this chapter we investigate the molecular effects of diazepam and identify its neurotoxic 
mode of action using an Agilent 4x44K zebrafish microarray. Additionally, alteration of gene 
expression of selected genes is analyzed in zebrafish larvae using qRT-PCR. In a second 
set of experiments behavioural studies are performed to analyze for any correlation between 
altered gene expressions and effects on the organism level. Furthermore, testis histology is 
conducted to link the down-regulation of hsd17b3 with effects on spermatogenesis.  
 
Chapter 4: Effects of the protein kinase inhibitor PKC412 on gene expression and link 
to physiological effects in zebrafish Danio rerio eleuthero-embryos 
To identify molecular effects of the novel antineoplastic agent PKC412 (midostaurin), we 
applied Agilent 4x44K zebrafish microarray. Subsequently behaviour and physiological 
effects were investigated in order to analyze for correlations between altered gene-
expression and effects on the organism level. Thereby, the locomotor activity, effects on 
vascular development, appearance of apoptotic cells, DNA damage and formation of reactive 
oxygen species were investigated. 
 
Chapter 5: Global gene expression profile induced by the UV-filter 2-ethyl-hexyl-4-
trimethoxycinnamate (EHMC) in zebrafish (Danio rerio) 
The lipophilic UV-filter 2-ethyl-hexyl-4-trimethoxycinnamate (EHMC) belongs to one of the 
most frequently used UV-filter in sunscreens, and accumulates in the aquatic food-chain. 
Despite its ubiquitous presence in water and biota, very little is known about its potential 
hormonal effects on aquatic organisms. Gene expression patterns of liver, testis and brain 
were investigated using Agilent 4x44K zebrafish microarrays. These changes were then 
analysed for linking gene expression to hormonal effects in order to investigate oestrogenic / 
antiestrogenic or androgenic / antiandrogenic activities. 
 
Chapter 6: General discussion and conclusion 
In the final chapter a general discussion is given, conclusions are drawn and an outlook is 
made. 
 
Chapter 1 
39 
1.8 References 
Balmer, M.E., Buser, H.R., Muller, M.D., and Poiger, T. (2005) Occurrence of some organic UV-filters in 
wastewater, in surface waters, and in fish from Swiss Lakes. Environ Sci Technol 39: 953-962. 
Beausse, J. (2004) Selected drugs in solid matrices: a review of environmental determination, occurrence and 
properties of principal substances. TrAC 23: 753-761. 
Bencan, Z., Sledge, D., and Levin, E.D. (2009) Buspirone, chlordiazepoxide and diazepam effects in a zebrafish 
model of anxiety. Pharmacol Biochem Behav 94: 75-80. 
Berset, J.D., Kupper, T., Etter, R., and Tarradellas, J. (2004) Considerations about the enantioselective 
transformation of polycyclic musks in wastewater, treated wastewater and sewage sludge and analysis 
of their fate in a sequencing batch reactor plant. Chemosphere 57: 987-996. 
Bester, K. (2005) Polycyclic musks in the Ruhr catchment area- transport, discharges of waste water, and 
transformations of HHCB, AHTN and HHCB-lactone. J Environ Monit 7: 43-51. 
Breitholtz, M., Wollenberger, L., and Dinan, L. (2003) Effects of four synthetic musks on the life cycle of the 
harpacticoid copepod Nitocra spinipes. Aquat Toxicol 63: 103-118. 
Bresolin, T., de Freitas Rebelo, M., and Celso Dias Bainy, A. (2005) Expression of PXR, CYP3A and MDR1 
genes in liver of zebrafish. Comp Biochem Physiol C Toxicol Pharmacol 140: 403-407. 
Brinkmann, U., and Eichelbaum, M. (2001) Polymorphisms in the ABC drug transporter gene MDR1. 
Pharmacogenomics J 1: 59-64. 
Brooks, B.W., Chambliss, C.K., Stanley, J.K., Ramirez, A., Banks, K.E., Johnson, R.D., and Lewis, R.J. (2005) 
Determination of selected antidepressants in fish from an effluent-dominated stream. Environ Toxicol 
Chem 24: 464-469. 
Bruce, G.M., Pleus, R.C., and Snyder, S.A. (2010) Toxicological relevance of pharmaceuticals in drinking water. 
Environ Sci Technol 44: 5619–5626. 
Buhler, D.R., and Wang-Buhler, J.-L. (1998) Rainbow trout cytochrome P450s: purification, molecular aspects, 
metabolic activity, induction and role in environmental monitoring. Comp Biochem Physiol C Toxicol 
Pharmacol 121: 107-137. 
Buser, H.-R., Poiger, T., and Müller, M.D. (1999) Occurrence and environmental behavior of the chiral 
pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33: 2529-2535. 
Buser, H.R., Balmer, M.E., Schmid, P., and Kohler, M. (2006) Occurrence of UV-filters 4-methylbenzylidene 
camphor and octocrylene in fish from various Swiss rivers with inputs from wastewater treatment plants. 
Environ Sci Technol 40: 1427-1431. 
Caminada, D., Zaja, R., Smital, T., and Fent, K. (2008) Human pharmaceuticals modulate P-gp1 (ABCB1) 
transport activity in the fish cell line PLHC-1. Aquat Toxicol 90: 214-222. 
Carr, R.L., and Chambers, J.E. (2001) Toxic responses of the nervous system. In Target organ toxicity in marine 
and freshwater teleosts. Schlenk, E., and Benson, W.H. (eds). London: Taylor and Francis, pp. 26-95. 
Celander, M., Hahn, M.E., and Stegeman, J.J. (1996) Cytochromes P450 (CYP) in the Poeciliopsis lucida 
hepatocellular carcinoma cell line (PLHC-1): dose- and time-dependent glucocorticoid potentiation of 
CYP1A induction without induction of CYP3A. Arch Biochem Biophys 329: 113-122. 
Chan, J., Bayliss, P.E., Wood, J.M., and Roberts, T.M. (2002) Dissection of angiogenic signaling in zebrafish 
using a chemical genetic approach. Cancer Cell 1: 257-267. 
Chou, Y.J., and Dietrich, D.R. (1999) Toxicity of nitromusks in early lifestages of South African clawed frog 
(Xenopus laevis) and zebrafish (Danio rerio). Toxicol Lett 111: 17-25. 
Christen, V., Hickmann, S., Rechenberg, B., and Fent, K. (2010a) Highly active human pharmaceuticals in 
aquatic systems: A concept for their identification based on their mode of action. Aquat Toxicol 96: 167-
181. 
General Introduction 
40 
Collodi, P., Kamei, Y., Ernst, T., Miranda, C., Buhler, D.R., and Barnes, D.W. (1992) Culture of cells from 
zebrafish (Brachydanio rerio) embryo and adult tissues. Cell Biol Toxicol 8: 43-61. 
Corcoran, J., Winter, M.J., and Tyler, C.R. (2010) Pharmaceuticals in the aquatic environment: a critical review of 
the evidence for health effects in fish. Crit Rev Toxicol 40: 287-304. 
Coronado, M., De Haro, H., Deng, X., Rempel, M.A., Lavado, R., and Schlenk, D. (2008) oestrogenic activity and 
reproductive effects of the UV-filter oxybenzone (2-hydroxy-4-methoxyphenyl-methanone) in fish. Aquat 
Toxicol 90: 182-187. 
Coverdale, L.E., Martyniuk, C.J., Trudeau, V.L., and Martin, C.C. (2004) Differential expression of the methyl-
cytosine binding protein 2 gene in embryonic and adult brain of zebrafish. Brain Res Dev Brain Res 153: 
281-287. 
Daughton, C.G., and Ternes, T.A. (1999) Pharmaceuticals and personal care products in the environment: agents 
of subtle change? Environ Health Perspect 107 Suppl 6: 907-938. 
Draisci, R., Marchiafava, C., Ferretti, E., Palleschi, L., Catellani, G., and Anastasio, A. (1998) Evaluation of musk 
contamination of freshwater fish in Italy by accelerated solvent extraction and gas chromatography with 
mass spectrometric detection. J Chromatogr A 814: 187-197. 
Erickson, R.J., Nichols, J.W., Cook, P.M., and Ankley, G.T. (2008) Bioavailability of chemical contaminants in 
aquatic systems. In The toxicology of fish. Di Guilio, R.T., and Hinton, D.E. (eds). New York: CRC Press, 
pp. 9-54. 
Fabbro, D., Ruetz, S., Bodis, S., Pruschy, M., Csermak, K., Man, A., Campochiaro, P., Wood, J., O'Reilly, T., and 
Meyer, T. (2000) PKC412- a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug 
Des 15: 17-28. 
Fent, K., Weston, A.A., and Caminada, D. (2006a) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76: 
122-159. 
Fent, K., Escher, C., and Caminada, D. (2006b) Oestrogenic activity of pharmaceuticals and pharmaceutical 
mixtures in a yeast reporter gene system. Reprod Toxicol 22: 175-185. 
Fent, K., Zenker, A., and Rapp, M. (2010) Widespread occurrence of oestrogenic UV-filters in aquatic ecosystems 
in Switzerland. Environ Pollut 158: 1817-1824. 
Flippin, J.L., Huggett, D., and Foran, C.M. (2007) Changes in the timing of reproduction following chronic 
exposure to ibuprofen in Japanese medaka, Oryzias latipes. Aquat Toxicol 81: 73-78. 
Ghosh, C., and Collodi, P. (1994) Culture of cells from zebrafish (Brachydanio rerio) blastula-stage embryos. 
Cytotechnology 14: 21-26. 
Ghosh, C., Zhou, Y.L., and Collodi, P. (1994) Derivation and characterization of a zebrafish liver cell line. Cell Biol 
Toxicol 10: 167-176. 
Glavinas, H., Krajcsi, P., Cserepes, J., and Sarkadi, B. (2004) The role of ABC transporters in drug resistance, 
metabolism and toxicity. Curr Drug Deliv 1: 27-42. 
Goksoyr, A., Tollefsen, K.E., Grung, M., Loken, K., Lie, E., Zenker, A., Fent, K., Schlabach, M., and Huber, S. 
(2009) Balsa raft crossing the Pacific finds low contaminant levels. Environ Sci Technol 43: 4783-4790. 
Gomez, E., Pillon, A., Fenet, H., Rosain, D., Duchesne, M.J., Nicolas, J.C., Balaguer, P., and Casellas, C. (2005) 
Oestrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks. J 
Toxicol Environ Health A 68: 239-251. 
Gooding, M.P., Newton, T.J., Bartsch, M.R., and Hornbuckle, K.C. (2006) Toxicity of synthetic musks to early life 
stages of the freshwater mussel Lampsilis cardium. Arch Environ Contam Toxicol 51: 549-558. 
Guengerich, F.P. (1992) Metabolic activation of carcinogens. Pharmacology & Therapeutics 54: 17-61. 
Gunnarsson, L., Jauhiainen, A., Kristiansson, E., Nerman, O., and Larsson, D.G. (2008) Evolutionary 
conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci 
Technol 42: 5807-5813. 
Chapter 1 
41 
Halling-Sorensen, B.N., S.N.; Lanzky, P.F.; Ingerslev, F.; Lutzhoft, H.C.H. and Jorgensen, S.E. (1998) 
Occurence, fate and effects of pharmaceutical substances in the environment- A review. Chemosphere 
36: 357-394. 
Hasselberg, L., Grosvik, B.E., Goksoyr, A., and Celander, M.C. (2005) Interactions between xenoestrogens and 
ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua). Comp Hepatol 4: 
2. 
Heberer, T., and Stan, H.-J. (1997) Determination of clofibric acid and N-(phenylsulfonyl)-sarcosine in sewage, 
river and drinking water. Int J Environ Anal Chem 67: 113 - 124. 
Heberer, T., Gramer, S., and Stan, H.-J. (1999) Occurrence and distribution of organic contaminants in the 
aquatic system in Berlin. Part III: Determination of synthetic musks in Berlin surface water applying solid-
phase microextraction (SPME) and gas chromatography-mass spectrometry (GC-MS). CLEAN 27: 150-
156. 
Hegelund, T., and Celander, M.C. (2003) Hepatic versus extrahepatic expression of CYP3A30 and CYP3A56 in 
adult killifish (Fundulus heteroclitus). Aquat Toxicol 64: 277-291. 
Hegelund, T., Ottosson, K., Radinger, M., Tomberg, P., and Celander, M.C. (2004) Effects of the antifungal 
imidazole ketoconazole on CYP1A and CYP3A in rainbow trout and killifish. Environ Toxicol Chem 23: 
1326-1334. 
Hogan, N.S., Currie, S., LeBlanc, S., Hewitt, L.M., and MacLatchy, D.L. (2010) Modulation of steroidogenesis and 
oestrogen signalling in the estuarine killifish (Fundulus heteroclitus) exposed to ethinylestradiol. Aquat 
Toxicol 98: 148-156. 
Holbech, H., Norum, U., Korsgaard, B., and Poul, B. (2002) The chemical UV-filter 3-benzylidene camphor 
causes an oestrogenic effect in an in vivo fish assay. Pharmacol Toxicol 91: 204-208. 
Hutter, H.P., Wallner, P., Moshammer, H., Hartl, W., Sattelberger, R., Lorbeer, G., and Kundi, M. (2005) Blood 
concentrations of polycyclic musks in healthy young adults. Chemosphere 59: 487-492. 
Inui, M., Adachi, T., Takenaka, S., Inui, H., Nakazawa, M., Ueda, M., Watanabe, H., Mori, C., Iguchi, T., and 
Miyatake, K. (2003) Effect of UV screens and preservatives on vitellogenin and choriogenin production in 
male medaka (Oryzias latipes). Toxicology 194: 43-50. 
Jobling, S., Nolan, M., Tyler, C.R., Brighty, G., and Sumpter, J.P. (1998) Widespread sexual disruption in wild 
fish. Environ Sci Technol 32: 2498-2506. 
Joss, A., Keller, E., Alder, A.C., Gobel, A., McArdell, C.S., Ternes, T., and Siegrist, H. (2005) Removal of 
pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39: 3139-3152. 
Joss, A., Zabczynski, S., Gobel, A., Hoffmann, B., Loffler, D., McArdell, C.S., Ternes, T.A., Thomsen, A., and 
Siegrist, H. (2006) Biological degradation of pharmaceuticals in municipal wastewater treatment: 
proposing a classification scheme. Water Res 40: 1686-1696. 
Jouvel, C., Maciejewski, P., Garcia, P., Bonnaire, Y., Horning, S., and Popot, M.A. (2000) Detection of diazepam 
in horse hair samples by mass spectrometric methods. Analyst 125: 1765-1769. 
Kafferlein, H.U., Goen, T., and Angerer, J. (1998) Musk xylene: analysis, occurrence, kinetics, and toxicology. Crit 
Rev Toxicol 28: 431-476. 
Karaman, M.W., Herrgard, S., Treiber, D.K., Gallant, P., Atteridge, C.E., Campbell, B.T., Chan, K.W., Ciceri, P., 
Davis, M.I., Edeen, P.T., Faraoni, R., Floyd, M., Hunt, J.P., Lockhart, D.J., Milanov, Z.V., Morrison, M.J., 
Pallares, G., Patel, H.K., Pritchard, S., Wodicka, L.M., and Zarrinkar, P.P. (2008) A quantitative analysis 
of kinase inhibitor selectivity. Nat Biotechnol 26: 127-132. 
Kennedy, C.J., Hochachka, P.W., and Mommsen, T.P. (1995) Chapter 15 Xenobiotics. In Biochemistry and 
Molecular Biology of Fishes: Elsevier, pp. 281-312. 
Khan, S.J., and Ongerth, J.E. (2002) Estimation of pharmaceutical residues in primary and secondary sewage 
sludge based on quantities of use and fugacity modelling. Water Sci Technol 46: 105-113. 
General Introduction 
42 
Kidd, K.A., Blanchfield, P.J., Mills, K.H., Palace, V.P., Evans, R.E., Lazorchak, J.M., and Flick, R.W. (2007) 
Collapse of a fish population after exposure to a synthetic oestrogen. Proc Natl Acad Sci U S A 104: 
8897-8901. 
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., and Schilling, T.F. (1995) Stages of embryonic 
development of the zebrafish. Dev Dyn 203: 253-310. 
Kinney, C.A., Furlong, E.T., Zaugg, S.D., Burkhard, M.R., Werner, S.L., Cahill, J.D., and Jorgensen, G.R. (2006) 
Survey of organic wastewater contaminants in biosolids destined for land application. Environ Sci 
Technol 40: 7207-7215. 
Kullman, S.W., and Hinton, D.E. (2001) Identification, characterization, and ontogeny of a second cytochrome 
P450 3A gene from the fresh water teleost medaka (Oryzias latipes). Mol Reprod Dev 58: 149-158. 
Kullman, S.W., Hamm, J.T., and Hinton, D.E. (2000) Identification and characterization of a cDNA encoding 
cytochrome P450 3A from the fresh water teleost medaka (Oryzias latipes). Arch Biochem Biophys 380: 
29-38. 
Kümmerer, K. (2008) Pharmaceuticals in the Environment - Sources, Fate, Effects and Risks Berlin, Heidelberg: 
Springer. 
Kunz, P.Y., and Fent, K. (2006a) Oestrogenic activity of UV-filter mixtures. Toxicol Appl Pharmacol 217: 86-99. 
Kunz, P.Y., and Fent, K. (2006b) Multiple hormonal activities of UV-filters and comparison of in vivo and in vitro 
oestrogenic activity of ethyl-4-aminobenzoate in fish. Aquat Toxicol 79: 305-324. 
Kunz, P.Y., Galicia, H.F., and Fent, K. (2006a) Comparison of in vitro and in vivo oestrogenic activity of UV-filters 
in fish. Toxicol Sci 90: 349-361. 
Kunz, P.Y., Gries, T., and Fent, K. (2006b) The ultraviolet filter 3-benzylidene camphor adversely affects 
reproduction in fathead minnow (Pimephales promelas). Toxicol Sci 93: 311-321. 
Kupper, T., Berset, J.D., Etter-Holzer, R., Furrer, R., and Tarradellas, J. (2004) Concentrations and specific loads 
of polycyclic musks in sewage sludge originating from a monitoring network in Switzerland. 
Chemosphere 54: 1111-1120. 
Länge, R., Hutchinson, T.H., Croudace, C.P., Siegmund, F., Schweinfurth, H., Hampe, P., Panter, G.H., and 
Sumpter, J.P. (2001a) Effects of the synthetic oestrogen 17alpha-ethinylestradiol on the life-cycle of the 
fathead minnow (Pimephales promelas). Environ Toxicol Chem 20: 1216-1227. 
Länge, R., Hutchinson, T.H., Croudace, C.P., Siegmund, F., Schweinfurth, H., Hampe, P., Panter, G.H., and 
Sumpter, J.P. (2001b) Effects of the synthetic oestrogen 17α-ethinylestradiol on the life-cycle of the 
fathead minnow (Pimephales promelas). Environ Toxicol Chem 20: 1216-1227. 
Langford, K.H., and Thomas, K.V. (2008) Inputs of chemicals from recreational activities into the Norwegian 
coastal zone. J Environ Monit 10: 894-898. 
Lee, I.S., Lee, S.H., and Oh, J.E. (2010) Occurrence and fate of synthetic musk compounds in water 
environment. Water Res 44: 214-222. 
Lee, L.E., Clemons, J.H., Bechtel, D.G., Caldwell, S.J., Han, K.B., Pasitschniak-Arts, M., Mosser, D.D., and Bols, 
N.C. (1993) Development and characterization of a rainbow trout liver cell line expressing cytochrome 
P450-dependent monooxygenase activity. Cell Biol Toxicol 9: 279-294. 
Lee, S.J., and Buhler, D.R. (2003) Cloning, tissue distribution, and functional studies of a new cytochrome P450 
3A subfamily member, CYP3A45, from rainbow trout (Oncorhynchus mykiss) intestinal ceca. Arch 
Biochem Biophys 412: 77-89. 
Li, D., Yang, X.L., Zhang, S.J., Lin, M., Yu, W.J., and Hu, K. (2008) Effects of mammalian CYP3A inducers on 
CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): Possible implications for the 
establishment of a fish CYP3A induction model. Comp Biochem Physiol C Toxicol Pharmacol 147: 17-
29. 
Liedtke, A., Muncke, J., Rufenacht, K., and Eggen, R.I. (2008) Molecular multi-effect screening of environmental 
pollutants using the MolDarT. Environ Toxicol 23: 59-67. 
Chapter 1 
43 
Lien, G.J., and McKim, J.M. (1993) Predicting branchial and cutaneous uptake of 2,2',5,5'-tetrachlorobiphenyl in 
fathead minnows (Pimephales promelas) and Japanese medaka (Oryzias latipes): Rate limiting factors. 
Aquat Toxicol 27: 15-31. 
Lister, A.L., and Van Der Kraak, G. (2008) An investigation into the role of prostaglandins in zebrafish oocyte 
maturation and ovulation. Gen Comp Endocrinol 159: 46-57. 
Livingstone, D.R. (1998) The fate of organic xenobiotics in aquatic ecosystems: quantitative and qualitative 
differences in biotransformation by invertebrates and fish. Comp Biochem Physiol A 120: 43-49. 
Loncar, J., Popovic, M., Zaja, R., and Smital, T. (2010) Gene expression analysis of the ABC efflux transporters in 
rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol C Toxicol Pharmacol 151: 209-215. 
Loraine, G.A., and Pettigrove, M.E. (2006) Seasonal variations in concentrations of pharmaceuticals and personal 
care products in drinking water and reclaimed wastewater in southern California. Environ Sci Technol 40: 
687-695. 
McArthur, A.G., Hegelund, T., Cox, R.L., Stegeman, J.J., Liljenberg, M., Olsson, U., Sundberg, P., and Celander, 
M.C. (2003) Phylogenetic analysis of the cytochrome P450 3 (CYP3) gene family. J Mol Evol 57: 200-
211. 
Mehta, V., Peterson, R.E., and Heideman, W. (2008) 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure prevents 
cardiac valve formation in developing zebrafish. Toxicol Sci 104: 303-311. 
Miranda, C.L., Henderson, M.C., and Buhler, D.R. (1998) Evaluation of chemicals as inhibitors of trout 
cytochrome P450s. Toxicol Appl Pharmacol 148: 237-244. 
Monteiro, S.C., and Boxall, A.B. (2010) Occurrence and fate of human pharmaceuticals in the environment. Rev 
Environ Contam Toxicol 202: 53-154. 
Moore, L.B., Parks, D.J., Jones, S.A., Bledsoe, R.K., Consler, T.G., Stimmel, J.B., Goodwin, B., Liddle, C., 
Blanchard, S.G., Willson, T.M., Collins, J.L., and Kliewer, S.A. (2000) Orphan nuclear receptors 
constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol 
Chem 275: 15122-15127. 
Muller, S., Schmid, P., and Schlatter, C. (1996) Occurrence of nitro and non-nitro benzenoid musk compounds in 
human adipose tissue. Chemosphere 33: 17-28. 
Nallani, S.C., Goodwin, B., Buckley, A.R., Buckley, D.J., and Desai, P.B. (2004) Differences in the induction of 
cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing 
primary human hepatocytes. Cancer Chemother Pharmacol 54: 219-229. 
Neumann, N.F., and Galvez, F. (2002) DNA microarrays and toxicogenomics: applications for ecotoxicology? 
Biotechnol Adv 20: 391-419. 
Nunes, B., Gaio, A.R., Carvalho, F., and Guilhermino, L. (2008) Behaviour and biomarkers of oxidative stress in 
Gambusia holbrooki after acute exposure to widely used pharmaceuticals and a detergent. Ecotoxicol 
Environ Saf 71: 341-354. 
Oaks, J.L., Gilbert, M., Virani, M.Z., Watson, R.T., Meteyer, C.U., Rideout, B.A., Shivaprasad, H.L., Ahmed, S., 
Chaudhry, M.J., Arshad, M., Mahmood, S., Ali, A., and Khan, A.A. (2004) Diclofenac residues as the 
cause of vulture population decline in Pakistan. Nature 427: 630-633. 
Owen, S.F., Giltrow, E., Huggett, D.B., Hutchinson, T.H., Saye, J., Winter, M.J., and Sumpter, J.P. (2007) 
Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish. Aquat 
Toxicol 82: 145-162. 
Paulos, P., Runnalls, T.J., Nallani, G., La Point, T., Scott, A.P., Sumpter, J.P., and Huggett, D.B. (2010) 
Reproductive responses in fathead minnow and Japanese medaka following exposure to a synthetic 
progestin, Norethindrone. Aquat Toxicol 99: 256-262. 
Plagellat, C., Kupper, T., Furrer, R., de Alencastro, L.F., Grandjean, D., and Tarradellas, J. (2006) Concentrations 
and specific loads of UV-filters in sewage sludge originating from a monitoring network in Switzerland. 
Chemosphere 62: 915-925. 
General Introduction 
44 
Pomati, F., Cotsapas, C.J., Castiglioni, S., Zuccato, E., and Calamari, D. (2007) Gene expression profiles in 
zebrafish (Danio rerio) liver cells exposed to a mixture of pharmaceuticals at environmentally relevant 
concentrations. Chemosphere 70: 65-73. 
Raldua, D., and Babin, P.J. (2007) BLT-1, a specific inhibitor of the HDL receptor SR-BI, induces a copper-
dependent phenotype during zebrafish development. Toxicol Lett 175: 1-7. 
Raldúa, D., André, M., and Babin, P.J. (2008) Clofibrate and gemfibrozil induce an embryonic malabsorption 
syndrome in zebrafish. Toxicol Appl Pharmacol 228: 301-314. 
Reif, R., Suárez, S., Omil, F., and Lema, J.M. (2008) Fate of pharmaceuticals and cosmetic ingredients during the 
operation of a MBR treating sewage. Desalination 221: 511-517. 
Reiner, J.L., Wong, C.M., Arcaro, K.F., and Kannan, K. (2007) Synthetic musk fragrances in human milk from the 
United States. Environ Sci Technol 41: 3815-3820. 
Richards, S.M., Wilson, C.J., Johnson, D.J., Castle, D.M., Lam, M., Mabury, S.A., Sibley, P.K., and Solomon, 
K.R. (2004) Effects of pharmaceutical mixtures in aquatic microcosms. Environ Toxicol Chem 23: 1035-
1042. 
Rimkus, G.G. (1999) Polycyclic musk fragrances in the aquatic environment. Toxicol Lett 111: 37-56. 
Rimkus, G.G., and Wolf, M. (1996) Polycyclic musk fragrances in human adipose tissue and human milk. 
Chemosphere 33: 2033-2043. 
Rodil, R., and Moeder, M. (2008) Development of a method for the determination of UV-filters in water samples 
using stir bar sorptive extraction and thermal desorption-gas chromatography-mass spectrometry. J 
Chromatogr A 1179: 81-88. 
Ross, D.T., Scherf, U., Eisen, M.B., Perou, C.M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S.S., Van de Rijn, M., 
Waltham, M., Pergamenschikov, A., Lee, J.C., Lashkari, D., Shalon, D., Myers, T.G., Weinstein, J.N., 
Botstein, D., and Brown, P.O. (2000) Systematic variation in gene expression patterns in human cancer 
cell lines. Nat Genet 24: 227-235. 
Roymans, D., Van Looveren, C., Leone, A., Parker, J.B., McMillian, M., Johnson, M.D., Koganti, A., Gilissen, R., 
Silber, P., Mannens, G., and Meuldermans, W. (2004) Determination of cytochrome P450 1A2 and 
cytochrome P450 3A4 induction in cryopreserved human hepatocytes. Biochem Pharmacol 67: 427-437. 
Rubinstein, A.L. (2003) Zebrafish: from disease modeling to drug discovery. Curr Opin Drug Discov Devel 6: 218-
223. 
Runnalls, T.J., Hala, D.N., and Sumpter, J.P. (2007) Preliminary studies into the effects of the human 
pharmaceutical clofibric acid on sperm parameters in adult fathead minnow. Aquat Toxicol 84: 111-118. 
Salas, C., Navarro, F., Torres, B., and Delgado-Garcia, J.M. (1992) Effects of diazepam and D-amphetamine on 
rhythmic pattern of eye movements in goldfish. Neuroreport 3: 131-134. 
Schlenk, D. (1998) Occurrence of flavin-containing monooxygenases in non-mammalian eukaryotic organisms. 
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 121: 185-195. 
Schlumpf, M., Cotton, B., Conscience, M., Haller, V., Steinmann, B., and Lichtensteiger, W. (2001) In vitro and in 
vivo estrogenicity of UV screens. Environ Health Perspect 109: 239-244. 
Schlumpf, M., Schmid, P., Durrer, S., Conscience, M., Maerkel, K., Henseler, M., Gruetter, M., Herzog, I., Reolon, 
S., Ceccatelli, R., Faass, O., Stutz, E., Jarry, H., Wuttke, W., and Lichtensteiger, W. (2004) Endocrine 
activity and developmental toxicity of cosmetic UV-filters- an update. Toxicology 205: 113-122. 
Schlumpf, M., Kypke, K., Vökt, C.C., Birchler, M., Durrer, S., Faass, O., Ehnes, C., Fuetsch, M., Gaille, C., 
Henseler, M., Hofkamp, L., Maerkel, K., Reolon, S., Zenker, A., Timms, B., Tresguerres, J.A.F., and 
Lichtensteiger, W. (2008) Endocrine active UV-filters: developmental toxicity and exposure through 
breast milk. CHIMIA 62: 345-351. 
Scholz, S., Kordes, C., Hamann, J., and Gutzeit, H.O. (2004) Induction of vitellogenin in vivo and in vitro in the 
model teleost medaka (Oryzias latipes): comparison of gene expression and protein levels. Mar Environ 
Res 57: 235-244. 
Chapter 1 
45 
Schreurs, R.H., Quaedackers, M.E., Seinen, W., and van der Burg, B. (2002) Transcriptional activation of 
estrogen receptor ERalpha and ERbeta by polycyclic musks is cell type dependent. Toxicol Appl 
Pharmacol 183: 1-9. 
Schultz, I.R., Skillman, A., Nicolas, J.-M., Cyr, D.G., and Nagler, J.J. (2003) Short-term exposure to 17alpha-
ethynylestradiol decreases the fertility of sexually maturing male rainbow trout (Oncorhynchus mykiss). 
Environ Toxicol Chem 22: 1272-1280. 
Seinen, W., Lemmen, J.G., Pieters, R.H., Verbruggen, E.M., and van der Burg, B. (1999) AHTN and HHCB show 
weak estrogenic--but no uterotrophic activity. Toxicol Lett 111: 161-168. 
Shader, R.I., and Greenblatt, D.J. (1977) Clinical implications of benzodiazepine pharmacokinetics. Am J 
Psychiatry 134: 652-656. 
Shved, N., Berishvili, G., Baroiller, J.F., Segner, H., and Reinecke, M. (2008) Environmentally relevant 
concentrations of 17alpha-ethinylestradiol (EE2) interfere with the growth hormone (GH)/insulin-like 
growth factor (IGF)-I system in developing bony fish. Toxicol Sci 106: 93-102. 
Si, M.S., Reitz, B.A., and Borie, D.C. (2005) Effects of the kinase inhibitor CGP41251 (PKC 412) on lymphocyte 
activation and TNF-alpha production. Int Immunopharmacol 5: 1141-1149. 
Smital, T., Luckenbach, T., Sauerborn, R., Hamdoun, A.M., Vega, R.L., and Epel, D. (2004) Emerging 
contaminants-pesticides, PPCPs, microbial degradation products and natural substances as inhibitors of 
multixenobiotic defense in aquatic organisms. Mutat Res 552: 101-117. 
Snell, T.W., Brogdon, S.E., and Morgan, M.B. (2003) Gene expression profiling in ecotoxicology. Ecotoxicology 
12: 475-483. 
Stackelberg, P.E., Furlong, E.T., Meyer, M.T., Zaugg, S.D., Henderson, A.K., and Reissman, D.B. (2004) 
Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional 
drinking-water-treatment plant. Sci Total Environ 329: 99-113. 
Stegeman, J.J. (1989) Cytochrome P450 forms in fish: Catalytic, immunological and sequence similarities. 
Xenobiotica 19: 1093-1110. 
Straub, J.O. (2008) Deterministic and probabilistic environmental risk assessment for diazepam. In 
Pharmaceuticals in the environment. Kümmerer, K. (ed). Berlin: Springer, pp. 343-371. 
Sturm, A., Segner, H., Mommsen, T.P., and Moon, T.W. (2005) Chapter 18 P-glycoproteins and xenobiotic efflux 
transport in fish. In Biochemistry and Molecular Biology of Fishes: Elsevier, pp. 495-533. 
Suárez, S., Carballa, M., Omil, F., and Lema, J.M. (2008) How are pharmaceutical and personal care products 
(PPCPs) removed from urban wastewaters? Rev Environ Sci Biotechnol 7: 125-138. 
Sun, Y., Yu, H., Zhang, J., Yin, Y., Shen, H., Liu, H., and Wang, X. (2006) Bioaccumulation and antioxidant 
responses in goldfish Carassius auratus under HC Orange No. 1 exposure. Ecotoxicol Environ Saf 63: 
430-437. 
Szakacs, G., Varadi, A., Ozvegy-Laczka, C., and Sarkadi, B. (2008) The role of ABC transporters in drug 
absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 13: 379-
393. 
Takahashi, I., Saitoh, Y., Yoshida, M., Sano, H., Nakano, H., Morimoto, M., and Tamaoki, T. (1989) UCN-01 and 
UCN-02, new selective inhibitors of protein kinase C. II. Purification, physico-chemical properties, 
structural determination and biological activities. J Antibiot (Tokyo) 42: 571-576. 
Tas, J.W., Balk, F., Ford, R.A., and van de Plassche, E.J. (1997) Environmental risk assessment of musk ketone 
and musk xylene in The Netherlands in accordance with the EU-TGD. Chemosphere 35: 2973-3002. 
Ternes, T.A. (1998) Occurrence of drugs in German sewage treatment plants and rivers Water Res 32: 3245-
3260(3216). 
Ternes, T.A., Joss, A. (2006) Human pharmaceuticals, hormones and fragrances. The challenge of 
micropollutants in urban water management. London: IWA Publishing. 
General Introduction 
46 
Thibaut, R., Schnell, S., and Porte, C. (2006) The interference of pharmaceuticals with endogenous and 
xenobiotic metabolizing enzymes in carp liver: an in vitro study. Environ Sci Technol 40: 5154-5160. 
Thorpe, K.L., Cummings, R.I., Hutchinson, T.H., Scholze, M., Brighty, G., Sumpter, J.P., and Tyler, C.R. (2003) 
Relative potencies and combination effects of steroidal estrogens in fish. Environ Sci Technol 37: 1142-
1149. 
Tixier, C., Singer, H.P., Oellers, S., and Muller, S.R. (2003) Occurrence and fate of carbamazepine, clofibric acid, 
diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 37: 1061-1068. 
Tredger, J.M., and Stoll, S. (2002) Cytochromes P450s - their impact on drug treatment. Hosp Pharm 9: 167-173. 
Trudeau, V.L., Metcalfe, C.D., Mimeault, C., Moon, T.W., Mommsen, T.P., and Moon, T.W. (2005) Chapter 17 
Pharmaceuticals in the environment: Drugged fish? In Biochemistry and Molecular Biology of Fishes: 
Elsevier, pp. 475-493. 
Tseng, H.P., Hseu, T.H., Buhler, D.R., Wang, W.D., and Hu, C.H. (2005) Constitutive and xenobiotics-induced 
expression of a novel CYP3A gene from zebrafish larva. Toxicol Appl Pharmacol 205: 247-258. 
van der Hoeven, N. (2004) Current issues in statistics and models for ecotoxicological risk assessment. Acta 
Biotheor 52: 201-217. 
van der Ven, K., Van Dongen, W., Maes, B.U., Esmans, E.L., Blust, R., and De Coen, W.M. (2004) Determination 
of diazepam in aquatic samples by capillary liquid chromatography-electrospray tandem mass 
spectrometry. Chemosphere 57: 967-973. 
Van Leeuwen, C.J., and Vermeire, T.G. (2007) Transport, accumulation and transformation processes. In Risk 
assessment of chemicals: An introduction. Van Leeuwen, C.J., and Vermeire, T.G. (eds). Heidelberg: 
Springer Berlin, pp. 133-147. 
Veldhoen, N., Boggs, A., Walzak, K., and Helbing, C.C. (2006) Exposure to tetrabromobisphenol-A alters TH-
associated gene expression and tadpole metamorphosis in the Pacific tree frog Pseudacris regilla. Aquat 
Toxicol 78: 292-302. 
Vignati, L.A., Bogni, A., Grossi, P., and Monshouwer, M. (2004) A human and mouse pregnane X receptor 
reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific 
CYP3A induction. Toxicology 199: 23-33. 
Weigel, S., Berger, U., Jensen, E., Kallenborn, R., Thoresen, H., and Huhnerfuss, H. (2004) Determination of 
selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on 
ibuprofen and its metabolites. Chemosphere 56: 583-592. 
Weisbrod, C.J., Kunz, P.Y., Zenker, A.K., and Fent, K. (2007) Effects of the UV-filter benzophenone-2 on 
reproduction in fish. Toxicol Appl Pharmacol 225: 255-266. 
Winkler, M., Kopf, G., Hauptvogel, C., and Neu, T. (1998) Fate of artificial musk fragrances associated with 
suspended particulate matter (SPM) from the River Elbe (Germany) in comparison to other organic 
contaminants. Chemosphere 37: 1139-1156. 
Xia, C.Q., Milton, M.N., and Gan, L.S. (2007) Evaluation of drug-transporter interactions using in vitro and in vivo 
models. Curr Drug Metab 8: 341-363. 
Xu, C., Li, C.Y., and Kong, A.N. (2005) Induction of phase I, II and III drug metabolism/transport by xenobiotics. 
Arch Pharm Res 28: 249-268. 
Zaja, R., Caminada, D., Loncar, J., Fent, K., and Smital, T. (2008) Development and characterization of P-
glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line. Toxicol 
Appl Pharmacol 227: 207-218. 
Zeilinger, J., Steger-Hartmann, T., Maser, E., Goller, S., Vonk, R., and Lange, R. (2009) Effects of synthetic 
gestagens on fish reproduction. Environ Toxicol Chem 28: 2663-2670. 
Zenker, A., Schmutz, H., and Fent, K. (2008) Simultaneous trace determination of nine organic UV-absorbing 
compounds (UV-filters) in environmental samples. J Chromatogr A 1202: 64-74. 
Chapter 1 
47 
Zhdanova, I.V., Wang, S.Y., Leclair, O.U., and Danilova, N.P. (2001) Melatonin promotes sleep-like state in 
zebrafish. Brain Res 903: 263-268. 
Zillioux, E.J., Johnson, I.C., Kiparissis, Y., Metcalfe, C.D., Wheat, J.V., Ward, S.G., and Liu, H. (2001) The 
sheepshead minnow as an in vivo model for endocrine disruption in marine teleosts: A partial life-cycle 
test with 17alpha-ethynylestradiol. Environ Toxicol Chem 20: 1968-1978. 
Zwiener, C., Richardson, S.D., DeMarini, D.M., Grummt, T., Glauner, T., and Frimmel, F.H. (2007) Drowning in 
disinfection byproducts? Assessing swimming pool water. Environ Sci Technol 41: 363-372. 
 
 
 
 
 48 
 
Chapter 2 
 
 
 
 
 
 
 
 
 
 
A microtiter-plate-based cytochrome 
P450 3A activity assay in fish cell lines 
 
 
 
 
Verena Christen† ||, Daniela M Oggier†‡ ||, Karl Fent† §  
 
 
 
 
Published in Environmental Toxicology and Chemistry, 2009 
 
 
 
 
 
† University of Applied Sciences Northwestern Switzerland, School of Life Sciences, Gründensrasse 40, CH–4132 Muttenz, 
Switzerland 
 
‡ University of Zürich, Institute of Plant Biology, Division of Limnology, Seestrasse 187, CH–8802 Kilchberg, Switzerland 
§ Swiss Federal Institute of Technology (ETHZ), Department of Environmental Sciences, CH–8092 Zürich, Switzerland 
 
|| These authors contributed equally to this work
 49 
Abstract 
 
Enzymes belonging to the cytochrome P450 3A (CYP3A) subfamily play an important role in 
the metabolism of endogenous substances and xenobiotics, including pharmaceuticals. 
Xenobiotics can alter CYP3A expression and activity, and therefore, changes in CYP3A 
activity may serve as a biomarker of xenobiotic exposure. To determine changes in CYP3A 
enzyme activity for environmental risk assessment of xenobiotics including pharmaceuticals, 
high-throughput assays are needed, but these are missing for fish cells to date. Here, we 
report on the development of a fluorescent-based CYP3A high-throughput assay for four fish 
cell lines cultivated in 96-well plates based on 7-benzyloxy-4-trifluoromethylcoumarin as a 
CYP3A substrate. We show that human CYP3A substrate BFC is catalyzed by fish CYP3A 
enzymes to a fluorescent product. Its formation is dependent on cell numbers and incubation 
time. Furthermore, we demonstrate that with this new CYP3A assay induction and inhibition 
of enzyme activity by pharmaceuticals can be determined. This new cell-based assay is 
suitable for detection of alteration in CYP3A enzyme activity in largescale experiments for 
screening of pharmaceuticals occurring in the environment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: Cytochrome P450 3A, Fish cell lines, High-throughput assay, Pharmaceuticals 
 
CYP3A Assay 
50 
2.1 Introduction 
Despite the occurrence of pharmaceuticals in the environment, little is known about their 
potential effects on ecosystems (Fent et al., 2006). Some pharmaceuticals have been 
investigated for their effects on aquatic organisms such as fish (Schwaiger et al., 2004; 
Runnalls et al., 2007), but it remains unclear whether dependable biomarkers of exposure 
and effects exist for human pharmaceuticals. Here, we propose the cytochrome P450 3A 
(CYP3A) enzyme as a potential candidate for exposure assessment in fish.  
 
The CYP3A family is the largest subfamily of CYPs found in the liver and small intestine of 
mammals and fish (Hegelund and Celander, 2003; Lee and Buhler, 2003; Nallani et al., 
2004). Cytochrome P450 3A plays an important role in the metabolism of endogenous 
substances and xenobiotics including pharmaceuticals. Induction of CYP3A expression by 
rifampicin and dexamethasone has been shown to occur in fish (Tseng et al., 2005). 
Cytochrome P450 3A was identified in several teleost species (e.g., CYP3A27 and CYP3A45 
in rainbow trout (Lee et al., 1993; Lee and Buhler, 2003), CYP3A38 and CYP3A40 in 
medaka (Kullman et al., 2000; Kullman and Hinton, 2001), CYP3A30 and CYP3A56 in 
killifish (McArthur et al., 2003), and CYP3A65 in Danio rerio (Tseng et al., 2005)).  
 
Because xenobiotics can influence CYP3A expression and activity, a change in CYP3A 
expression could serve as an indicator of exposure of an organism to them and provide 
information on their metabolism. There are several requirements for assays to be suitable as 
potential biomarkers. They should have a toxicological basis and short handling time, be low 
in costs, and, preferably, have a high-throughput potential. Alterations of CYP3A activity, 
respectively, mRNA level, are known as a suitable biomarker used for assessing 
contaminant exposure and effects. 
 
Cytochrome P450 3A enzymes of mammals and fish exhibit similar catalytic properties due 
to structural similarities (Bork et al., 1989). In fish, they are regulated by the same receptors 
as in mammals, namely, through the pregnane X receptor (PXR) (Bresolin et al., 2005; 
Meucci and Arukwe, 2006; Milnes et al., 2008). The CYP3A expression can also be 
modulated by the constitutive androstane receptor, but the constitutive androstane receptor 
is restricted to mammals (Krasowski et al., 2005; Reschly and Krasowski, 2006). Due to 
these similarities, specific probes to determine CYP3A activity used in humans are supposed 
to be also specific for CYP3A activity in fish. Up to now, several substrates and their 
metabolites, respectively, have been used to determine CYP3A activity in mammals and in 
fish. The most widely used substrates to test CYP3A activity are testosterone (James et al., 
2005) and erythromycin (erythromycin N-demethylase activity) (Vaccaro et al., 2005; Li et al., 
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2008). Assays using these substrates have the disadvantage that they require time-intensive 
analytical tools such as high-performance liquid chromatography coupled with UV 
spectrophotometric detection or coupled with mass spectroscopy to investigate the 
metabolites. In addition, O-alkyl derivatives of resorufin, fluorescein, 7-hydroxycoumarins, 
and 6-hydroxyquinolines have been examined as substrates in mammals (Cohen et al., 
2003). Commercial kits (P450- GloTM Assays, Promega) offer another possibility to measure 
CYP activity based on a luminescent method. These biochemical assays using purified 
components or subcellular fractions are designed to measure the activities of P450 enzymes 
from recombinant and native sources and can also be used for cellbased CYP450 induction 
assays. The assays contain different human substrates for different CYP450 enzymes such 
as CYP3A, CYP2C, etc. 
 
Currently, only assays with testosterone hydroxylase, erythromycin N-demethylase, 7-
benzyloxy-4-trifluoromethylcoumarin (BFC), or aminopyrine N-demethylase as a substrate 
have been used to show CYP3A activity in microsomal preparations in fish (Stegeman et al., 
1997; Machala et al., 1998; Thibaut et al., 2006). Thus far, there have been no whole-cell-
based assays in microtiter plates for measuring CYP3A activity. Absorbance- or 
fluorescence-based assays in microtiter plates that do not require metabolite separation by 
chemical analytical techniques represent important progress and should be developed for 
large-scale monitoring of xenobiotics including pharmaceuticals.  
 
Here, we present a CYP3A assay based on fluorescence measurement in a 96-well plate 
reader using fish cell lines suitable for large-scale measurements of CYP3A activity. Previous 
studies demonstrated that CYP1A can be induced by xenobiotics in Poeciliopsis lucida 
hepatoma cell-line 1 (PLHC-1) cells (Hahn and Chandran, 1996; Fent and Bätscher, 2000), 
zebrafish liver (ZFL) cells (Zeruth and Pollenz, 2005), and rainbow trout gonadal cell-line 2 
(RTG-2) cells (Trattner et al., 2008). However, data on induction or inhibition of CYP3A 
enzyme activity and mRNA expression in fish are currently missing. The aim of the present 
study was to develop a versatile high-throughput assay for CYP3A activity in several fish cell 
lines, ZFL, RTG-2, and PLHC-1, using BFC as a substrate for potential use in studies of 
effects of pharmaceuticals, metabolism, and biomonitoring. We also analyzed whether 
pharmaceuticals can act as inducers or inhibitors of CYP3A-related enzyme activities in fish 
cell lines. Such information could facilitate the establishment of a new biomarker tool for 
pharmaceuticals, which can lead to induction or inhibition of CYP3A activity. 
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2.2 Materials and Methods 
2.2.1 Chemicals 
Dimethylsulfoxide (DMSO), acetonitrile (ACN), rifampicin, and BFC were purchased from 
Sigma-Aldrich. Phosphate buffered saline and diazepam were purchased from Roche 
Diagnostics.  
Stock solutions of all pharmaceuticals were prepared in DMSO or ACN at a concentration of 
100 μM if not otherwise stated. For the assay, stock solutions were diluted in cell culture 
medium resulting in a maximal solvent concentration of 0.1 %. Further concentrations were 
prepared by serial dilution.  
 
2.2.2 Cells  
ZFL. Danio rerio liver cells were obtained from the American Type Culture Collection (ATCC 
No. CRL-2643). The medium consisted of 50 % Leibovitz’s L-15 medium (LuBioScience), 
35 % Dulbecco’s modified Eagle’s medium with 4.5 g/L glucose (LuBioScience), and 15 % 
Ham’s F12 (LuBioScience) (all without sodium bicarbonate) supplemented with 0.15 g/L 
sodium bicarbonate, 15 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
0.01 mg/ml insulin, 50 ng/ml epidermal growth factor, and 5 % heat-inactivated fetal bovine 
serum (all from Sigma-Aldrich). The ZFL cells were grown at 28 °C in a humidified incubator. 
Cells were split usually every 7 d and subcultured at split ratios of approximately 1:3.  
 
PLHC-1. Poeciliopsis lucida hepatoma cell-line 1 cells were grown in DMEM/F12 
(LuBioScience) supplemented with 5 % fetal bovine serum (FBS; Sigma-Aldrich) in a 
humidified incubator with 5 % CO2 at 30 °C. Cells were split usually every 4 d and 
subcultured at split ratios of approximately 1:6.  
 
FHM. Pimephales promelas (fathead minnow) (FHM) cells were grown in DMEM/F12 
(LuBioScience) supplemented with 5 % FBS (Sigma-Aldrich) and 20 mM HEPES at pH 7.2 
(Sigma-Aldrich) at room temperature (21 ± 2 °C). Cells were split usually every 7 d and 
subcultured at split ratios of approximately 1:3.  
 
RTG-2. Oncorhynchus mykiss (rainbow trout) gonadal cellline 2 (RTG-2) was obtained from 
the American Type Culture Collection (ATCC No. CCL-55). They were grown in DMEM/ F12 
supplemented with 10 % FBS, 20 mM HEPES at pH 7.2 (Sigma-Aldrich) at room 
temperature (21 ± 2 °C). Cells were split usually every 7 d and subcultured at split ratios of 
approximately 1:3.  
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Huh7. The human hepatoma cells Huh7 were grown in DMEM/F12 with GlutaMAXTM 
(LuBioScience) supplemented with 5 % FBS in a humidified incubator with 5 % CO2 at 37 °C. 
Cells were split usually every 4 d and subcultured at split ratios of approximately 1:6.  
 
2.2.3 Determination of CYP3A65 catalytic activity 
Assays performed in Eppendorf tubes. Approximately 2.5 million cells of each cell line were 
transferred to an Eppendorf tube and incubated in phenolred-free medium for 5 h. 
Phenolred- free medium was used to prevent the color of phenol red from interfering with 
spectrophotometric and fluorescence measurements in assays containing 50 μM BFC 
(Sigma- Aldrich) or ACN, respectively. 7-Benzyloxy-4-trifluoromethylcoumarin is metabolized 
by human CYP3A4 to give highly fluorescent 7-hydroxy-4-(trifluoromethyl)coumarin that can 
be detected readily spectrofluorometrically (Mensah-Osman et al., 2007). After 5 h, the cells 
were centrifuged for 4 min at 2,000 g at 4 °C. The supernatant was collected and transferred 
into a black 96-well plate (Huber). To stop the reaction, a stop solution (80 % ACN and 20 % 
0.5 M Tris base) equal to 40% of the reaction volume was added. The plate was read on a 
GENios Tecan reader (Tecan) using an excitation wavelength of 410 nm and an emission 
wavelength of 530 nm. Each experiment was repeated three times.  
 
Assays in 24-, 48-, and 96-well plates. Different numbers of cells were seeded in 24-, 48-, 
and 96-well plates and grown in culture medium. After 24 h, the medium was removed, and 
the cells were incubated in phenol-red-free medium containing 50 μM BFC or ACN, 
respectively, for 5 h. After this exposure time, the supernatant was transferred into a black 
96-well plate and mixed with the stop solution, and the experiment was performed as 
described above.  
 
Exposure to pharmaceuticals. Cells (~100,000 cells per well) were seeded in 96-well plates 
and grown in culture medium. After 24 h, the medium was removed, and cells were 
incubated in phenol-red-free medium containing the test pharmaceutical or the solvent 
control, respectively. The cells were incubated for an additional 24 h, and the CYP3A-assay 
was performed as described above. To control for equal numbers of cells in each well, the 
cells were removed from the well with trypsin and incubated with lysis buffer (50 mM TrisHCl, 
150 mM NaCl, 2 mM ethylenediaminetetraacetic acid, 1% Triton X- 100, and 0.1 % sodium 
dodecyl sulfate) to obtain whole cell extracts. From each whole cell extract, the protein 
content was determined with a Bradford assay (Bio-Rad Laboratories). Only wells with equal 
protein concentrations were analyzed for CYP3A activity.  
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Statistical analysis. Data were graphically illustrated with GraphPadH Prism 4 (GraphPad 
Software). Data distribution for normality was tested by Kolmogorov–Smirnov test, and the 
homogeneity of variance was tested by Levene’s test. Differences between treatments were 
assessed by analysis of variance followed by a Bonferroni (Levene’s test p > 0.05) test to 
compare the treatment means with the respective controls. In correlation tests, the different 
treatment groups were obtained by Pearson coefficients r. The results are given as mean ± 
standard deviation. Differences were considered significant at p ≤ 0.05. All computations 
were performed with SPSS® 16.0 for Windows. 
 
2.3 Results 
2.3.1 Basic CYP3A activity in different fish cell lines  
In the first set of experiments, we determined the CYP3A activity in vitro according to the 
protocol of Mensah-Osman et al. (Mensah-Osman et al., 2007). Our aim was to evaluate 
whether the human CYP3A substrate (BFC) is also a substrate for fish CYP3A enzymes. To 
control for known CYP3A activity, the human hepatoma cell line Huh7 was used. Figure 1 
demonstrates that all evaluated fish cell lines showed basic CYP3A activity. The PLHC-1 and 
FHM cell lines displayed a more than 1.5-fold higher CYP3A activity than Huh7. The ZFL 
cells showed the lowest CYP3A activity, but the detected values were clearly above the 
background signals.  
 
Treatment of cells with different drugs at different concentrations at the same time for 
monitoring the CYP3A activity is not feasible, so far. For this reason, we changed the existing 
protocol to a more efficient experimental system that allows the processing of multiple 
samples at the same time. For this procedure, approximately 100,000 cells per well were 
seeded in a 96-well plate. After cultivation of the cells for 24 h, they were incubated with the 
CYP3A substrate directly in the wells instead of trypsinizing the cells and transferring them 
into a 1.5-ml tube for incubation with the substrate. Hence, product formation was assessed 
with intact cells. 
 
Figure 2A illustrates the two different procedures schematically (left panel: assay performed 
in 1.5-ml tubes; right panel: assay performed in microtiter plate). Figure 2B shows that 
CYP3A activity was detected when performing the assay in the wells. This is more elegant 
than performing the assay in a 1.5-ml tube. Because of fewer handling steps, more samples 
can be investigated in a shorter time, and there are fewer sources of potential handling 
mistakes. 
Chapter 2 
55 
Huh7 PLHC-1 FHM ZFL RTG-2
0
200
400
600
800
C
YP
3A
 A
ct
iv
ity
 (a
rb
itr
ar
y 
un
its
)
 
Figure 1  
Endogenous cytochrome P450 3A (CYP3A) activity of the human hepatoma cells (Huh7), Poeciliopsis lucida cell-
line 1 (PLHC-1), fathead minnow (FHM), zebrafish liver (ZFL), and rainbow trout (RTG-2) cells. Shown are results 
of at least three independent experiments ± standard deviation for each cell line. The CYP3A activity assays were 
performed in 1.5-ml tubes as described by Mensah-Osman et al. 
 
 
Figure 2  
(A) Diagram comparing the procedure of the cytochrome P450 3A (CYP3A) assay performed in 1.5-ml tubes (left) 
and our new cellular assay in 96-well plates (right). (B) Endogenous CYP3A activity obtained by performing the 
assay in 96-well plates. The CYP3A activity assay was performed in the human hepatoma (Huh7), Poeciliopsis 
lucida cell-line 1 (PLHC-1), fathead minnow (FHM), zebrafish liver (ZFL), and rainbow trout gonadal (RTG-2) 
cells. The incubation step was performed directly in the wells. Results of three independent experiments ± 
standard deviation for each cell line. 
 
Through the use of 96-well plates, the amounts of reagents used such as pharmaceuticals, 
cell media, and buffers can be reduced. Without trypsinization of the cells, the risk of 
inducing cellular stress responses that could alter the outcome of the assay is reduced. 
Hence, the results are more reproducible. The measured basic CYP3A activities in the 
different cell lines obtained by the new cell assay were comparable to the activities obtained 
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with the former protocol. Again, PLHC-1 and FHM cells showed the highest activity, and ZFL 
cells showed again much lower activity. From these experiments, we conclude that it is 
possible to perform the CYP3A activity assay directly in the culture dish without trypsinizing 
the cells.  
 
2.3.2 Dependency of CYP3A activity on different conditions  
To evaluate and validate the newly established CYP3A assay, different numbers of ZFL cells 
were seeded in 96- and 48-well plates. After 24 h of cultivation, the CYP3A activity assay 
was performed in the culture plates. Figure 3A demonstrates that increasing conversion of 
the CYP3A substrate into the fluorescent product was detected with increasing numbers of 
cells.  
 
This clearly confirms that the detected fluorescence is based on CYP3A enzyme activity of 
the cells and not due to background fluorescence. Additionally, zebrafish cells grown 
overnight in a 96-well plate were incubated with CYP3A substrate, and the enzyme reaction 
was stopped at different time points. As shown in Figure 3B, there was a clear correlation 
between incubation time and amount of measured fluorescence. This result confirms again 
that the measured fluorescence signals originate from cellular enzyme activity.  
 
2.3.3 Dependency of CYP3A activity on BFC concentration 
As another control experiment to control the functionality of the CYP3A assay, we incubated 
ZFL and FHM cells with different concentrations of BFC (10, 20, 30, 40, and 50 μM). There 
was a clear correlation between measured fluorescence and concentration of BFC. The 
highest fluorescent signal was measured with 50 μM BFC (Figure 3C and D). This BFC 
concentration was used for all of the other experiments. As a proof of function of the enzyme 
in this new assay, the assay was stopped by protein precipitation with trichloroacetic acid. No 
conversion of the substrate was detectable when incubating cells with 10 % trichloroacetic 
acid for 1 h prior to the incubation with BFC. These results clearly show that only living cells 
and active enzyme, respectively, can cause substrate conversion (data not shown).  
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Figure 3 
(A) Correlation between measured fluorescence originating from cytochrome P4503A (CYP3A) enzyme activity 
and number of zebrafish liver (ZFL) cells (105–106, r2 = 0.93). Results of three independent assays ± standard 
deviation. (B) Correlation between measured fluorescence and incubation time. The ZFL cells were incubated 
with CYP3A substrate 7-benzyloxy-4-trifluoromethylcoumarin (BFC), and the reactions were stopped after 1 to 5 h 
(r2 = 0.88). Shown are the mean values of three experiments ± standard deviation (SD). (C and D) Correlation 
between measured fluorescence originating from CYP3A enzyme activity and different BFC concentrations. The 
ZFL (C, r2 = 0.84) and fathead minnow (FHM) cells (D, r2 = 0.84) cells were incubated with different 
concentrations of the CYP3A substrate BFC (10, 20, 30, 40, and 50 μM) for 5 h. Shown are mean values of three 
independent experiments ± SD. (E and F) No alteration of CYP3A activity through incubation with solvents. 
Human hepatoma (Huh7, E) and Poeciliopsis lucida cell-line 1 (PLHC-1, F) cells were incubated for 24 h with 
0.1% dimethylsulfoxide (DMSO) and acetonitrile (ACN), respectively, to control for the influence of the solvents on 
CYP3A activity. No influence on CYP3A activity detectable. Shown are mean values of three independent 
experiments ± SD. 
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Figure 4  
Induction of cytochrome P450 3A (CYP3A) activity by rifampicin in different cell lines: (A) human hepatoma cells 
(Huh7), (B) Poeciliopsis lucida cell-line 1 (PLHC-1), (C) rainbow trout (RTG-2) cells, (D) fathead minnow (FHM) 
cells. Cells, treated with 10, 25, and 50 μM rifampicin for 24 h followed by CYP3A activity measurement. Shown 
are mean inductions of CYP3A activity of three experiments ± standard deviation. Differences in enzymatic 
activity between solvent controls with dimethylsulfoxide (DMSO) and rifampicin-treated cells were significant for 
25 μM (p = 0.023) and for 50 μM (p = 0.001) in (A), for 25 μM (p = 0.004) and for 50 μM (p = 0.012) in (B), for 
10 μM (p < 0.0001), for 25 μM (p < 0.0001), and for 50 μM (p < 0.0001) in (C), and for 25 μM (p = 0.042) and for 
50 μM (p = 0.009) in (D). 
 
2.3.4 Induction and inhibition of CYP3A activity  
To confirm the functionality of CYP3A enzymes in fish cells and to demonstrate the 
usefulness of the new CYP3A cellular assay, we evaluated the induction or inhibition 
potential of CYP3A enzyme activity by model compounds. First, we tested the influence of 
the solvents used on CYP3A activity. To this end, Huh7 cells and PLHC-1 cells, grown 
overnight in 96-well plates, were left untreated or treated for 24 h with 0.1 % ACN and 0.1 % 
DMSO prior to incubation. As shown in Figure 3E and F, the solvents had no effects on 
CYP3A activity. After confirming that solvents do not alter CYP3A activity, we treated the 
cells with the model compounds. For this purpose, PLHC-1, RTG-2, FHM, and control Huh7 
cells, all grown separately in a 96-well plate, were treated for 24 h with 10, 25, and 50 μM 
rifampicin before performing the CYP3A activity assay in the plate. Treatment of Huh7 cells 
with rifampicin resulted in an increase in enzyme activity up to around 250 % compared with 
that of solvent control cells treated with DMSO (Figure 4A).  
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The treatment of PLHC1, RTG-2, and FHM with rifampicin also resulted in an induction of 
CYP3A enzyme activity (Figure 4B–D). In all three cell lines, the induction was up to 150 %. 
In addition to the induction of CYP3A activity, the inhibition of CYP3A activity was evaluated 
by treatment of PLHC-1 cells and Huh7 cells as controls with the known human CYP3A 
inhibitor diazepam. PLHC-1 and Huh7 cells grown in a 96-well plate were treated for 24 h 
with diazepam followed by CYP3A activity measurement. As shown in Figure 5, the 
CYP3Aactivity in PLHC-1 cells was inhibited up to 50 %; in Huh7 cells, the CYP3A activity 
was inhibited to 60 to 70 %. 
 
(A) 
 
(B) 
 
 
Figure 5  
Inhibition of cytochrome P450 3A (CYP3A) activity by diazepam treatment of Poeciliopsis lucida cell-line 1 
(PLHC-1) cells (A) and human hepatoma (Huh7) cells (B). The CYP3A activity of PLHC-1 cells was inhibited 
significantly (p = 0.017) at 100 μM diazepam and at 200 μM (p < 0.0001) and at 20 μM (p = 0.002), 40 μM 
(p = 0.009), and at 80 μM (p = 0.004) in Huh7 cells. 
 
2.4 Discussion 
The aim of our present study was to develop a highthroughput procedure that allows the 
analysis of the effects of many different environmental chemicals and pharmaceuticals on 
fish CYP3A activity at the same time. The basic principle of existing CYP3A activity assays is 
to incubate CYP3A enzymes with a specific substrate for a few hours. During this time, the 
substrate is converted by the CYP3A enzymes into a product that is determined afterward. 
Different CYP3A substrates exist for the incubation step, but all of them are substrates for 
human CYP3A. In the present study, we decided to work with the human CYP3A substrate 
BFC, which is catalyzed by CYP3A and small contribution of CYP1A2 (Stresser et al., 2000; 
Stresser et al., 2002), that is converted into a fluorescent product by CYP3A. We first wanted 
to know whether this human CYP3A substrate is also metabolized by CYP3A enzymes of 
different fish. For this reason, we adapted the protocol from Mensah-Osman et al. to evaluate 
whether the human-specific CYP3A substrate BFC (Renwick et al., 2000; Stresser et al., 
2000) can also be catalyzed through fish CYP3A enzymes into the fluorescent product, as in 
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carp (Thibaut et al., 2006). As shown in Figure 1, fish CYP3A enzymes indeed can catalyze 
BFC. We demonstrate this in four cell lines from different tissues and different fish families. 
Surprisingly, the basal catalytic activities of PLHC-1 and FHM were even higher than that of 
the human Huh7, which was used as a control. The ZFL and RTG-2 cells showed lower 
enzyme activities than the human cells, but the detected signals were above the background 
level. After demonstrating that the human substrate is also a substrate for fish cells, we 
modified the existing protocol so that the whole procedure can be completely performed on 
microtiter plates. The cells were seeded on a 96-well plate, and after recovery overnight, the 
substrate BFC was added directly to the well. After incubation, the supernatant of each well 
was transferred to a new 96-well plate, loaded already with Stopp buffer, and the plate was 
read on a spectrofluorophotometer. Figure 2 demonstrates the same pattern of CYP3A 
activity as with the original protocol. Again, PLHC-1 and FHM cells showed higher CYP3A 
activity than Huh7 cells, and ZFL and RTG-2 cells again showed the lowest CYP3A activity. 
To verify that we actually measured CYP3A activity, we performed a number of control 
experiments to evaluate the effects of different cell numbers, different incubation times with 
the substrate, and different concentrations of the substrate. Figure 3A shows a clear 
correlation between the number of cells and measured fluorescence. There is also a good 
correlation between measured fluorescence and incubation time (Figure 3B): The longer the 
incubation time was, the higher the amount of fluorescence. The best results were obtained 
when the incubation time with the substrate was 5 h. This confirms that an enzyme activity 
was measured and not an artificial signal. We could also demonstrate a correlation between 
the concentration of BFC used and the measured fluorescence after incubation (Figure 3C 
and D). The highest fluorescence signal was detected when the cells were incubated with 
50 μM BFC. These results confirm again that we measured enzyme activity and not an 
artificial signal. Because we want to use this assay to evaluate the effects of different 
environmental pollutants and pharmaceuticals on CYP3A activity, we performed control 
experiments with the solvents that will be used later to dissolve the compounds. For this 
purpose, cells were incubated with 0.1 % solvent (DMSO or ACN) for 24 h, and the CYP3A 
activity was measured afterward. As shown in Figure 3E and F, there is no influence of the 
solvents on CYP3A activity. With all of these control experiments, we were able to set up the 
optimal conditions, namely, 5 h of incubation with 50 μM BFC, for the CYP3A assay that 
were used later for induction and inhibition experiments. To strengthen our newly developed 
assay, the effect of inducers and inhibitors on CYP3A activity was assessed. The CYP3A 
inducer rifampicin led to induction of CYP3A activity in PLHC-1 (Figure 4B), RTG-2 (Figure 
4C), and FHM (Figure 4D) cells, being significant already at 10 μM rifampicin. Compared with 
human control cells that show induction of enzyme activity up to 350 %, the fish CYP3A 
enzymes which show an induction up to 150 % are obviously less inducible than the human 
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CYP3A. In addition to the induction of CYP3A activity, our new cell assay is also suitable to 
detect an inhibition of enzyme activity by pharmaceuticals. A clear dose-dependent inhibition 
of the enzymatic activity is found with diazepam (Figure 5). Therefore, our cell assay is not 
only suitable for determining induction of CYP3A activity but also for detecting its inhibition. 
Our results clearly show that our modified protocol can be used to detect alteration in CYP3A 
activity by chemicals. The overall advantage of our assay lies in the fact that the whole 
procedure can be performed on microtiter plates. Specifically, different compounds or 
different concentrations of one compound can be investigated on one plate at the same time; 
most of the steps can be performed using multichannel pipettes, which reduces handling 
time and minimizes pipetting mistakes and moreover has the potential for adaption for a 
pipetting robot; and the assay is not expensive compared with existing CYP3A kits on the 
market. This assay can be used as a first screening step in the environmental risk 
assessment of pharmaceuticals. With this method, pharmaceuticals or chemicals can be 
screened easily with regard to their abilities to alter CYP3A activity. Identified compounds 
can be examined further, including the quantification of CYP3A activity. Another interesting 
potential of this assay is the comparison of different sensitivities of different fish species to 
environmental contaminants in regard to CYP3A activity alterations. The CYP3A activity and 
expression are regulated by PXR (Bresolin et al., 2005; Meucci and Arukwe, 2006). The PXR 
is a member of the nuclear hormone receptor superfamily. Pregnane X receptor functions as 
a ligand-activated transcription factor and regulates the metabolism, transport, and excretion 
of exogenous compounds, steroid hormones, vitamins, bile salts, and xenobiotics. Pregnane 
X receptor genes have been cloned and functionally characterized from a variety of 
vertebrate species, including human, rhesus monkey, mouse, rat, rabbit, dog, pig, chicken, 
frog, and zebrafish (Reschly and Krasowski, 2006). Like other nuclear receptors, PXRs have 
a modular structure with two major domains: an N-terminal DNA-binding domain and a larger 
C-terminal ligand-binding domain (LBD). The PXR LBD is unusually divergent across 
species, compared with other nuclear receptors, with only 50% sequence identity between 
mammalian and nonmammalian PXR sequences; other nuclear receptors tend to have 
corresponding sequence identities at least 10 to 20 % higher. Even the PXR DNA-binding 
domain, which is more highly conserved across species than the LBD, shows more cross-
species sequence diversity than other nuclear receptors (Krasowski et al., 2005; Reschly and 
Krasowski, 2006). Due to this diversity, we would expect different sensitivities of different fish 
species to pharmaceuticals in regard to the alteration of CYP3A activity. Future steps will be 
the use of this novel assay to screen pharmaceuticals for their abilities to alter CYP3A 
activity in different fish cell lines. This screening will help to identify compounds of 
ecotoxicological interest that subsequently will be investigated further.  
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Abstract 
 
We applied zebrafish whole genome microarrays to identify molecular effects of diazepam, a 
neuropharmaceutical encountered in wastewater-contaminated environments, and to 
elucidate its neurotoxic mode of action. Behavioral studies were performed to analyze for 
correlations between altered gene expression with effects on the organism level. Male 
zebrafish and zebrafish eleuthero-embryos were exposed for 14 d or up to 3 d after hatching, 
respectively, to nominal levels of 273 ng/L and 273 μg/L (determined water concentrations in 
the adult experiment 235 ng/L and 291 μg/L). Among the 51 and 103 altered transcripts at 
both concentrations, respectively, the expression of genes involved in the circadian rhythm in 
adult zebrafish and eleuthero-embryos were of particular significance, as revealed both by 
microarrays and quantitative PCR. The swimming behavior of eleuthero-embryos was 
significantly altered at 273 μg/L. The study leads to the conclusion that diazepam-induced 
alterations of genes involved in circadian rhythm are paralleled by effects in neurobehavior at 
high, but not at low diazepam concentrations that may occur in polluted environments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Brief: Effects of diazepam on gene expression and behavior in different life stages in 
zebrafish 
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3.1 Introduction 
In the last decade, steadily increasing levels of aquatic environmental residues of human and 
veterinary pharmaceuticals have continuously alerted the scientific community. As a result, 
multiple research efforts have been initiated to scrutinize possible input pathways and fate of 
these newly emerging pollutants. Additionally, effects on non-target species have been 
studied to protect prospectively the environmental health and to minimize exposure risks 
(Fent et al., 2006; Ankley et al., 2007; Kümmerer, 2008). Pharmaceuticals active on the brain 
and nervous system functions, including antidepressants, antipsychotics and anaesthetics 
are of direct environmental relevance because of their potential effects on non-target 
species. Based on evolutionarily conserved pharmacological targets, receptors and cellular 
biomolecules, environmental pharmaceuticals have been shown to provoke adverse effects 
such as hormonal dysfunction and neurotransmission disruption (Jones et al., 2007; 
Gunnarsson et al., 2008; Kostich and Lazorchak, 2008).  
 
A prominent representative pharmaceutical of this group is the environmental contaminant 
and highly prescribed neuropharmaceutical diazepam. Diazepam is the active ingredient of 
Valium® and belongs to the benzodiazepine group, which has widespread application in 
human medicine (Jouvel et al., 2000). Concentrations of up to 0.66 µg/L (van der Hoeven, 
2004) have been measured in effluents of sewage treatment plants. In surface water, 
concentrations have been found ranging from 0.04 µg/L in Germany (Ternes, 1998) to 
0.66 µg/L in Belgium (van der Ven et al., 2004). This substantial environmental exposure 
may lead to negative effects on non-target species.  
 
Benzodiazepines mechanism is through binding to the GABA receptor resulting in central 
nervous system (CNS) depression. In addition, diazepam has also anxiolytic, sedative, 
muscle-relaxant, anti-convulsive and anti-epileptic properties (Shader and Greenblatt, 1977). 
As in mammals, three subtypes of GABA target receptors (GABAA, GABAB and GABAC) 
occur in fish, and the binding site for benzodiazepines in the fish brain is suggested to be 
highly conserved between fish and mammals (Carr and Chambers, 2001). In non-target 
species acute diazepam toxicity in the high and chronic toxicity in the low mg/L range 
(Straub, 2008). The measured "no observed effect concentration" (NOEC) of diazepam in 
early life stage tests with D. rerio was found to be 273 μg/L, and the "lowest observed effect 
concentration" (LOEC) was found to be 2.57 mg/L (Straub, 2008). Exposure of fish to 
diazepam may impair locomotion (Zhdanova et al., 2001; Nunes et al., 2008), affect vision 
(Salas et al., 1992) and can produce anxiolytic effects at concentrations between 1.25 to 
5 mg/L, doses that do not cause sedation (Bencan et al., 2009). Nevertheless, there is a lack 
of chronic environmental toxicity studies concentrating on the modes of action on this 
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residual pharmaceutical (Fent et al., 2006). Furthermore, proper ecological risk assessments 
of diazepam at environmentally realistic concentrations in aquatic organisms have to be 
further investigated. 
 
Classical ecotoxicological tests, e.g. OECD guideline 204 (prolonged 14 d fish test), are 
important for risk assessment, but are often not sensitive enough to identify the subtle effects 
of pharmaceuticals. Adverse effects of pharmaceuticals may be more accurately determined 
by focusing on mode of action (Fent et al., 2006; Owen et al., 2007; Runnalls et al., 2007). 
Based on these considerations, the environmental consequences of diazepam deserve 
further attention, in particular as effects of diazepam on the global gene expression profile in 
aquatic organisms are unknown. 
 
In our present study, we determine the neurotoxic mode of action of diazepam in zebrafish to 
clarify potential molecular effects of this drug by analyzing the global gene expression after 
exposure for 14 d exposure. This toxicogenomics approach allows the identification of 
several thousand genes and the corresponding expression profiles upon drug exposure 
which will assist in the elucidation of both the molecular effects and the compound’s modes 
of action (Robbens et al., 2007). 
 
The aim of our study was to focus on the modes of action in the brain and in eleuthero-
embryos at low diazepam concentrations using a whole genome oligonucleotide microarray 
for zebrafish. By analyzing diazepam at the NOEC of zebrafish eleuthero-embryos (273 μg/L) 
we compared the effects on the transcriptional level with known effects in the early life stages 
test (Straub, 2008). Our hypothesis is that the response of zebrafish to diazepam exposure is 
similar to the human response, as the GABA receptors are evolutionary highly conserved. 
On this basis, we searched for alteration of gene expression patterns associated with 
anxiolytic or sedative effects. Thereby, we hypothesize that alterations in gene expression - 
because of multiple endpoints and mechanistic information - are more sensitive than 
physiological or morphological parameters (although they are perhaps less ecologically 
relevant). Moreover, we compared the global gene expression pattern in the brain to the 
behavior of zebrafish to analyze, whether the observed molecular effects may correlate with 
and propagate to higher levels of biological organization. In addition, gene expression 
analysis may also reveal unknown regulatory mechanisms in fish not directly related to the 
modes of action of diazepam in humans. 
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3.2 Materials and Methods 
3.2.1 Chemicals 
Diazepam (≥ 99%, MW: 284.74, logKOW: 2.82-2.99) was kindly supplied by F.Hoffmann- La 
Roche Ltd (Basel Switzerland). Acetonitrile was purchased from Brunschwig 
(Basel,Switzerland), methanol and isopropanol were from Stehelin (Basel, Switzerland). 
NaH2PO4, Na2HPO4, HCl, chloroform, ammonium hydroxide and phosphoric acid were 
obtained from Sigma Aldrich (Buchs, Switzerland). Paraffin tissuewax, xylol, UltraClear and 
hematoxylin were purchased from Medite (Nunningen, Switzerland) and eosin from Carl 
Zeiss AG (Feldbach, Switzerland). 
 
3.2.2 Maintenance of zebrafish 
Juvenile zebrafish (Danio rerio) were obtained from Harlan Laboratories (Itingen, 
Switzerland). They were transferred to culture tanks (300 L) and raised for 4 months in our 
laboratory. Fish were held in reconstituted tap water with a total hardness of 125 mg/L as 
CaCO3 and a conductivity of 270 μS/cm. The water temperature was held constant at 
27±1 °C with the photoperiod set at 16:8 h light/dark. Fish were fed twice daily with TetraMin 
pellets (Tetra GmbH, Melle, Germany) ad libitum, once a day with brine shrimp (Artemia 
salina) and twice a week with Daphnia magna. 
 
3.2.3 Exposure experiment  
Exposure of adult males. The experimental setup consisted of four replicates of water 
controls and two diazepam doses. Twenty male zebrafish per replicate were held in 20-L 
stainless steel tanks in well-aerated exposure water. Fish were exposed for 14 d to the 
nominal concentrations of 273 ng/L and 273 μg/L diazepam, respectively. The lower 
concentration (273 ng/L) was assumed to represent the worst case environmental 
concentration, and 273 μg/L refers to the NOEC in the early life stages test (Straub, 2008). 
During the experiment fish survival, appearance and behavior were determined.  
 
A 48 h static-renewal procedure was used to minimize handling stress for the fish. Thereby 
after 24 h, food remains and feces were removed by siphoning 1/3 of the water and 
replacement by new exposure water containing the appropriate diazepam concentrations. 
After 48 h, the water renewal procedure was repeated, but this time by replacing total tank 
water (20 L). The quality of the exposure water was continuously monitored by the oxygen 
concentration determination (>70%), the pH value (6.7-7.2) and the temperature (27±1 °C). 
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Mortality and abnormal behavior were recorded daily. At the end of the experiment (day 14), 
all fish were anaesthetized in a clove oil solution (Fluka AG, Buchs, Switzerland). Individual 
fish length and weight was measured in order to assess the condition factor 
(CF=weight(g)/length(mm) x 100). The brain of each fish was dissected after 14 d and stored 
in RNAlater. A total of 15 brains were pooled for microarray analysis and for quantitative real-
time polymerase chain reaction (qRT-PCR) confirmation. 
 
Eleuthero-embryo exposure. The static exposure setup consisted of six replicates of water 
control and two diazepam doses. A total of 15 fertilized eggs per replicate were exposed up 
to 3 d after hatching to nominal concentrations of 273 ng/L and 273 μg/L diazepam, 
respectively. Every 24 h, lethal and sublethal effects were evaluated and dead eleuthero-
embryos were removed. The quality of the exposure water was continuously monitored by 
oxygen concentration determination (>70%), the pH value (6.7-7.2) and the temperature 
(27±1 °C). At the end of exposure, eleuthero-embryos were anaesthetized a clove oil 
solution. A total of 15 eleuthero-embryos per replicate were pooled in RNAlater for qRT-PCR. 
RNA was extracted using the RNeasy Mini Kit (Qiagen, Basel, Switzerland). 
 
3.2.4 Chemical analysis 
To determine actual exposure concentrations, 250-mL aliquots of exposure water were taken 
during the experiment for diazepam concentration analysis. Water samples of each treatment 
group were taken at the beginning (0 h), before siphoning (24 h) and prior to full water 
renewal (48 h). This was done on days 1 to 3, 7 to 9 and 11 to 13, respectively, from different 
randomly selected replicate tanks. The water samples were stored at -20 °C until analysis by 
HPLC. Extraction of water samples was performed according to (Cordero and Paterson, 
2007) and chemical analysis according to (Rouini et al., 2008). The chemical analysis was 
performed separately for the microarray experiment and the behavior experiment. Due to 
limited amounts of exposure water, the concentration in the exposure water of the eleuthero-
embryos experiment could not be measured. 
 
3.2.5 RNA isolation, array hybridization and sample selection 
Total RNA was extracted from zebrafish brain pools using the RNeasy Mini Kit (Qiagen, 
Basel, Switzerland). RNA concentrations were measured spectrophotometrically using a 
NanoDrop ND-1000 UV-VIS Spectrophotometer at 260 nm. The integrity of each RNA 
sample was verified using an Agilent 2100 Bioanalyzer (Agilent Technologies, Basel, 
Switzerland). Only samples containing a 260/280 nm ratio between 1.8-2.1, a 28S/18S ratio 
between 1.5-2 and an RNA integrity number (RIN) > 8 were processed further. A total of 12 
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arrays (Agilent 4 × 44 K Zebrafish microarray) were used, including four for the control group, 
four for the 273 ng/L and four for the 273 μg/L diazepam dose group. Total RNA samples 
(600 ng) were reverse-transcribed into double-strand cDNA in the presence of RNA poly-A 
controls with the Agilent One-Color RNA Spike-In Kit.  
 
3.2.6 Cy3 labeling and hybridization 
After reverse-transcription of RNA into double-stranded cDNA, double-strand cDNA was in 
vitro transcribed into cRNA in the presence of Cy3 labeled nucleotides using a Low RNA 
Input Linear Amp Kit +Cy dye (Agilent Technologies, Basel, Switzerland), performed at the 
Functional Genomic Centre of ETH and University of Zürich, Switzerland. The Cy3-labeled 
cRNA was purified using an RNeasy mini kit (Qiagen, Basel, Switzerland), and quality and 
quantity was determined using a NanoDrop ND-1000 UV-VIS Spectrophotometer and an 
Agilent 2100 Bioanalyzer, respectively. Only cRNA samples with a total cRNA yield higher 
than 2 µg and a dye incorporation rate between 9 pmol/µg and 20 pmol/µg were used for 
hybridization. Cy-3-labeled cRNA samples (1.65 µg) were mixed with Agilent blocking 
solution, subsequently fragmented randomly to 100-200 bp at 65 °C with fragmentation 
buffer and resuspended in hybridization buffer as provided by the gene expression 
hybridization Kit (Agilent Technologies). Target cRNA samples (100 µL) were hybridized to 
the Agilent Zebrafish 4x44K Gene Expression Microarray for 17 h at 65 °C. The hybridized 
arrays were then washed using Agilent GE wash buffers 1 and 2 according to the 
manufacturer's instructions and scanned by an Agilent Microarray Scanner (Agilent p/n 
G2565BA) at 5 μm resolution with the green photomultiplier tube set to 100% and a scan 
area of 61 x 21.6 mm. Image generation and feature extraction was performed using the 
Agilent Feature Extraction (FE) software version 9.5.3. Quality control was additionally 
considered before performing the statistical analysis. These included array hybridization 
pattern inspection: absence of scratches, bubbles, areas of non-hybridization, proper grid 
alignment, spike performance in controls with a linear dynamic range of 5 orders of 
magnitude and the number of green-feature non-uniformity outliers which should be below 
100 for all samples. 
 
3.2.7 qRT-PCR analysis 
Eight differentially expressed genes of interest were selected for microarray result 
confirmation using qRT-PCR. Gene-specific primers were designed based on published 
zebrafish sequences (Table 1). Total RNA from a pool of 15 zebrafish brains and a pool of 15 
eleuthero-embryos was isolated as described above (n = 5 replicates for adults, and n = 6 
replicates for eleuthero-embryos). 
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1 μg of total RNA template was reverse-transcribed using Moloney murine leukemia virus 
reverse transcriptase (Promega Biosciences Inc., Wallisellen, Switzerland) in the presence of 
random hexamers (Roche Diagnostics, Basel, Switzerland) and deoxynucleoside 
triphosphate (Sigma-Aldrich, Buchs, Switzerland). The reaction mixture was incubated for 5 
min at 70 °C and then for 1 h at 37 °C. The reaction was stopped by heating at 95 °C for 5 
min. 
 
Table 1             
Primer sequences for quantitative real-time PCR analysis.        
Probe ID Gene Sequence Accession # dir Sequence 
Ampl. 
size 
- RpL13α NM_212784 fw 
rv 
agc tca aga tgg caa cac ag 
aag ttc ttc tcg tcc tcc 
100 bp 
A_15_P121171 arntl2 NM_131578.1 
fw 
rv 
gtg tca acc aac acg gtt gta tcc 
tgg aac ttg ttg gga ttt ctt ggc 
120 bp 
A_15_P106879 arr3 NM_200792 
fw 
rv 
cat gat ggg agg tgg act ct 
act tgc tcc tca ctg gct gt 
140 bp 
A_15_P173191 cry2b NM_131792 
fw 
rv 
aaa cga cgc atc gtc tta tag 
aat tcg tgg ttg tgg tcc g 
138 bp 
A_15_P103946 cry5 NM_131788.1 
fw 
rv 
cat gga gag aac gaa ctg gg 
gtg cag aca agc agc cga ac 
115 bp 
A_15_P191501 gabrr OTTDART00000004249 
fw 
rv 
acg tca tgc gag tgc 
tcg tcg tca gta tag gcg tag 
151 bp 
A_15_P104177 hsd17b3a NM_200364.1 
fw 
rv 
ttc acg gct gag gag ttt g 
gga ccc agg tag gaa tgg 
121 bp 
A_15_P187316 nr1d1 NM_205729.1 
fw 
rv 
gtg aac aac cag ctg cag aa 
act gta agg cct gga cat gg 
125 bp 
A_15_P236266 per1 NM_001030183.1 
fw 
rv 
atg cgt gca aga agt ggt g 
acg tcc tca ttt agc gga ctc 
131 bp 
 
arntl2 (aryl hydrocarbon receptor nuclear translocator-like 2), arr3 (arrestin 3, retinal), cry2b (Cryptochrome 2b), cry5 
(Cryptochrome 5), gabrr (gamma-aminobutyric acid (GABA) receptor, rho 1), hsd17b3 (hydroxystereoid (17-beta) 
dehydrogenase 3), nr1d1 (nuclear receptor subfamily 1, group d, member 1), per1 (period homolog 1), a Hoffmann et al., 2008 
 
The cDNA was used to perform SYBR-PCR based on SYBR-Green Fluorescence (FastStart 
Universal SYBR Green Master, Roche Diagnostics, Basel, Switzerland). The following PCR 
reaction profile was used: one cycle at 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 
sec, and 61 °C for 60 sec followed by a melting curve analysis post run.  
 
The delta CT value was derived by subtracting the threshold cycle (CT) value for the 
housekeeping gene (RpL13α), which served as an internal control, from the CT value of the 
target gene, respectively. All reactions were run in duplicate using the Biorad CFX96 
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RealTime PCR Detection System (Biorad, Reinach, Switzerland). The mRNA expression 
level of the different genes was expressed as fold-increase according to the formula:  
 
2∆CT(untreated sample)- ∆CT(treated sample). 
 
PCR efficiencies for each primer were determined from a standard curve using dilutions of 
pooled brain cDNA (r2>0.96 for all primers). Due to the high efficiency no corrections in the 
calculation of the delta CT were necessary. 
 
3.2.8 Measurement of locomotor activity 
Multispecies Freshwater Biomonitor®. Diazepam effects on locomotor activity were measured 
in both male zebrafish and zebrafish eleuthero-embryos. Fish activity was observed using 
flow-through test chamber with quadrupole impedance conversion as measuring device, 
connected to a measuring unit and personal computer with data analysis software (Gerhardt 
et al., 1994). 
 
Measurement chambers, made of an acryl glass cylinder sealable on both ends, with a size 
of 15 cm in length and a diameter of 5 cm for the adult fish, and of 4 cm in length and a 
diameter of 2 cm for the eleuthero-embryos, allowed free movement during measurement. 
To measure locomotor activity, 12 male zebrafish were exposed to nominal concentrations of 
273 ng/L (measured 330 ng/L) or 273 μg/L (measured 260 μg/L) diazepam in addition to a 
water control for 14 d in stainless steel aquaria as described above. After 3 d and 14 d of 
diazepam exposure the animals were placed into the measurement chambers placed in a 
stainless steel aquaria filled with 15 L uncontaminated water. The chambers themselves 
were laid horizontally on the bottom of the test tanks. Following an acclimation time of 2 h 
measurements were started and behavior of 12 male zebrafish per treatment was 
continuously recorded at intervals of 10 min for a 24 h duration. Behavioral recording during 
these intervals lasted for 4 min each. 
 
For eleuthero-embryos locomotor activity measurements, fertilized eggs were exposed to 
273 ng/L or 273 μg/L diazepam as described above. Locomotor activities of hatched 
eleuthero-embryos were assessed 3 d after hatching for 20 eleuthero-embryos per diazepam 
dose and the water control, respectively, as described above. Following an acclimation 
phase of 10 min measurements were started and behavior was monitored with a recording 
duration lasting 4 min for a period of 2 h with intervals of 10 min each. For locomotor activity 
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measurements, means of locomotor activities (% time spent on locomotion) for each fish 
were calculated for two hours during the 2-h or 24-h time period. 
 
3.2.9 Histological analysis of testes 
The testes of 14-19 male fish per group were examined histologically to reveal diazepam 
induced changes. Whole animals were fixed in neutral buffered formalin (Roth, Arlesheim, 
Switzerland), dehydrated in graded ethanol and xylene, paraffinized in a tissue processor 
(Gewebeentwässerungsautomat TPC 15 Duo; Medite, Nunningen (Switzerland)) and 
embedded in paraffin wax. Cross sections of 4.5 μm thickness were stained with hematoxylin 
and eosin. Sections were examined microscopically to determine the fish reproductive 
condition (staging according to Schulz et al 2009). The testes were analyzed 
histomorphometrically (Olympus BX41, Olympus Schweiz AG, Volketswil, Switzerland) by 
counting and categorizing the spermatogenic cysts (spermatogonia, spermatocytes, mature 
spermatozoa) at 40x magnification. 
 
3.2.10 Data analysis and statistics 
Raw microarray data was analyzed using the GeneSpring GX 10 software (Agilent 
Technologies). In a first step, the Agilent Feature Extraction software output was filtered on 
the basis of feature saturation, non-uniformity, pixel population consistency and signal 
strength relative to back ground level (Agilent Feature Extraction Manual). Only positively 
marked entities, in which at least 50% of the values for any out of the three conditions were 
accepted for further evaluation. All data was quantile normalized. In a second step, several 
quality control steps (e.g. correlation plots and correlation coefficients, quality metric plots 
and PCA) using the quality control tool of GeneSpring were performed to ensure that the 
data were of good quality.  
 
Differentially expressed genes from the microarray were determined using a Benjamini-
Hochberg multiple correction-ANOVA test (p<0.05), followed by a TukeyHSD post-hoc test. 
The genes were considered differentially expressed when p<0.05 and the fold change 
(FC)≥2. To determine gene ontology (GO) categories of differentially expressed genes, the 
GO analysis tool in GeneSpring GX 10 was used. Only those categories where p<0.05 were 
considered differentially altered. MetaCore TM (GeneGo, San Diego, CA) was used to 
identify and visualize the involvement of the differentially expressed genes in specific 
pathways (FDR< 0.05). The microarray data used in this analysis have been submitted to 
NCBI GEO database under accession number GSE23157 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=nfudjckukeakytk&acc=GSE23157). 
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Data from qRT-PCR, locomotor activity and histology were illustrated graphically with 
GraphPad® Prism 5 (GraphPad Software, San Diego, CA, USA). Data distribution for 
normality was assessed with the Kolmogorov-Smirnov test and the variance homogeneity 
with the Bartlett test. Differences between treatments were assessed by analysis of variance 
followed by a Tukey test (Bartelett test p<0.05) to compare treatment means with respective 
controls. Results are given as mean ± standard error of mean. Differences were considered 
significant at p≤0.05. 
 
3.3 Results and Discussion 
3.3.1 Alteration of gene expression by diazepam 
Diazepam concentrations in the exposure water were measured at 0, 24 and 48 h in order to 
determine the actual exposure concentrations (Table 2). At nominal 273 ng/L, diazepam 
concentration was 243±16 ng/L (n=3) at 0 h and decreased to 225±30 ng/L (n=3) at 48 h, but 
this was not significant. At 273 μg/L, diazepam decreased from 315±16 μg/L (n=3) to 
272±6 μg/L (n=3). The geometric mean of actual exposure concentrations were 235 ng/L and 
291 μg/L. In none of the treatment groups, mortalities occurred. No significant differences on 
condition factors (CF) were noted (Table 3, Figure 1).  
 
Table 2  
Nominal concentration and measured concentrations of diazepam in exposure waters after 14 days of exposure 
Nominal 
concentration 
Exposure waters 
Measured concentration 
0h % of nominal 24h 
% of 
nominal 48h 
% of 
nominal 
Geometric 
Mean 
273 ng/L 242.9±16 ng/L 89 236.8±23 ng/L 87 225.4±30 ng/L 82 235 ng/L 
273 μg/L 314.9±16 μg/L 115 287.6± 10 μg/L 101 272.4±6 μg/L 104 291 μg/L 
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Table 3  
Body weight, length and Condition Factor (CF) of exposed fish after 14 days of exposure (n = 20 males per 
treatment) to 235 ng/L and 291 μg/L diazepam. 
 Exposure (μg/L) Survival (%) 
Male 
Body weight (mg) Body length (mm) CF 
Control Water 100 372.97 ± 15.1 36.54 ± 0.4 0.76 ± 0.01 
      
Diazepam 0.235 100 364.48 ± 5.2 35.92 ± 0.3 0.79 ± 0.02 
 291 100 372.35 ± 23.5 35.73 ± 0.7 0.82 ± 0.01 
 
 
 
 
Figure 1   
Condition factor (CF) of male zebrafish. Controls (white bar) and fish exposed to 235 ng/L and 291 μg/L diazepam 
(black and grey bar). Values are means ± SEM (n = 20 males). Measured median diazepam concentrations are 
given. 
 
Gene expression profiles derived from microarray results of control and diazepam-exposed 
adult zebrafish brains (control, n = 3; diazepam, n = 4) are based on 15 pooled individuals. 
To test the data quality normalized data were then subjected to a PCA. As shown in Figure 2, 
the replicates of the 235 ng/L diazepam treatment group differ less from the control than the 
replicates from the 292 μg/L diazepam treatment group. The similarity to the control group is 
also reflected in the fact that fewer genes were significantly regulated in the lower 
concentration (Appendix 1 Table 1). 
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As listed in Appendix 1 Table 1, 51 and 103 genes were differentially expressed in the brain 
of male zebrafish (log2>2, p<0.05) after exposure 235 ng/L and 291 μg/L diazepam, 
respectively. At 235 ng/L diazepam, 31 (61 %) genes were down-regulated, and 20 (39 %) 
up-regulated. Of the 103 genes differentially expressed at 292 μg/L diazepam 59 (57 %) 
genes were down-regulated, and 44 (43 %) were up-regulated. All 51 genes differentially 
expressed at the lower dose of 235 ng/L were also altered at 291 μg/L, and all of them were 
regulated in the same direction. Comparing our results with those obtained in goldfish 
(Popesku et al., 2008), it seems that different compounds acting as GABA agonists alter 
similar gene families. Similar to our study alterations in the aldehyde dehydrogenase family, 
GABA receptor subunits, hydroxysteroid dehydrogenase family, solute carrier, rev erb family, 
DnaJ-like genes and in the per3 gene have been observed. Diazepam is an allosteric 
modulator of the GABAA receptor, which is an inhibitory channel and can decrease the 
neuronal activity in its activated form (Sigel and Buhr, 1997). The GABAA receptor effects 
chloride permeability and hence, voltage dependent transmission of neural signals. 
Interference with this receptor will primarily affect neuronal activity, but not gene expression 
or cellular signal transduction pathways that may lead to changes in gene expression. 
Therefore, effects of diazepam on gene expression may be regarded as a secondary mode 
of action and side effects not directly related to the neurotoxic mode of action. On the other 
hand, the data may indicate hitherto unknown links and pathways related to the action of 
diazepam in the brain. In case of neuropharmaceuticals other than GABA agonists such as 
mianserin (van der Ven et al., 2006) alteration of other gene transcripts occur, as they act in 
a different manner. 
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Figure 2  
Three major dimensions of unsupervised PCA analysis. Brown dots are the control samples, red dots are the 
235 ng/L diazepam treated samples, blue dots are the 291 μg/L diazepam treated samples. There exists a 
hyperplane that divides treated samples from untreated samples, so there is enough separability. However, 
samples do not group in concise clusters, so we have to consider all replicates within treatment. 
 
Gene Ontology (GO) analysis was performed to identify functional groups of genes of 
interest. GO defines terms representing gene product properties and covers three domains 
namely cellular components, molecular functions and biological processes. At 235 ng/L 
diazepam, functionally identified genes fell into 57 different categories and at 291 μg/L 
diazepam into 40 categories. The following 8 categories shown in Figures 3A and 3B contain 
the highest percentage of differentially expressed genes: DNA photolyase activity, 
photoperiodism, IMP dehydrogenase activity, rhythmic process, circadian rhythm, GMP 
metabolic process, GMP biosynthetic process and response to temperature stimulus. In all of 
these 8 functional groups, a higher percentage of differentially expressed genes occurred at 
291 μg/L diazepam as compared to 235 ng/L. Among those categories, alteration of genes 
involved in rhythmic processes, especially in the circadian rhythm, is of particular 
significance.  
 
 
 
235 ng/L 
control 
291 μg/L 
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Figure 3  
Gene Ontology categories of differentially expressed genes (fold change (log2) ≥ 2; p < 0.05) in zebrafish brain 
after exposure to (A) 235 ng/L and (B) 291 μg/L diazepam. Values are calculated as the percent of differentially 
expressed genes out of the total number of significantly altered genes. 
 
Through GABAeric influence on the hypothalamic suprachiastic nuclei (SCN), diazepam has 
been shown to affect the circadian rhythm in mammals (Carpentieri et al., 2006). The 
activation of the GABAA receptor can mediate phase-shifting in the circadian clock (Smith et 
al., 1989). In addition, GABAA receptor activation can lead to gene expression changes of 
circadian rhythm genes in mammals (Akiyama et al., 1999; Novak et al., 2006). However, the 
mechanism of this gene expression alteration is not fully understood. It is hypothesized that 
different stimuli - in our present study GABAA receptor activation by diazepam- can alter the 
phase of the circadian clock by increasing and decreasing the expression of different clock 
genes (Albrecht, 2002; Nishii et al., 2006). GABA receptors are highly conserved and occur 
also in fish (Carr and Chambers, 2001). Due to their high homology of up to 90% with the 
human GABA receptors, a similar mode of action in fish is expected (Christen et al., 2010). 
Indeed, diazepam showed a dose-dependent effect on the regulation of genes involved in 
the circadian rhythm (Table 4), including the down-regulation of period genes, which is in 
agreement with data in mice (Akiyama et al., 1999).  
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Table 4  
Fold changes of selected genes involved in the circadian rhythm, whose expression was significantly altered in 
male zebrafish brain after 14 d exposure at 235 ng/L and 291 μg/L (fold change (log2) ≥ 2; p < 0.05) 
 Fold change (log2) 
Gene name 235 ng/L diazepam (measured conc.) 
291 μg/L diazepam 
(measured conc.) 
aryl hydrocarbon receptor nuclear translocator-like 
1a (arntl1a) 2.2 2.7
aryl hydrocarbon receptor nuclear translocator-like 
1b (arntl1b) 2.4 3.2
aryl hydrocarbon receptor nuclear translocator-like 2 
(arntl2) 2.7 5.6 
basic helix-loop-helix domain containing, class B, 2 
(bhlhb2) - - 3.1
basic helix-loop-helix domain containing, class B, 3 
like (bhlhb3l) - 2.3 - 3.5
cryptochrome 1b (cry1b) - 2.5 - 3.2
cryptochrome 2b (cry2b) 1.7 3.3
cryptochrome 3 (cry3)  - 2.1 - 2.8
cryptochrome 4 (cry4) 1.5 2.1
cryptochrome 5 (cry5) - 3.6 - 4.3
cryptochrome DASH (cry-dash) - 3.2 - 3.9
nuclear factor, interleukin 3 regulated (nfil3) 2.1 2.5
nuclear receptor subfamily 1, group d, member 1 
(nr1d1) - 6.3 - 3.1
Rev-erbgamma A (nr1d4a) 1.6 4.4
Rev-erbgamma B (nr1d4b) 2.4 10.5
period homolog 1 (per1) - 5.8 - 4.5
period homolog 3 (per3) - 3.3 - 7.9 
period homolog 4 (per4) - 3.8 - 6.5
rar related orphan receptor C (rorcb) 4.8 7.4
 
Further experiments are needed to unravel the role of circadian rhythm gene expression 
alteration as a result of diazepam toxicity. Gene knock-downs of circadian rhythm genes 
could help to elucidate these observed gene expression changes. Additionally to the GO 
analysis, we performed a pathway analysis with MetaCore. The circadian rhythm is the most 
significantly altered pathway (Table 5).  
 
In order to confirm microarray results, qRT-PCR was performed for selected genes. Five 
genes belonging to the circadian rhythm, arntl2, cry2b, cry5, nr1d1 and per1 were selected. 
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Additionally, the differential expression patterns of arr3, gabrr1 and hsd17b3 were verified as 
shown in Figure 4 and Table 6. The expression of arntl2 and cry2b showed a dose-
dependent induction in adult fish, and a dose-dependent down-regulation in case of cry5, 
nr1d1, per1, arr3, gabrr1 and hsd17b3 (Figure 4, Table 6). The differential expression of 
these genes upon exposure of adult male zebrafish was confirmed in zebrafish eleuthero-
embryos exposed to the same nominal concentrations of 273 ng/L and 273 μg/L diazepam 
(15 eleuthero-embryos pooled for each of the six replicates).  
 
Table 5   
Relevant pathways represented in MetaCore (FDR< 0.05). 
Pathway Pathway Group Cell Process p-Value Gene 
Circadian rhythm  Neurophysiological process 1.31E-10 6/47 
Putative SUMO-
1 pathway Protein degradation Proteolysis 2.83E-2 1/29 
Urea cycle Protein degradation  6.70E-2 1/70 
Polyamine 
metabolism Apoptosis  6.80E-2 1/71 
GnRH signalling  Reproduction 6.89E-2 1/72 
(L)-Arginine 
metabolism 
Aminoacid metabolism and 
its regulation   7.26E-2 1/76 
GTP-XTP 
metabolism 
Nucleotide metabolism 
and its regulation  8.54E-2 1/90 
Arginine 
metabolism 
Aminoacid metabolism and 
its regulation  9.18E-2 1/97 
 
The same genes were up- and down-regulated, respectively. These changes in transcripts 
were particularly found in genes involved in the circadian rhythm. It is known that the 
circadian clock becomes functional already on the first day of development in zebrafish 
embryos (Dekens and Whitmore, 2008). Although the same trends in the expression pattern 
occurred in the microarray and qRT-PCR data of adult fish and eleuthero-embryos for most 
of the genes, statistical significance and absolute fold-change differed between the methods 
and developmental stages. Exceptions were gabrr1 and hsd17b3, which presented an up-
regulation in eleuthero-embryos, but a down-regulation in adults (both microarray and qRT-
PCR data).The alteration of a nearly identical set of genes at both concentrations in adults 
and eleuthero-embryos demonstrates that the effect of diazepam is consistent in both life 
stages, showing effects on gene expression already at nominal concentrations of 273 ng/L. 
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The almost identical pattern of gene expression profiles also indicates that diazepam acts 
through a neuropharmacological mode of action in fish on a molecular level, similar to that in 
mammals. This supports the notion that pharmaceuticals should be assessed for potential 
environmental risks through their mode of action.  
 
Table 6  
Fold changes of selected genes differentially regulated in zebrafish brain determined by microarray and qRT-PCR 
in adult zebrafish brain as well as qRT-PCR determination in zebrafish eleuthero-embryos after exposure to low 
concentration (235 ng/L) and high concentration (291 μg/L) of diazepam (adults) and nominal 273 ng/L and 
273 μg/L (eleuthero-embryos), respectively. Values are expressed as average fold change (log2). 
 Fold Change (log2) 
Gene name 
low concentration diazepam   high concentration diazepam  
Array 
(adult) 
qRT-PCR 
(adult) 
qRT-PCR 
(eleuthero-
embryos) 
 
Array 
(adult) 
qRT-PCR 
(adult) 
qRT-PCR 
(eleuthero-
embryos) 
aryl hydrocarbon receptor 
nuclear translocator-like 2 
(arntl2) 
2.7 1.5* 0.8*  5.6 2.8* 2.0* 
cryptochrome 2b (cry2b) 1.7 0.9* 1.6*  3.3 1.8* 2.7* 
cryptochrome 5 (cry5) - 3.6 -1.8* -0.8*  - 4.3 -1.9* -1.3* 
nuclear receptor subfamily 
1, group d, member 1 
(nr1d1) 
- 6.3 -2.7* -1.0  - 3.1 -1.7* -1.3 
period homolog 1 (per1) - 5.8 -2.5* -2.0*  - 4.5 -2.2* -3.6* 
arrestin 3, retinal (X-
arrestin) (arr3) - 3.8 -0.7 -0.5  - 4.4 -1.7* -0.7 
gamma-aminobutyric acid 
(GABA) receptor, rho 1 
(gabrr1) 
-2 -1.2* 0.2  - 4.1 -2.3* 0.04 
hydroxysteroid (17-beta) 
dehydrogenase 3 
(hsd17b3) 
- 1.6 -0.3 0.2  - 2.3 -1.1* 0.6 
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Figure 4  
Comparison of gene expression in zebrafish brain determined by microarray (n = 4 replicates, 15 male fish 
pooled, white bars), qRT-PCR (n = 5, 15 male fish pooled, grey bars) determined in zebrafish brain and qRT-PCR 
measured in zebrafish eleuthero-embryos (n = 6, 15 eleuthero-embryos pooled, black bars) after exposure to 
nominal 273 ng/L and 273 μg/L diazepam, respectively. Values are expressed as average fold change (log2) with 
standard error compared to control animals as indicated for selected genes. Asterisks, statistically significant 
difference to control (p < 0.05). 
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3.3.2 Effects of diazepam on the circadian rhythm and locomotor activity 
In mammals, the circadian rhythm controls a diversity of behavioral and physiological 
rhythmic processes such as regulation of sleep wakefulness, secretion of hormones and 
locomotor activity (Hastings, 1997). Therefore, a second set of experiments was performed 
to evaluate whether changes found in the gene expression pattern of circadian genes in the 
brain were paralleled by changes in the locomotor activity of adult zebrafish and eleuthero-
embryos. The behavioral experiments revealed that adult males did not show statistically 
significant differences to controls in their locomotor activity, both after 3 and 14 d of exposure 
to diazepam (Figure 5). We chose two time-points (3 and 14 d) to test for possible tolerance 
to diazepam, as found in Gambusia holbrooki (Nunes et al., 2008). The lack of significant 
changes in locomotion in adult fish may be interpreted in a way that the gene alterations 
were not propagated to significant behavioral changes, or alternatively as rapid tolerance 
against diazepam exposure. However, there is a dose-dependent trend to a more locally 
restricted swimming behavior after the 14-d exposure, which is interpreted as an indication of 
the known sedative effect of diazepam (Figure 5). 
 
(A)             (B) 
  
Figure 5  
Comparison of the locomotor activity (percent of total time spent in locomotion during 2 h) of adult D. rerio 
exposed for 14 d to 330 ng/L and 260 μg/L diazepam and held in water (control). (A) Active swimming behaviour 
showing a slight decrease in diazepam treated fish. (B) Locally restricted swimming and ventilation showing a 
slight increase in diazepam treated fish. Significant differences between treatments: *p < 0.05.  
 
In eleuthero-embryos the locomotor activity at nominal concentration of 273 μg/L diazepam 
was distinctly different from that of control eleuthero-embryos. The diazepam-exposed 
eleuthero-embryos featured higher activity with less pauses. Movement patterns of controls 
(Figure 6A) differed from that of diazepam-exposed eleuthero-embryos (Figure 6B). The 
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locomotor activity was significantly increased at 273 μg/L diazepam compared to eleuthero-
embryos exposed to 273 ng/L and the controls, which did not differ from each other 
(Figure 7). This indicates that eleuthero-embryos seem to react more sensitive in their 
behavior than adults and that diazepam provoked a “paradoxical reaction”, e.g. restlessness 
instead of sedation. This observation was also made in children, who became hyperactive 
after administration of diazepam (Saias and Gallarda, 2008). However, it was observed that 
zebrafish eleuthero-embryos locomotor activity was reduced when treated with 1 μM 
(284.7 μg/L) diazepam (Zhdanova et al., 2001). The discrepancy to our observation may be 
explained that the locomotor activity was determined in the dark, whereas we measured it in 
the light.  
 
(A) 
  
  
(B)  
  
Figure 6  
Typical examples of spontaneous locomotor movement patterns. Movement pattern (left; amplitude (V) vs. 
time (s) recorded over 250 s) and fast Fourier transformation (FFT) histogram (right; activity in % of the time 
(250 s)). (A) Control D. rerio eleuthero-embryos. (B) D. rerio eleuthero-embryos treated with 273 μg/L diazepam 
showing an increased locomotor activity. The red bars in the FFT histogram (right) indicate the different 
frequencies of locomotion and ventilation. Signals for locomotion were in the range of 0.5 to 2.5 Hz (green bar 
left), and frequencies for ventilation lay above 2.5 Hz (green bar right). 
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Figure 7  
Comparison of the locomotor activity (percent of total time spent in locomotion during 2 h) of D. rerio eleuthero-
embryos exposed for up to 3 d after hatching to nominal concentration of 273 ng/L and 273 μg/L or water control. 
Asterisks, significant differences between treatments (p < 0.05).  
 
3.3.3 Effects of diazepam on hsd17β3 expression and testis histology 
(unpublished data) 
In mammals testosterone formation and inactivation are performed by different members of 
the hsd17β enzymes. Zebrafish hsd17β3 catalyzes the conversion of androstenedione to 
testosterone in vitro (Mindnich et al., 2005). In our study, we demonstrated that hsd17β3 is 
significantly down-regulated after exposure to diazepam (Figure 4, Table 6). In order to 
assess potential physiological and histological effects of this down-regulated gene, the testes 
of exposed adult zebrafish were analyzed histologically. In males exposed to 235 ng/L and 
291 μg/L diazepam, we observed no statistically significant alterations in the frequency of 
different development stages of sperms (spermatogonia, spermatocytes and spermatides) in 
the seminiferous tubuli. However, a tendency to an altered pattern of the different stages of 
sperms in the seminiferous tubuli was observed, which was characterized by the occurrence 
of more interstitial tissue (Figure 8). In the interstitial tissue Leydig cells, harboring a 
GABAergic system, are mainly found. In humans it was shown that GABA and 
benzodiazepines are able to stimulate Leydig cell proliferation and regulate the steroid 
synthesis by Leydig cells via the GABAA receptor (Geigerseder et al., 2004). Our results are 
in agreement with this observation, but are in contrast to results obtained in rats, where 
shrinkage of seminiferous tubules and a significant reduction of spermatocytes occurred. 
Additionally, the Leydig cells were small and there were wide gaps between the 
spermatocytes (Siddiqui et al., 2008). In our study using microarrays, we identified mainly the 
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alteration of genes involved in regulation of the circadian rhythm as a significant mode of 
action of diazepam in zebrafish. Nevertheless, attention should also be placed on other 
mechanisms such as alteration of steroidogenesis.  
 
  
Figure 8  
Histology of zebrafish testes; of (A) control male and (B) male exposed to 291 μg/L diazepam. 
SG= spermatogonia; SC= spermatocytes; M= mature spermatids; IT = interstitial tissue. 
 
In our study we show that the response of zebrafish to diazepam is similar to the human 
response. Significant changes in gene expression of circadian rhythm, which is also altered 
in mammals, occurred at low concentrations of 235 ng/L diazepam. This demonstrates that 
alterations in gene expression are may be more sensitive than behavioral, histological or 
other toxicological effects (Straub, 2008), although no mechanistic support for the potential 
role of the circadian rhythm genes in mediating neurotoxic effects is provided or yet known. 
The lack of behavioral and physiological changes at the low concentration, however, raises 
the question when gene expression changes propagate to toxicological relevant measures 
such as reduction of the ability to find food, to reproduce or to escape from predators. In 
contrast a positive correlation between alteration in gene expression and behavior occurred 
at the higher diazepam concentration; therefore, the gene expression pattern is interpreted 
as indicative for effects at the organism level.  
 
In conclusion the present study confirms that the toxicogenomic approach provides important 
data to identify and characterize molecular effects and to elucidate potential modes of action 
of a pharmaceutical found in the environment. This allows for establishing new biomarkers, 
not regularly assessed in routine ecotoxicological studies. However, molecular studies 
should be paralleled with ecotoxicological investigations of known ecological relevance. 
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Abstract 
 
To identify molecular effects of the antineoplastic agent PKC412 (Midostaurin), we applied 
gene expression profiling in zebrafish using whole genome microarrays. Behavioral, 
developmental and physiological effects were investigated in order to analyze for correlations 
between altered gene-expression profiles with effects on development and physiology. 
Zebrafish blastula-stage embryos were exposed for 6 days post fertilization (dpf) to nominal 
levels of 2 μg/L and 40 μg/L PKC412. Among the 259 and 511 altered transcripts at both 
concentrations, respectively, the expressions of genes involved in the circadian rhythm were 
further investigated. Alteration of swimming behavior was not observed. Pathways of interest 
affected by PKC412 were angiogenesis, apoptosis, DNA damage response and response to 
oxidative stress. Angiogenesis was analyzed in double transgenic zebrafish embryos 
Tg(fli1a:EGFP)y1;Tg(gata1:dsRed)sd2; no major defects were induced by PKC412 treatment 
at both concentrations. Apoptosis occurred in olfactory placodes of embryos exposed to 40 
μg/L, and DNA damage was induced at both PKC412 concentrations. However, there were 
no significant effects on reactive oxygen species formation. This study leads to the 
conclusion that PKC412-induced alterations of gene transcripts are partly paralleled by 
physiological effects at high, but not at low PKC412 concentrations expected to be of 
environmental relevance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: PKC412, Danio rerio, transgenic zebrafish, microarray, angiogenesis, 
apoptosis
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4.1 Introduction 
Antineoplastic agents have widespread use in cancer treatment. They include different 
classes, such as antibodies, protein kinase inhibitors (such as PKC412), topoisomerase I 
and II inhibitors, antimetabolites, alkylating agents and others (Chabner et al., 2006). 
Antineoplastic agents are mainly found in the ng/L to the lower μg/L range in effluents 
(Monteiro and Boxall, 2010). For example ifosfamide was found in Germany up to a 
concentration of 2.9 μg/L (Ternes, 1998). 
 
As many pharmacological targets are evolutionary conserved, antineoplastic agents are 
supposed to have similar effects in aquatic organisms as in humans (Jones et al., 2007; 
Gunnarsson et al., 2008) Therefore, environmental exposure may pose a risk for negative 
effects on non-target species, due to the mutagenic and cancerogenic properties of such 
compounds. 
 
A newly developed antineoplastic agent is midostaurin (PKC412, logKOW = 4.26; Novartis 
Pharma AG, internal data) which belongs to the family of indolocarbazoles and is a selective 
inhibitor of several isoforms of protein kinase C in humans (Karaman et al., 2008). It is a 
sugar ring variant of staurosporine which was originally isolated from Streptomyces 
staurosporeus (Takahashi et al., 1989). PKC412 inhibits a large variety of tyrosine kinases 
including FLT3 (FMS-like tyrosine kinase), PDGF (platelet derived growth factor) receptors 
and c-kit (stem cell factor) receptor (Fabbro et al., 2000). PKC412 has been developed as a 
therapeutic agent against acute myeloid leukemia (AML), because of its ability to inhibit 
growth, angiogenesis and P-glycoprotein mediated multidrug resistance in tumor cells 
(Fabbro et al., 2000). In addition, PKC412 affects other cellular processes such as immune 
responses or neuronal functions, as shown by effective inhibition of human T-cell activation, 
proliferation and TNFα production (Si et al., 2005). 
 
Only very few data are available on the toxicity of PKC412 to organisms that may be 
exposed via wastewater. Exposure of zebrafish blastula-stage embryos to 100 nM (57 μg/L) 
PKC412 resulted in a curved body axis (Chan et al., 2002). Recent data indicates that the no 
observed effect concentration (NOEC) of PKC412 was 14 μg/L in a Danio rerio early life 
stage test, and the lowest observed effect concentration (LOEC) for mortality was 43 μg/L. 
The 96 h LC50 in adult D. rerio was 25 μg/L and the NOEC 19 μg/L (Novartis Pharma AG, 
internal data). The estimated predicted environmental concentration (PEC) is 1.5 μg/L 
(Novartis Pharma AG, internal data).  
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Currently there is a lack of chronic toxicity studies with focus on the modes of action on this 
pharmaceutical in vertebrates and invertebrates. Furthermore, ecological risk assessments 
of PKC412 within the framework of EMEA (2006), in particular at environmentally realistic 
concentrations in aquatic organisms, are not publicly available. Ecotoxicological tests used 
for risk assessments are often not sensitive enough to identify subtle adverse effects of 
pharmaceuticals. They may be more accurately determined by focusing on the modes of 
action (Fent et al., 2006; Runnalls et al., 2007). Therefore, potential environmental 
consequences of PKC412 are unknown. In detail, data on the gene expression profile and 
their correlation to environmentally relevant endpoints such as behavior and mortality are 
missing. 
 
In our present study, we aim at determining the modes of action of this novel antineoplastic 
agent in zebrafish embryos to clarify its potential molecular effects by analyzing the global 
gene expression pattern. The toxicogenomics approach allows to identify several thousands 
of genes and the corresponding expression profiles upon exposure, which will assist in the 
elucidation of the molecular effects and the compound’s modes of action (Robbens et al., 
2007). We analyze effects at low concentrations in zebrafish embryos and compare the 
effects on the transcriptional level with effects on mortality and physiological outcomes. We 
hypothesize that the response of zebrafish to PKC412 exposure is similar to the human 
response, as their targets, the protein kinases, are evolutionary conserved. Therefore, we 
searched for alterations in gene expression patterns associated with cellular signaling (e.g. 
angiogenesis, apoptosis), and oxidative stress. We also hypothesized that alterations in gene 
expression - because of multiple endpoints and mechanistic information - are more sensitive 
than physiological or morphological parameters (although they are perhaps less ecologically 
relevant), but that the observed molecular effects correlate with and propagate to higher 
levels of the biological organization. In addition, gene expression analysis may also reveal 
unknown regulatory mechanisms in fish not directly related to the modes of action of PKC412 
in humans. 
 
4.2 Materials and Methods 
4.2.1 Chemicals 
PKC412 (≥ 99%, MW: 570.6, logKOW = 4.26) was kindly provided by Novartis Pharma AG 
(Basel Switzerland). Acetonitrile was purchased from Brunschwig (Basel, Switzerland) and 
methanol was from Stehelin (Basel, Switzerland). Ammonium formiate, dimethyl sulfoxide 
(DMSO), formic acid, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), MgCl2, 
NaCl, sucrose, Triton X-100, H2O2, 4',6-diamidino-2-phenylindole (DAPI) and 
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dichlorofluorescein-diacetate (DCFH-DA) were obtained from Sigma Aldrich (Buchs, 
Switzerland). 4-2-Aminoethyl-benzensulfonyl fluoride hydrochloride (AEBSF), ethylene 
diamine tetraacetic acid (EDTA), low melting agarose and Tris-HCl were purchased from 
AppliChem.GmbH (Darmstadt, Germany). Roti®-Histofix 10% was purchased from Carl Roth 
GmbH & Co KG (Karlsruhe, Germany). PBS was obtained from F. Hoffmann-La Roche Ltd 
(Basel, Switzerland) 
4.2.2 Exposure experiment  
For the microarray, behavioral and toxicity studies, freshly fertilized zebrafish embryos were 
obtained from Harlan Laboratories Ltd. (Itingen, Switzerland). Embryos were transferred to 
the laboratory and examined under a stereomicroscope. All embryos used in the experiments 
were at blastula stage (Kimmel et al., 1995). They were placed in 750 mL covered glass 
beakers of reconstituted water (total hardness of 125 mg/L as CaCO3 and a conductivity of 
270 μS/cm) and the appropriate concentration of PKC412 or DMSO (0.01 %, solvent 
control). The water temperature was held constant at 27±1 °C with the photoperiod set at 
16:8 h light/dark.  
 
The semi-static exposure setup consisted of six replicates of water control, solvent control 
(0.01 % DMSO) and two PKC412 doses. A total of 100 fertilized eggs per replicate (n = 6) 
were exposed up to 6 days post fertilization (dpf) to nominal concentrations of 2 μg/L and 
40 μg/L PKC412, respectively. This exposure duration seemed to be appropriate as lethal 
effects occurred already after 3 dpf in the ELS test. Every 24 h, lethal and sublethal effects 
were evaluated, dead embryos or eleuthero-embryos were removed and the water was 
changed. The quality of the exposure water was continuously monitored by oxygen 
concentration determination (>70%), the pH value (6.7-7.2) and the temperature (27±1 °C). 
At the end of exposure, eleuthero-embryos were anaesthetized in a clove oil solution (Fluka 
AG, Buchs, Switzerland). A total of 80 eleuthero-embryos per replicate were pooled in 
RNAlater for microarray and qRT-PCR. Total RNA was extracted using the RNeasy Mini Kit 
(Qiagen, Basel, Switzerland). 
 
4.2.3 Chemical analysis 
To determine actual exposure concentrations, 10-mL aliquots of exposure water were taken 
during the experiment for PKC412 analysis. Water samples of each treatment group were 
taken at the beginning (0 h) and prior to full water renewal (24 h). This was done three times 
on different days from different randomly selected replicate tanks. Acetonitrile (2 mL) was 
added to the water samples for LC-MS analysis preparation, and then stored at -20 °C until 
analysis. The chemical analysis was performed separately for the microarray experiment, the 
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behavioral experiment and additional experiments (TUNEL assay, comet assay, ROS 
assay).  
 
PKC412 concentrations were determined by LC-MS. The chromatographic separation was 
achieved by using an Inertsil ODS-3 column (2.1 mm x 50 mm; 3 μm particle size) from 
Ercatech AG (Bern, Switzerland) at a column temperature of 30° C. For the analysis a binary 
gradient mixture containing eluent A (0.1% (v/v) in formic acid in water:acetonitrile (95:5)) 
and eluent B (0.1% (v/v) in formic acid in water:acetonitrile (5:95)) was used at a flow rate of 
0.4 mL/min. The gradient started with a mixture of 60% eluent A and 40% eluent B and 
increased to 100% eluent B after 4 min. The conditions were held for 1 min and then the 
system was set back to the initial conditions. The column was re-equilibrated for 2 min before 
the next injection. 5 μL of the samples were injected. The retention time for PKC412 was 3.3 
min. Data was then quantified using DataAnalysis for 6300 Series Ion Trap LC/MC version 
3.4. Quantification of PKC412 was based on an external calibration curve. 
 
4.2.4 RNA isolation, array hybridization and sample selection 
Total RNA was extracted from zebrafish eleuthero-embryos using the RNeasy Mini Kit 
(Qiagen, Basel, Switzerland). Total RNA concentrations were measured 
spectrophotometrically using a NanoDrop ND-1000 UV-VIS Spectrophotometer at 260 nm. 
The integrity of each RNA sample was verified using an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Basel, Switzerland). Only samples containing a 260/280 nm ratio between 
1.8-2.1, a 28S/18S ratio between 1.5-2 and an RNA integrity number (RIN) > 8 were 
processed further. A total of 16 arrays (Agilent 4 × 44 K Zebrafish microarray) were used, 
including four for the water control group, four for the solvent control group, four for the 
2 μg/L and four for the 40 μg/L PKC412 dose group. Total RNA samples (600 ng) were 
reverse-transcribed into double-strand cDNA in the presence of RNA poly-A controls with the 
Agilent One-Color RNA Spike-In Kit. Cy3 labeling and hybridization were performed 
according to the manufacturer's manual.  
 
After reverse-transcription of RNA into double-stranded cDNA, double-strand cDNA was in 
vitro transcribed into cRNA in the presence of Cy3 labeled nucleotides using a Low RNA 
Input Linear Amp Kit +Cy dye (Agilent Technologies, Basel, Switzerland), performed at the 
Functional Genomic Centre (ETHZ and University of Zürich, Switzerland). The Cy3-labeled 
cRNA was purified using an RNeasy mini kit (Qiagen, Basel, Switzerland), and quality and 
quantity was determined using a NanoDrop ND-1000 UV-VIS Spectrophotometer and an 
Agilent 2100 Bioanalyzer, respectively. Only cRNA samples with a total cRNA yield higher 
than 2 µg and a dye incorporation rate between 9 pmol/µg and 20 pmol/µg were used for 
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hybridization. Cy-3-labeled cRNA samples (1.65 µg) were mixed with Agilent blocking 
solution, subsequently fragmented randomly to 100-200 bp at 65 °C with fragmentation 
buffer and resuspended in hybridization buffer as provided by the gene expression 
hybridization Kit (Agilent Technologies). Target cRNA samples (100 µL) were hybridized to 
the Agilent Zebrafish 4x44K Gene Expression Microarray for 17 h at 65 °C. The hybridized 
arrays were then washed using Agilent GE wash buffers 1 and 2 according to the 
manufacturer's instructions and scanned by an Agilent Microarray Scanner (Agilent p/n 
G2565BA) at 5 μm resolution with the green photomultiplier tube set to 100% and a scan 
area of 61 x 21.6 mm. Image generation and feature extraction was performed using the 
Agilent Feature Extraction (FE) software version 9.5.3. Quality control was additionally 
considered before performing the statistical analysis. These included array hybridization 
pattern inspection: absence of scratches, bubbles, areas of non-hybridization, proper grid 
alignment, spike performance in controls with a linear dynamic range of 5 orders of 
magnitude and the number of green-feature non-uniformity outliers which should be below 
100 for all samples. 
 
4.2.5 qRT-PCR analysis 
1 μg of total RNA of the microarray experiment template was reverse-transcribed using 
Moloney murine leukemia virus reverse transcriptase (Promega Biosciences Inc., Wallisellen, 
Switzerland) in the presence of random hexamers (Roche Diagnostics, Basel, Switzerland) 
and deoxynucleoside triphosphate (Sigma-Aldrich, Buchs, Switzerland). The reaction mixture 
was incubated for 5 min at 70 °C and then for 1 h at 37 °C. The reaction was stopped by 
heating at 95 °C for 5 min. 
 
The cDNA was used to perform SYBR-PCR based on SYBR-Green Fluorescence (FastStart 
Universal SYBR Green Master, Roche Diagnostics, Basel, Switzerland). Eight differentially 
expressed genes of interest (ATP-binding cassette, sub-family C (abcc4), cryptochrome 5 
(cry5), N-myc downstream regulated gene 1, like (ndrg1l), opsin 1 (cone pigments), medium-
wave-sensitive, 2 (opn1mw2), 3-phosphoinositide dependent protein kinase-1 (pdpk1), 
period homolog 1 (per1), similar to son of sevenless homolog 2 (sos), xeroderma 
pigmentosum, complementation group C (xpc)) were selected for confirmation of microarray 
results using qRT-PCR. Gene-specific primers were designed based on published zebrafish 
sequences (Table 1). 
 
The following PCR reaction profile was used: one cycle at 95 °C for 10 min, followed by 40 
cycles at 95 °C for 15 sec, and 59 °C for 60 sec followed by a melting curve analysis post 
run.  
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The delta CT value was derived by subtracting the threshold cycle (CT) value for the 
housekeeping gene ribosomal protein L13 α (RpL13α), which served as an internal control, 
from the CT value of the target gene, respectively. All reactions were run in duplicate using 
the Biorad CFX96 RealTime PCR Detection System (Biorad, Reinach, Switzerland). The 
mRNA expression level of the different genes was expressed as fold-increase according to 
the formula:  
 
2∆CT(untreated sample)- ∆CT(treated sample)  
 
Table 1              
Primer sequences for quantitative real-time PCR analysis  
Probe ID Gene Sequence Accession # dir Sequence 
Amplicon 
size 
- RpL13α NM_212784 fw 
rv 
agc tca aga tgg caa cac ag 
aag ttc ttc tcg tcc tcc 
100 bp 
A_15_P104624 abcc4 NM_001007038 
fw 
rv 
ctg gaa aca cga ctc agc aa 
gct cac cag agc att gaa ca 
122 bp 
A_15_P103946 cry5 NM_131788.1 
fw 
rv 
cat gga gag aac gaa ctg gg 
gtg cag aca agc agc cga ac 
115 bp 
A_15_P196411 ndrg1l NM_200692.1 
fw 
rv 
agc gtc ttt gag ctg gac at 
tgg aag gtc agg atg gta gg 
113 bp 
A_15_P544897 opn1mw2 NM_182891.2 
fw 
rv 
cca tgg cag ttt aag gca ct 
ttt tgt gct gag ctg tga cc 
100 bp 
A_15_P112731 pdpk1 NM_001077344.1 
fw 
rv 
cgt tta gag ctg gga acg ag 
cgc tgg acc aga tct tta gc 
103 bp 
A_15_P236266 per1 NM_001030183.1 
fw 
rv 
atg cgt gca aga agt ggt g 
acg tcc tca ttt agc gga ctc 
131 bp 
A_15_P197856 sos XM_685079.2 
fw 
rv 
ctg ccc tca ctt ctc acc tc  
cac tgg tcc aca cca aac ac 
109 bp 
A_15_P134231 xpc NM_001045210.1 
fw 
rv 
aag aag tcg gca gtg agg aa 
gca tat ttt cac ggc tcc at 
101 bp 
 
abcc4 (ATP-binding cassette, sub-family C), cry5 (Cryptochrome 5), ndrg1l (N-myc downstream regulated gene 1, like), 
opn1mw2 (opsin 1 (cone pigments), medium-wave-sensitive, 2), pdpk1 (3-phosphoinositide dependent protein kinase-1), per1 
(period homolog 1), sos (similar to son of sevenless homolog 2), xpc (xeroderma pigmentosum, complementation group C) 
 
4.2.6 Measurement of locomotor activity 
Multispecies Freshwater Biomonitor®. Effects of PKC412 on locomotor activity were 
measured in zebrafish eleuthero-embryos. Their locomotor activity was observed using a 
flow-through test chamber with quadrupole impedance conversion as measuring device, 
connected to a measuring unit and personal computer with data analysis software (Gerhardt 
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et al., 1994). Measurement chambers, made of an acryl glass cylinder sealable on both 
ends, with a size of 4 cm in length and a diameter of 2 cm allowed free movement of the 
eleuthero-embryos during measurement.  
 
For locomotor activity measurements, embryos in the blastula stage were exposed to 
2.1 μg/L and 31 μg/L PKC412, respectively, for 6 dpf as described above. Locomotor 
activities of hatched eleuthero-embryos were assessed 6 dpf for 20 animals per PKC412 
dose and the appropriate controls, respectively, as described above. Following an 
acclimation phase of 10 min, measurements were started and behavior was monitored with a 
recording duration lasting 4 min for a period of 2 h with intervals of 10 min each. For 
locomotor activity measurements, means of locomotor activities (% time spent on 
locomotion) for each individual were calculated for 2 h time period. 
 
4.2.7 Angiogenesis 
Double transgenic zebrafish embryos (Tg(fli1a:EGFP)y1;Tg(gata1:dsRed)sd2) (Lawson and 
Weinstein, 2002; Traver et al., 2003) were exposed to 2 and 40 μg/L PKC412 and held in 
water and DMSO control water (50 embryos each) for 6 dpf as described above. Embryos 
were monitored for morphological defects using a fluorescent binocular at 24 hpf, 48 hpf and 
6 dpf. Formation of blood vessels was observed with transgenic expression of enhanced-
green-fluorescent-protein (EGFP) in endothelial cells and DsRed (red fluorescent protein 
from Discosoma sp.) expression in blood cells. Transgenic fish were kept heterozygotic, 
therefore only half of the progeny is double transgenic and these were analyzed in detail. 
Representative embryos taken from treated and control groups were imaged using Leica 
TCS SP5 Confocal Microscopy System. 
 
4.2.8 Apoptotis assay 
Apoptotic cells of eleuthero-embryos were determined by the TUNEL assay. Eleuthero-
embryos were exposed 6 dpf as described above. Embryos exposed to 1% H2O2 served as a 
positive control. After 6 dpf, the eleuthero-embryos were fixed in 4% Roti®-Histofix at 4° C for 
24 h. Thereafter, the embryos were rehydrated through a series of methanol (100%, 90%, 
70% and 50%). The TUNEL assay (Roche "In situ Cell Death Detection Kit, TMR red") was 
performed as described in the manufacturer's manual. In brief, single eleuthero-embryos (n = 
3 per replicate) were permeabilized in phosphate buffered saline containing 0.1% Triton X-
100 (PBST) for 8 min. Thereafter, they were washed twice with PBS and then labeled for 60 
min at 37 °C. The embryos were then embedded in agarose and analyzed under the 
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fluorescent microscope at excitation and emission wavelength of 360-370 nm and 420 nm, 
respectively. 
 
4.2.9 Alkaline comet assay 
This assay allows detecting DNA breakages induced by genotoxic agents. The comet assay 
was performed as described (F. Duong, University Hospital Basel, Switzerland, personal 
communication). Briefly, embryos were exposed to PKC412 as described above for 6 dpf. As 
a positive control, embryos were exposed to 1% H2O2 for 10 min prior to anaestization. A 
pool of 8 eleuthero-embryos per replicate (n = 4) was macerated in 1 mL PBS containing 20 
mM EDTA for 5 min. The supernatant was removed and the embryos were shred in 500 μL 
PBS containing 20 mM EDTA for 10 min. The remaining tissue was sedimented for 2 min 
and the supernatant was embedded in agarose on a microscope slide. Cells were then lysed 
at 4 °C for 1 h with lysis buffer (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris-HCl, pH 10, 1% Triton 
X-100) and electrophoresed for 5 min at 25 V. Damaged DNA fragments migrate faster in the 
electric field than intact DNA which can be visualised after staining with 4',6-diamidino-2-
phenylindole (DAPI). Cells (24 cells per replicate) were observed under the fluorescence 
microscope and the length of comets, % DNA in tail, tail moment and olive tail moment were 
calculated using CometScore 1.5 (TriTekTM, Sumerduck, VA, USA).  
 
4.2.10 ROS measurements 
In this assay, the non-fluorescent probe DCFH-DA is oxidized into the highly fluorescent 2,7-
dichlorofluorescein in the presence of reactive oxygen species (ROS). ROS measurements 
were conducted according to (Deng et al., 2009). In brief, 8 pre-exposed eleuthero-embryos 
(pre-exposure for 6 dpf as described for the microarray experiment) were washed with cold 
PBS and then homogenized in cold lysis buffer containing 0.32 mM sucrose, 20 mM HEPES, 
1mM MgCl2 and 0.5 mM AEBSF, pH 7.4. As a positive control, 8 eleuthero-embryos were 
exposed for 10 min to water containing 1% H2O2. Thereafter the homogenate was 
centrifuged at 15'000g at 4 °C for 20 min and the supernatant was discharged. The pellet 
was then resuspended in PBS and 20 μL were added to a 96-well plate and incubated for 5 
min at room temperature. Thereafter, 100 μL of PBS and 8.3 μL of DCFH-DA (stock solution 
in DMSO, 10 mg/mL) were added to each well. The plate was incubated at 37 °C for 30 min 
and fluorescence measurements were made with excitation at 485 nm and emission at 530 
nm, respectively.  
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4.2.11 Data analysis and statistics 
Raw microarray data was analyzed using the GeneSpring GX 10 software (Agilent 
Technologies). In a first step, the Agilent Feature Extraction software output was filtered on 
the basis of feature saturation, non-uniformity, pixel population consistency and signal 
strength relative to back ground level (Agilent Feature Extraction Manual). Only positively 
marked entities were accepted for further evaluation. All data was quantile normalized. In a 
second step, several quality control steps (e.g. correlation plots and correlation coefficients, 
quality metric plots and PCA) using the quality control tool of GeneSpring were performed to 
ensure that the data were of good quality.  
 
Differentially expressed genes from the microarray were determined using a Benjamini-
Hochberg multiple correction-ANOVA test (p<0.05), followed by a TukeyHSD post-hoc test. 
The genes were considered differentially expressed when p<0.05 and the fold change 
(FC) ≥2. To determine gene ontology (GO) categories of differentially expressed genes, the 
GO analysis tool in GeneGo, San Diego, CA, USA was used. Only those categories where 
p<0.05 were considered differentially altered. MetaCore TM (GeneGo, San Diego, CA, USA) 
was used to identify and visualize the involvement of the differentially expressed genes in 
specific pathways (FDR< 0.05). The microarray data used in this analysis have been 
submitted to NCBI GEO database under accession number GSE23156 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=fnotryskkqyaoba&acc=GSE23156). 
Data from microarray analysis, qRT-PCR, locomotor activity, comet assay and ROS assay 
were illustrated graphically with GraphPad® Prism 5 (GraphPad Software, San Diego, CA, 
USA). Data distribution for normality was assessed with the Kolmogorov-Smirnov test and 
the variance homogeneity with the Bartlett test. Differences between treatments were 
assessed by analysis of variance followed by a Tukey test (Bartelett test p<0.05) to compare 
treatment means with respective controls. If the data was not normally distributed, 
differences between treatments were assessed by the Kruskal-Wallis test followed by Dunn's 
multiple comparison test. Results are given as mean ± standard error of mean. Differences 
were considered significant at p≤0.05.  
 
4.3 Results 
4.3.1 PKC412 concentrations and embryo survival 
PKC412 concentrations in the exposure water were measured at 0 h and 24 h in order to 
determine the actual exposure concentrations. The PKC412 concentrations measured 
independently in the different experiments are given in Table 2. In the microarray experiment, 
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actual concentrations were lower than nominal, and they decreased during exposure. 
Geometric mean concentrations (n=3) were 1.3 μg/L and 21 μg/L. Also in the behavioral 
experiment using the Multispecies Freshwater Biomonitor® the PKC412 concentration 
decreased during the 24 h exposure and the mean measured concentration was 2.1 μg/L 
and 31 μg/L. In the experiments, where the comet assay, TUNEL assay and ROS assay 
were performed, the initial concentrations were close to nominal, and decreased again during 
the 24 h exposure. The mean measured concentrations were 1.6 μg/L and 31 μg/L. No 
significant mortality was observed in any of the different experiments and treatment groups. 
 
Table 2                        
Nominal and measured concentrations of PKC412 in exposure waters after 6 dpf of exposure for the microarray, 
Multispecies Freshwater Biomonitor® experiment and comet assay 
Nominal Concentration 
Exposure waters 
Measured concentration (μg/L) 
0h % of nominal 24h % of nominal Geometric Mean 
Microarray      
2 μg/L 1.50 ± 0.1 75.2 1.06 ± 0.2 52.9 1.3 
40 μg/L 25.12 ± 1.6 62.8 17.20 ± 3.1 43.0 21 
Multispecies Freshwater Biomonitor®     
2 μg/L 2.36 ± 0.1 117.8 1.90 ± 0.2 95.1 2.1 
40 μg/L 37.45 ± 1.7 93.6 25.10 ± 1.7 62.7 31 
TUNEL assay, comet assay, ROS assay    
2 μg/L 2.19 ± 0.2 109.5 1.23 ± 0.1 61.7 1.6 
40 μg/L 38.60 ± 6.4 96.5 24.93 ± 5.2 62.3 31 
 
4.3.2 Alteration of gene expression  
Gene expression profiles derived from microarray results of control and PKC412-exposed 
embryos (n = 4) are based on 80 pooled individuals. As listed in Appendix 2 Table 1, 259 and 
511 genes were differentially expressed in zebrafish eleuthero-embryos (log2≥2, p<0.05) 
after exposure to 1.3 μg/L and 21 μg/L PKC412, respectively. At 1.3 μg/L PKC412, 112 
(43 %) genes were down-regulated, and 147 (57 %) up-regulated. 
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Of the 511 genes differentially expressed at 21 μg/L PKC412 130 (25%) genes were down-
regulated, and 381 (75 %) were up-regulated. Only 101 of the significantly altered genes 
were regulated at both concentrations, however, all of them were regulated in the same 
direction. At both concentrations, most functional groups of genes (fold change (FC, log2) at 
least 2-fold, p ≤ 0.05) were similar. Gene Ontology (GO) analysis was performed to identify 
functional groups of genes. GO defines terms representing gene product properties, and 
covers three domains namely cellular components, molecular functions and biological 
processes. At both concentrations, functionally identified genes fell into more than 1500 
different categories. In Appendix 2 Table 2 the top 100 GO processes are listed. GO-
categories including all kind of different detections or responses to stimuli are of particular 
importance e.g. detection of light stimulus, detection of abiotic stimulus, detection / response 
to external stimulus, visual perception etc. (Appendix 2 Table 2). 
 
Additionally to the GO analysis, we performed a pathway analysis with MetaCore. The 
different treatments had 28 maps (1.3 μg/L PKC412: 29 maps; 21 μg/L PKC412: 34 maps) 
with their corresponding pathways in common (Appendix 2 Table 3). These maps include 
pathways for lipid biosynthesis and regulation, cholesterol and bile acid homeostasis, 
angiogenesis, vitamin and cofactor metabolism and its regulation, mitogenic signaling and 
apoptosis. For validation of these results, additional experiments were performed focusing on 
five significantly altered maps (Appendix 2 Table 3). Effects on angiogenesis were analyzed 
by performing an additional experiment with transgenic zebrafish. In addition, effects on 
apoptosis were analyzed by performing a TUNEL assay, DNA damage was assessed by a 
comet assay and oxidative stress response by a ROS assay.  
 
In order to confirm the microarray results, qRT-PCR was performed for eight selected genes 
(Table 3, Figure 1). These genes belong to different pathways and were selected on their 
importance in different pathways: abcc4 (ATP-binding cassette, sub-family C), cry5 
(cryptochrome 5), ndrg1l (N-myc downstream regulated gene 1, like), opn1mw2 (opsin 1 
(cone pigments), medium-wave-sensitive, 2), pdpk1 1 (3-phosphoinositide dependent protein 
kinase-), per1 (period homolog 1), sos (similar to son of sevenless homolog 2), and xpc 
(xeroderma pigmentosum, complementation group C). A down-regulation occurred for abcc4, 
cry5, per1, and xpc, whereas an up-regulation was found for ndrg1l, opn1mw2, pdpk and sos 
(Figure 1). In all cases, except sos, the same tendency for up- or down-regulation occurred 
for the microarray and for qRT-PCR analysis. 
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Table 3  
Fold changes of selected genes differentially regulated in zebrafish eleuthero-embryos determined by microarray 
and qRT-PCR after exposure to 1.3 μg/L and 21 μg/L PKC412. Values are expressed as average fold change. 
Asterisks show statistically significant difference to control (p < 0.05).  
 Fold Change (log2) 
Gene name 
1.3 μg/L PKC412  21 μg/L PKC412  
Array qPCR Array qPCR 
ATP-binding cassette, sub-family C (abcc4) -2.00* -1.21*  -2.98* -1.03* 
Cryptochrome 5 (cry5) -2.68* -2.35*  -2.86* -2.12* 
N-myc downstream regulated gene 1, like (ndrg1l) 4.00* 1.99*  4.10* 2.41* 
Opsin 1 (cone pigments), medium-wave-sensitive, 
2 (opn1mw2) 2.60* 0.45*  2.36* 1.00* 
3-Phosphoinositide dependent protein kinase-1 
(pdpk1) 2.60* 0.88*  1.71* 1.05* 
Period homolog 1 (per1) -9.80* -3.58*  -6.41* -3.16* 
Similar to son of sevenless homolog 2 (sos) 0.85* -0.27  2.03* 0.62 
Xeroderma pigmentosum, complementation group 
C (xpc) -2.90* -1.40*  -2.20* -0.55 
 
4.3.3 Effects on the circadian rhythm and locomotor activity 
As shown in Table 3, PKC412 altered the expression of genes regulating circadian rhythm 
e.g. cry1-5 (1.3 μg/L PKC412: -2.08, 3.9, -4.4, 2.3, -2.7-fold change log2, respectively; 21 
μg/L PKC: -1.54, 2.7, -3, 1.8 -2.9-fold change log2, respectively), per1,2,4 (1.3 μg/L PKC412: 
-9.8, -2.04, -4.5-fold change log2, respectively; 21 μg/L PKC: -6.4, -3.08, -3.17-fold change 
log2, respectively), arntl (1.3 μg/L PKC412: 2.5-fold change log2; 21 μg/L PKC: 3.12-fold 
change log2), clock (1.3 μg/L PKC412: 2.9-fold change log2; 21 μg/L PKC: 2.7-fold change 
log2) etc. In mammals, the circadian rhythm controls a diversity of behavioral and 
physiological rhythmic processes such as regulation of sleep wakefulness, secretion of 
hormones and locomotor activity (Hastings, 1997). In zebrafish, diazepam alters the same 
set of genes and influences the swimming behavior (Oggier et al., 2010).  
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Figure 1  
Comparison of gene expression in zebrafish larvae determined by microarray (n = 4 replicates, 80 eleuthero-
embryos pooled, white bars) and qRT-PCR (n = 6, 80 eleuthero-embryos, black bars) after exposure to 1.3 μg/L 
and 21 μg/L PKC412, respectively. Values are expressed as average fold change (log2) with standard error 
compared to control animals as indicated for selected genes. Asterisks (*) indicate statistically significant 
difference to control (p < 0.05).  
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Figure 2  
Comparison of the locomotor activity (percent of total time spent in locomotion during 2 h) of D. rerio eleuthero-
embryos exposed for 6 dpf to 2.1 and 31 μg/L PKC412 or water control and solvent control. Asterisks (*) indicate 
significant differences between treatments (p < 0.05).  
 
Therefore, an additional set of experiments was performed to evaluate whether changes 
found in the gene expression pattern of circadian genes in eleuthero-embryos were 
paralleled by changes in the locomotor activity. The behavioral experiments revealed that 
exposure of the embryos to PKC412 did not significantly affect their locomotor activity 
(Figure 2). 
 
4.3.4 Effects on angiogenesis 
Angiogenesis is an important process during cancerogenesis, which is affected by PKC412 
in humans (Fabbro et al., 2000). We hypothesized that similar effects occur in zebrafish 
embryos during development. Important genes in angiogenesis are the vascular endothelial 
growth factor (vegf), which is down-regulated by PKC412 in humans (Fabbro et al., 2000), 
and angiopoietin (ang). In our study we did not find a significant alteration in vegf transcript 
levels in zebrafish eleuthero-embryo (data not shown). However, there is a significant up-
regulation of ang2 (3.6-fold change log2) in the higher PKC412 concentration of 31 μg/L 
(Appendix 2 Table 1). Ang2 is an antagonist of ang1 and disrupts blood vessel formation 
when over-expressed (Maisonpierre et al., 1997). In addition to alterations in gene 
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expression, we also found a significant alteration of pathways involved in vascular 
development (Appendix 2 Table 3).  
 
In order to link these findings with physiological changes in blood vessel development, we 
exposed (Tg(fli1a:EGFP)y1;Tg(gata1:dsRed)sd2) double transgenic zebrafish embryos to 2 
μg/L and 40 μg/L PKC412. While focusing mostly on the trunk vasculature, we did not 
observe any abnormalities in cardiovascular development compared to control embryos. At 
24 hpf, the dorsal aorta and the posterior cardinal vein developed normally and normal 
sprouting of the intersegmental vessels was observed. At 6 dpf all the main vessels looked 
virtually identical in treated and control embryos (Figure 3). Dorsal aorta, posterior cardinal 
vein and intersegmental vessels were normally developed and normal heart beat and blood 
flow was observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3  
Vascular development is not affected by PKC412 treatment. The vascular system was visualized in a double 
transgenic zebrafish eleuthero-embryo (TG:fli1a:EGFPy1; gata1:DsRedsd2) on a Leica TCS SP5 Confocal 
Microscope. Endothelial cells are labelled in green and erythrocytes are labelled in red. (A) DMSO solvent control 
and (B) 40 μg/L PKC412. The pictures are maximal intensity projections of confocal z-stacks. DA – dorsal aorta, 
PCV – posterior cardinal vein, ISV – intersomitic vessel, DLAV – dorsal longitudinal anastomotic vessel. No major 
defects were detected in treated PKC412 embryos. 
 
25 double transgenic embryos from each treatment were analyzed in detail. We also looked 
at general morphology of the embryos. Single embryos from treated and control groups 
showed mild developmental abnormalities, which can occasionally be observed in non-
treated fish, especially in transgenic lines. 5 of 25 embryos treated with 40 ug/L PKC412 had 
a slightly misshaped trunk with the tail bend dorsally. However, the vasculature of these 
embryos was normal (Figure 3). More analyses on wild type embryos would be needed to 
find out whether this misshaping is due to the drug treatment. 
DA 
PCV 
ISV 
DLAV 
DA 
PCV 
ISV 
DLAV 
(A) (B) 
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Therefore, PKC412 did not negatively interfere up to 6 days with the vascular development of 
zebrafish embryos at both concentrations. However, the vascular network at this stage is 
already very complicated and subtle differences might have been gone unnoticed. 
 
4.3.5 Effects on apoptosis in olfactory placodes 
PKC inhibitors can induce apoptosis in humans (Tenzer et al., 2001). Thereby the PI3K3/Akt 
pathway is of high importance as the cytotoxic effect of PKC412 is mediated by this pathway. 
In the apoptosis pathway the phosphoinositide dependent kinase PDK1 (also called PDPK1) 
leads to phosphorylation of v-akt murine thymoma viral oncogene homolog Akt, and 
therefore to its activation. Constitutively active Akt results in an enhanced protection against 
apoptotic cellular insults. In contrast to findings in humans, we found an up-regulation of 
pdpk (Appendix 2 Table 1, 2.6-fold change log2) in the lower PKC412 concentration. 
 
(A)            (B) 
 
(C) 
 
(D) 
  
Figure 4 
Zebrafish larvae exposed to 1.6 µg/L and 31 µg/L PKC412 until 144 hpf were stained with TMred. Apoptotic cells 
appeared mainly in the olfactory placodes. (A) Solvent control, (B) positive control, (C) 1.6 µg/L PKC412, (D) 
31 µg/L PKC412  
 
In addition, we found a down-regulation of transcripts of xpc, a gene that is important for 
DNA damage recognition. Additionally, apoptotic pathways are of significance (Appendix 2 
DMSO H2O2
1.6 μg/L PKC 31 μg/L PKC 
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Table 3). Based on these findings, we conducted a TUNEL assay to search for regions and 
tissue in the eleuthero-embryo, where apoptosis is induced by PKC412. Figure 4 illustrates 
that apoptosis mostly occured in the head region. The olfactory placode, which is important 
for the perception of odorants, is mainly affected. This finding is in parallel to the observed 
up-regulation of gene transcripts of some odorant receptors or102-3 (2.8-fold change log2) 
and or11-10 (2.2-fold change log2) found by microarray analysis for the highest PKC412 
concentration (Appendix 2 Table 1), suggesting a repair of these affected cells. 
 
4.3.6 Effects on DNA damage 
PKC412 led to significant down-regulation of xpc. At 1.6 μg/L and 31 μg/L PKC412 we found 
a 2.9- and 2.2-fold change log2, respectively, in xpc transcripts (Appendix 2 Table 1, 
Figure1). Additionally, there was a down-regulation of apex nuclease 1 (-2.7-fold change 
log2) at 31 μg/L PKC412. As xpc is important in DNA damage recognition and APEX1 for 
DNA repair, we conducted a comet assay to evaluate whether this alteration occurs not only 
on the transcription, but also on the physiological level. Further support for potential DNA 
damage induced by PKC412 comes from the fact that pathways involved in DNA damage 
response were significantly affected (Appendix 2 Table 3). The comet assay demonstrates a 
dose-dependent increase in DNA damage in eleuthero-embryos exposed to PKC412 (Figure 
5). Significant DNA damage occurred in the embryos at 31 μg/L PKC412 (Figure 5). At the 
lower concentration of 1.6 μg/L PKC412 a significant increase in tail length, but not in % DNA 
in tail, tail moment and olive tail moment occurred (Figure 5). 
 
4.3.7 Effects on formation of reactive oxygen species (ROS) 
MetaCore pathway analysis indicated that there is an alteration in oxidative stress regulation. 
To evaluate whether this is related to increased formation of ROS by PKC412, we performed 
an additional experiment to determine formation of ROS. The results show that the ROS-
levels remained unchanged at both PKC412 concentrations as compared to the control 
(Figure 6) and thus PKC412 is not inducing ROS. 
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(A)            (B) 
(C) (D) 
  
Figure 5  
Comet assay in zebrafish eleuthero-embryos exposed to 1.6 μg/L and 31 μg/L PKC412. (A) Tail length, (B) % 
DNA in Tail, (C) Tail Moment and (D) Olive Tail Moment were calculated using Comet score. 4 slides per dosage 
were examined and 24 cells per slides were scored. The values are presented as the mean ± SEM. Asterisks (*) 
indicate values that are significantly different from the control (Kruskall-Wallis test followed by posthoc Dunn’s 
multiple comparison test; p < 0.05). 
 
4.4 Discussion 
This is the first study investigating the effects of PKC412 on gene expression on non-target 
organisms in aquatic systems. We show effects of PKC412 at low concentrations in zebrafish 
eleuthero-embryos. Thereby we demonstrate that human pharmaceuticals exhibit their 
effects in aquatic organisms by similar molecular modes of action as in humans due to target 
conservation in vertebrates. We also tested the hypothesis that alteration in gene expression 
propagate into physiological effects. 
 
PKC412 was designed as tyrosine kinase inhibitor with a broad inhibition spectrum of the 
human kinome. It was shown that at high-affinity interactions (Kd < 100 nM), this compound 
was not highly selective for kinases (Karaman et al., 2008). Consequently, it is not surprising 
that PKC412 alters more than 500 genes in zebrafish eleuthero-embryos at a concentration 
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of 21 μg/L. Furthermore, the broad spectrum of kinases inhibited by the non-selective 
PKC412 makes the interpretation of the results challenging due to the involvement of many 
cellular pathways. 
 
Figure 6 
Effects of 1.6 µg/L and 31 µg/L PKC412 on ROS formation after 144 hpf of exposure. The values are presented 
as the mean ± SEM. Asterisks (*) indicate values that are significantly different from the control (ANOVA followed 
by a posthoc test: Tukeys’s multiple comparison test; p < 0.05) 
 
In humans PKC412 inhibits FLT3, PDGF receptors, VEGF and c-kit by preventing the 
tyrosine autophosphorylation (Fabbro et al., 2000). In addition, this compound inhibits P-
glycoprotein mediated multidrug resistance in tumor cells. When comparing our results with 
human effects and gene expression changes obtained in MV4-11 cells (human lymphoblast 
cells) after treatment with 570 μg/L PKC412 (Stolzel et al., 2010), some similarities show up. 
In zebrafish eleuthero-embryos there were also alterations of solute carriers as in human 
cells (Stolzel et al., 2010), albeit a solute carrier of family 2 was significantly down-regulated 
in the lower concentration only. In addition, we similarly found a significant down-regulation 
of the ABC-transporter abcc4, which is important for the efflux of anti-cancer drugs. However, 
there was no alteration of flt3, pdgfr, vegf and c-kit at the transcript level in zebrafish 
embryos. Binding of PKC412 leads to inhibition of these kinases, therefore we hypothesize 
that PKC412 does not interfere with gene expression but protein function. One important 
identified GO-category is visual perception. Expression of genes encoding proteins involved 
in vision such as chrystallins and opsins were significantly altered by PKC412. Crystallins are 
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important for the protection against lens opacity (Clark, 2004), and Opsins are important for 
dim-/daylight-vision and color-vision (Takechi and Kawamura, 2005). These findings in 
zebrafish are similar to results obtained in mice and humans after treatment with PKC412. 
There are several VEGF and PDGF receptors in the retina. The inhibition of these receptors 
can lead to decreased epiretinal membrane formation in mice (Saishin et al., 2003) and 
reduction in macular edema in humans (Campochiaro, 2004). Therefore, up-regulation of 
Chrystallins and Opsins may be a response to the inhibition of VEGF and PDGF receptors.  
 
In addition to visual perception, we also found that responses to light and external/internal 
stimuli are important targets of PKC412. As the circadian rhythm is dependent on stimuli, 
namely Zeitgeber, there is a significant alteration of those genes at both PKC412 
concentrations in zebrafish. It is known that in mice several protein kinases C are expressed 
in the hypothalamic suprachiastic nuclei (SCN) (Van der Zee and Bult, 1995), the region 
which is important for circadian processes. Therefore, protein kinases C play an important 
role in the mammalian circadian rhythm, and inhibition of PKC can lead to phase advances 
(Schak and Harrington, 1999; Jakubcakova et al., 2007). As PKC is already expressed in the 
early zebrafish development (Slatter et al., 2005; Patten et al., 2007), it could be affected in 
the SCN. Additionally, it was shown in the marine dinoflagellate Lingulodinium polyedrum 
that staurosporine (precursor of PKC412) leads to phase-shifting and increases the free 
running period of the circadian rhythm (Comolli and Hastings, 1999). At the behavioral level 
altered expression of clock genes is correlated with changes in the locomotor activity 
(Jakubcakova et al., 2007). For this reason we investigated the effects of PKC412 on the 
locomotor activity. However, PKC412 had no significant effect on the locomotor activity in our 
experimental set-up. A reason could be that an observation over 2 h is too short to obtain 
significant effects. Also the time-point when the measurements took place could have an 
influence. We performed our measurements at day-light, and effects would have probably 
been more pronounced at night. 
 
In addition to exploring effects on different GO-categories we performed a pathway analysis 
in order to elucidate altered maps and pathways after PKC412 exposure. Out of the 28 maps 
we chose four different maps with their corresponding pathways to perform additional 
experiments. It is known from humans that PKC412 can have effects on angiogenesis and 
apoptosis including DNA damage repair. However, there are no indications from mammalian 
studies that PKC412 exposure can lead to the formation of reactive oxygen species. 
 
The need for new blood vessels is important during embryogenesis, as well as in processes 
during cancerogenesis (Carmeliet and Jain, 2000). The formation of blood vessels and 
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evaluation of blood flow can be observed in zebrafish eleuthero-embryos, rendering it an 
ideal model organism to study angiogenesis. As angiogenesis is affected by PKC412 in 
humans (Fabbro et al., 2000), we hypothesize that similar effects occur in zebrafish 
eleuthero-embryos. Thereby, angiopoietins play an important role (Pham et al., 2001; Kubota 
et al., 2005). In fact, we found a significant up-regulation of ang2. It was shown that over-
expression of ang2 can lead to blood vessel disruption in the mouse embryo (Maisonpierre et 
al., 1997). There is also a simultaneous regulation of VEGF and angiopoietin. However, 
angiopoietins do not participate in the initial vascular phase of vascular development, but 
rather play an important role in angiogenic outgrowth, vessel remodeling and maturation 
(Dumont et al., 1994; Suri et al., 1996). Our results obtained after the exposure of double 
transgenic zebrafish eleuthero-embryos support the findings that angiopoietins do not 
participate in the initial vascular phase. In addition, our findings are in agreement with those 
obtained after exposure of zebrafish eleuthero-embryos to 57 μg/L for 24 hpf (Chan et al., 
2002). PKC412 did not generate measurable antiangiogenic effects during the exposure 
time. It may be possible that there are strain differences between zebrafish that account for 
our failure to detect vascular defects in transgenic fish. However, our results are in line with 
the microarray data in the sense that we did not find any alteration in vegf transcript levels. In 
addition, the defects in the vasculature might be too subtle to detect upon PKC412 treatment, 
so that the went unnoticed in our assays. 
 
PKC inhibitors can induce apoptosis in humans (Tenzer et al., 2001). To protect mammals 
from apoptotic stress stimuli, the phosphatidylinositol 3'-kinase (PI3K)/Akt survival pathway is 
important. In this pathway Akt needs to be phosphorylated by the phosphoinositide 
dependent kinase PDK1, which was found to be down-regulated in mice after treatment with 
staurosporine (Hill et al., 2001). In mice PKC412 can mediate its cytotoxic effects partly via 
down-regulation of this pathway. Additionally, PKC412 decreased the site-specific 
phosphorylation of Akt, required for its activity (Tenzer et al., 2001). In contrast to these 
findings, we found an up-regulation of the upstream pdpk1 at the lower PKC412 
concentration. This leads to the hypothesis that there is no down-regulation of the Akt 
pathway but a protection against apoptosis. However, there is the indication that the failure in 
DNA damage recognition (down-regulation of xpc) is more important, and therefore 
apoptosis is induced in limited regions of the eleuthero-embryo. The TUNEL assay showed 
that apoptotic cells were located in the olfactory placodes (Figure 4). As there is also an up-
regulation of odorant receptors, which are mainly expresssed in the olfactory placodes, we 
suggest that this is a reaction to the damage and associated to repairing the loss of cells. 
Yet, there is no evidence for this phenomenon in mammals. 
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DNA damage can be paralleled with apoptosis. To evaluate whether alterations in xpc and 
apex can be linked to DNA damage, we performed comet assays. There is a clear link 
between gene expression alteration and DNA damage at both PKC412 concentrations. 
Although there is not significantly more DNA in the tail, there is a significant increase in tail 
length indicating that DNA damage took place. Data from the comet assay demonstrate that 
gene expression changes in DNA damage recognition are paralleled with intracellular DNA 
damage. This data is in agreement with the results obtained in human lymphoblast cells after 
treatment with PKC412 (Seedhouse et al., 2006). 
 
We also showed that physiological outcomes of maps of low significance, as the regulation of 
oxidative stress, do not correlate with the obtained gene expression. Nevertheless, several 
markers such as metallothionein (mt, 2.3-fold down-regulated at 21 µg/L) and glutathione S-
transferase M (gstm, 1.1- and 1.2-fold down-regulated at 1.3 and 21 µg/L, respectively) were 
significantly altered. It is known that mt is up-regulated by free radicals in rainbow trout cells 
(Kling and Olsson, 2000). Our findings on the alteration of gst are in contrast with those 
obtained in goldfish after treatment with gemfibrozil, which is supposed to down-regulate the 
antioxidant defense system (Mimeault et al., 2006). However, the gene expression of other 
markers such as the superoxide dismutase (sod) or the catalase (cat) was not altered. 
 
In our study we demonstrate that the response of zebrafish eleuthero-embryo to different 
PKC412 concentrations is partly similar to the response in humans. Significant changes in 
gene expression occurred at low concentrations of 1.3 μg/L PKC412. This demonstrates that 
alterations in gene expression are more sensitive than mortality and physiological effects. 
Additionally, the gene expression profile points to the modes of action of PKC412 in 
zebrafish. Due to the very broad kinase inhibition spectrum of PKC412 a correlation to 
physiological alterations is difficult. In some cases gene expression changes were not 
paralleled by physiological changes at low concentrations and sometimes even at high 
concentrations. This raises the question whether and when gene expression changes 
propagate to toxicological relevant measures such as reduction of the ability to find food, to 
reproduce or to escape from predators. 
 
In conclusion, the present study confirms that the toxicogenomic approach provides 
important data to identify and characterize molecular effects and to investigate potential 
modes of action of an antineoplastic agent. This allows for establishing new biomarkers, not 
regularly assessed in routine ecotoxicological studies. PKC412-induced alterations of gene 
transcripts were partly paralleled by physiological effects at high, but not at low PKC412 
concentrations that may be of environmental relevance. Our study also shows that molecular 
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studies should be paralleled with ecotoxicological investigations of known ecological 
relevance to interrelate sensitive changes in gene expression to physiological effects. 
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Abstract 
 
Residues of the UV-filter 2-ethyl-hexyl-4-trimethoxycinnamate (EHMC) are ubiquitously found 
in aquatic biota, but potential adverse effects in fish are fairly unknown. To identify molecular 
effects and modes of action of EHMC we applied gene expression profiling in zebrafish using 
whole genome microarrays. Transcriptome analysis and validation of target genes were 
performed after 14 days of exposure of male zebrafish. Concentrations of 2.2 µg/L and 
890 µg/L EHMC lead to alteration of 1096 and 1137 transcripts, respectively, belonging to 
many pathways. Genes involved in lipid metabolism and estrogenic pathway (vtg1), lipid 
biosynthesis (ptgds), vitamin A metabolic process (rbp2a), DNA damage and apoptosis 
(gadd45b), and regulation of cell growth (igfbp1a) were investigated by qRT-PCR analysis in 
whole body, liver, brain and testis. The analysis showed tissue-specific gene profiles and 
revealed that EHMC slightly affects the transcription of genes involved in hormonal pathways 
including vtg1, esr1, esr2b, ar, cyp19b and hsd17β3.  
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5.1 Introduction 
Personal care products are increasingly used in daily life and chemical residues enter 
aquatic systems, where they may lead to adverse effects in biota. UV-absorbing chemicals 
(UV-filters) are widely used in sunscreens and in a wide variety of cosmetics (lipsticks, 
shampoos, creams, fragrances, skin lotions, hair sprays). In addition, UV-protection is also 
applied in numerous materials and products, where UV-filters (Balmer et al., 2005; Fent et 
al., 2010a,b) or benzotriazole UV-stabilizers (Nakata et al., 2009) are used. UV-filters are 
organic (e.g. 2-ethyl-hexyl-4-trimethoxycinnamate, EHMC) or inorganic (TiO2, ZnO) 
ingredients of personal care products, whose purpose is to filter UV-A and/or UV-B radiation 
from sunlight in order to protect the human skin and products, respectively, from negative 
effects.  
 
Currently, 28 UV-filters are registered in the European Union (Zenker et al., 2008; Schlumpf 
et al., 2008). As a result of their various applications, UV-filters enter the aquatic environment 
either directly via wash-off from skin and clothes, or via effluents of wastewater treatment 
plants or swimming pool waters, where rather high levels of different UV-filters were 
measured (Balmer et al., 2005; Zwiener et al., 2007; Rodil and Moeder, 2008). Further 
sources of UV-filter residues are landfill leachates, sewage sludge, as well as deposition 
from building parts, which are protected with coatings (Plagellat et al., 2006).  
 
Many organic UV-filters are lipophilic, photostable and relatively stable in the aquatic 
environment. They adsorb into sewage sludge (Plagellat et al., 2006), and some of them 
bioaccumulate in aquatic biota. 2-Ethyl-hexyl-4-trimethoxycinnamate (EHMC), 
benzophenone-3 and 4-methoxycinnamate were demonstrated to accumulate in fish (Buser 
et al., 2006; Fent et al., 2010a), and in human breast milk (Schlumpf et al., 2008). The acute 
toxicity of some UV-filter increases with the log Pow (lipophilicity) of the compound in D. 
magna showing an LC50 value of 0.28 mg/L for EHMC (Fent et al., 2010b). Since significant 
amounts of these chemicals are used today, there are health concerns, and therefore, more 
knowledge is needed for a better understanding of potential toxicological effects and on the 
modes of action of these compounds.  
 
Some UV-filters interfere with the sex hormone system and may act as endocrine disruptors. 
Hormonal activity was documented in vitro (Schlumpf et al., 2001; Kunz and Fent, 2006a) as 
well as in vivo (Kunz et al., 2006a). In fathead minnows, the UV-filters 3-benzylidene 
camphor and benzophenone-2 exhibit estrogenic activity and adverse effects on fertility and 
reproduction (Kunz et al., 2006a,b; Weisbrod et al., 2007). Benzophenone-3 (BP-3) led to 
induction of vitellogenin in rainbow trout and Japanese medaka (Coronado et al., 2008), and 
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benzophenone-4 (BP-4) was demonstrated to interfere with the sex hormone system 
displaying multiple hormonal activities in zebrafish (Danio rerio) (Zucchi et al., 2010).  
 
EHMC is one of the most widely used UV-filters and included in more that 90% of 
commercial topically applied sunscreens formulation (Diaz-Cruz et al., 2008). The 
environmental concentration of EHMC ranges between 0.01-0.1 µg/L in treated wastewater, 
and up to 19 µg/L in untreated municipal wastewater (Balmer et al., 2005). EHMC residues 
were detected in lakes and rivers (Balmer et al., 2005; Fent et al., 2010a) and in coastal 
seawater up to 390 ng/L were reported (Langford and Thomas, 2008). Recently up to 3 µg/L 
EHMC were found in a lake (Rodil et al., 2009), and 0.26 to 5.61 μg/L were reported in 
drinking water (Loraine and Pettigrove, 2006). Unexpectedly, even at very remote 
environments such as the Pacific Ocean (Polynesia) this compound was detected (Goksoyr 
et al., 2009). EHMC is lipophilic (logP = 5.66; Zenker et al., 2008) and accumulates in aquatic 
biota (Fent et al., 2010a). Residues were found in different trophic levels showing a tendency 
for bioaccumulation along the food-chain, with concentrations up to 340 ng/g lipids in 
cormorants (Fent et al., 2010a).  
 
Despite its widespread presence in the environment, little is known about the potential risk 
posed by EHMC to aquatic life. In recombinant yeast systems EHMC showed anti-estrogenic 
and anti-androgenic activities, combined with weak androgenic activity (Kunz and Fent, 
2006b). Injection of high concentrations of EHMC in male medaka led to induction of 
vitellogenin (VTG) (Inui et al., 2003), while no significant VTG induction was observed in 
juvenile fathead minnows exposed to lower aqueous concentrations (Kunz and Fent, 2006b). 
Despite these studies the potential endocrine activity and molecular modes of action of 
EHMC in fish remain elusive and need further investigation. In light of the importance and 
increasing use of this UV-filter, and considering that potential hormonal activities and 
adverse effects on fertility are of concern, there is a need for a better understanding of 
potential environmental risks associated with EHMC contamination.  
 
Since changes in gene expression often precede cellular, physiological and toxicological 
responses, analysis of gene expression profiles upon exposure may be a sensitive tool for 
investigating adverse effects of pollutants including their molecular mode of action (Oggier et 
al. 2010, 2011). Thus far, toxicogenomics was applied mainly with compounds whose modes 
of action are known (e.g. Lettieri, 2006; Hoffmann et al., 2006, 2008). However, microarray 
analysis focusing on thousands of genes also offers the potential to analyse for the molecular 
effects of chemicals with unknown modes of action. By employing global gene expression 
analysis, in the present study, we focus on EHMC to elucidate its unknown mode of action in 
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order to shed a new light on its potential effects in fish. Whole-adult microarray analysis 
performed on a small vertebrate such as zebrafish might represent a strategy to potentially 
obtain a large amount of in vivo data on the transcriptome of the entire organism (Lam et al., 
2008), and thus to obtain insight into the mode of action of EHMC.  
 
The aim of our present study is to evaluate the overall molecular effects of EHMC by 
analysing the whole body of adult male zebrafish. This allows an overall fingerprint of EHMC 
as a sum effect in all tissues, which is in contrast to analysis of only one tissue alone, hard to 
select without knowledge about the target tissues of the compound. Data from previous 
studies suggest that EHMC interferes with the sex hormone system (Inui et al., 2003; Kunz 
and Fent 2006b). Additionally, by analyzing transcriptional changes of selected target genes 
belonging to different pathways including vitellogenin 1 (vtg1), prostaglandin D2 synthase 
(ptgds), insulin growth factor binding protein 1a (igfbp1a), retinol-binding protein type II 
(rbp2a), and growth arrest and DNA-damage-inducible beta (gadd45b), we aimed at 
comparing expressional changes in the whole body to those in the liver, brain and testis. To 
analyse for potential hormonal effects, we focused on expressional changes of more 
classical genes involved in hormonal pathways and steroidogenesis including vitellogenin 3 
(vtg3), ERalpha (esr1), ERbeta1 (esr2b), androgen receptor (ar), hydroxysteroid 17-ß 
dehydrogenase-3 (hsd17ß3), P450aromB (cyp19b) and P450aromA (cyp19a).  
 
By following an approach to analyse for unknown molecular effects of EHMC by means of 
global expression analysis (microarrays), and by following a targeted gene expression 
approach (qRT-PCR) focusing on mainly hormonal pathways in multiple tissues, we 
demonstrate the involvement of several pathways in response to EHMC exposure. 
 
5.2 Materials and Methods 
5.2.1 Chemicals 
2-Ethyl-hexyl-4-trimethoxycinnamate (EHMC, CAS No. 5466-77-3) and 3-(4-
methylbenzylidene)-camphor (4MBC; CAS No. 36861-47-9) were purchased from Merck 
(Glattbrugg, Switzerland), ethanol (EtOH), methanol and dichloromethane in HPLC grade 
from J.T. Baker (Stehelin AG, Basel, Switzerland). Formic acid and dimethyl sulfoxide 
(DMSO) were purchased from Sigma Aldrich (Fluka AG, Buchs, Switzerland). All compounds 
were >99% pure. The water solubility of EHMC is 0.2 mg/L at 20 ˚C (http://www.merck-
chemicals.com), and the log P is 5.66 (Zenker et al., 2008). Master concentrated stock 
solution of 30 and 0.3 g/L EHMC were made up in DMSO and stored in the dark at 4°C 
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between uses. After dilution with tank water (10L), DMSO concentrations did not exceed 
0.01% in each tanks used in the experiment. 
 
5.2.2 Analytical chemistry 
During the experiment aliquots of exposure water were taken three times randomly from the 
tanks to determine the actual exposure concentration of EHMC. Water samples of each 
replicate were taken at the beginning (0 h), after 24 h and prior to water renewal (48 h). This 
was done on days 1 to 3, 7 to 9 and 11 to 13, respectively, from different replicate tanks. The 
water samples were stored in the dark at -20 °C until analysis by HPLC-DAD. Extraction of 
water samples and chemical analysis was performed according to Kunz et al. (2006b). 
 
5.2.3 Maintenance of adult zebrafish 
Adult zebrafish (Danio rerio) (>121 days) were obtained from a local dealer 
(Swisstropicalfish, Niederönz, Switzerland), transferred to culture tanks (300 L) and 
acclimatized one month in our laboratory prior to commencing the experiments. Fish of both 
sexes were held in reconstituted tap water with a total hardness of 125 mg/L as CaCO3 and a 
conductivity of 270 μS/cm. The water temperature was held constant at 27±1 °C with the 
photoperiod set at 16:8 h light/dark. Fish were fed twice daily with TetraMin flakes (Tetra 
GmbH, Melle, Germany) and once a day with a combination of brine shrimp (Artemia salina) 
and white mosquito larvae. 
 
5.2.4 Exposure of adult male zebrafish  
Adult male zebrafish were selected from the culture tank and randomly placed into 10 L 
stainless steel tanks in well-aerated water (12 fish/ tank). The experimental setup consisted 
of 4 groups: 3 μg EHMC/L, 3000 μg EHMC/L, solvent control (SC, 1 ml of DMSO in 10 litres 
of reconstituted water) and water control (reconstituted water). Each dose-group and the 
control consisted of four replicates. The quality of the exposure water was continuously 
monitored by measuring the oxygen concentration (>70%), pH value (6.7-7.2) and 
temperature (27±1 °C). During the experiment, appearance, mortality and abnormal 
behaviour of fish were recorded daily.  
 
Fish were exposed for 14 days to EHMC in a semi-static renewal procedure; every 48 h fish 
were transferred to new tanks containing the appropriate EHMC concentrations. During the 
exposure period fish were fed daily as previously described. At the end of the experiment, 
fish were euthanized in a clove oil solution (Fluka AG, Buchs, Switzerland), the total body 
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length and weight were measured. For whole-body microarray analyses and subsequent 
quantitative real-time polymerase chain reaction (qRT-PCR) confirmation, two fish per 
replicate of every group were snap-frozen in liquid nitrogen after sex determination.  
Zebrafish sex determination was carried out opening the belly to ensure testis presence 
before collecting fish for further molecular analysis. 
 
A number of 10 fish of each replicate of each dose group were used for qRT-PCR analysis, 
and liver, brain and testis were immediately excised. Pools of tissues of ten fish per replicate 
were collected, placed in RNAlater and stored at −80 °C for subsequent total RNA extraction. 
 
5.2.5 RNA isolation, array hybridization and sample selection 
For microarray analysis one whole fish per replicate of each dose group was pounded in a 
ceramic mortar to powder with liquid nitrogen, and subsequently equally transferred into two 
Eppendorf tubes for subsequent total RNA extraction using RNeasy Mini Kit (Qiagen, Basel, 
Switzerland). 
 
For qRT-PCR analysis of tissues, total RNA was extracted from pools of 10 fish of liver, brain 
and testis using RNeasy Mini Kit (Qiagen, Basel, Switzerland). RNA concentrations were 
measured spectrophotometrically using a NanoDrop ND-1000 UV-VIS spectrophotometer at 
260 nm. The integrity of each RNA sample was verified using an Agilent 2100 Bioanalyzer 
(Agilent Technologies, Basel, Switzerland). Only samples containing a 260/280 nm ratio 
between 1.8- 2.1, a 28S/18S ratio between 1.5- 2 and an RNA integrity number (RIN) > 8 
were processed further.  
 
For transcriptom analysis, a total of 16 arrays (Agilent 4 × 44 K Zebrafish microarray) were 
used, including four for the 3 µg/L, four for the 3000 μg/L EHMC dose group, four for the 
solvent control group (DMSO) and four for the water control group. Total RNA samples 
(600 ng) were reverse-transcribed into double-strand cDNA in the presence of RNA poly-A 
controls with the Agilent One-Color RNA Spike-In Kit. Cy3 labeling and hybridization were 
performed according to the manufacturer's manual.  
 
After reverse-transcription of RNA into double-stranded cDNA, double-strand cDNA was in 
vitro transcribed into cRNA in the presence of Cy3 labeled nucleotides using a Low RNA 
Input Linear Amp Kit +Cy dye (Agilent Technologies, Basel, Switzerland), performed at the 
Functional Genomic Centre (ETHZ and University of Zürich, Switzerland). The Cy3-labeled 
cRNA was purified using an RNeasy mini kit (Qiagen, Basel, Switzerland), and quality and 
quantity was determined using a NanoDrop ND-1000 UV-VIS Spectrophotometer and an 
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Agilent 2100 Bioanalyzer, respectively. Only cRNA samples with a total cRNA yield higher 
than 2 µg and a dye incorporation rate between 9 pmol/µg and 20 pmol/µg were used for 
hybridization. Cy-3-labeled cRNA samples (1.65 µg) were mixed with Agilent blocking 
solution, subsequently fragmented randomly to 100-200 bp at 65 °C with fragmentation 
buffer and resuspended in hybridization buffer as provided by the gene expression 
hybridization Kit (Agilent Technologies). Target cRNA samples (100 µL) were hybridized to 
the Agilent Zebrafish 4 x 44K Gene Expression Microarray for 17 h at 65 °C. The hybridized 
arrays were then washed using Agilent GE wash buffers 1 and 2 according to the 
manufacturer's instructions and scanned by an Agilent Microarray Scanner (Agilent p/n 
G2565BA) at 5 μm resolution with the green photomultiplier tube set to 100% and a scan 
area of 61 x 21.6 mm. Image generation and feature extraction was performed using the 
Agilent Feature Extraction (FE) software version 9.5.3. Quality control was additionally 
considered before performing the statistical analysis. These included array hybridization 
pattern inspection: absence of scratches, bubbles, areas of non-hybridization, proper grid 
alignment, spike performance in controls with a linear dynamic range of 5 orders of 
magnitude and the number of green-feature non-uniformity outliers which should be below 
100 for all samples. 
 
5.2.6 qRT-PCR analysis  
Changes in the expression of selected genes identified as being different following 
microarray analysis were validated using real-time reverse transcription-polymerase chain 
reaction (qRT-PCR). The selected genes included, vitellogenin 1 (vtg1), insulin-like growth 
factor binding protein 1(igfbp1), prostaglandin D2 synthase (ptgds), growth arrest and DNA-
damage-inducible beta (gadd45b) and cellular retinol-binding protein type II (rbp2a) 
(Table 1). In addition, seven target transcripts were chosen for qRT-PCR analysis, because 
of their involvement in hormonal pathways and steroidogenesis. They included vitellogenin 3 
(vtg3), estrogen receptor alpha (esr1), estrogen receptor beta 1 (esr2b), hydroxysteroid 17-ß 
dehydrogenase-3 (hsd17ß3), androgen receptor (ar), P450aromB (cyp19b) and P450aromA 
(cyp19a). 
 
Gene-specific primers of all the genes were obtained either from published zebrafish primers 
sequences, or designed based on zebrafish sequences available at NCBI 
(http://www.ncbi.nlm.nih.gov/) (Table 1). Primer sequences not previously published were 
designed using IDTDNA software (www.idtdna.com). 
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Amplicons were analyzed by 1.5% agarose gel electrophoresis stained with ethidium 
bromide, in order to confirm correct product size and primers specificity. Total RNA from 
individual whole body fish and pools of 10, each of zebrafish liver, brain and testis were  
isolated as described above (n = 4). 
 
Table 1  
Primer sequences for quantitative real-time PCR analysis and sources 
 
vtg1 (vitellogenin 1), vtg3 (vitellogenin 3), esr1 (ERalpha), esr2b (ERbeta1), ar (androgen receptor), hsd17ß3 (hydroxysteroid 
17-ß dehydrogenase-3), cyp19b (P450aromB), cyp19a (P450aromA), gadd45b (growth arrest and DNA-damage-inducible 
beta), rbp2a (retinol-binding protein type II), ptgds (prostaglandin D2 synthase), igfbp1 (insulin growth factor binding protein 1) 
and RpL13α. a Hoffmann, et al., 2006 b Meng et al., 2010 c Martyniuk et al., 2007 d Chandrasekar et al., 2010 e  Hossain et al., 
2008 f  Hoffmann, et al., 2008 g Arukwe et al., 2008 h Oggier et al., 2010 
 
RNA samples used for qRT-PCR analysis were further treated with RNase free DNase set 
(Qiagen, Basel, Switzerland) to purify the RNA preparations from DNA contamination and to 
subsequently remove DNase and divalent cations from the samples. 
 
Subsequently, 1 μg of total RNA template was reverse-transcribed using Moloney murine 
leukemia virus reverse transcriptase (Promega Biosciences Inc., Wallisellen, Switzerland) in 
the presence of random hexamers (Roche Diagnostics, Basel, Switzerland) and 
desoxynucleoside triphosphate (Sigma-Aldrich, Buchs, Switzerland). The reaction mixture 
was incubated for 5 min at 70 °C and then for 1 h at 37 °C. The reaction was stopped by 
heating at 95 °C for 5 min. The cDNA was used to perform SYBR-PCR based on SYBR-
Target gene GenBank number Sense primer (5'-3') Antisense primer (5'-3') Product size (bp) 
Vtg1 a AY034146 AGCTGCTGAGAGGCTTGTTA GTCCAGGATTTCCCTCAGT 94 
Vtg3 b AF254638 TTAGAACCAGCAAAGGATGC CATCTCTTTTCTCCTTAAATAC 208 
esr1 c NM_152959 TGAGCAACAAAGGAATGGAG GTGGGTGTAGATGGAGGGTTT 163 
esr2b d NM_174862.3 CGCTCGGCATGGACAAC CCCATGCGGTGGAGAGTAAT 80 
ar e NM_001083123 CACTACGGAGCCCTCACTTGCGGA GCCCTGAACTGCTCCGACCTC 237 
hsd17ß3 f NM_200364.1 TTCACGGCTGAGGAGTTTG GGACCCAGGTAGGAATGG 121 
cyp19b g AF183908 CGACAGGCCATCAATAACA CGTCCACAGACAGCTCATC 94 
cyp19a g AF226620 CTGAAAGGGCTCAGGACAA TGGTCGATGGTGTCTGATG 92 
gadd45b NM_213031 GGGACGAACATTTTGAAGGA AACACGGTCCTTTTCAGTGC 131 
rbp2a AF363957 GGAGATGCTCAGCAATGACA TCTGCACAATGACCTTCGTC 110 
ptgds NM_213634 CCATCAAGACCAAAGGAGGA TCCATTTTGTGGAAGCATGA 152 
Igfbp1 a NM_173283 GTCATCCTGGAATGGGAAGA TGTGTGACGGATCAGTGGTT 93 
RpL13α h NM_212784 AGCTCAAGATGGCAACACAG AAGTTCTTCTCGTCCTCC 100 
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Green Fluorescence (FastStart Universal SYBR Green Master, Roche Diagnostics, Basel, 
Switzerland).  
 
The real-time PCR program included an enzyme activation step at 95 °C (10 min) and 40 
cycles of 95 °C (30 s), 57–60 °C, depending on transcript target as shown in Table 1 (30 s) 
and 72 °C (30 s), followed by a melting curve analysis post run. All reactions were run in 
duplicate using the Biorad CFX96 RealTime PCR Detection System (Biorad, Reinach, 
Switzerland).  
 
For determining the efficiencies of the PCR reactions, reaction mixtures with template diluted 
1:10 in five steps were also run and the slopes of the regression curves were calculated. For 
calculating expression levels of selected genes, mRNA normalization was performed against 
the housekeeping gene (RpL13α). The ∆CT values were calibrated against the control ∆CT 
values for both target genes. The relative linear amount of target molecules relative to the 
calibrator was calculated by 2-∆∆CT (Livak and Schmittgen, 2001), all gene expression data 
are reported as log2-transformed. 
 
5.2.7 Data analysis and statistics 
To identify lists of differentially-expressed genes (DEGs) in this study, the text outputs (raw 
microarray data) obtained from Functional Genomic Centre Zurich (FGCZ) were imported 
into GeneSpring GX 11 (Agilent Technologies). In a first step, the Agilent Feature Extraction 
software output was filtered on the basis of feature saturation, non-uniformity, pixel 
population consistency and signal strength relative to back ground level (Agilent Feature 
Extraction Manual). Only positively marked entities, in which at least 50% of the values for 
any out of the three conditions were accepted for further evaluation. All data were quantile 
normalized. In a second step, several quality control steps (e.g. correlation plots and 
correlation coefficients, quality metric plots and PCA) using the quality control tool of 
GeneSpring were performed to ensure that the data were of good quality.  
 
Differentially expressed genes from the microarray were determined using a Benjamini-
Hochberg multiple correction-ANOVA test (p<0.05), followed by a TukeyHSD post-hoc test. 
The genes were considered differentially expressed when p<0.05 and the fold change (FC) 
was ≥2.  
 
To determine gene ontology (GO) categories of differentially expressed genes, the GO 
analysis tool in GeneGo (GeneGo, San Diego, CA, Version 6.3, http://www.genego.com) was 
used. Enrichment was examined in all three major GO categories (e.g., biological process, 
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cellular component, molecular function), but only biological process results are reported here, 
as they were the most relevant category for the purposes of this study. Only those categories 
where p<0.05 are considered differentially altered. 
 
MetaCoreTM (GeneGo, San Diego, CA, Version 6.3) from GeneGo Inc. 
http://www.genego.com was used to identify and to visualize the involvement of the 
differentially expressed genes in specific pathways (FDR< 0.05). 
 
Data from qRT-PCR were illustrated graphically with GraphPad® Prism 5 (GraphPad 
Software, San Diego, CA, USA). Data distribution for normality was assessed with the 
Kolmogorov-Smirnov test and the variance homogeneity with the Bartlett test. Differences 
between treatments were assessed by analysis of variance followed by a Tukey test 
(Bartelett test p<0.05) to compare treatment means with respective controls. Results are 
given as mean ± standard error of mean. Differences were considered significant at p≤0.05. 
 
5.3 Results 
5.3.1 EHMC exposure concentrations and gross behaviour 
Concentrations of EHMC in experimental water were determined by HPLC-DAD after 0, 24, 
and 48 h of exposure for each treatment group. At the nominal EHMC concentration of 
3 µg/L, measured concentrations were 2.2 µg/L at 0 h, 3.6 µg/L at 24 h, and not detectable 
(n.d.) at 48 h. At the nominal EHMC concentration of 3000 µg/L measured concentrations 
(median±SD) were 1741±23 µg/L (n=3) at 0 h, and decreased to 890±9 µg/L (n=3) at 24 h, 
and to 140±2 µg/L (n=3) at 48 h. This gives a median of the actual exposure concentration 
over this time period of 2.2 and 890 μg/L (Table 2). The data demonstrate that actual 
concentrations of EHMC (expressed as median concentrations) were lower than nominal and 
further decreased during exposure.  
 
During the 14-d experiment, no mortality occurred even in the highest dose group and there 
were no indications of abnormal behaviour during the exposure. No significant alteration of 
condition factors (CF) was noted (Figure 1). 
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Table 2  
Nominal and median of actual concentrations of EHMC in exposure waters at different time points (0, 24 and 48 
hour). 
Nominal 
Concentration 
(μg/L) 
Exposure waters 
Measured concentration (μg/L) 
0 h 24 h 48 h Median** 
0 (n=3) 0* 0* 0* 0 
3 (n=1)1 2.2 3.6 0 2.2 
3000 (n=3) 1741± 23* 890 ±9* 140±2* 890 
 
* median±standard deviation of replicates 
** median of actual exposure concentration after 0, 24 and 48 h 
1 only one replicate could be measured due lack of sampling water evaluated 
 
 
5.3.2 Differential expression of genes in whole body determined by 
microarrays 
All microarray hybridizations in this experiment met our quality requirements and were 
included in the analysis. For gene expression profiles determined by microarrays, four 
individual whole body samples, each of control, DMSO-solvent control and EHMC-exposed 
male fish, were analysed. Exposure to 2.2 μg/L and 890 μg/L EHMC resulted in a differential 
expression of 1096 and 1137 genes (fold change ≥2, p<0.05), respectively, as listed in 
Appendix 3 Table 1. At 2.2 μg/L EHMC, 594 (54.2 %) genes were down-regulated, and 502 
(45.8 %) up-regulated. Of the 1137 genes differentially expressed at 890 μg/L EHMC 699 
(61.48 %) were down-regulated, and 438 (38.52 %) up-regulated. A total of 708 of the 
significantly altered genes were regulated at both EHMC concentrations, and they were 
always regulated in the same direction (up or down) (Appendix 3 Table 1). The Venn 
Diagram (Figure 2) indicates that the expression of 388 and 429 genes were differently 
altered (fold change ≥2, p<0.05) by 2.2 and 890 μg/L EHMC, respectively. 
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Figure 1  
Condition factor (CF) of male zebrafish. Controls (white bar) and fish exposed to 3 μg/L and 3000 μg/L EHMC 
(black and grey bar). Values are means ± SEM (n = 12 males). Nominal median EHMC concentrations are given. 
 
The Gene Ontology (GO) provides a controlled way to describe gene products in three 
categories, namely cellular components, molecular functions and biological processes 
(Ashburner et al., 2000). GO terms for biological processes were examined to determine the 
function of genes with altered patterns of expression. At both concentrations, functionally 
identified genes fell into 1650 different categories. ‘Cellular Process’ was the most 
significantly overrepresented Biological Process GO term (Appendix 3 Table 2). The top 50 
GO processes are listed in Appendix 3 Table 2. GO-categories show that mainly cellular 
processes, development processes, system development, multicellular organismal 
development, anatomical structure development, muscle system process, muscle contraction 
and response to hormone stimulus are affected at both EHMC concentrations (Appendix 3 
Table 2). 
 
Additionally to the GO analysis, we performed a pathway analysis (GeneGo Pathway Maps) 
with MetaCore TM. The different treatments showed 33 maps (2.2 μg/L EHMC: 33 maps; 
890 μg/L: 36 maps) with their corresponding pathways in common (Appendix 3 Table 3). The 
890 μg/L EHMC treatment displayed 3 additional maps, namely, retinoid signalling, hypoxia 
response regulation and visual perception. 
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The 15 most relevant maps shown in Appendix 3 Table 3 include pathways involved in tissue 
remodeling and wound repair, immune system response, inflammatory response, cell 
differentiation, DNA-damage response, cell cycle and its regulation, apoptosis, blood clotting, 
protein synthesis, calcium signalling, vasoconstriction, vascular development (angiogenesis), 
mitogenic signalling, protein degradation and androgen signalling.  
 
Figure 2 
Venn diagram illustrating the number of altered genes that are in common between the two EHMC exposures 
(708 genes), and number of genes that are only regulated by 2.2 (388) and 890 (429) μg/L EHMC, respectively. 
 
5.3.3 Validation of microarray data by real-time qRT-PCR assessment of target 
genes 
To validate gene expression changes determined by microarrays, five genes involved in 
different pathways were selected. They include genes belonging to hormonal pathways such 
as vitellogenin 1 (vtg1), lipid metabolism such as the prostaglandin D2 synthase (ptgds), a 
gene that mediates cell growth, and known to be induced by estrogenic compounds (Riley et 
al., 2004; Hoffman et al., 2006; Martyniuk et al., 2007; Baker et al., 2009) such as the insulin 
growth factor binding protein 1a (igfbp1a), a gene involved in vitamin A metabolism, the 
retinol-binding protein type II (rbp2a), and a gene involved in apoptosis, DNA damage and 
immune response such as the growth arrest and DNA-damage-inducible beta (gadd45b). 
The latter was previously found to be modulated by EE2 (Hoffmann et al., 2006).  
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These genes, ptgds, igfbp1a, rbp2a and gadd45b (except for vtg1, MetaCore software 
visualize mouse, rat, worm, fly, yeast and dog data on networks) were then used to build 
corresponding networks using MetaCore, as illustrated in Figure 3 A, B, C and D. 
 
(A)                                                            (B) 
 
 
(C) 
 
 
(D) 
 
 
Figure 3 
A, B, C, D:  Gene networks for ptgds (A), igfbp1a (B), rbp2a (C) and gadd45b (D) as constructed by MetaCore 
version 6.4. 
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These selected genes were validated by qRT-PCR in whole-body samples. In addition, these 
five genes were analysed in different tissues including liver, brain and testis to compare their 
expression in individual organs with those in the whole body (Table 3).  
 
The observed mRNA alterations occurred always in the same direction in the whole body in 
both the microarrays and qRT-PCR measurements. This demonstrates that the 
transcriptional changes determined by microarrays are paralleled by qRT-PCR 
measurements, but the magnitude of the fold increase of these transcripts was more 
pronounced in the microarray analysis.  
 
Different trends in expressional changes were observed in whole-body samples, and 
different tissues (Table 3). The vtg1 mRNA was significantly down-regulated in the whole 
body at both EHMC concentrations, and this was also noted in the brain and testis. 
Conversely, a dose-related vtg1 up-regulation occurred in the liver (Table 3). It is important to 
highlight that for the vtg1 transcript the microarray data demonstrate a down regulation for 3 
vtg1 partial sequences (as for example agilent probe ID: A_15_P110740; Appendix 3 
Table 1). Based on BLAST (http://blast.ncbi.nlm.nih.gov/) comparisons and ClustalW multiple 
sequence alignment (http://www.ebi.ac.uk/Tools/clustalw/) we confirmed that the 3 partial 
vtg1 sequences correspond to the Danio rerio gene vtg1 with accession number 
NM_001044897. 
 
Similar to the vtg1 transcript, the ptgds transcript showed a different expression in the liver as 
compared to the whole body and the other tissues. This transcript was up-regulated in the 
whole body, brain and testis at both concentrations, while in the liver, it was down-regulated 
(Table 3). In the brain we observed a tendency for induction, whereas in the testis a 
significant up-regulation occurred, especially at 890 µg/L EHMC. 
 
A dose-related and parallel increase occurred for the igfbp1a transcript in the whole body, 
and in the liver, brain and testis (Table 3). In brain and testis a considerable up-regulation is 
noted at 890 µg/L EHMC. The rbp2 mRNA was down-regulated in the whole body and in all 
of the investigated tissues. The microarray data show that rbp2 mRNA was strongly down-
regulated in the whole body at 2.2 µg/L EHMC (Table 3). A significant induction was noted at 
both EHMC concentrations for the gadd45b transcript in the whole body, whereas the 
alteration was not significant in individual tissues (Table 3). 
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Table 3 
Fold changes (Log2) of selected genes differentially regulated in zebrafish adult male determined by microarray 
(GeneSpring normalization) and qRT-PCR (2-∆∆Ct normalization) after exposure to 2.2 μg/L and 890 μg/L EHMC. 
Values are expressed as average fold change. Asterisks show statistically significant difference to control (p < 
0.05). 
 
5.3.4 Transcriptional changes of selected target genes in tissues 
Based on our previous study (Zucchi et al., 2010) seven additional candidate genes were 
chosen for the evaluation of molecular effects of EHMC with a focus on hormonal activity and 
steroidogenesis to test the hypothesis that this UV-filter acts on these processes. The 
selected genes included vitellogenin 3 (vtg3), estrogen receptor alpha (esr1), estrogen 
receptor beta 1 (esr2b), androgen receptor (ar) and hydroxysteroid 17-ß dehydrogenase-3 
(hsd17ß3). Their expression levels were evaluated by qRT-PCR in the whole body, liver, 
brain and testis (Figure 4; Figure 5 A, B, C; Figure 6). Additionally, differential expressions of 
P450aromB (cyp19b) and P450aromA (cyp19a) were determined in brain and testis, 
respectively. The selected genes belong to three categories including an estrogen-
responsive gene (vtg3), nuclear receptors (esr1, esr2b, ar) and steroid metabolism 
(hsd17ß3, cyp19b and cyp19a). 
 
 
 
 
 
 
 
 
 2.2 µg/L EHMC 890 µg/L EHMC 
  Whole fish 
Whole 
fish Liver Brain Testis 
Whole 
fish 
Whole 
fish Liver Brain Testis 
GenBank  Description Array qRT-PCR 
qRT-
PCR 
qRT-
PCR 
qRT-
PCR Array 
qRT-
PCR 
qRT-
PCR 
qRT-
PCR qRT-PCR 
NM_001044897 vitellogenin 1 (vtg1) -5.03* -1.66* 1.05* -0.60* -0.57* -2.96* -3.31* 1.39* -0.63* -0.69* 
NM_213634 
prostaglandin  
D2 synthase 
(ptgds) 
1.75* 1.35* -0.90 0.51 1.58* 2.54* 1.93* -0.57 0.70 2.38* 
NM_173283 
insulin-like 
growth factor 
binding protein 
1a (igfbp1a) 
1.46* 0.71 1.03* 0.83* 1.66* 1.18* 1.82* 1.48* 3.24* 3.62* 
AF363957 
retinol-binding 
protein type II 
(rbp2a) 
-5.08* -0.51 -0.60 -2.53* -0.23 -3.69* -0.97* -0.55 -1.60* -0.59 
NM_213031 
growth arrest 
and DNA-
damage-
inducible, beta 
(gadd45b) 
2.80* 2.26* -1.17 -0.74 -0.83 1.61* 0.98* -0.42 0.61 -0.42 
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Figure 4 
Relative gene expression of vtg3 in whole body, liver, brain and testis of adult male zebrafish after exposure to 
2.2 and 890 μg/L of EHMC.  Relative transcript abundance was quantified by real-time reverse transcription PCR 
(qRT-PCR); the fold changes in vtg3 abundance as compared to control values were determined using 2-∆∆CT 
method. Results are given as the mean value ± standard deviation (n=4 replicates for adults).  
 
The modulation of esr1 and esr2b transcripts in whole-body and tissue samples show an 
almost identical trend and similar expression pattern. An induction occurred in the whole 
body and liver, whereas the transcripts were down-regulated in brain and testis (Figure 5A 
and B). The alterations were mostly significant at 890 µg/L EHMC, except for the brain, were 
the down-regulation was significant at 2.2 µg/L. The vtg3 transcript was not significantly 
altered in all the investigated tissues (Figure 4). 
 
The ar transcript was significantly down-regulated in the whole body at 890 µg/L (Figure 5C). 
A dose-related down-regulation was also noted in the liver (Figure 5C), whereas in the brain, 
a slight but significant up-regulation occurred at 890 µg/L EHMC. The hsd17ß3 transcript 
was significantly down-regulated in whole-body samples in a dose-dependent manner 
(Figure 6).  
 
In the brain the transcription of cyp19b, encoding the aromatase B, was significantly induced 
at 890 µg/L EHMC (Figure 7). However, the amount of cyp19a transcripts, encoding 
aromatase A, did not significantly change after EHMC treatment (Figure 8). 
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(A)          (B) 
 
(C) 
 
 
 
Figure 5 
Relative gene expression of (A) esr1, (B) esr2b and (C) ar in whole body, liver, brain and testis of adult male 
zebrafish after exposure to 2.2 and 890 μg/L of EHMC.  Relative transcript abundance was quantified by real-time 
reverse transcription PCR (qRT-PCR); the fold changes in esr1 abundance as compared to control values were 
determined using 2-∆∆CT method. Results are given as the mean value ± standard deviation (n=4 replicates for 
adults). Asterisks indicate significantly higher expression than control (*p< 0.05), and (**p<0.01). 
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Figure 6 
Relative gene expression of hsd17ß3 in whole body, liver, brain and testis of adult male zebrafish after exposure 
to 2.2 and 890 μg/L of EHMC. Relative transcript abundance was quantified by real-time reverse transcription 
PCR (qRT-PCR); the fold changes in hsd17ß3 abundance as compared to control values were determined using 
2-∆∆CT method. Results are given as the mean value ± standard deviation (n=4 replicates for adults). Asterisks 
indicate significantly higher expression than control (*p< 0.05), and (**p<0.01). 
 
 
Figure 7 
Relative gene expression of cyp19b in brain of adult male zebrafish after exposure to 2.2 and 890 μg/L of EHMC. 
Relative transcript abundance was quantified by real-time reverse transcription PCR (qRT-PCR); the fold changes 
in cyp19b abundance as compared to control values were determined using 2-∆∆CT method. Results are given as 
the mean value ± standard deviation (n=4 replicates for adults). Asterisks indicate significantly higher expression 
than control (*p< 0.05), and (**p<0.01). 
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Figure 8 
Relative gene expression of cyp19a in testis of adult male zebrafish after exposure to 2.2 and 890 μg/L of 
EHMC. Relative transcript abundance was quantified by real-time reverse transcription PCR (qRT-PCR); the 
fold changes in cyp19a abundance as compared to control values were determined using 2-∆∆CT method. 
Results are given as the mean value ± standard deviation (n=4 replicates for adults).  
 
5.4 Discussion 
In the present study we examined molecular effects of EHMC in zebrafish by applying gene 
expression profiling and a targeted gene expression approach. Global gene expression 
profiling was applied in the whole body and alterations of selected microarray-detected target 
genes were validated by means of qRT-PCR. Therefore, we determined the expression of a 
suite of target genes to compare the response in the whole body to that in individual tissues. 
Based on previous in vitro and in vivo studies (Kunz and Fent 2006b; Inui et al., 2003) 
indicating a hormonal activity, we additionally chose target genes to test the hypothesis that 
EHMC interferes with genes involved in sex hormonal signalling and steroidogenesis. 
 
We analyzed the response in whole organisms, because this captures the total sum of the 
transcriptional changes in the entire organism, and thus the overall molecular effect giving 
indications on the mode of action of EHMC on the transcriptome. However, at the same time, 
this approach has its limitations, such as loss of weak signals or signals from small tissues, 
and the tissue-specific contributions cannot be unravelled. The microarray data demonstrate 
a high number of expressional changes in the whole-body samples and associated biological 
pathways. As in the case of our present study, they do not necessarily provide a defined, 
clear and simple picture of affected processes, making data interpretation challenging. 
Despite these limitations, we have chosen this promising approach as the predictive power of 
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whole-organism genomics has been demonstrated in zebrafish exposed to polycyclic 
aromatic hydrocarbons and estrogenic compounds (Lam et al., 2008). This approach also 
provides a fingerprint of all expressional changes within the organism, as the specific target 
organs of EHMC are unknown. This is in contrast to our previous studies on pharmaceuticals 
having a known mode of action (Oggier et al. 2010, 2011). In addition, we chose a target 
gene approach to scrutinize potential mode of actions, with emphasis on hormonal pathways. 
 
5.4.1 Microarray analysis and gene categorization in whole organism 
Exposure to EHMC altered the expression of a considerable number of genes in the entire 
organism. A comparison of the transcriptional profiles in whole bodies and different tissues 
demonstrated that the overall expression pattern and tissue-specific profiles do not 
necessarily match. 
 
A total of 1096 and 1137 genes were altered at 2.2 μg/L and 890 μg/L EHMC, respectively, 
which is in the same range of genes affected in the liver of zebrafish after exposure to 17α-
ethynylestradiol (EE2) (Hoffmann et al., 2006). Complex interrelationships in expressional 
changes with most genes showing differential responses between tissues (and sexes) were 
also reported upon exposure of fathead minnows to 17ß-estradiol (E2) (Filby et al., 2006).  
EHMC influences mainly the biological process (GO:008150) and molecular function 
(GO:003674) as highlighted by GO terms classification. At both EHMC concentrations 
differentially altered genes belong to many biological processes indicating a diverse effects 
pattern. The top 50 GO processes include cell processes (e.g.: cell death, cellular metabolic 
process, cell cycle and transmembrane transport), developmental process (e.g.: multicellular 
organismal development, anatomical structure development), muscle system process and 
contraction (e.g.: muscle cell differentiation, smooth muscle contraction), response to 
hormone stimulus (e.g.: response to steroid hormone stimulus,  response to chemical 
stimulus), response to endogenous stimulus (e.g.: response to epidermal growth factor 
stimulus, response to hormone stimulus), regulation of multicellular organismal process (e.g.: 
regulation of angiogenesis, regulation of nervous system development, regulation of cytokine 
production), tissue development (e.g.: multicellular organismal development, organ 
development), among others (Appendix 3 Table 2). According to the GO processes, the 
major altered pathways by EHMC are mainly involved in tissue remodeling, wound repair, 
immune system response, inflammatory response, cell differentiation, DNA-damage 
response, cell cycle and its regulations and apoptosis.  
 
Often GO analysis can be useful in providing information about the modes of action of a 
chemical, but the many GO terms affected by EHMC exposure are general descriptions, 
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which based on the results of this experiment alone without phenotypic anchoring, makes it 
difficult to link them to a specific mode of action. The differentially expressed genes involve 
many pathways indicating that EHMC rather than affecting just a few key pathways exhibits 
distributed effects across several biological processes and pathways. This is in contrast to 
our previous study on the neuropharmaceutical diazepam, which selectively affects few 
processes related to its known mode of action in zebrafish brain (Oggier et al., 2010).  
 
We critically screened the genes involved in the most altered pathways by EHMC. 
Interestingly, we found genes such as talin 1 (tln1; NM_001009560) and transcripts of many 
homeobox genes to be affected by EHMC. In particular, hoxa13b (NM_131194), hoxb6b 
(NM_131538), hoxa10b (NM_131155) were increased at both EHMC concentrations, while 
the expression of hoxb6a (NM_131119) and hoxc6b (NM_131119) was reduced. EHMC lead 
to down-regulation of tln1; this gene encodes a cytoskeletal protein, which is concentrated in 
areas of cell-substratum and cell–cell contacts. The down-regulation by EHMC is in 
agreement with the observed affected tissue remodelling and wound repair pathways. In 
contrast, EE2 was found to induce tln1 in stickleback (Katsiadaki et al., 2010), and estrogenic 
compounds are effective regulators of cell migration via cytoskeleton alteration (Acconcia et 
al., 2006; Giretti and Simoncini, 2008).  
 
Hox genes play an important role in controlling development processes and patterning of the 
body axis during embryogenesis but hox genes are also expressed in the adult organism 
(Morgan, 2006). Expressional changes of hox genes suggest effects of EHMC on 
developmental processes, but functions and consequences of hox genes in the adult fish 
remain unclear. A similar pattern (although not involving all the same genes) occurred in the 
zebrafish telencephalon exposed to EE2 (Martyniuk et al., 2007). Moreover, alteration of hox 
gene expression in whole-body homogenates occurred in zebrafish after exposure to E2 
(Cohen et al., 2008). Several hormones regulate hox gene expression (Daftary and Taylor, 
2006), and estrogens including diethylstilbestrol (Akbas et al., 2004) and methoxychlor (Fei 
et al., 2005) alter hox expression. These data suggest that EHMC also acts similarly as 
hormonally active compounds on these genes. In addition, we found xeroderma 
pigmentosum, complementation group C, (xpc; NM_001045210), excision repair cross-
complementing rodent repair (ercc1; NM_001103138), proliferating cell nuclear antigen 
(pcna; NM_131404), fanconi anemia complementation group L (fancl; NM_212982),  
replication protein A2 (rpa2; NM_131711), ezrin like (ezrl; NM_001020490),  wingless-type 
MMTV integration site family, member 7Aa (wnt7a; NM_001025540), phosphatase and 
tensin homolog B (ptenb; NM_001001822), mitogen-activated protein kinase 1 (map2k1; 
NM_213419) and glutathione S-transferase pi (gstp1; BC083467) being altered in both 
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EHMC dose groups. The alteration of these genes, in particular those involved in nucleotide 
excision repair (NER) pathway, such as xpc, ercc1, fancl, rpa2, pcna and gadd45b are in 
agreement with the observed modulated pathways such as DNA-damage response, 
apoptosis and inflammatory response. This is in accordance to data in human cell lines, 
where xpc and ercc1 involved in cellular response to DNA damage repair was altered after 
exposure to EHMC (Duale et al., 2010). NER is an important DNA repair system that 
eliminates a wide variety of helix-distorting DNA base lesions. EE2 led to a decrease in 
hepatic NER gene expression in adult male zebrafish including xpc (Notch et al., 2007), 
similarly to the effects displayed by EHMC in the present study.  
 
5.4.2 Validation of microarray data 
Based on the results obtained from GeneSpring normalization, canonical pathways analysis, 
and based on literature we choose 5 target-genes including vtg1, ptgds, igfbp1a, rbp2a and 
gadd45b to validate the microarray results by means of qRT-PCR. We found that the mRNA 
alterations occurred always in the same direction in the whole body, both in microarrays and 
qRT-PCR. This demonstrates the validity of the microarray data.  
 
5.4.3 Differentially regulated genes in whole body, liver, brain and testes 
The differential expression profile of the chosen genes upon exposure to EHMC is often 
tissue-specific. For some genes including igfbp1a and rbp2a, similar changes were observed 
in the whole body and different tissues, for the other chosen genes, however, a differential 
expression occurred (Table 3; Figure 5, Figure 6 A, B, C). As for the selected genes, the data 
obtained by microarrays seem more similar to the data obtained by qRT-PCR in the brain 
than those in the liver. To a lesser extent this also holds for the testis, where we observed 
the highest variability in terms of Ct value and the lowest responsiveness among the selected 
genes. The expressional changes were, however, not paralleled in the liver, which is often 
analysed (Sumpter and Jobling 1995; Hoffmann et al., 2006; Filby et al., 2007). This 
indicates that the molecular effects and modes of action of a compound cannot sufficiently be 
described in one organ alone, but rather needs a multi-organ approach for a more complete 
understanding. This has also been shown in fathead minnows (Pimephales promelas) 
experimentally exposed to E2 (Filby et al., 2006). 
 
A similar responsiveness of some transcripts selected from microarrays was observed 
between whole body and the tissues. This holds for the expression of genes involved in 
regulation of growth and proliferation (igfbp1a), and those involved in vitamin A biosynthesis 
(rbp2a), which are also modulated by estrogens (Hoffmann et al., 2006; Martyniuk et al., 
Chapter 5 
143 
2007). The alterations by EHMC (up-regulation of igfbp1a, down-regulation of rbp2a, 
Table 3) are similar in the whole-body and in all the investigated tissues (liver, brain and 
testis), although not to the same extent. A similar pattern, up-regulation of igfbp1a and down-
regulation of rbp2a, was found after exposure of zebrafish to EE2 (Hoffmann et al., 2006), 
which suggests an estrogenic activity of EHMC towards these genes and processes.  
 
A well established biomarker for estrogenic activity is the induction of vtg1 and its protein, 
which is tissue-, stage- and sex-specific (Sumpter and Jobling 1995; Tyler and Sumpter, 
1998). Whole-body microarray data in zebrafish show that among other genes vtg1 
expression occurs after exposure to estradiol, diethylstilbestrol and bisphenol A (Lam et al., 
2008). In our study, we observed a down-regulation of vtg1 transcripts in the whole body by 
EHMC. However, the differential expression profile was not equal in all the tissues. Similar to 
the whole body, vtg1 expression was down-regulated in brain and testis, whereas a dose-
related up-regulation occurred in the liver. Thus far, induction of vtg1 by estrogens has 
mainly been investigated in the liver (Islinger et al., 2003; Wang et al., 2005; Hoffman et al., 
2006; Sun et al., 2009; Levi et al., 2009). Consequently, our data suggest an estrogenic 
activity of EHMC in the liver, which is supported by the parallel induction of esr2b. On the 
other hand, down-regulation of vtg1 in the whole body, brain and testis suggests an 
antiestrogenic activity of EHMC in these extrahepatic tissues. This finding is supported by 
recent findings in fish, where estradiol and BP-4 induced vtg1 not only in liver, but also in 
heart and brain (Yin et al. 2009; Ma et al., 2009; Zucchi et al., 2010). An alteration of vtg 
expression cannot univocally be ascribed to an estrogenic response as its induction occurs 
by hypoxia (Wu, 2003), and recently Zhang et al. (2010) demonstrated that vitellogenin plays 
an important role in innate immune responses.  
 
In the whole body, liver, brain and testis EHMC led to a dose-dependent up-regulation of the 
insulin-like growth factor binding protein 1a (igfbp1a). This transcript was selected in our 
study, because of its alteration by estrogens in fish (Riley et al., 2004; Hoffman et al., 2006; 
Martyniuk et al., 2007; Baker et al., 2009). Our data on EHMC are in agreement with 
previous studies in fish that showed alteration of igfbp1a, a transcript involved in cell growth. 
However, the igfbp1a up-regulation cannot univocally be ascribed as a pure estrogenic 
response, since other physiological factors are also inducers (Kelley et al., 2002; Riley et al., 
2004). Further studies should evaluate, whether the alteration of genes involved in growth 
and proliferation will result in effects on these processes.  
 
A gene involved in vitamin A biosynthesis, the retinol binding protein type II (rbp2a), was 
down-regulated by EHMC in the whole body and brain (and in liver and testis, although not 
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significantly). The expression of retinol binding protein (rbp) has been proposed as a possible 
biomarker for exposure to endocrine disrupting compounds (Levy et al., 2004). Similar to our 
observation with EHMC, the expression of rbp2a was down-regulated by EE2 in zebrafish 
(Hoffmann et al., 2006), and rainbow trout (Sammar et al., 2001). The effect of EHMC on 
rbp2a and thus vitamin A biosynthesis, metabolism and transport seems to represent an 
estrogenic response, but this needs to be further evaluated on a physiological level.  
 
The prostaglandin D2 synthase catalyzes the conversion of prostaglandin H2 (PGH2) to 
prostaglandin D2 (PGD2) and the expression of ptgds is androgen-regulated (Love et al., 
2009). This transcript is down-regulated after exposure to (EE2) (Hoffman et al., 2006), but 
also by the androgen 17ß-trenbolone (Dorst et al., 2009). In contrast, in our study EHMC led 
to up-regulation of ptgds in the whole body and testis. Similarly, an up-regulation was 
observed in flounder (P. americanus) experiencing multiple stress (Straub et al., 2004). 
 
EHMC led to significant induction of DNA-damage-inducible beta (gadd45b) in the whole 
body, which is in agreement with the pathways identified including apoptosis and growth 
arrest. Similarly, EE2 led to a significant up-regulation of this transcript in zebrafish liver 
(Hoffmann et al., 2006). No significant differential expression of gadd45b occurred in the 
tissues analysed. Consequently, its transcription is induced in tissues other than liver, testis 
and brain. 
 
5.4.3 Effects of EHMC on genes involved in hormonal pathways and 
steroidogenesis 
EHMC led to a significant down-regulation of vtg1, which was not the case for vtg3, although 
the same trend was observed. Estrogens alter the expression of both vtg1 and vtg3 in fish 
(Miracle et al., 2006), although the responsiveness may differ (Islinger et al., 2003; Martyniuk 
et al., 2007).  
 
The estrogen receptor genes esr1 and esr2b were significantly up-regulated by EHMC in the 
whole body, which seems in contrast to the down-regulation of the vtg1 transcript (as parallel 
induction occurs with estrogens). In contrast, down-regulation of vtg1 was paralleled with 
esr1 and esr2b down-regulation in the brain. In the liver, however, esr2b up-regulation would 
support the observed hepatic vtg1 induction. The differential effect of EHMC on vtg1 
expression in different tissues highlights the importance for analyzing transcription profiles in 
multiple tissues. 
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In the whole body and liver, we observed a down-regulation of ar expression, while a slight 
up-regulation occurred at 890 µg/L EHMC in the brain. Filby et al. (2007) found no 
modulation of the ar transcript after EE2 exposure in male fathead minnows, while a strong 
down-regulation in hepatic ar mRNA was observed after exposure to the antiandrogen 
flutamide. This suggests an anti-androgenic activity of EHMC in the liver, and possibly in 
other organs.  
 
EHMC-exposure slightly affected the expression of genes involved in steroidogenesis. A 
significant down-regulation of hsd17ß3 was observed in the whole body. This may suggest a 
reduced formation of the enzyme, and in turn, reduction of testosterone synthesis. 
Additionally, expression of cyp19b was significantly up-regulated in the brain. Estrogens 
enhance the expression of cyp19 in fish, in particular cyp19b in the brain (Callard et al., 
2001), but also androgens differentially affect cyp19 expression (Govoroun et al., 2001; 
Mouriec et al., 2009). This infers that EHMC acts on the expression of genes important for 
sex hormone synthesis. Forthcoming studies are needed to evaluate the consequences of 
observed transcriptional changes on plasma sex steroid levels, and on fertility and 
reproduction. 
 
5.4.5 Conclusions 
Our microarray study demonstrates that the expression profile in whole fish after EHMC-
exposure affects many biological processes with pathways mainly involved in tissue 
remodelling, immune system response, inflammatory response, DNA-damage and apoptosis. 
The high abundance of significantly altered transcripts by EHMC makes a pathway analysis 
interpretation challenging. No single pathway or a simply defined pattern of affected cellular 
mechanisms could be identified. The whole-body microarray analysis approach captures the 
total sum of the transcriptional changes, hence providing an overall expression profile. As it 
is less sensitive than the organ-specific analysis, data interpretation is more challenging. For 
obtaining a more complete toxicological profile of a compound, we conclude that the analysis 
should cover multiple tissues.  
 
Based on previous knowledge about hormonal activities of EHMC (Inui et al. 2003, Kunz and 
Fent 2006) we focused on hormone and related pathways (lipid and cholesterol metabolism, 
thyroid hormone biosynthesis or metabolism). We found that EHMC induces transcriptional 
chances of genes involved in hormone pathways and steroidogenesis. A down-regulation of 
vtg1 in whole-body, brain and testis, but a dose-related up-regulation was observed in the 
liver. The induction of estrogen receptors esr1 and esr2b in the whole body and of vtg1, 
igfbp1, and esr2b in the liver suggests an estrogenic activity of EHMC. The associated down-
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regulation of ar in the liver seems to reflect an additional anti-androgenic activity. Differently, 
in the brain, a down-regulation of vtg1, esr1, esr2b and rbp2a suggests an anti-estrogenic, 
and the up-regulation of ar and cyp19b a potential androgenic activity. Therefore, the 
observed multiple hormonal activities of EHMC on gene expression in different tissues 
coincide with the activities in vitro (Kunz and Fent, 2006a). Differential expression profiles in 
the whole body and analysed tissues (brain, liver, testis) for several genes underlines the 
need for analysing multi-tissue gene profiling for understanding potential effects of this UV-
filter. The data lead to the conclusion that EHMC has an overall low, but multiple hormonal 
activity. Furthermore, additional biological processes are modulated by EHMC, including 
tissue remodelling, cell differentiation, immune system response, DNA damage response 
and apoptosis. 
 
The transcriptional changes were observed at environmentally realistic concentrations of 
2.2 µg/L EHMC. Up to 19 and 3 µg/L EHMC were reported in raw wastewater (Balmer et al., 
2005) and in a lake (Rodil et al., 2009), respectively. Forthcoming studies should investigate 
the toxicological consequences and environmental risks of EHMC, in particular by linking 
expressional changes with physiological outcomes including fertility and reproduction. 
 
Acknowledgements 
We thank Andrea Ieronimo, Nancy Blüthgen and Michael Küry for technical assistance. We 
also thank Andrea Patrignani, Hubert Rehrauer and Sabina Hafen-Wirth, Functional 
Genomics Center Zurich, for support in microarray analysis.This work was supported by the 
Swiss Federal Office for the Environment (contract to K.F. no. 09.0007.KP/I112-0860, 
A2111.0239) and the Swiss National Science Foundation (contract to K.F. no. 31003A-
121829/1). 
 
Chapter 5 
147 
5.5 References 
Acconcia, F., Barnes, C.J., and Kumar, R. (2006) Estrogen and tamoxifen induce cytoskeletal remodeling and 
migration in endometrial cancer cells. Endocrinology 147: 1203–1212. 
Akbas, G.E., Song, J., and Taylor, H.S. (2004) A HOXA10 estrogen response element (ERE) is differentially 
regulated by 17 beta-estradiol and diethylstilbestrol (DES). J Mol Biol 340: 1013–1023. 
Arukwe, A., Nordtug, T., Kortner, T.M, Mortensen, A.S., and Brakstad, O.G. (2008) Modulation of steroidogenesis 
and xenobiotic biotransformation responses in zebrafish (Danio rerio) exposed to water-soluble fraction 
of crude oil. Environ Res 107 (3): 362-370. 
Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., 
Eppig, J.T., (2000) Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium. 
Nat Genet 25: 25–29. 
Baker, M.E., Ruggeri, B., Sprague, L.J., Eckhardt-Ludka, C., Lapira, J., Wick, I., Soverchia, L., Ubaldi, M., 
Polzonetti-Magni, A.M., Vidal-Dorsch, D., Bay, S., Gully, J.R., Reyes, J.A.,Kelley, K.M., Schlenk, D., 
Breen, E.C., Šášik, R., and Hardiman, G. (2009) Analysis of endocrine disruption in southern California 
coastal fish using an aquatic multispecies microarray. Environ Health Perspect 117: 223–230. 
Balmer, M.E., Buser, H.R., Muller, M.D., and Poiger, T. (2005) Occurrence of some organic UV-filters in 
wastewater, in surface waters, and in fish from Swiss lakes. Environ Sci Technol 39: 953-962. 
Buser, H.R., Balmer, M.E., Schmid, P., and Kohler, M. (2006) Occurrence of UV-filters 4-methylbenzylidene 
camphor and octocrylene in fish from various Swiss rivers with inputs from wastewater treatment plants. 
Environ Sci Technol 40: 1427-1431. 
Callard, G.V., Tchoudakova, A.V., Kishida, M., Wood, E. (2001) Differential tissue distribution, developmental 
programming, estrogen regulation and promoter characteristics of cyp19 genes in teleost fish. J. Steroid 
Biochem Mol Biol 79: 305–314. 
Chandrasekar G., Archer A., Gustafsson J.-A., and Andersson Lendahl M. (2010) Levels of 17β-estradiol 
receptors expressed in embryonic and adult zebrafish following in vivo treatment of natural or synthetic 
ligands. PLoS ONE 5(3): e9678. doi:10.1371/journal.pone.0009678  
Cohen, A., Shmoish, M., Levi, L., Cheruti, U., Levavi-Sivan, B. and Lubzens, E. (2008) Alterations in micro-
ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation. Endocrinology 149: 
1687–1696. 
Coronado, M., De Haro, H., Deng, X., Rempel, M.A., Lavado, R. and Schlenk, D. (2008) Estrogenic activity and 
reproductive effects of the UV-filter oxybenzone (2-hydroxy-4-methoxyphenyl-methanone) in fish. Aquat 
Toxicol 90: 182-187. 
Daftary, G.S, and Taylor, H.S (2006) Endocrine regulation of HOX genes. Endocr Rev 27: 331–355. 
Díaz-Cruz, M.S, Llorca, M., Barceló, D. (2008) Organic UV filters and their photodegradates, metabolites and 
disinfection by-products in the aquatic environment. Trends Anal Chem 27: 873-887. 
Dorts, J., Richter, C.A., Wright-Osment, M.K., Ellersieck, M.R., Carter, B.J., and Tillitt, D.E. (2009) The genomic 
transcriptional response of female fathead minnows (Pimephales promelas) to an acute exposure to the 
androgen, 17ß-trenbolone. Aquatic Toxol 91: 44-53. 
Duale, N., Olsen, A.-K., Christensen, T., Butt, S.T., Brunborg, G. (2010) Octyl methoxycinnamate modulates gene 
expression and prevents cyclobutane pyrimidine dimer formation but not oxidative DNA Damage in UV-
exposed human cell lines. Toxicol Sci 114: 272–284. 
Fei, X., Chung, H., and Taylor, H.S. (2005) Methoxychlor disrupts uterine Hoxa10 gene expression. 
Endocrinology 146: 3445–3451. 
Fent, K., Zenker, A., and Rapp, M. (2010) Widespread occurrence of estrogenic UV-filters in aquatic ecosystems 
in Switzerland. Environ Pollut 158: 1817-1824. 
Effects of EHMC on zebrafish 
148 
Fent, K., Kunz, P.Y., Zenker, A., Rapp, M. (2010b) A tentative environmental risk assessment of the UV-filters 3-
(4-methylbenzylidene-camphor), 2-ethyl-hexyl-4-trimethoxycinnamate, benzophenone-3, benzophenone-
4 and 3-benzylidene camphor. Mar Environ Res 69: S4–S6. 
Filby, A.L., Thorpe, K.L., Maack, G., and Tyler, C.R. (2007) Gene expression profiles revealing the mechanisms 
of anti-androgen- and estrogen-induced feminization in fish. Aquat Toxicol 81: 219–231. 
Filby, A.L., Thorpe, K.L., and Tyler, C.R. (2006) Multiple molecular effect pathways of an environmental oestrogen 
in fish. J Mol Endocrinol 37: 121–134. 
Giretti, M.S., and Simoncini T. (2008) Rapid regulatory actions of sex steroids on cell movement through the actin 
cytoskeleton. Steroids 73: 895–900. 
Goksoyr, A., Tollefsen, K.E., Grung, M., Loken, K., Lie, E., Zenker, A., Fent, K., Schlabach, M., and Huber, S. 
(2009) Balsa raft crossing the Pacific finds low contaminant levels. Environ Sci Technol 43: 4783-4790. 
Govoroun, M., McMeel, O.M., Mecherouki, H., Smith, T.J., and Guiguen, Y. (2001) 17ß-Estradiol treatment 
decreases steroidogenic enzyme messenger ribonucleic acid levels in the rainbow trout testis. 
Endocrinology 142: 1841-1848. 
Hoffmann, J.L., Torontali, S.P., Thomason, R.G., Lee, D.M., Brill, J.L., Price, B.B., Carr, G.J., and Versteeg, D.J. 
(2006) Hepatic gene expression profiling using genechips in zebrafish exposed to 17alpha-
ethynylestradiol. Aquat Toxicol 79: 233-246. 
Hoffman, J.L., Thomason, R.G., Lee, D.M., Brill, J.L., Price, B.B., Carr, G.J., Versteeg, D.J. (2008) Hepatic gene 
expression profiling using GeneChips in zebrafish exposed to 17α-methyldihydrotestosterone. Aquat 
Toxicol 87: 69-80. 
Hossain, M.S., Larsson, A., Scherbak, N., Olsson, P.E., and Orban, L. (2008) Zebrafish androgen receptor: 
isolation, molecular, and biochemical characterization. Biol Reprod 78 (2): 361-369. 
Inui, M., Adachi, T., Takenaka, S., Inui, H., Nakazawa, M., Ueda, M., Watanabe, H., Mori, C., Iguchi, T., and 
Miyatake, K. (2003) Effect of UV screens and preservatives on vitellogenin and choriogenin production in 
male medaka (Oryzias latipes). Toxicology 194: 43-50. 
Islinger, M., Willimski, D., Völkl, A., and Braunbeck, T. (2003) Effects of 17a-ethinylestradiol on the expression of 
three estrogen-responsive genes and cellular ultrastructure of liver and testes in male zebrafish. Aquat 
Toxicol 62: 85-103. 
Katsiadaki, I., Williams, T.D., Ball, J.S., Bean, T.P., Sanders, M.B., Wu, H., Santos, E.M., Brown, M.M., Baker, P., 
Ortega, F., Falciani, F., Craft, J.A., Tyler, C.R., Viant, M.R., and Chipman, J.K. (2010) Hepatic 
transcriptomic and metabolomic responses in the stickleback (Gasterosteus aculeatus) exposed to 
ethinyl-estradiol. Aquat Toxicol 97: 174-187. 
Kelley, K.M., Schmidt, K.E., Berg, L., Sak, K., Galima, M.M., Gillespie, C., Balogh, L., Hawayek, A., Reyes, J.A., 
and Jamison, M. (2002) Comparative endocrinology of the insulin-like growth factor-binding protein. J 
Endocrinol 175: 3 – 18. 
Kunz, P.Y., and Fent, K. (2006a) Multiple hormonal activities of UV-filters and comparison of in vivo and in vitro 
estrogenic activity of ethyl-4-aminobenzoate in fish. Aquat Toxicol 79: 305-324. 
Kunz, P.Y., and Fent, K. (2006b) Estrogenic activity of UV-filter mixtures. Toxicol Appl Pharmacol 217: 86-99. 
Kunz, P.Y., Galicia, H.F., and Fent, K. (2006a) Comparison of in vitro and in vivo estrogenic activity of UV-filters in 
fish. Toxicol Sci 90: 349-361. 
Kunz, P.Y., Gries, T., and Fent, K. (2006b) The ultraviolet filter 3-benzylidene camphor adversely affects 
reproduction in fathead minnow (Pimephales promelas). Toxicol Sci 93: 311-321. 
Lam, S.H., Mathavan, S., Tong, Y., Li, H., Karuturi, R.K.M., Wu, Y., Vega, V.B., Liu, E.T., and Gong, Z. (2008) 
Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical 
biology. PLoS Genetics 4: e1000121. 
Langford, K.H., and Thomas, K.V. (2008) Inputs of chemicals from recreational activities into the Norwegian 
coastal zone. J Environ Monit 10: 894-898. 
Chapter 5 
149 
Lettieri, T. (2006) Recent applications of DNA microarray technology to toxicology and ecotoxicology. Environ 
Health Perspect 114: 4–9. 
Levi, L., Pekarski, I., Gutman, E., Fortina, P., Hyslop, T., Biran, J., Levavi-Sivan, B., and Lubzens, E. (2009) 
Revealing genes associated with vitellogenesis in the liver of the zebrafish (Danio rerio) by transcriptome 
profiling. BMC Genomics 10: 1471-2164. 
Levy, G., Lutz, I., Kruger, A., von Tumpling, W., and Kloas, W. (2004) Retinol-binding protein as a biomarker to 
assess endocrine-disrupting compounds in the environment. Anal. Bioanal. Chem., 378: 676–68. 
Livak, K.J., and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative 
PCR and the 2-∆∆CT method. Methods 25: 402-408. 
Loraine, G.A., and Pettigrove, M.E. (2006) Seasonal variations in concentrations of pharmaceuticals and personal 
care products in drinking water and reclaimed wastewater in southern California. Environ Sci Technol 40: 
687-695. 
Love, H.D., Booton, S.E., Boone, B.E., Breyer, J.P., Koyama, T., Revelo, M.P., Shappell, S.B., Smith, J.R., and 
Hayward, S.W. (2009) Androgen regulated genes in human prostate xenografts in mice: Relation to BPH 
and prostate cancer. PLoS ONE 4:e8384. 
Ma, L., Li, D., Wang, J., He, J., and Yin, Z. (2009) Effects of adrenergic agonists on the extrahepatic expression of 
vitellogenin Ao1 in heart and brain of the Chinese rare minnow (Gobiocypris rarus). Aquat Toxicol 91, 
19–25. 
Martyniuk, C.J., Gerrie, E.R., Popesku, J.T., Ekker, M., and Trudeau, V.L. (2007) Microarray analysis in the 
zebrafish (Danio rerio) liver and telencephalon after exposure to low concentration of 17alpha-
ethinylestradiol. Aquat Toxicol 84: 38–49. 
Meng, X., Bartholomew, C., and Craft, J.A. (2010) Differential expression of vitellogenin and oestrogen receptor 
genes in the liver of zebrafish, Danio rerio. Anal Bioanal Chem 396: 625–630. 
Miracle, A., Ankley, G., and Lattier, D. (2006) Expression of two vitellogenin genes (vg1 and vg3) in fathead 
minnow (Pimephales promelas) liver in response to exposure to steroidal estrogens and androgens. 
Ecotox Environ Saf 63:337–342. 
Mouriec, K., Gueguen, M.M., Manuel, C., Percevault, F., Thieulant, M.L., Pakdel, F., and Kah, O. (2009a) 
Androgens upregulate cyp19a1b (aromatase B) gene expression in the brain of zebrafish (Danio rerio) 
through estrogen receptors. Biol Reprod 80: 889-96.  
Morgan, R. (2006) Hox genes: a continuation of embryonic pattering? Trend in Genetics 22: 67-69. 
Nakata H., Murata S., and Filatreau J. (2009) Occurrence and concentrations of benzotriazole UV-stabilizers in 
marine organisms and sediments from the Ariake Sea, Japan. Environ Sci Technol 43: 6920-6926. 
Notch, E.G., Miniutti, D.M., Mayer, G.D. (2007) 17α-Ethinylestradiol decreases expression of multiple hepatic 
nucleotide excision repair genes in zebrafish (Danio rerio). Aquat Toxicol 84: 301–309. 
Oggier, D.M., Weisbrod, C. J., Stoller, A.M., Zenker, A.K., and Fent, K. (2010) Effects of diazepam on gene 
expression and link to physiological effects in different life stages in zebrafish Danio rerio. Environ Sci 
Technol 44: 7685-7691. 
Oggier, D.M., Lenard, A.,Küry, M., Höger, B., Affolter, M., Fent, K., 2010b. Effects of the protein kinase inhibitor 
PKC412 on gene expression and link to physiological effects in zebrafish Danio rerio eleuthero-embryos. 
Tox Sci 119: 104-115. 
Plagellat, C., Kupper, T., Furrer, R., de Alencastro, L.F., Grandjean, D., and Tarradellas, J. (2006) Concentrations 
and specific loads of UV-filters in sewage sludge originating from a monitoring network in Switzerland. 
Chemosphere 62: 915-925. 
Riley, L.G., Hirano, T., and Grau, E.G. (2004) Estradiol-17ß and dihydrotestosterone differentially regulate 
vitellogenin and insulin-like growth factor-I production in primary hepatocytes of the tilapia Oreochromis 
mossambicus. Comp Biochem Physiol C Toxicol Pharmacol 138: 177–186. 
Rodil, R., Schrader, S., and Moeder, M. (2009) Non-porous membrane-assisted liquid-liquid extraction of UV-filter 
compounds from water samples. J Chromatogr A 1216: 4887-4894. 
Effects of EHMC on zebrafish 
150 
Rodil, R., and Moeder, M. (2008) Development of a method for the determination of UV-filters in water samples 
using stir bar sorptive extraction and thermal desorption-gas chromatography-mass spectrometry. J 
Chromatogr A 1179: 81-88. 
Sammar M., Babin, P.J., Durliat, M., Meiri, I., Zchori, I., Elizur, A., and Lubzens, E. (2001) Retinol binding protein 
in rainbow trout: molecular properties and mRNA expression in tissues. Gen Comp Endocrinol 123: 51-
61. 
Schlumpf, M., Cotton, B., Conscience, M., Haller, V., Steinmann, B., and Lichtensteiger, W. (2001) In vitro and in 
vivo estrogenicity of UV screens. Environ Health Perspect 109: 239-244. 
Schlumpf, M., Kypke, K., Vökt, C.C., Birchler, M., Durrer, S., Faass, O., Ehnes, C., Fuetsch, M., Gaille, C., 
Henseler, M., Hofkamp, L., Maerkel, K., Reolon, S., Zenker, A., Timms, B., Tresguerres, J.A.F., and 
Lichtensteiger, W. (2008) Endocrine active UV-filters: developmental toxicity and exposure through 
breast milk. CHIMIA 62: 345-351. 
Straub, P.F., Higham, M.L, Tanguy, A., Landau, B.J., Phoel, W.C., Hales, L.S., and Thwing, T.K.M. (2004) 
Suppression subtractive hybridization cDNA libraries to identify differentially expressed genes from 
contrasting fish habitats. Mar Biotechnol 6: 386–399. 
Sumpter, J.P. and Jobling, S. (1995) Vitellogenesis as a biomarker for estrogenic contamination of the aquatic 
environment. Environ Health Perspect 103: 173–178. 
Sun, L., Wen, L., Shao, X., Qian, H., Jin, Y., Liu, W., and Fu, Z. (2010) Screening of chemicals with anti-
estrogenic activity using in vitro and in vivo vitellogenin induction responses in zebrafish (Danio rerio). 
Chemosphere 78: 793–799. 
Tyler C.R., and Sumpter J.P. (1998) Endocrine disruption in wildlife: A critical review of the evidence. Crit Rev 
Toxicol 28: 319-361. 
Wang, H., Tan, J.T.T., Emelyanov, A., Korzh, V., and Gong, Z. (2005) Hepatic and extrahepatic expression of 
vitellogenin genes in the zebrafish, Danio rerio. Gene 356: 91-100. 
Weisbrod, C.J., Kunz, P.Y., Zenker, A.K., and Fent, K. (2007) Effects of the UV-filter benzophenone-2 on 
reproduction in fish. Toxicol Appl Pharmacol 225: 255-266. 
Wu R.S.S., Zhou, B,S,, Randall, D.J.,, Woo, N.Y., Lam, P.K. (2003) Aquatic hypoxia is a disrupter and impairs fish 
reproduction. Environ Sci Technol 37: 1137–1141. 
Yin, N., Jin, X., He, J., and Yin, Z. (2009) Effects of adrenergic agents on the expression of zebrafish (Danio rerio) 
vitellogenin Ao1. Toxicol Appl Pharmacol 238: 20–26. 
Zenker, A., Schmutz, H., and Fent, K. (2008) Simultaneous trace determination of nine organic UV-absorbing 
compounds (UV-filters) in environmental samples. J Chromatogr A 1202: 64-74. 
Zhang, S., Wang, S., Li, H., Li, L. (2010) Vitellogenin, a multivalent sensor and an antimicrobial effector. Int. J. 
Biochem Cell Biol doi :10.1016/j.biocel.2010.11.003. 
Zwiener, C., Richardson, S.D., De Marini, D.M., Grummt, T., Glauner, T., and Frimmel, F.H. (2007) Drowning in 
disinfection by products? Assessing swimming pool water. Environ Sci Technol 41: 363-372. 
Zucchi, S., Blüthgen, N., Ieronimo, A., Fent, K. (2010) The UV-absorber benzophenone-4 alters transcripts of 
genes involved in hormonal pathways in zebrafish (Danio rerio) eleuthero-embryos and adult males. 
Toxicol Appl Pharmacol In press. doi:10.1016/j.taap.2010.10.001. 
 
 151 
 
Chapter 6 
 
 
 
 
 
 
 
 
 
 
 
General Discussion and Conclusions 
 
 
General Discussion and Conclusion 
152 
6.1 General discussion 
The results achieved in the different studies of this thesis were discussed in detail in chapter 
two to five. This chapter provides a more general summary and the final discussion of all 
results obtained. We will highlight our results with relevance to the field of ecotoxicology and 
in environmental risk assessment of xenobiotics. 
 
The present thesis focuses on the effects of human pharmaceuticals (diazepam and 
PKC412) and personal care products (UV-filter EHMC) on fish. PPCPs may be of concern as 
some of them can be active at extremely low concentrations (e.g. synthetic steroid 
hormones), may accumulate in organisms, or have unknown adverse effects. They have 
widespread use and are continuously released into the environment, so that concentrations 
in the range of ng/L to μg/L can be found in surface water. They can also have unpredictable 
biochemical interactions in mixtures and are able to bio-magnify in the food chain. 
Pharmaceuticals in particular are designed to interact with cellular receptors at low 
therapeutic doses and elicit specific biological effects. Since many target receptors have 
been conserved during evolution, pharmaceuticals may have a similar mode of action, and 
therefore evoke similar effects in fish to humans (Jones et al., 2007; Gunnarsson et al., 2008; 
Kostich and Lazorchak, 2008; Christen et al., 2010). Furthermore, other PPCPs such as 
cosmetic additives may have unexpected effects on lower organisms, due to their differences 
in targets and metabolism compared to mammals. 
 
In addition to acute effects, studies in ecotoxicology also focus on chronic toxicity endpoints 
including biochemical and physiological effects, and effects on early life stages. Chemicals 
that are suspected of interfering with the hormonal system are investigated with respect to 
the effects on vitellogenin induction, fecundity, secondary sex-characteristics and 
reproduction. In addition, research has been recently performed focusing on expression 
changes of genes belonging to the detoxification system (phase I and phase II), hormonal 
pathways, stress response etc (Evrard et al., 2010; Li et al., 2010). However, there have 
been very few studies performed which try to link gene expression changes to ecologically 
more relevant effects such as behavioural alterations, adverse effects on reproduction, the 
ability to find food or to escape from predators. As only little is known about such 
correlations, they need investigating in more detail. 
 
This thesis basically consists of two different parts. In the first part, a study is conducted to 
optimize a cellular assay for rapid measuring CYP3A enzyme activity changes. The up- or 
down-regulation of CYP3A enzyme activity may be an indication for exposure to PPCPs. 
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This enzyme plays a crucial role in detoxification processes and in the degradation of foreign 
substances (Guengerich, 1992; Livingstone, 1998; Hasler, 1999).  
 
In the second part, several studies were performed to investigate correlations between gene 
expression changes and physiological changes induced by PPCPs in fish. Zebrafish at 
different developmental stages were exposed to two different pharmaceuticals (diazepam 
and PKC412) or to the UV-filter EHMC, respectively. Effects on the gene expression patterns 
were determined and then linked to physiological effects such as locomotor activity or effects 
on different spermatogenic stages. The hypothesis was thereby tested, whether alterations in 
gene expression are more sensitive than physiological effects, and whether gene expression 
alterations can be linked to physiological effects. In the following section, a short summary of 
the obtained results together with the most important conclusions are given. 
 
Alteration of CYP3A activity in vitro 
We modified a human whole cell assay to measure CYP3A enzyme activity in fish. We used 
7-benzyloxy-4-trifluoromethylcoumarin (BFC) as a substrate, which is known to be 
metabolized by the human CYP3A4 into a measurable fluorescent product. The basal 
catalytic activity in PLHC-1 and FHM cells is found to be higher than in human cells. In 
addition, it was demonstrated that this assay is capable of analysing for CYP3A induction by 
rifampicin, which is a known human CYP3A inducer, as well as inhibition by diazepam, a 
human CYP3A inhibitor. 
 
Our findings have shown that BFC also acts as a substrate for fish CYP3A. The overall 
advantage of this optimised assay is that it can be performed on microtiter plates. This 
facilitates the screening for CYP3A inducers and inhibitors, as it is possible to simultaneously 
investigate different compounds and different concentrations on the same plate. However, 
there are also some critical aspects to be considered. BFC is not a sole substrate catalysed 
by CYP3A, but is found to be a substrate for CYP1A in mammals (Renwick et al., 2001). 
Therefore, for each compound an additional EROD assay (measures CYP1A activity) is 
necessary as a control. Furthermore, the CYP3A assay is not very sensitive as enzyme 
activity can only be detected at very high concentrations. This should be taken into 
consideration when the assay is applied as a first screening step for CYP3A inducers or 
inhibitors in environmental risk assessment. 
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Effects of diazepam on different developmental stages in zebrafish 
This study focused on investigating the modes of action of diazepam in different 
developmental stages in zebrafish. We exposed adult males over 14 d to two different 
concentrations of diazepam (nominal 273 ng/L and 273 μg/L). In addition, zebrafish 
eleuthero-embryos were exposed for 5 dpf to the same diazepam concentrations. Gene 
expression changes were obtained by performing a microarray analysis with brain samples 
of adult males. Mainly genes belonging to the circadian rhythm were significantly altered. 
This alteration was also found in eleuthero-embryos. We attempted to link changes of the 
gene expression pattern with those on physiological endpoints. In the process the locomotor 
activity of adults and eleuthero-embryos were measured after 14 d or 6 dpf of exposure, 
respectively. However, only at the highest concentration is the locomotor activity significantly 
affected in eleuthero-embryos. In addition to behavioural changes, we performed histological 
analysis of seminferous tubuli in the testes to analyse different spermatogenic stages. 
However, a tendency towards an altered pattern of the different stages of sperm is only 
observed at the highest concentration, which is characterized by the occurrence of more 
interstitial tissue. 
 
Diazepam binds on the GABAA receptor, which is the basic mode of action of these 
pharmaceutical eliciting effects on the CNS. Additionally, we have shown that this compound 
affects gene expression in the brain. The transcriptional response to diazepam at 
concentrations of 235 ng/L and 292 μg/L in zebrafish seems to be similar to that found in 
mammals (Akiyama et al., 1999; Carpentieri et al., 2006; Nishii et al., 2006; Novak et al., 
2006). Genes belonging to the circadian rhythm, which are also altered in mammals 
(Akiyama et al., 1999; Carpentieri et al., 2006; Nishii et al., 2006; Novak et al., 2006), were 
significantly changed in fish. In addition, the swimming behaviour of eleuthero-embryos was 
significantly altered at 273 μg/L. No significant histological effects were observed in male 
testes, although changes in interstitial tissue were noted. In contrast to transcriptional 
changes occurring at both concentrations, physiological alterations were only observed at 
nominal 273 μg/L diazepam in eleuthero-embryos. This indicates that alterations in gene 
expression are more sensitive than the determined classical ecotoxicological endpoints. 
However, the lack of behavioural and physiological changes at 235 ng/L diazepam raises the 
question of whether and at which concentrations gene expression changes propagate to 
toxicological relevant measures at the organism level (that may affect even populations). In 
conclusion, this study confirms that important data are obtained by microarrays and qRT-
PCR for identifying molecular effects and modes of action of pharmaceuticals that occur in 
the environment. However, such studies should be paralleled by classical ecotoxicological 
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tests to obtain effects on organisms relevant for populations, especially at environmentally 
relevant concentrations. 
 
Effects of PKC412 on zebrafish eleuthero-embryos 
Similar to the diazepam study, we tested the hypothesis that gene expression alteration is a 
more sensitive parameter than physiological parameters, but that they are linked with each 
other. In this study a microarray analysis was also performed. Zebrafish eleuthero-embryos 
are exposed for 6 dpf at two different concentrations of PKC412 (1.6 μg/L and 21 μg/L), 
which is a novel antineoplastic agent, not yet on the market. The aim of this study was the 
analysis of a novel compound prior to market release in order to obtain information about the 
ecotoxicological potential at concentrations expected to occur in the environment after it 
comes into use. This study is in contrast to the diazepam study where environmental 
concentrations are already known. The data obtained on gene expression changes were 
difficult to interpret as PKC412 is a non-selective kinase inhibitor with a broad spectrum. 
Again an alteration of circadian rhythm genes was observed, as kinases were also 
expressed in the hypothalamic suprachiastic nuclei. However, PKC412 had no significant 
effect on the locomotor activity in our experimental set-up. One reason could be that an 
observation over 2 h is too short to obtain significant effects. The time-points when 
measurements took place could also induce differences in behaviour. We performed our 
measurements in daylight, and effects would have probably been more pronounced at night. 
Additionally, effects on vascular development, appearance of apoptotic cells, DNA damage 
and formation of reactive oxygen species were further investigated. PKC412 had neither any 
influence on the vascular development in transgenic zebrafish eleuthero-embryos nor on the 
formation of reactive oxygen species. In contrast, apoptosis occurred on cells of the olfactory 
placodes and DNA damage was induced even to some extent at the 1.6 ug/L PKC412. 
 
The overall conclusion of this study is the same as for the diazepam study. We demonstrate 
that the response of zebrafish eleuthero-embryos to different PKC412 concentrations was 
partly similar to the response in humans. Also here, alteration of gene expression was a 
more sensitive parameter than the measured physiological parameters. However, this study 
identified an additional challenge of microarray studies, the abundance of altered genes.  
Due to the broad kinase inhibition spectrum of PKC412, many genes were altered and 
therefore it was a challenge to identify a clear mode of action of this compound. This was in 
contrast to the findings with diazepam, where a clear effect pattern on the circadian rhythm 
was discovered. To obtain more precise insights into the mode of action of PKC412 in 
zebrafish, additional experiments on protein and physiological levels are indispensable. 
Furthermore, this study also raises the question as to what concentration the gene 
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expression changes propagate to significant changes at organism or even at population 
level. Therefore although gene expression studies are a novel and challenging tool for 
elucidation of molecular effects and even mechanisms of action, they are not sufficient for 
ecotoxicological risk assessment of pharmaceuticals. Therefore they have to be paralleled 
with physiological measures analyzed in classical tests. 
 
Hormonal activity of UV-filter EHMC in zebrafish 
Our interest in the following study focused on gene expression changes in zebrafish after 
exposure to the UV-filter EHMC, which belongs to one of the most frequently used 
compounds in sunscreens (Hauri, 2009). EHMC is found in the aquatic environment (Balmer 
et al., 2005), and accumulates in biota (Fent et al., 2010). The aim was to investigate 
molecular effects and the mode of action of EHMC.  
 
In this study, adult male zebrafish were exposed over 14 d to nominal concentrations of 
2.2 μg/L and 890 μg/L EHMC. The lower concentration was selected on the basis of 
environmental residue levels (Balmer et al., 2005), while the higher was selected in order to 
stimulate mRNA expression of genes to elucidate molecular modes of action of EHMC. 
Microarray analyses performed on small vertebrates such as zebrafish is a strategy for 
potentially obtaining a large amount of in vivo data on the transcriptome of the entire adult 
organism (Lam et al., 2008). Additionally, qRT-PCR was performed in the brain, liver and 
testes to compare tissue-specific expression patterns with those of whole body obtained with 
microarrays. 
 
The expression profile in the whole body displays complex molecular effects, including 
multiple hormonal activities. This is reflected by the down-regulation of vtg1, which was not 
the case for vtg3, although the same trend was observed. This suggests an anti-estrogenic 
activity. Estrogens alter the expression of both vtg1 and vtg3 in fish (Miracle et al., 2006; 
Martyniuk et al., 2007). Similar to EHMC, the effect on vtg1 expression was more 
pronounced than on vtg3 expression (Martyniuk et al., 2007; Meng et al., 2010). In contrast, 
the induction of esr1, esr2b and hsd17ß3 points to an estrogenic activity.  
 
In the different tissues, EHMC displayed multiple effects on the expression of target genes, 
determined by qRT-PCR. An up-regulation of vtg1, igfbp1, and esr2b was observed in the 
liver, which is in accordance to a potential estrogenic activity of EHMC (Palmer and Palmer, 
1995; Kloas et al., 1999). The associated down-regulation of ar may either reflect an 
estrogenic activity (due to feedback regulation), or an additional anti-androgenic activity. 
(Filby et al., 2007) found no modulation of the ar transcript after EE2 exposure in male 
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fathead minnows, while a strong down-regulation in hepatic ar mRNA was observed after 
exposure to the anti-androgen flutamide.  
 
However, in the brain, a down-regulation of vtg1, esr1 and esr2, rbp2 and an up-regulation of 
ar was observed, which is in accordance to a potential anti-estrogenic and androgenic 
activity. In testes, with the exception of gadd45b transcript, the same trend was observed for 
target-genes selected from microarray results. The differential effect of EHMC on vtg1 
expression in different tissues highlights the importance for analyzing transcription profiles in 
multiple tissues to identify molecular effects and mode of actions. However, for the testes no 
clear dose-response-relationship upon EHMC exposure was observed. In fact, in testes we 
observed the highest variability in terms of Ct value and the lowest responsiveness among 
the selected genes. In agreement with the pathways involved in apoptosis, growth arrest and 
DNA-damage-inducible beta (gadd45b) was significantly up-regulated in whole body, in 
particular at 2.2 μg/L EHMC. This gene, which is involved in regulation of growth and 
apoptosis, was significantly up-regulated after EE2 exposure in zebrafish liver (Hoffmann et 
al., 2006). However, this was not the case in our study.  
 
EHMC-exposure also affected the expression of genes involved in steroidogenesis. A 
significant down-regulation of hsd17ß3 was observed in the whole body. This may suggest a 
reduced formation of the enzyme, and in turn, reduction of testosterone synthesis. 
Additionally, expression of cyp19b was significantly up-regulated in the brain. Estrogens 
enhance the expression of cyp19 in fish, in particular cyp19b in the brain (Callard et al., 
2001), but also androgens differentially affect cyp19 expression (Govoroun et al., 2001; 
Mouriec et al., 2009). This infers that EHMC acts on the expression of genes important for 
sex hormone synthesis.  
 
In addition, Gene Ontology (GO) analysis was performed to identify functional groups of 
genes of interest. At both concentrations differentially altered genes fell into 1637 different 
categories. The many GO terms affected by EHMC exposure are general descriptions, which 
based on the results of this experiment alone, makes it difficult to link them to a specific 
mode of action. Furthermore, we performed a pathway analysis with MetaCore. The different 
treatments had 33 (2.2 μg/L EHMC: 33 maps; 890 μg/L EHMC: 36 maps) maps in common. 
No single pathway or a simply defined pattern of affected cellular mechanisms could be 
identified. On the contrary, the affected pathways are numerous and include those belonging 
to tissue remodelling, cell differentiation, immune system response, DNA-damage response 
and apoptosis, to name the most significant ones. Taken together, our data support the 
hypothesis of an endocrine activity of EHMC. 
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This study demonstrates that the expression profile after EHMC treatment is tissue-specific 
and varies between different organs. In contrast, the whole body gene expression analysis 
captures the total sum of the transcriptional changes in the entire organism as a single entity. 
This gives an overall gene expression profile of the compound, but has limitations such as 
loss of weak signals from smaller tissues (tissue-specific location of the response cannot be 
achieved) and in particular do not provide a clear cut-off of altered genes and consequently 
pathways. Therefore, even if the whole-body analysis provides an overall picture on altered 
genes, it is less sensitive and, as consequence, data interpretation is much more challenging 
than investigating a single tissue alone, such as liver. On the other hand, focusing on a 
single organ does not allow one to obtain a more complete feature of the effects determined 
from a weak study compound such as EHMC. Therefore, for obtaining a more complete 
toxicological profile of the compound, the analysis should cover multiple tissues.  
 
When using whole-body microarrays the most influential tissue for the response remains 
undefined. In case of EHMC, data from the whole body (microarray) mainly reflected the 
results obtained by qRT-PCR in the brain (and to a lesser extent those obtained in testes), 
but interestingly, not those of the liver, which is often analysed (Pesonen and Andersson, 
1991; Hinton and Couch, 1998; Hinton, 2000). This demonstrates that transcriptional effects 
of chemicals should be analysed by a multiple organ approach, and not by one tissue alone. 
 
The expression profile in the whole body displays a complex molecular effects profile. The 
abundance of significantly altered genes by EHMC is even higher than in case of PKC412 
(Chapter 4). EHMC affects the transcription of genes involved in hormonal pathways and 
steroidogenesis, pointing to multiple hormonal activities of this UV-filter, which is in 
accordance to in vitro activities (Kunz and Fent, 2006). The transcriptional changes involve a 
large number of genes and pathways. This makes a pathway analysis interpretation of 
EHMC even more complicated, and therefore, no single pathway or a clearly defined pattern 
of affected cellular mechanisms could be identified, as in case of diazepam (Chapter 3). On 
the contrary, the affected pathways are numerous and include - among others - those 
belonging to tissue remodelling, cell differentiation, immune system response, DNA-damage 
response and apoptosis.  
 
Additionally, this study also points out the need for a correlation of the transcriptional 
changes with physiological effects in order to interpret relevant toxicological impacts on the 
organism. One should always keep in mind that gene expression changes do not necessarily 
translate to physiological changes, as there are several modification steps from the mRNA to 
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the protein and to the physiological outcome. Therefore, forthcoming studies are needed to 
show whether EHMC affects plasma sex steroid levels and consequently, fertility and 
reproduction in adult zebrafish.  
 
To summarize the experiments on two human pharmaceuticals and the UV-filter EHMC, it 
was shown that they can cause adverse effects on gene expression and physiology at 
concentrations not far from worst-case environmental concentrations. The major advantage 
of the transcriptional analysis is the identification of possible mechanisms of action of a given 
compound. However, in most cases gene expression alteration gives some preliminary 
indications about which physiological effects are compound-induced. There are several 
modification steps from the gene to the protein, and therefore gene expression changes do 
not necessarily affect protein expression or other physiological processes. Nevertheless, 
such analyses offer a powerful tool of identifying underlying molecular mechanisms of 
toxicological effects and possibly, for screening for new biomarkers. 
 
It has to be borne in mind that physiological effects can have their limitations. As the studies 
are conducted in the laboratory and not in the field, they do not exactly reflect the 
environmental situation. As a consequence, extrapolation from the laboratory to the field 
should take this limitation into consideration. However, the results obtained are nevertheless 
a good indication of what can happen in the environment. 
 
To obtain mechanistic information on molecular effects and the toxic modes of action of 
PPCPs, microarray analysis offers great potential. Nevertheless, there is the necessity of 
correlating effects obtained at gene expression level with effects at higher levels of biological 
organization. In our studies we have partly shown that gene expression changes can be 
linked to ecologically more relevant effects such as swimming behaviour (diazepam) or 
apoptosis (PKC412). 
 
In summary, based on transcription profiles and associated physiological effects, this thesis 
has given new insights into the modes of action of two different pharmaceuticals and the UV-
filter EHMC on fish. Our findings that gene expression changes could partly be linked to 
physiological effect are promising for further research on the mode of action of 
environmentally relevant PPCPs. 
 
More research is needed in the future on the linkage between gene expression and 
physiological effects, in order to assess the value of transcription profiling in ecotoxicology. 
As gene expression analysis is not a standardized procedure yet, further validation is needed 
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with a broader set of compound classes, and with respect to the correlation with 
physiological effects. It should be pointed out that further research is needed to investigate 
the value of gene expression changes for environmental risk assessment. The ultimate aim 
of using this approach will be to gain more important information and a better focus on the 
molecular modes of action of compounds for application in environmental risk assessment, 
complementing already existing test systems (i.e. OECD guidelines). 
 
In case of diazepam, significant physiological changes of single compounds are only found at 
concentrations that were up to 10,000 times higher than environmental concentrations. 
However, in the environment, different compounds occur not as single entities, but in 
mixtures of different compounds. Mixtures of the same substance class often act on the 
same target receptor and usually exhibit an additive nature (Kunz and Fent, 2009). 
Therefore, a compound can supplement other similar substances in a mixture resulting in a 
higher net effect. PPCPs should also be analysed in mixtures to evaluate whether they 
exhibit physiological effects at environmentally relevant concentrations. These considerations 
could be of importance for environmental risk assessment. Knowledge about the potential 
toxicological modes of actions and associated hazards of PPCPs ultimately leads to an 
improvement in environmentally safe handling of these substances, their environmental 
management, and consequently, to limited harm to the aquatic environment. 
 
6.2 Outlook  
This thesis reveals new insight towards different modes of action of PPCPs in fish. Our 
research mainly focused on the investigation of gene expression patterns upon exposure to 
PPCPs and their linkage to physiological effects.  
 
Effects on gene expression were mostly found at concentrations near environmentally 
relevant concentrations and higher. In contrast, physiological effects mainly occurred at 
concentrations that were significantly higher than environmental concentrations, indicating 
that transcription profiles represent a more sensitive toxicological parameter.  
 
In consequence, the following questions should be addressed for further studies: 
- Are there similar gene expression patterns that are shared by individual PPCPs 
belonging to the same substance class? And if so, is there a specific and common 
expression pattern that allows the identification of this class of compounds, and the 
possibility of predicting them for novel similar compounds? 
- To what extent can gene expression patterns be correlated to physiological effects, 
and is there a concentration range where a correlation exists? 
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- What are the effects of PPCPs mixtures on gene expression and on higher levels of 
biological organization? 
- Can toxicogenomic approaches be used for analysing the modes of action of 
environmental chemicals? Is a standardisation possible for using the results for 
environmental risk assessment? 
- What is the value of gene expression changes for assessing the ecotoxicologcial 
potential of compounds and for their environmental risk assessment? 
 
In order to answer some of these questions, several general points should be regarded. 
Before starting a microarray analysis and obtaining a broad spectrum of information, the goal 
of the project should be clearly formulated and it should be defined for what purpose the 
microarray data will be used. Depending on the goal, it is better to perform a whole body 
analysis to obtain a more general and overall transcriptional profile, instead of achieving 
specific tissue-specific information. This could be a good approach for analysing compounds 
whose mode of action is not clear, and if a detailed mechanistic study is not needed. 
However, to address more specific questions on the toxicological profile of a compound, the 
analysis of single tissues is more appropriate, as demonstrated in this thesis for diazepam. 
The selection of the appropriate tissue might be difficult, but can be based on known 
information from mammals. If no such information exists, as in the case of the UV-filter 
EHMC, a multiple-organ approach is more appropriate. Analysis of single tissues has also 
the advantage that the abundance of altered genes is lower, and therefore, an interpretation 
becomes more reliable and comprehensible.  
 
Up to now, most analytical tools for evaluating microarray data, such as MetaCore pathway 
analysis, are designed for human purposes only. However, for many genes in zebrafish or 
fathead minnows there are no human orthologues. Therefore, the possibility of losing 
information that could be otherwise important for the interpretation of the whole data set, is 
often present. Potentially, a solution would be to start generating special zebrafish maps with 
available data found in literature; however, this is a time-consuming procedure.  
 
To obtain a more general gene expression pattern specific for compounds of a given 
chemical class, a set of chemicals should be tested. The data set may then offer the 
possibility of defining prediction models for this kind of chemical class, with the assumption 
that substances with similar mechanistic effects or modes of action share similar biological 
and toxicological responses. The gene expression pattern of a novel compound or mixture 
can then be compared with that of the model, and possibly, predictions about its mode of 
action and toxicity can be made.  
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In addition to pathway analysis and possible prediction models, an attempt should be made 
to link gene alteration patterns with physiological and biological effects. In order to restrict the 
transcription profile to a core set of genes, proteomics would be a helpful technique, thus 
allowing restriction of the expression pattern to those genes where the corresponding protein 
is also altered. 
 
In addition, it is important that not only high concentrations of a compound are tested, but 
also environmentally relevant concentrations. Linking physiological and biological effects to 
gene expression patterns at low concentrations is more significant than evaluating high 
concentrations alone for environmental risk assessment, because this reflects better the 
situation in the environment. 
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Table 1  
Significantly altered genes in the brain of male zebrafish after exposure to 235 ng/L and 291 μg/L diazepam 
(adjusted p<0.05) 
 Fold change (log2) 
Agilent ID Sequence Accession # Gene name 235 ng/L 291 μg/L 
A_15_P100260 NM_131790 cryptochrome 1b 2.51 -3.00 
A_15_P100831 NM_212679 basic helix-loop-helix domain containing, class B, 2  -3.11 
A_15_P100884 NM_131787 cryptochrome 4 1.55 2.04 
A_15_P101039 NM_131577 aryl hydrocarbon receptor nuclear translocator-like 1a 2.19 2.67 
A_15_P102608 TC338072  2.48 -3.36 
A_15_P103210 NM_200692 N-myc downstream regulated gene 1, like 1.78 3.97 
A_15_P103364 NM_131584 period homolog 3 (Drosophila) -3.29 -7.88 
A_15_P103946 NM_131788 cryptochrome 5 -3.56 -4.27 
A_15_P104122 NM_001017652 synaptotagmin XIII (syt13), zgc:112063 -1.53 -2.17 
A_15_P104177 NM_200364 hydroxysteroid (17-beta) dehydrogenase 3 -1.59 -2.32 
A_15_P104502 NM_212439 period homolog 4 -3.78 -6.52 
A_15_P105008 NM_201064 zgc:66475 -1.62 -2.01 
A_15_P105258 NM_001113589 similar to Hsp70 protein, LOC560210 -1.61 -3.40 
A_15_P105750 XM_001335424 hypothetical protein LOC797197  2.77 
A_15_P106879 NM_200792 arrestin 3, retinal (X-arrestin) -2.48 -4.42 
A_15_P108054 NM_131400 thyrotroph embryonic factor -1.88 -2.40 
A_15_P109547 TC346523  2.32 2.19 
A_15_P110290 NM_205729 nuclear receptor subfamily 1, group d, member 1 -6.28 -3.14 
A_15_P110618 ENSDART00000010477  -1.46 -2.71 
A_15_P111207 ENSDART00000043507 si:ch211-284a13.1 -9.09 -8.71 
A_15_P111741 XM_001337603 similar to Wu:fk63e10 protein  5.46 8.25 
A_15_P112116 XM_679130 hypothetical LOC572734 1.49 2.10 
A_15_P113877 NM_201158 
Danio rerio aldehyde dehydrogenase 4 
family, member A1 (aldh4a1), nuclear gene 
encoding mitochondrial protein, 
mRNAzgc:63592 
-1.56 -2.18 
A_15_P114878 TC322430  -1.87 -2.72 
A_15_P115546 NM_178300 aryl hydrocarbon receptor nuclear translocator-like 1b  2.44 3.17 
A_15_P116826 NM_131867 heat shock factor 2 -2.68 -3.04 
A_15_P117222 XR_029365 similar to RCE1 homolog, prenyl protein peptidase  -2.65 
A_15_P118405 XM_688726 hypothetical LOC565446 -1.50 -2.09 
A_15_P118684 ENSDART00000006474 glycine receptor, alpha 4b  1.67 2.24 
A_15_P119540 CK015579 wu:fj84d10 -2.61 -2.86 
A_15_P120707 NM_205686 cryptochrome DASH -3.21 -3.91 
A_15_P120925 NM_201056 MAX dimerization protein 3  2.01 2.91 
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A_15_P121171 BC066388 aryl hydrocarbon receptor nuclear translocator-like 2 2.65 5.57 
A_15_P130406 NM_001014369 si:dkey-31f5.7 1.91 2.54 
A_15_P133821 BC060943 wu:fk63e10 5.88 9.25 
A_15_P137031 ENSDART00000073440 similar to DnaJ-like subfamily A member 4 -1.58 -2.58 
A_15_P137886 NM_131787 cryptochrome 4 1.58 2.15 
A_15_P141096 NM_001039107 basic helix-loop-helix domain containing, class B, 3 like -2.30 -3.55 
A_15_P143946 ENSDART00000041615 UDP glucuronosyltransferase 5 family, polypeptide G1  2.07 2.82 
A_15_P144496 ENSDART00000075588 similar to MGC115669 protein -2.42 -2.78 
A_15_P144761 ENSDART00000083569 ornithine decarboxylase antizyme 2, like -1.35 -2.00 
A_15_P144886 NM_212439 period homolog 4 -3.09 -5.23 
A_15_P147921 NM_001004120 nuclear factor, interleukin 3 regulated 2.08 2.54 
A_15_P150786 NM_199611 arginase, type II -2.05 -3.18 
A_15_P151176 NM_001082936 cytochrome P450, family 2, subfamily J, polypeptide 29  -2.54 
A_15_P153641 NM_200914 abhydrolase domain containing 2 -1.81 -2.23 
A_15_P159451 NM_001014369 si:dkey-31f5.7 2.02 2.85 
A_15_P160171 ENSDART00000082475 Rev-erbgamma-B 2.36 10.49 
A_15_P161566 NM_131786 cryptochrome 3 -2.06 -2.77 
A_15_P166596 NM_131400 thyrotroph embryonic factor -1.92 -2.46 
A_15_P168101 NM_131790 cryptochrome 1b -2.54 -3.18 
A_15_P170926 NM_001014369 si:dkey-31f5.7 2.13 2.78 
A_15_P173191 NM_131792 cryptochrome 2b 1.67 3.26 
A_15_P175566 NM_131578 aryl hydrocarbon receptor nuclear translocator-like 2 2.64 5.40 
A_15_P176961 BC097065  1.92 2.34 
A_15_P177056 ENSDART00000043507 si:ch211-284a13.1 -10.81 -9.57 
A_15_P180171 ENSDART00000077084 similar to LOC553272 protein 1.41 2.55 
A_15_P183846 ENSDART00000103169 Rev-erbgamma-A 1.55 4.43 
A_15_P186116 ENSDART00000023506 
similar to Solute carrier family 16 
(monocarboxylic acid transporters), member 
1 
-1.71 -2.57 
A_15_P186256 ENSDART00000103263 similar to cysteinyl leukotriene receptor 1 -1.95 -5.15 
A_15_P187316 NM_205729 nuclear receptor subfamily 1, group d, member 1 -5.94 -2.77 
A_15_P188666 ENSDART00000040156 hypothetical protein LOC793064 1.59 2.07 
A_15_P191501 ENSDART00000012376 gamma-aminobutyric acid (GABA) receptor, rho 1 -2.02 -4.12 
A_15_P191926 ENSDART00000013140  4.77 7.38 
A_15_P194301 NM_001077731 zgc:154093 -1.39 -2.44 
A_15_P196411 NM_200692 N-myc downstream regulated gene 1, like 1.66 3.05 
A_15_P198036 NM_001111164 encephalopsin 2.29 3.28 
A_15_P200426 ENSDART00000076153 hypothetical LOC559531 1.57 2.01 
A_15_P204936 NM_131400 thyrotroph embryonic factor -1.94 -2.25 
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A_15_P206011 NM_001045115 si:ch211-63o20.5 -3.13 -3.41 
A_15_P206101 NM_001045055 si:ch211-132b12.7 -5.07 -8.68 
A_15_P210616 NM_001017753 zgc:112094 -2.0 -2.2 
A_15_P212226 BC090493 similar to IMP (inosine monophosphate) dehydrogenase 1  2.01 2.61 
A_15_P212631 BC134075  -6.26 -17.51 
A_15_P236266 NM_001030183 period homolog 1 (Drosophila) -5.83 -4.48 
A_15_P243801 XM_692570 hypothetical LOC569202 1.40 2.49 
A_15_P262641 AI965034  1.46 2.03 
A_15_P263411 BC096780 cryptochrome 2b 1.67 3.00 
A_15_P265011 XM_001340943 hypothetical protein LOC100000872 -1.47 -2.41 
A_15_P265381 XM_689253 pleckstrin homology domain containing, family G (with RhoGef domain) member 2 1.52 2.25 
A_15_P280791 TC344055  1.99 3.92 
A_15_P280961 TC344117  -3.48 -4.54 
A_15_P281421 TC344277  2.36 6.27 
A_15_P290916 XM_001332002 similar to Wu:fk63e10 protein 5.99 11.31 
A_15_P297801 CA475016  -1.96 -2.48 
A_15_P348800 TC333899  1.30 2.03 
A_15_P358610 CT662681  1.70 2.72 
A_15_P359680 CN168295  -6.86 -12.31 
A_15_P378335 ENSDART00000041615 UDP glucuronosyltransferase 5 family, polypeptide G1 2.12 3.18 
A_15_P382570 TC356482  -2.36 -4.18 
A_15_P394380 EL651135  5.93 10.54 
A_15_P433820 BC131854 basic helix-loop-helix domain containing, class B, 3 like -2.29 -3.49 
A_15_P465930 TC353762  -1.74 -2.85 
A_15_P477630 XM_691681 hypothetical LOC568355 -1.98 -2.87 
A_15_P509447 ENSDART00000097466  -1.65 -2.10 
A_15_P509602 CT670730  -2.87 -6.46 
A_15_P519787 CT670730  -2.27 -4.98 
A_15_P520947 CK236112  2.49 5.84 
A_15_P544952 NM_200061 arachidonate 5-lipoxygenase-activating protein -1.68 -2.15 
A_15_P551002 XM_694484 hypothetical LOC570947 1.67 2.33 
A_15_P561512 TC336646  1.73 3.43 
A_15_P567227 NM_001083013 tensin 3 -1.50 -2.41 
A_15_P597722 CT652640  -1.86 -2.01 
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Table 1                  
Significantly altered genes in zebrafish eleuthero-embryo after exposure to 1.3 μg/L and 21 μg/L PKC412 
(adjusted p<0.05). 
Agilent ID Sequence Accession # Gene name 
Fold change (log2) 
1.3 μg/L  21 μg/L 
A_15_P100036 BC124598  1.52 2.24 
A_15_P100059 NM_001020482 carboxypeptidase A1 (pancreatic) 2.89 - 
A_15_P100260 NM_131790 cryptochrome 1b -2.08 -1.54 
A_15_P100294 XM_692376 hypothetical LOC569014 -1.84 -2.36 
A_15_P100312 NM_001013276 crystallin, gamma S1 - 2.20 
A_15_P100495 NM_001001843 tryptophan hydroxylase 1, like - -2.19 
A_15_P100560 NM_001045235 zgc:136815 2.04 - 
A_15_P100658 TC316008  - 4.30 
A_15_P100666 NM_131190 serum response factor - 2.03 
A_15_P100836 BQ480828  1.63 2.32 
A_15_P100839 NM_001007054 zgc:92590 2.61 - 
A_15_P100919 EH535115 wu:fb48d04 1.69 2.21 
A_15_P101039 NM_131577 aryl hydrocarbon receptor nuclear translocator-like 1a 2.5 3.12 
A_15_P101064 ENSDART00000043658 solute carrier family 2 (facilitated glucose/fructose transporter), member 5 -2.10 - 
A_15_P101201 ENSDART00000043434 zgc:103728 - 4.04 
A_15_P101305 TC334332  3.19 6.28 
A_15_P101403 BM071654  1.58 2.58 
A_15_P101676 NM_001003426 zgc:92745 3.41 - 
A_15_P101734 NM_001020795 crystallin, gamma M7 - 2.08 
A_15_P101959 BM571381  - 2.05 
A_15_P102163 NM_200100 hypoxia induced gene 1 -2.59 -1.82 
A_15_P102261 NM_001003776 zgc:100982 -2.99 -1.70 
A_15_P102367 NM_001080182 zgc:158752 - -2.59 
A_15_P102459 NM_182857 period homolog 2 (Drosophila) -2.14 -3.08 
A_15_P102468 NM_001110478 capthepsin B, b - -2.00 
A_15_P102953 NM_199869 insulin induced gene 1 2.09 - 
A_15_P102987 NM_001002567 zgc:92754 - -2.16 
A_15_P103003 NM_213050 zgc:56053 - -2.11 
A_15_P103094 NM_001044836 si:dkey-14d8.7 2.12 - 
A_15_P103210 NM_200692 N-myc downstream regulated gene 1, like 3.16 4.26 
A_15_P103395 NM_001045343 zgc:153037 - -2.71 
A_15_P103587 NM_200186 zgc:56005 - -4.17 
A_15_P103702 BC154648  2.09 - 
A_15_P103714 NM_194393 guanylate cyclase activator 1C -2.32 -1.50 
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A_15_P103716 NM_131870 guanylate cyclase activator 1A - -3.17 
A_15_P103946 NM_131788 cryptochrome 5 -2.68 -2.86 
A_15_P104101 BI428525 hypothetical LOC556853 - -2.61 
A_15_P104271 NM_001002674 zgc:92440 2.78 - 
A_15_P104346 ENSDART00000099847  2.11 - 
A_15_P104502 NM_212439 period homolog 4 -4.40 -3.17 
A_15_P104513 NM_207052 midnolin - 2.03 
A_15_P104616 XM_677857 retinoic acid receptor, alpha b - 2.76 
A_15_P104624 NM_001007038 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 -2.03 -1.80 
A_15_P104868 XM_001343386 hypothetical protein LOC100003999 -4.68 -6.94 
A_15_P104936 BQ074590  - 2.10 
A_15_P104960 NM_213130 adenylate kinase 3-like 1 - -2.21 
A_15_P105015 NM_199607 carboxyl ester lipase, tandem duplicate 1 3.86 - 
A_15_P105032 EH605763 hemoglobin beta embryonic-3 - 2.20 
A_15_P105154 NM_212950 parathyroid hormone 1a - 3.04 
A_15_P105312 NM_131372 invariant chain-like protein 2 2.12 - 
A_15_P105715  angiopoietin 2 - 3.63 
A_15_P105742 NM_001077744 zgc:152772 -3.63 - 
A_15_P105955 NM_001007051 vesicle amine transport protein 1 homolog (T californica) -2.07 - 
A_15_P106368 NM_131814  - 2.18 
A_15_P106535 TC306742  3.12 - 
A_15_P106633 NM_001003737 zgc:92041 2.41 - 
A_15_P106879 NM_200792 arrestin 3, retinal (X-arrestin) -3.82 -3.49 
A_15_P107148 NM_182891 opsin 1 (cone pigments), medium-wave-sensitive, 2 - 2.36 
A_15_P107160 AA495045  - 2.14 
A_15_P107533 NM_200871 phosphodiesterase 6C, cGMP-specific, cone, alpha prime -2.24 -2.00 
A_15_P107751 NM_182942 myxovirus (influenza) resistance A - 2.96 
A_15_P107809 XM_684946 hypothetical LOC561538 2.18 - 
A_15_P107868 BC059655 zgc:73337 - 2.51 
A_15_P108001 CK019211 wu:fb40b03 - 3.36 
A_15_P108054 NM_131400 thyrotroph embryonic factor -3.48 -3.09 
A_15_P108174 NM_131581 odorant receptor, family D, subfamily 111, member 10 - 2.02 
A_15_P108216 NM_001005394 glycophorin C (Gerbich blood group) - -2.15 
A_15_P108469 ENSDART00000066833  2.13 - 
A_15_P108688 NM_001001949 granulin a 2.21 - 
A_15_P109076 CK707447  - 2.22 
A_15_P109078 DT061329  -1.67 -2.44 
A_15_P109206 CK363363  - 6.42 
A_15_P109244 TC346477  - 2.18 
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A_15_P109267 TC316344  2.17 - 
A_15_P109281 BI878336  - 2.71 
A_15_P109547 TC346523  - 2.57 
A_15_P109551 TC330139  1.75 2.63 
A_15_P109660 NM_001008579 zgc:92239 -2.09 -1.79 
A_15_P109678 NM_001020732 zgc:109977 -2.57 -1.94 
A_15_P109683 NM_212999 sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D 1.86 2.86 
A_15_P110098 NM_001007763 N-acylsphingosine amidohydrolase 2 - -4.69 
A_15_P110142 TC353878  - 2.59 
A_15_P110191 BI673679  - 2.36 
A_15_P110290 NM_205729 nuclear receptor subfamily 1, group d, member 1 -14.73 -7.41 
A_15_P110367 ENSDART00000014183 glycosyltransferase 25 domain containing 2 - 2.11 
A_15_P110417 ENSDART00000101764 similar to type IV antifreeze protein - 3.15 
A_15_P110650 NM_199733 zgc:56201 - -2.77 
A_15_P110860 NM_001004112 zgc:92375 - -2.27 
A_15_P111207 ENSDART00000043507 si:ch211-284a13.1 -7.04 -4.21 
A_15_P111244 TC347468  2.20 3.54 
A_15_P111724 CN500628  -2.42 - 
A_15_P111741 XM_001337603 similar to Wu:fk63e10 protein 5.74 6.13 
A_15_P111830 XM_686911 hypothetical LOC563546 -4.36 -3.43 
A_15_P111831 NM_213196 zgc:77836 - 2.01 
A_15_P112208 NM_001109850 zgc:173915 2.51 - 
A_15_P112394 NM_198072 5-methyltetrahydrofolate-homocysteine methyltransferase -1.69 -2.52 
A_15_P112425 NM_131372 invariant chain-like protein 2 2.57 - 
A_15_P112603 NM_131610 adenosine deaminase, RNA-specific, B1 -2.06 -1.47 
A_15_P112700 NM_001002181 
methylenetetrahydrofolate dehydrogenase 
(NADP+ dependent) 2, methenyltetrahydrofolate 
cyclohydrolase 
-2.04 - 
A_15_P112731 NM_001077344 zgc:153787 2.64 - 
A_15_P113163 ENSDART00000063484 hypothetical LOC568321 2.88 - 
A_15_P113243 BM316038  - 2.37 
A_15_P113391 BC142906  -2.05 -1.95 
A_15_P113683 NM_001003777 zgc:100975 2.04 2.13 
A_15_P113690 BC153933  -2.29 -1.64 
A_15_P113950 ENSDART00000024615  2.07 4.93 
A_15_P114484 AF246175 T cell receptor alpha constant 1.88 2.12 
A_15_P114533 AI964281 progesterone receptor membrane component 1 - 2.33 
A_15_P114542 NM_001083825 
similar to Glutaminase, kidney isoform, 
mitochondrial precursor (GLS) (L-glutamine 
amidohydrolase) (K-glutaminase) 
2.07 - 
A_15_P114615 ENSDART00000024136 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 1.85 2.34 
A_15_P114692 NM_201195 non-metastatic cells 4, protein expressed in 2.25 - 
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A_15_P114878 TC322430  -3.10 -3.73 
A_15_P114960 NM_130957 clock 2.85 2.70 
A_15_P115043 NM_131075 metallothionein - 2.29 
A_15_P115158 ENSDART00000066936 zgc:56123 2.26 - 
A_15_P115437 NM_001017779 zgc:110366 - -2.01 
A_15_P115542 NM_130978 neurogenic differentiation 2.23 2.85 
A_15_P115546 NM_178300 aryl hydrocarbon receptor nuclear translocator-like 1b 3.10 2.03 
A_15_P115579 EH602155  -2.33 - 
A_15_P115758 NM_001082930 si:ch211-240l19.8 2.74 - 
A_15_P115764 NM_199848 adenosine monophosphate deaminase 3 2.35 1.80 
A_15_P116070 ENSDART00000080859  - 2.10 
A_15_P116148 NM_001003450 zgc:92511 2.03 - 
A_15_P116208 NM_199271 carboxypeptidase A5 3.01 - 
A_15_P116231 NM_001002868 dpy-19-like 1, like (H. sapiens) 1.77 2.42 
A_15_P116346 NM_200160 zgc:55511 2.12 - 
A_15_P116484 NM_001013478 si:dkey-13a21.4 2.44 - 
A_15_P116818 CD606691  - 2.40 
A_15_P116981 TC335896  2.72 1.63 
A_15_P117021 NM_001083023 zgc:158846 2.15 - 
A_15_P117046 NM_131253 opsin 1 (cone pigments), medium-wave-sensitive, 1 2.06 2.70 
A_15_P117062 NM_001006039 zgc:103427 -2.39 -1.72 
A_15_P117089 NM_001080176 zgc:158856 - 2.09 
A_15_P117344 XM_678566 LOC555906 -2.02 - 
A_15_P117376 BM184314  - 2.09 
A_15_P117784 NM_199271 carboxypeptidase A5 3.61 - 
A_15_P117864 NM_001024408 elastase 3 like 3.56 - 
A_15_P118032 TC363214  2.72 3.18 
A_15_P118042 ENSDART00000082372  1.98 2.23 
A_15_P118079 NM_001007349 zgc:103473 -2.03 -2.03 
A_15_P118514 NM_201077 zgc:63647 2.28 - 
A_15_P118528 NM_200071 Rhesus blood group, B glycoprotein - -2.22 
A_15_P118532 NM_001002217 zgc:91794 2.06 - 
A_15_P118568 TC351820  -2.42 -2.34 
A_15_P119281 NM_001002143 zgc:86722 - -2.08 
A_15_P119413 NM_131192 opsin 1 (cone pigments), short-wave-sensitive 2 1.82 2.15 
A_15_P119429 NM_001002443 opsin 1 (cone pigments), long-wave-sensitive, 2 2.43 2.13 
A_15_P119431 CN170396 ribosomal protein S26, like - 2.56 
A_15_P119515 NM_198984 purinergic receptor P2X, ligand-gated ion channel, 7 - -2.99 
A_15_P119523 BC142812  -4.00 -1.72 
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A_15_P119540 CK015579 wu:fj84d10 -5.05 -2.97 
A_15_P119573 CK353894  -2.59 - 
A_15_P119688 XM_690900 intermedin precursor 2.80 2.85 
A_15_P119893 NM_001044861 si:ch211-200o3.4 - -2.42 
A_15_P119933 TC322484  - 2.27 
A_15_P120064 CK017430  - 3.06 
A_15_P120105 NM_131518 CD81 antigen - -2.67 
A_15_P120127 NM_200610 zgc:63622 - 2.07 
A_15_P120164 CK027491  - 2.27 
A_15_P120402 TC346262  -2.32 - 
A_15_P120615 XM_001332059 similar to prominin-like 2 - 2.61 
A_15_P120653 ENSDART00000077511 LOC553366 2.12 - 
A_15_P120707 NM_205686 cryptochrome DASH -2.37 -2.06 
A_15_P120767 NM_001007132 zgc:123068 - 3.28 
A_15_P120802 BQ783861  - 2.35 
A_15_P120815 ENSDART00000040598  3.81 - 
A_15_P120831 NM_001037101 PASG -2.00 -2.09 
A_15_P120851 NM_001013526 six-cysteine containing astacin protease 3 2.25 - 
A_15_P120925 NM_201056 MAX dimerization protein 3 - 2.28 
A_15_P121032 ENSDART00000076523  2.31 1.41 
A_15_P131306 DQ851840 PR domain containing 1b 2.3 2.88 
A_15_P131706 ENSDART00000035967 bromodomain-containing 2a - 2.34 
A_15_P132596 AY050507 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 1.94 2.30 
A_15_P132666 AY193826 nidogen 2 (osteonidogen) - -2.47 
A_15_P133501 NM_212999 sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D 1.88 2.94 
A_15_P133581 BC051151  -2.66 - 
A_15_P133821 BC060943 wu:fk63e10 5.82 6.49 
A_15_P134231 NM_001045210 zgc:113032 -2.92 -2.19 
A_15_P134246 BC090504 si:ch211-219i10.1 - -2.32 
A_15_P135406 ENSDART00000023265 hypothetical protein LOC797548 - 2.42 
A_15_P135701 ENSDART00000041988 similar to solute carrier family 34 (sodium phosphate), member 1 - 2.20 
A_15_P136186 ENSDART00000035894 hypothetical LOC570421 1.57 2.94 
A_15_P136411 ENSDART00000104449 hypothetical LOC571565 - 2.23 
A_15_P136686 ENSDART00000103901  - 2.03 
A_15_P136851 ENSDART00000103620 similar to Leucine rich repeat containing 56 - 2.78 
A_15_P137851 ENSDART00000082490 similar to K+ channel tetramerization protein 2.18 1.48 
A_15_P137856 ENSDART00000065377 hypothetical LOC570940 2.60 6.52 
A_15_P137886 NM_131787 cryptochrome 4 2.29 1.80 
A_15_P138221 ENSDART00000105618  - 2.32 
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A_15_P139056 ENSDART00000104909  -5.13 -2.81 
A_15_P139066 ENSDART00000086936 si:ch211-239j15.1 -4.91 -3.15 
A_15_P139526 NM_001024812 zgc:113944 1.74 2.15 
A_15_P140252 NM_001024402 zgc:109991 1.58 -2.02 
A_15_P141026 NM_001018121 gammaM2a-crystallin - 2.36 
A_15_P141096 NM_001039107 basic helix-loop-helix domain containing, class B, 3 like -2.56 -2.63 
A_15_P141136 NM_001020785 interleukin 10 2.41 -2.04 
A_15_P141456 NM_001020788 interleukin 17c - 2.55 
A_15_P141526 NM_001102388 zgc:171642 -2.39 -2.38 
A_15_P141596 NM_001020506 taste receptor, type 2, member 203 - 2.85 
A_15_P142196 NM_001045376 zgc:153417 -2.35 -1.43 
A_15_P143116 NM_001017825 zgc:110200 - -2.15 
A_15_P143801 NM_001103197 zfconnexin 41.04 2.28 - 
A_15_P144356 ENSDART00000075014 similar to Autocrine motility factor receptor 2.23 1.63 
A_15_P144496 ENSDART00000075588 similar to MGC115669 protein -2.69 -2.17 
A_15_P144641 ENSDART00000021013  1.97 2.18 
A_15_P144801 ENSDART00000073932 hypothetical LOC560802 -2.48 -2.84 
A_15_P144876 ENSDART00000073827 collagen, type IV, alpha 5 (Alport syndrome) - -2.96 
A_15_P144886 NM_212439 period homolog 4 -4.52 -2.91 
A_15_P144901 ENSDART00000045089  2.41 - 
A_15_P145966 ENSDART00000051616 hypothetical LOC557008 -2.91 -2.52 
A_15_P146096 ENSDART00000051505 similar to chemokine receptor D6 1.35 2.15 
A_15_P146356 ENSDART00000098273 hypothetical LOC566714 2.27 - 
A_15_P148046 NM_001100144 gastric inhibitory polypeptide 2.55 - 
A_15_P148136 NM_001098257 insulin-like growth factor binding protein-1b 2.67 - 
A_15_P149021 NM_001020787 interleukin 17a/f1 - 3.01 
A_15_P150036 NM_200733 pyrophosphatase (inorganic) -2.15 -2.16 
A_15_P150101 NM_001020565 zgc:110064 2.19 - 
A_15_P150431 NM_001076593 zgc:153394 -2.89 -2.10 
A_15_P150521 NM_001037690 zgc:123280 -2.33 -2.37 
A_15_P150526 NM_001025474 zgc:112368 3.00 - 
A_15_P150751 NM_001080022 zgc:153767 - -2.71 
A_15_P151116 NM_001017909 zgc:112992 -2.88 -7.51 
A_15_P151491 NM_173257 MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae) - -2.07 
A_15_P151696 NM_001044973 si:dkey-94n12.3 2.16 - 
A_15_P152006 NM_001007322 myosin binding protein C, slow type - 2.56 
A_15_P153321 NM_131253 opsin 1 (cone pigments), medium-wave-sensitive, 1 2.15 2.46 
A_15_P153511 NM_001080059 glucose-dependent insulinotropic polypeptide 2.31 - 
A_15_P153641 NM_200914 abhydrolase domain containing 2 -2.14 -2.06 
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A_15_P155136 ENSDART00000043226  -2.86 -1.79 
A_15_P155226 ENSDART00000082465 solute carrier family 39 (zinc transporter), member 4 - -2.79 
A_15_P155481 ENSDART00000097408 similar to LOC560949 protein 2.37 3.43 
A_15_P156806 ENSDART00000081029 similar to MGC53544 protein 3.41 3.19 
A_15_P157246 NM_001008579 zgc:92239 - -2.16 
A_15_P157521 ENSDART00000043936  2.03 - 
A_15_P158259 ENSDART00000014683  - 2.56 
A_15_P158856 NM_213421 APEX nuclease (multifunctional DNA repair enzyme) 1 - -2.70 
A_15_P159091 ENSDART00000102534 si:dkey-207j16.6 - 2.40 
A_15_P159371 ENSDART00000067011 hypothetical LOC567234 -2.12 - 
A_15_P160152 ENSDART00000008810 similar to Tumor differentially expressed 2 2.36 2.10 
A_15_P160691 NM_001037101 PASG - -3.13 
A_15_P160696 NM_001079996 zgc:154042 2.68 - 
A_15_P161031 NM_001037428 zgc:123097 - -2.58 
A_15_P161566 NM_131786 cryptochrome 3 -4.39 -2.95 
A_15_P161661 NM_001030266 zgc:114168 2.53 - 
A_15_P162166 NM_001017864 zgc:110697 2.14 2.35 
A_15_P163936 NM_001002405 arrestin 3, retinal (X-arrestin), like -1.78 -2.46 
A_15_P162951 NM_200272 zgc:56628 2.09 - 
A_15_P164071 NM_001080631 zgc:158792 1.78 2.25 
A_15_P164116 NM_001017746 zgc:112531 2.27 - 
A_15_P164676 ENSDART00000035654 hypothetical LOC572114 2.15 - 
A_15_P165256 ENSDART00000101463 hypothetical protein LOC100005979 - 2.14 
A_15_P165726 ENSDART00000076749 SAM domain, SH3 domain and nuclear localisation signals, 1 - 2.39 
A_15_P165946 ENSDART00000051966 similar to Clca1 protein 2.74 - 
A_15_P166596 NM_131400 thyrotroph embryonic factor -2.40 -2.52 
A_15_P166631 ENSDART00000105802 similar to Wnt3 -2.03 - 
A_15_P167021 ENSDART00000105508  - -2.21 
A_15_P167691 ENSDART00000092421  - 2.30 
A_15_P167811 ENSDART00000100832  - 2.11 
A_15_P167831 ENSDART00000060172 hypothetical LOC557339 2.15 - 
A_15_P168016 ENSDART00000100131 si:ch211-242e8.1 -2.80 -1.76 
A_15_P168101 NM_131790 cryptochrome 1b -1.92 -2.39 
A_15_P168471 ENSDART00000088309 similar to mixed lineage kinase 2 - 2.75 
A_15_P169136 NM_001020536 zgc:109962 1.82 2.30 
A_15_P169291 NM_001077719 zgc:153935 -2.48 -1.55 
A_15_P169381 NM_131547 Rh50-like protein - -2.94 
A_15_P169411 NM_001082819 RORgamma-A 3.28 2.72 
A_15_P169496 NM_001098772 zgc:165502 -1.64 -2.56 
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A_15_P169621 zgc:152898 NM_001077722 2.01 - 
A_15_P169776 NM_001030281 MEP1A protein - -2.35 
A_15_P169966 NM_178436 MCM5 minichromosome maintenance deficient 5 (S. cerevisiae) - -2.16 
A_15_P170086 NM_001089470 zgc:162183 - 2.01 
A_15_P171336 NM_001045210 zgc:113032 -2.11 -2.12 
A_15_P171766 NM_001080600 SHQ1 homolog (S. cerevisiae) - 4.28 
A_15_P172406 NM_131667 GTP cyclohydrolase 2 -2.83 -3.58 
A_15_P172761 NM_001089408 similar to Acheron 4.35 4.00 
A_15_P172846 NM_199970 non-metastatic cells 2-like, protein (NM23B) expressed in -2.39 -1.94 
A_15_P172886 NM_200559 zgc:66109 -1.69 -2.03 
A_15_P173156 NM_001045400 zgc:153443 -2.83 -2.64 
A_15_P173191 NM_131792 cryptochrome 2b 3.91 2.66 
A_15_P173416 NM_001024446 alpha-2,3-sialyltransferase v2 2.29 3.00 
A_15_P173426 NM_001045367 zgc:152970 -2.03 - 
A_15_P173841 NM_001030152 si:ch211-240l19.5 2.22 - 
A_15_P175166 NM_001080655 zgc:158748 - 2.53 
A_15_P175721 NM_001007132 zgc:123068 - 3.25 
A_15_P176381 NM_001083859 zgc:162331 -2.01 - 
A_15_P177056 ENSDART00000043507 si:ch211-284a13.1 -7.07 -5.27 
A_15_P177151 BC108026  - 2.19 
A_15_P177256 BC115099  1.40 2.80 
A_15_P178836 BC150339  -2.80 - 
A_15_P179346 NM_001109737 zgc:171699 - 2.18 
A_15_P180961 ENSDART00000101151 similar to Syncollin 2.11 - 
A_15_P182441 ENSDART00000055619  - 3.79 
A_15_P183391 ENSDART00000010270 similar to Major facilitator superfamily domain containing 4 2.49 - 
A_15_P183481 ENSDART00000054685 hypothetical LOC563546 -4.26 -3.56 
A_15_P183531 ENSDART00000047784 similar to QEK5 protein - 2.26 
A_15_P183756 ENSDART00000033429 similar to opioid receptor-like protein Zf-orl - 2.55 
A_15_P184026 NM_001110035 zgc:171755 -2.57 -2.04 
A_15_P184201 ENSDART00000026234 meprin A, alpha.2 - -2.10 
A_15_P185221 NM_001007038 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 -2.06 -2.98 
A_15_P185766 ENSDART00000087300 hypothetical LOC566922 -1.68 -2.22 
A_15_P185801 ENSDART00000023686 hypothetical LOC569518 -3.66 -3.05 
A_15_P185901 ENSDART00000103833 similar to Slc26a6 C 2.37 - 
A_15_P187316 NM_205729 nuclear receptor subfamily 1, group d, member 1 -12.23 -11.13 
A_15_P188231 ENSDART00000043204 hypothetical LOC563995 - 2.19 
A_15_P188331 ENSDART00000074388 hypothetical LOC556193 - -2.25 
A_15_P188516 NM_200586 myoglobin 2.62 - 
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A_15_P188666 ENSDART00000040156 hypothetical protein LOC793064 2.05 1.81 
A_15_P188671 ENSDART00000073694 similar to Smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) -2.78 -3.88 
A_15_P188946 ENSDART00000081657 hypothetical LOC560602 2.69 4.96 
A_15_P190351 ENSDART00000106687 hypothetical protein LOC798372 - 2.05 
A_15_P190371 ENSDART00000055728 similar to TBC1 domain family, member 2 - 2.18 
A_15_P190421 ENSDART00000106671  - 3.26 
A_15_P190576 ENSDART00000040383 hypothetical LOC556714 2.23 - 
A_15_P191926 ENSDART00000013114  5.77 7.33 
A_15_P192081 ENSDART00000104017 hypothetical protein LOC796555 - 3.00 
A_15_P192721 NM_001077453 zgc:153647 - -3.40 
A_15_P193091 NM_001089401 zgc:162907 -2.36  
A_15_P193906 NM_001011660 guanylate cyclase activator 1g -2.86 -3.25 
A_15_P193916 NM_001031841 G-protein-coupled receptor kinase 7a -2.81 -2.01 
A_15_P194791 NM_001024386 integrin, beta 4 -2.13 - 
A_15_P195056 NM_001044839 si:dkey-14d8.6 2.16 - 
A_15_P196291 NM_001011661 guanylate cyclase activator 1d -2.92 -2.46 
A_15_P196411 NM_200692 N-myc downstream regulated gene 1, like 4.06 4.11 
A_15_P196701 ENSDART00000065660 similar to nuclear receptor subfamily 0, group B, member 2 3.24 - 
A_15_P197381 ENSDART00000037585 hypothetical LOC557043 2.67 - 
A_15_P197441 ENSDART00000057600 hypothetical LOC568302 - -2.21 
A_15_P197486 ENSDART00000051886 similar to MGC82104 protein - -2.38 
A_15_P197596 ENSDART00000078346 similar to SH2 domain containing 4B 2.10 - 
A_15_P197856 ENSDART00000085319 similar to Son of sevenless homolog 2 (Drosophila) - 2.03 
A_15_P198476 NM_001031841 G-protein-coupled receptor kinase 7a -2.04 -2.25 
A_15_P198681 ENSDART00000052065 hypothetical LOC563472 - -2.84 
A_15_P198761 ENSDART00000087687 hypothetical LOC568099 1.78 2.18 
A_15_P198866 ENSDART00000057462 similar to MAM domain containing 4 -1.73 -2.17 
A_15_P198956 ENSDART00000056577 similar to Retinol-binding protein I, cellular (Cellular retinol-binding protein) (CRBP) - 3.09 
A_15_P199141 ENSDART00000042974 similar to EAAT1 -2.31 -2.19 
A_15_P201121 ENSDART00000062940 hypothetical protein LOC100002385 - 2.47 
A_15_P201166 ENSDART00000062292 similar to activating transcription factor 2 - 4.23 
A_15_P201661 ENSDART00000004619 hypothetical LOC558093 -2.19 -1.50 
A_15_P201281 ENSDART00000011757 collagen, type IV, alpha 2 - 2.34 
A_15_P201816 ENSDART00000077937 hypothetical LOC566497 - -2.13 
A_15_P202031 ENSDART00000085738  - -2.29 
A_15_P202046 ENSDART00000082368 similar to putative scavenger receptor MARCO 2.44 - 
A_15_P202616 ENSDART00000104161  - -3.61 
A_15_P203161 ENSDART00000104161 similar to novel 7 transmembrane receptor (rhodopsin family) 7.44 4.37 
A_15_P203856 ENSDART00000091183 hypothetical LOC565909 - 2.41 
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A_15_P203951 ENSDART00000080372 -3.43 -3.43 -3.43 
A_15_P204061 ENSDART00000002751 similar to Sphingomyelin phosphodiesterase, acid-like 3B - -2.18 
A_15_P204191 ENSDART00000009774 hypothetical protein LOC100006926 - 2.36 
A_15_P204926 NM_200858 zgc:77748 - -2.50 
A_15_P204936 NM_131400 thyrotroph embryonic factor -3.30 -2.11 
A_15_P206011 NM_001045115 si:ch211-63o20.5 -2.32 -1.91 
A_15_P206036 NM_001079657 zgc:158340 -2.99 - 
A_15_P206101 NM_001045055 si:ch211-132b12.7 -4.85 -5.67 
A_15_P207166 NM_001020557 zgc:110025 1.93 2.22 
A_15_P207586 NM_001030267 zgc:114203 - 2.28 
A_15_P208051 NM_001039890 si:dkey-3n7.3 4.72 4.36 
A_15_P208126 NM_001004666 zgc:103645 - 3.72 
A_15_P208246 NM_001077310 zgc:153102 3.03 - 
A_15_P208311 NM_001003446 zgc:92530 2.58 - 
A_15_P208526 NM_001076557 zgc:153679 -1.84 -2.60 
A_15_P209096 ENSDART00000063389  3.01 - 
A_15_P211836 NM_001030280 solute carrier family 24, member 5 - 2.50 
A_15_P212516 BC124513 forkhead box P1a - 2.61 
A_15_P212631 BC134075  -6.97 -5.74 
A_15_P213183 NM_001039624 odorant receptor - 2.79 
A_15_P224061 XM_684482  2.43 - 
A_15_P215921 NM_001037385 solute carrier family 22 (organic cation transporter), member 18 - 2.43 
A_15_P218651 TC348083  - 4.34 
A_15_P219596 ENSDART00000101347 hypothetical protein LOC799808 - 2.16 
A_15_P222321 ENSDART00000074896  - 2.76 
A_15_P224021 TC316412  - 2.47 
A_15_P226721 NM_001076593 zgc:153394 -2.74 -3.51 
A_15_P227491 TC318046  - 2.02 
A_15_P228111 NM_001006083 zgc:101667 - -3.78 
A_15_P228786 EH999121  - 2.33 
A_15_P229176 EB935053  -2.86 - 
A_15_P230491 EE205554  -2.07 - 
A_15_P232521 EH502679  - -2.12 
A_15_P232661 EH511842  - 4.33 
A_15_P234591 EH596069  - 2.12 
A_15_P236266 NM_001030183 period homolog 1 (Drosophila) -9.82 -6.41 
A_15_P241411 AL925363  - 2.30 
A_15_P242891 ENSDART00000082490 similar to K+ channel tetramerization protein 2.20 1.53 
A_15_P243506 XM_694154 hypothetical LOC570649 3.60 3.91 
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A_15_P246021 DN901390  - 3.08 
A_15_P246931 BC155059  -4.45 -2.65 
A_15_P247446 EE686394  - -2.26 
A_15_P250981 CO351285  - 3.14 
A_15_P251976 CV110355  - 3.06 
A_15_P252806 DN599439  - 3.64 
A_15_P254451 DT883475  - 2.56 
A_15_P254726 DV598736  2.37 3.58 
A_15_P257341 Y389459 toll-like receptor 21 2.03 3.66 
A_15_P259081 XM_001338656 hypothetical protein LOC798239 - 2.80 
A_15_P259686 XM_001339096 hypothetical protein LOC100004871 - 2.10 
A_15_P259981 NM_001005946 zgc:103681 - -2.55 
A_15_P260781 NM_001003446 zgc:92530 3.73 - 
A_15_P262061 AI444433 wu:fb38d07 - 3.13 
A_15_P262786 CF595273 ribosomal protein S7 3.22 4.20 
A_15_P263281 CN168062  -1.79 -2.28 
A_15_P263411 BC096780 cryptochrome 2b 3.30 4.02 
A_15_P263661 CT639065 wu:fc63c08 2.35 5.42 
A_15_P266921 CN168062 wu:fj43c12 - 3.43 
A_15_P269346 ENSDART00000106078  2.21 2.17 
A_15_P269561 CT731659 hypothetical LOC567878 - 2.15 
A_15_P271316 XM_001345452 similar to peptidylaminoacyl-L/D-isomerase 2.13 2.10 
A_15_P271441 BC096780 interleukin 7 receptor - 3.67 
A_15_P272306 NM_001110021 carboxypeptidase B1 (tissue) 3.55 - 
A_15_P274886 TC315630  2.87 - 
A_15_P275176 CN168062  - 2.32 
A_15_P275181 CN168062 bridging integrator 2 - -2.59 
A_15_P275781 TC316122  3.35 4.77 
A_15_P278446 XM_689666 hypothetical LOC566399 - -2.25 
A_15_P278841 TC343394  - 2.08 
A_15_P280791 TC344055  - 2.80 
A_15_P280961 TC344117  -3.94 -2.80 
A_15_P283191 NM_001037428 zgc:123097 - -2.73 
A_15_P284626 ENSDART00000102525  -2.72 - 
A_15_P285436 ENSDART00000099439 hypothetical protein LOC100001311 - 3.96 
A_15_P288956 XM_001344560 hypothetical protein LOC100005588 2.21 2.59 
A_15_P289391 CK396210 hypothetical LOC556736 - 2.22 
A_15_P290051 XM_001334265 similar to zinc finger of the cerebellum 1 - 5.98 
A_15_P290916 XM_001332002 similar to Wu:fk63e10 protein 4.91 3.38 
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A_15_P292696 TC363916  - 2.79 
A_15_P295001 TC364538  - 2.89 
A_15_P295031 TC364547  - 3.26 
A_15_P297976 BC092811  2.46 - 
A_15_P298126 NM_001040251 zgc:136872 2.68 - 
A_15_P298356 XM_682578 hypothetical LOC559258 - 2.35 
A_15_P300356 EB942130  - 2.51 
A_15_P302861 TC352260  - 2.14 
A_15_P303381 TC352423  - 3.09 
A_15_P303431 TC352442  - 2.72 
A_15_P303531 XM_001335593 hypothetical protein LOC799059 -2.30 -1.49 
A_15_P304011 TC352635  - 2.32 
A_15_P305511 TC353105  - 2.48 
A_15_P305641 CT591646  - 2.47 
A_15_P305731 TC353185  - 4.88 
A_15_P308261 NM_001099240 zgc:154142 - -2.45 
A_15_P308396 ENSDART00000103833 similar to Slc26a6 C 2.20 - 
A_15_P308831 CD283185  - 2.40 
A_15_P309601 XM_001342053 hypothetical protein LOC100002262 2.12 - 
A_15_P309716 EE690478  2.91 - 
A_15_P311056 EE203571  - 2.04 
A_15_P313936 CT650977  - 2.03 
A_15_P317051 EB830191  - 2.32 
A_15_P318121 EH531036  - 3.10 
A_15_P318196 EE204985  - 2.04 
A_15_P318581 CT725582  - 2.83 
A_15_P318841 CT736991  - 2.12 
A_15_P319046 TC344353  - 2.36 
A_15_P319486 TC344505  - 2.63 
A_15_P321731 TC345231  - 5.19 
A_15_P322763 TC345590  - 2.42 
A_15_P324316 TC346137  - 3.76 
A_15_P325286 CT692152  - 3.98 
A_15_P325956 CT733358  2.00 3.07 
A_15_P326496 CT688180  - 2.13 
A_15_P329931 CT708607  -2.09 - 
A_15_P331459 TC360823  - 5.73 
A_15_P332779 TC361229  - -2.15 
A_15_P333534 TC361458  2.25 2.67 
A_15_P334824 TC361867  - 2.03 
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A_15_P335194 TC361981  - -2.35 
A_15_P335504 TC362099  - 2.34 
A_15_P336640 XM_693742 SET domain containing 5 - 2.30 
A_15_P338720 TC363080  - 3.82 
A_15_P339265 TC363245  2.07 1.60 
A_15_P339845 TC363420  1.70 2.03 
A_15_P347220 TC333289  - 2.71 
A_15_P350505 TC334544  - 2.38 
A_15_P351415 CT631401  - 2.83 
A_15_P353140 CT731542  - 2.45 
A_15_P353355 CT688213  - 2.38 
A_15_P353640 CT623166  -2.36 - 
A_15_P354090 CT673684  - 2.51 
A_15_P354190 CT702703  - 2.60 
A_15_P358140 CT686876  -3.99 - 
A_15_P358445 CT695905  - 3.45 
A_15_P359680 CN168295  -6.73 -4.00 
A_15_P359710 CT672419  - 2.56 
A_15_P360105 CT706569  - 2.55 
A_15_P361565 CT711464  - 2.85 
A_15_P363340 ENSDART00000097915  6.59 - 
A_15_P364405 NM_001039890 si:dkey-3n7.3 2.10 2.41 
A_15_P365520 NM_001020536 zgc:109962 1.78 2.28 
A_15_P367020 NM_001033732 zgc:114126 - 2.01 
A_15_P367705 TC308620  -2.38 -1.82 
A_15_P368095 BC155350  - -3.00 
A_15_P368790 CT606464  - 2.59 
A_15_P369485 CT736611  - 2.22 
A_15_P369710 EH998102 wu:fc32g11 - 2.01 
A_15_P369935 XM_001344193 hypothetical protein LOC100005092 1.83 2.05 
A_15_P371510 EE689330 im:6912096 - 3.26 
A_15_P372385 CT730275  - 2.16 
A_15_P372920 EE329293  1.48 2.21 
A_15_P373125 BI866341 wu:fb72d11 -3.13 - 
A_15_P374010 EB966777  - 2.19 
A_15_P374990 EH450222 hypothetical LOC557975 -2.29 - 
A_15_P374230 EH583758  - 2.86 
A_15_P374540 AL924095  - 2.33 
A_15_P376390 NM_001089401 zgc:162907 -2.27 -2.14 
A_15_P376945 XM_691260 hypothetical LOC567946 - 3.07 
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A_15_P378720 XM_001335658 similar to Gamma crystallin B (Gamma crystallin II) - 2.51 
A_15_P378930 XM_001335565 hypothetical protein LOC795423 - 2.97 
A_15_P379375 TC355423  - 4.94 
A_15_P381345 TC356055  - 2.22 
A_15_P382570 TC356482  -2.11 - 
A_15_P386305 CT614185  - 2.86 
A_15_P386790 CT586615  - 2.16 
A_15_P386810 CT601103  - 2.28 
A_15_P388395 CT588602  - 2.04 
A_15_P388405 CT588636  - 2.46 
A_15_P389025 A_15_P389025  - 2.30 
A_15_P389365 CT618214  - 2.03 
A_15_P391640 EH475578 wu:fj39g12 - 2.02 
A_15_P392370 CT674856  - 3.38 
A_15_P394265 XM_680029 similar to novel 7 transmembrane receptor (rhodopsin family) 4.75 5.64 
A_15_P394380 EL651135  4.54 4.00 
A_15_P394650 CK024843  - 2.30 
A_15_P399615 NM_001110481 zgc:162150 -1.98 -2.30 
A_15_P401915 CR927166 hypothetical LOC562717 1.67 2.21 
A_15_P403580 AW232471  -2.17 - 
A_15_P405850 BI980905  - 2.02 
A_15_P407880 CK360637 wu:fc23d08 - 4.18 
A_15_P408365 NM_200371 zgc:64051 2.23  
A_15_P411150 ENSDART00000091905  - 3.84 
A_15_P413080 NM_001077722 zgc:152898 2.02 - 
A_15_P413960 TC328927  2.21 3.31 
A_15_P415460 ENSDART00000008810 similar to Tumor differentially expressed 2 - 2.66 
A_15_P415750 TC329665  - 4.05 
A_15_P416845 TC330079  -2.82 -1.65 
A_15_P417665 TC330397  - 2.28 
A_15_P419550 NM_131667 GTP cyclohydrolase 2 - -8.06 
A_15_P419620 TC341009  - 2.15 
A_15_P419955 NM_213178 regulator of chromosome condensation 1 - 3.29 
A_15_P420430 TC341274  - 3.05 
A_15_P420960 NM_001037690 zgc:123280 -2.59 -3.50 
A_15_P421305 NM_200825 zgc:73075 -1.90 -3.37 
A_15_P422020 TC341819  2.11 3.00 
A_15_P422690 TC341819  - 2.03 
A_15_P423620 TC342050  - 4.79 
A_15_P423795 TC342429  -2.07 - 
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A_15_P423805 TC342431  - 2.22 
A_15_P428200 CT605017  - 3.58 
A_15_P429050 CT628419  - 2.43 
A_15_P430240 EB855957  -1.57 -2.07 
A_15_P430680 A_15_P430680  - 3.00 
A_15_P433315 TC331696  - 2.26 
A_15_P433820 BC131854 basic helix-loop-helix domain containing, class B, 3 like -3.60 -2.72 
A_15_P435710 TC332639  - 2.61 
A_15_P437940 TC350648  - 2.63 
A_15_P438615 TC350858  - 2.65 
A_15_P439000 TC350973  - 2.24 
A_15_P439415 XM_693448 similar to Rho GTPase activating protein 24 - -2.08 
A_15_P441135 ENSDART00000053878  - 3.98 
A_15_P445490 NM_001045248 zgc:136342 -2.05 - 
A_15_P447010 NM_001012485 bloody fingers 2.38 -2.06 
A_15_P447820   - 2.13 
A_15_P448870 EH565417  -2.05 - 
A_15_P449805 AI943111  - 2.78 
A_15_P451195 BG728808  - 2.33 
A_15_P452670 EH438046  1.62 2.39 
A_15_P453500 AW420829  1.73 2.24 
A_15_P454180 BG305747  - 2.14 
A_15_P455140 BI878623  - 4.75 
A_15_P458000 BI475899  - 2.27 
A_15_P459290 EE703225  - 2.95 
A_15_P459940 CT708543  - 3.01 
A_15_P460410 CO812634  - 3.46 
A_15_P464200 AI878648  - 2.36 
A_15_P465255 AW165029  -2.12 - 
A_15_P467610 TC354275  1.58 2.14 
A_15_P469570 TC354906  - 2.02 
A_15_P469650 TC354933  -2.20 -1.64 
A_15_P470115 TC355081  2.00 3.88 
A_15_P471925 TC334983  - 3.36 
A_15_P472415 TC335154  1.72 2.97 
A_15_P472645 XM_684040 similar to glycerophosphodiester phosphodiesterase 2 - 2.05 
A_15_P472765 TC335278  3.10 2.00 
A_15_P473010 TC335357  - 4.00 
A_15_P474625 TC335954  - -3.27 
Chapter 4 
190 
A_15_P476655 CT649594  - 4.01 
A_15_P476910 CT653988  - 2.36 
A_15_P476960 CT623784  - 2.41 
A_15_P477900 CT636524  - 2.81 
A_15_P478835 CT731857  - 4.79 
A_15_P479260 CT666198  2.02 3.08 
A_15_P481125 CT681073  - 2.48 
A_15_P481925 CT596461  - 2.47 
A_15_P482005 CT637568  - 2.22 
A_15_P482500 CT612049  - 4.10 
A_15_P484195 TC348669  - 3.06 
A_15_P484345 TC348705  - -2.53 
A_15_P485460 TC349070  - 3.58 
A_15_P485495 TC349078  - 2.17 
A_15_P487485 TC349720  -2.01 -2.31 
A_15_P488585 TC349720 hypothetical protein LOC100000824 - 3.02 
A_15_P489657 EE690052 hypothetical protein LOC796736 - 2.31 
A_15_P491697 AL926171  - -4.12 
A_15_P493442 ENSDART00000085738 zgc:153269 - -3.58 
A_15_P495077 NM_001077548 zgc:154054 - -2.76 
A_15_P500277 NM_001077724 hypothetical protein LOC100001741 - 2.13 
A_15_P500527 XM_001341647 hypothetical protein LOC791562 - 2.29 
A_15_P500942 EH434502 similar to Slc5a8 protein - 2.62 
A_15_P501492 BM776399 hypothetical LOC561397 2.81 2.72 
A_15_P502402 NM_213379 glutamic-oxaloacetic transaminase 2a, mitochondrial (aspartate aminotransferase 2) - -2.09 
A_15_P503747 TC321541  - 2.06 
A_15_P505562 TC322396  - 2.26 
A_15_P505732 TC322491  - 2.30 
A_15_P506732 TC338714  - 5.11 
A_15_P509242 CT652640  -2.08 -1.93 
A_15_P509602 CT670730  - -3.99 
A_15_P509712 TC339744  - 8.11 
A_15_P510292 TC339972  - 3.24 
A_15_P510937 TC340210  3.28 - 
A_15_P511872 TC340549  - 2.05 
A_15_P512177 TC308992  - 3.22 
A_15_P513927 TC310020  - 2.23 
A_15_P514182 TC310162  - 2.59 
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A_15_P517652 XM_001342326 similar to Tceb3 protein - 2.54 
A_15_P518137 NM_001113336 chromosome 6 open reading frame 85-like 1.31 2.09 
A_15_P519787 CT670730  - -2.49 
A_15_P522977 CT716541  - 2.84 
A_15_P523502 CT649297  - 2.46 
A_15_P524847 CT680479  - 2.57 
A_15_P525547 CT695215  3.88 4.51 
A_15_P526882 CT638051  -2.45 - 
A_15_P527677 CT626710  - 2.15 
A_15_P528372 ENSDART00000099926 si:ch211-219a15.4 2.77 2.10 
A_15_P529657 BC058069 similar to nuclear receptor subfamily 0, group B, member 2 3.39 - 
A_15_P531517 TC326163  - 3.28 
A_15_P532052 TC326380  -3.68 - 
A_15_P532382 NM_001077625 cytokine receptor family member b7 4.48 - 
A_15_P533222 TC359125  - 2.17 
A_15_P534387 TC359501  2.59 2.50 
A_15_P534632 TC359578  2.28  
A_15_P535392 TC359819  1.62 2.01 
A_15_P535487 TC359853  2.00 3.82 
A_15_P538302 NM_001030152 si:ch211-240l19.5 2.19 - 
A_15_P539017 TC365088  - 3.02 
A_15_P539682 TC365267  - 2.67 
A_15_P541482 TC323411  - 2.18 
A_15_P543477 TC324222  -3.29 - 
A_15_P544897 NM_182891 opsin 1 (cone pigments), medium-wave-sensitive, 2 2.61 2.16 
A_15_P546127 EH492283 similar to hCG1811317 - -2.26 
A_15_P546287 NM_131547 Rh50-like protein - -2.68 
A_15_P546292 XM_687194 similar to dilute suppressor 5.17 7.15 
A_15_P546422 ENSDART00000056274 hypothetical protein LOC793909 - 2.15 
A_15_P547707 XM_001340852 similar to laminin alpha 1 - 5.67 
A_15_P548947 XM_001336219 similar to Pnpo protein - 4.53 
A_15_P549472 XM_001340512 hypothetical protein LOC100002731 2.03 1.90 
A_15_P551682 AL921834  2.04 4.13 
A_15_P551817 XM_001338394 hypothetical protein LOC797982 2.03 - 
A_15_P557897 DV585246  - 3.26 
A_15_P557947 CT733242  - 2.08 
A_15_P557992 CT603811  - 7.37 
A_15_P558422 XM_001337807 hypothetical protein LOC797371 - -2.21 
A_15_P558612 EH514414  - 2.44 
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A_15_P558852 EH522417  1.92 2.18 
A_15_P559492 EH540378  - 2.39 
A_15_P559622 EH543423  2.02 - 
A_15_P561042 EH471363 hypothetical LOC560023 - 2.27 
A_15_P561347 EH459661  - 3.56 
A_15_P561512 TC336646  1.89 2.42 
A_15_P564302 TC337698  - 2.30 
A_15_P564457 TC337764  - -2.43 
A_15_P564722 NM_001080652 zgc:158791 - 2.68 
A_15_P565687 TC338188  - -2.36 
A_15_P567422 NM_001089476 zgc:162225 - 2.09 
A_15_P567677 XM_001339077 hypothetical protein LOC798678 - 2.27 
A_15_P567697 XM_001345243 hypothetical protein LOC100006575 1.75 2.45 
A_15_P568002 XM_001344538 similar to LOC560949 protein 2.01 2.29 
A_15_P569042 NM_001099993 hypothetical LOC558964 - -2.04 
A_15_P569632 CT680561  - 2.19 
A_15_P570472 XM_683484 hypothetical LOC560089 1.86 2.27 
A_15_P573132 ENSDART00000085185  -2.35 - 
A_15_P573622 ENSDART00000013709  -3.12 - 
A_15_P573797 EH459390  - 2.55 
A_15_P574287 EL651166  - 2.14 
A_15_P576122 CD759910  - 2.29 
A_15_P576582 EE325777  - -2.26 
A_15_P577387 CR927034  - 2.92 
A_15_P578012 CT681880  - 5.07 
A_15_P580312 TC319482  3.89 4.91 
A_15_P582117 TC320334  - 2.19 
A_15_P582887 CN840802  - 2.03 
A_15_P584927 AL914742  - 2.80 
A_15_P585497 CD604692  - 2.35 
A_15_P585942 EH464326  - 2.48 
A_15_P586112 CD606517  - 2.59 
A_15_P586902 CK142812  - 4.58 
A_15_P587002 CK238860  - 2.05 
A_15_P589387 EB940944  - 2.08 
A_15_P589742 EE206580  - 2.82 
A_15_P591802 AL729664 wu:fc31e09 -2.03 -1.53 
A_15_P593992 ENSDART00000067200 hypothetical LOC560669 -3.16 - 
A_15_P596397 ENSDART00000045089  2.42 - 
A_15_P597092 AA658655 wu:fa55d03 - 2.22 
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A_15_P597232 EH995454  - 3.20 
A_15_P597382 CV488726 wu:fa92c06 - 2.16 
A_15_P597722 CT652640  -2.17 -1.93 
A_15_P597972 XM_689666 hypothetical LOC566399 - -2.51 
A_15_P598077 AL928045  - 4.47 
A_15_P599852 TC357259  - 2.57 
A_15_P600772 TC357532  - 3.06 
A_15_P603812 XM_686774 Relaxin 3c -2.13 - 
A_15_P603827 TC358489  - 2.16 
A_15_P605152 TC358895  - 5.03 
 
 
 
Table 2   
100 top GO processes represented in MetaCore (FDR< 0.05)  
Process p-value 
phototransduction 2.128e-09 
detection of light stimulus 6.058e-09 
positive regulation of cholesterol esterification 2.377e-08 
regulation of cholesterol esterification 4.045e-08 
detection of abiotic stimulus 4.897e-08 
response to external stimulus 8.596e-08 
digestion 1.803e-07 
positive regulation of cGMP metabolic process 5.646e-07 
positive regulation of cGMP biosynthetic process 5.646e-07 
positive regulation of steroid metabolic process 9.739e-07 
detection of external stimulus 1.133e-06 
very-low-density lipoprotein particle remodeling 1.241e-06 
regulation of cGMP biosynthetic process 1.251e-06 
regulation of cGMP metabolic process 1.587e-06 
cGMP-mediated signaling 1.587e-06 
alcohol metabolic process 1.655e-06 
lipid metabolic process 1.763e-06 
regulation of steroid metabolic process 1.805e-06 
cellular response to stimulus 1.843e-06 
sensory perception of light stimulus 2.514e-06 
visual perception 2.514e-06 
positive regulation of low-density lipoprotein receptor catabolic process 2.792e-06 
triglyceride-rich lipoprotein particle remodeling 2.885e-06 
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axon regeneration in the peripheral nervous system 2.885e-06 
macromolecular complex remodeling 3.037e-06 
plasma lipoprotein particle remodeling 3.037e-06 
protein-lipid complex remodeling 3.037e-06 
cholesterol catabolic process 4.139e-06 
sterol catabolic process 4.139e-06 
response to light stimulus 5.353e-06 
phospholipid efflux 5.754e-06 
multicellular organismal lipid catabolic process 6.933e-06 
nitric oxide mediated signal transduction 7.565e-06 
low-density lipoprotein particle remodeling 7.791e-06 
negative regulation of cell migration 8.680e-06 
plasma lipoprotein particle assembly 1.032e-05 
protein-lipid complex assembly 1.032e-05 
high-density lipoprotein particle remodeling 1.032e-05 
steroid catabolic process 1.042e-05 
cholesterol metabolic process 1.090e-05 
regulation of membrane protein ectodomain proteolysis 1.340e-05 
positive regulation of nitric-oxide synthase activity 1.340e-05 
negative regulation of blood vessel endothelial cell migration 1.340e-05 
regulation of cholesterol biosynthetic process 1.340e-05 
negative regulation of cholesterol biosynthetic process 1.377e-05 
regulation of low-density lipoprotein receptor catabolic process 1.377e-05 
very-low-density lipoprotein particle clearance 1.377e-05 
chylomicron remodeling 1.377e-05 
regulation of fatty acid biosynthetic process 1.404e-05 
negative regulation of cellular component movement 1.493e-05 
regulation of lipid biosynthetic process 1.493e-05 
negative regulation of locomotion 1.856e-05 
sterol metabolic process 1.976e-05 
regulation of lipid transport 2.076e-05 
negative regulation of steroid biosynthetic process 2.152e-05 
triglyceride metabolic process 2.274e-05 
Cdc42 protein signal transduction 2.395e-05 
positive regulation of interleukin-5 production 2.395e-05 
positive regulation of interleukin-13 production 2.395e-05 
negative regulation of platelet activation 2.395e-05 
negative regulation of steroid metabolic process 2.671e-05 
folic acid and derivative metabolic process 2.671e-05 
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reverse cholesterol transport 2.671e-05 
regulation of MAP kinase activity 3.049e-05 
positive regulation of nucleotide metabolic process 3.105e-05 
positive regulation of cyclic nucleotide biosynthetic process 3.105e-05 
positive regulation of nucleotide biosynthetic process 3.105e-05 
positive regulation of cyclic nucleotide metabolic process 3.105e-05 
steroid metabolic process 3.427e-05 
response to radiation 3.449e-05 
phospholipid transport 3.499e-05 
entrainment of circadian clock 3.806e-05 
chylomicron remnant clearance 3.806e-05 
high-density lipoprotein particle assembly 3.806e-05 
response to organic substance 3.852e-05 
phototransduction, visible light 3.976e-05 
response to dietary excess 3.976e-05 
positive regulation of monooxygenase activity 3.976e-05 
glycerolipid metabolic process 4.124e-05 
cholesterol transport 4.918e-05 
cellular lipid metabolic process 5.124e-05 
sterol transport 5.478e-05 
high-density lipoprotein particle clearance 5.672e-05 
positive regulation of triglyceride catabolic process 5.672e-05 
lipoprotein catabolic process 5.672e-05 
positive regulation of fatty acid biosynthetic process 5.696e-05 
positive regulation of lipid transport 5.696e-05 
negative regulation of endothelial cell migration 5.696e-05 
cholesterol efflux 5.696e-05 
cellular aromatic compound metabolic process 5.841e-05 
acylglycerol metabolic process 6.071e-05 
vasodilation 6.087e-05 
negative regulation of cellular protein metabolic process 6.328e-05 
regulation of lipid metabolic process 6.585e-05 
regulation of nitric-oxide synthase activity 6.734e-05 
neutral lipid metabolic process 7.029e-05 
regulation of circadian rhythm 7.458e-05 
glycerol ether metabolic process 7.551e-05 
regulation of lipoprotein lipase activity 7.903e-05 
Spemann organizer formation at the anterior end of the primitive streak 7.954e-05 
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Table 3  
Relevant maps and pathways represented in MetaCore (FDR< 0.05). Gray shapes mark maps for which 
additional experiments were conducted.  
Map Pathway p-Value 
Lipid Biosynthesis and 
regulation 
- Regulation of lipid metabolism_RXR-dependent 
regulation of lipid metabolism via PPAR, RAR and VDR  
- Regulation of lipid metabolism_Insulin signaling:generic 
cascades  
1.882e-3  
Cholesterol and bile 
acid homeostasis  
- Niacin-HDL metabolism  
- Transport_Intracellular cholesterol transport in norm  
- Cholesterol Biosynthesis 
4.132e-3  
Vascular development 
(Angiogenesis) 
- Transcription_Role of Akt in hypoxia induced HIF1 
activation  
- Transcription_Receptor-mediated HIF regulation  
- Development_FGFR signaling pathway 
3.414e-2  
Vitamin and cofactor 
metabolism and its 
regulation  
- Niacin-HDL metabolism 
- Folic acid metabolism  3.421e-2  
Mitogenic signaling  
- Development_IGF-1 receptor signalling 
- Development_EGFR signaling via PIP3  
- Development_FGFR signaling pathway  
- Development_EGFR signaling pathway  
- Development_Membrane-bound ESR1: interaction with 
growth factors signalling 
- Signal transduction_PTEN pathway 
- Development_HGF signaling pathway 
4.713e-2  
Apoptosis  
- Transcription_P53 signaling pathway  
- Development_Flt3 signaling 
- Apoptosis and survival_Role of CDK5 in neuronal death 
and survival 
- Apoptosis and survival_BAD phosphorylation 
- Apoptosis and survival_Anti-apoptotic action of Gastrin 
- Apoptosis and survival_HTR1A signalling  
5.423e-2  
Nuclear receptor 
signaling 
- Regulation of lipid metabolism_RXR-dependent 
regulation of lipid metabolism via PPAR, RAR and VDR 
- Development_Ligand-independent activation of ESR1 
and ESR2 
- Transcription_Androgen Receptor nuclear signalling  
- Transcription_PPAR Pathway  
7.081e-2  
Hematopoiesis  - Development_Flt3 signaling - Development_Thrombopoietin-regulated cell processes 9.665e-2  
Estrogen signaling 
- Development_Membrane-bound ESR1: interaction with 
growth factors signalling 
- Development_Ligand-independent activation of ESR1 
and ESR2  
1.094e-1  
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DNA-damage response 
- Transcription_P53 signaling pathway  
- DNA damage_Role of Brca1 and Brca2 in DNA repair  
- DNA damage_Brca1 as a transcription regulator  
- DNA damage_Nucleotide excision repair  
- Apoptosis and survival_BAD phosphorylation 
1.146e-1  
Tissue remodeling and 
wound repair  
- Development_EGFR signaling pathway  
- Development_EGFR signaling via PIP3  
- Development_HGF signaling pathway  
- Cytoskeleton remodeling_TGF, WNT and cytoskeletal 
remodelling  
1.183e-1  
Neurotransmission 
- Development_Dopamine D2 receptor transactivation of 
EGFR 
- Neurophysiological process_NMDA-dependent 
postsynaptic long-term potentiation in CA1 hippocampal 
neurons  
1.266e-1  
Immune system 
response  
- Immune response_BCR pathway  
- Immune response_IFN gamma signaling pathway  
- Immune response_Regulation of T cell function by 
CTLA-4  
- Immune response_IL-4 signaling pathway  
- Immune response_IL-2 activation and signaling pathway  
- Immune response_IL-15 signaling  
- Immune response_CD40 signaling  
1.380e-1  
Protein synthesis  
- Translation _Regulation activity of EIF2  
- Translation_Non-genomic (rapid) action of Androgen 
Receptor 
- Translation_Insulin regulation of translation 
- Translation _Regulation activity of EIF4F  
1.599e-1  
Androgen signaling  
- Translation_Non-genomic (rapid) action of Androgen 
Receptor  
- Transcription_Androgen Receptor nuclear signalling  
1.696e-1  
Inflammatory response 
- Immune response_Gastrin in inflammatory response 
- Immune response_CCR5 signaling in macrophages and 
T lymphocytes  
1.860e-1  
Energy metabolism and 
its regulation  
- Regulation of lipid metabolism_RXR-dependent 
regulation of lipid metabolism via PPAR, RAR and VDR 
- Regulation of lipid metabolism_Insulin regulation of 
glycogen metabolism  
- Regulation of lipid metabolism_Insulin regulation of fatty 
acid methabolism  
1.982e-1  
Myogenesis regulation  
- Development_EDG5 and EDG3 in cell proliferation and 
differentiation 
- Development_Role of HDAC and calcium/calmodulin-
dependent kinase (CaMK) in control of skeletal 
myogenesis 
2.366e-1  
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Nucleotide metabolism 
and its regulation  - CTP/UTP metabolism  3.040e-1  
Cell cycle and its 
regulation  
- Cell cycle_Start of DNA replication in early S phase 
- Apoptosis and survival_nAChR in apoptosis inhibition 
and cell cycle progression 
- Cell cycle_Role of Nek in cell cycle regulation 
- Cell cycle_Transition and termination of DNA replication 
3.339e-1  
Vasodilation  - Development_A2A receptor signaling  3.614e-1  
Calcium signaling  
- Transcription_CREB pathway  
- Signal transduction_IP3 signaling  
- Signal transduction_PKA signaling  
3.886e-1  
Cardiac Hypertrophy  - Development_PIP3 signaling in cardiac myocytes  4.066e-1  
Oxidative stress 
regulation  
- Development_Dopamine D2 receptor transactivation of 
EGFR  4.140e-1  
Cell differentiation  
- Development_Regulation of epithelial-to-mesenchymal 
transition (EMT)  
- Development_TGF-beta-dependent induction of EMT 
via RhoA, PI3K and ILK. 
- Development_Beta-adrenergic receptors regulation of 
ERK  
4.175e-1  
Cystic fibrosis disease  - Cholesterol and Sphingolipids transport / Recycling to plasma membrane in lung (normal and CF)  5.200e-1  
Vasoconstriction  
- Cytoskeleton remodeling_Alpha-1A adrenergic receptor-
dependent inhibition of PI3K 
- Immune response_HTR2A-induced activation of cPLA2 
- Transport_Alpha-2 adrenergic receptor regulation of ion 
channels 
- Development_EDNRB signaling 
- Muscle contraction_ACM regulation of smooth muscle 
contraction 
5.792e-1  
Aminoacid metabolism 
and its regulation  - Histidine-glutamate-glutamine metabolism 5.928e-1  
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Table 1 
Significantly altered genes in zebrafish adult male after exposure to 2.2 μg/L and 890 μg/L EHMC (GeneSpring 
GX 11 adjusted p<0.05 and adjusted Fold Change≥2). 
  
 Agilent ID 
  
Gene Symbol GenBank Accession Regulation Fold change (log2) 
3 μg/L 3000 μg/L 
A_15_P201331 ankzf1 BC090778 down 4.25 4.27 
A_15_P187481 LOC572483 XM_001922419 up 2.31 2.35 
A_15_P118515 ptgds NM_213634 up 3.36 5.83 
A_15_P131446  L48874 down 3.53 2.00 
A_15_P178126 top2b NM_001045191 down 2.62 4.13 
A_15_P426955  CT713922 down 2.23 2.80 
A_15_P224196   up 3.82 2.93 
A_15_P398495 pcsk5b NM_001083829 down 2.41 3.01 
A_15_P103847 zgc:136383 NM_001045294 down 7.55 5.81 
A_15_P349790 si:dkey-228a15.3 NM_001128533 down 3.36 3.29 
A_15_P515257   down 35.79 7.96 
A_15_P180906   up 5.21 3.02 
A_15_P110272 LOC100149222 BC151959 down 2.63 5.10 
A_15_P199381 LOC793259 XM_001332950 down 2.77 3.47 
A_15_P325751  CT706689 down 2.83 3.01 
A_15_P170916 arhgef11 NM_001031840 down 2.19 2.69 
A_15_P161071 zgc:153253 NM_001160823 up 2.04 2.07 
A_15_P118059 zgc:101566 NM_001005996 up 5.27 3.56 
A_15_P309431  DT059977 up 2.96 3.39 
A_15_P109473 gdf6a NM_001159994 up 2.31 2.24 
A_15_P159781 CH211-209N20.1 XM_001920619 down 2.80 17.33 
A_15_P106118 zgc:110222 NM_001017643 up 2.00 2.52 
A_15_P212111  BC076429 down 2.05 3.30 
A_15_P106147  CO354205 down 10.52 6.67 
A_15_P168216 si:dkey-261h15.1 NM_001080159 down 3.40 2.85 
A_15_P115758 si:ch211-240l19.8 NM_001082930 up 2.33 2.47 
A_15_P535007   down 3.72 2.32 
A_15_P600377   down 2.97 2.25 
A_15_P225051   down 13.17 25.10 
A_15_P184996 dsc2l BC124676 down 2.45 2.40 
A_15_P179486 LOC566408 BC151988 down 3.23 2.83 
A_15_P170386 si:dkey-4c15.14 NM_001089575 up 2.74 2.40 
A_15_P133416 dnmt1 BC044335 down 3.36 4.37 
A_15_P120419 rbp2a AF363957 down 33.75 12.87 
A_15_P109079 ddefl1 NM_001039992 down 2.39 2.32 
A_15_P160886 rpa2 NM_131711 up 2.38 2.19 
A_15_P472850   up 19.92 8.22 
A_15_P101803 zgc:172075 NM_001114408 up 2.51 2.73 
A_15_P584632  AL927245 up 4.06 8.47 
Appendix 3 
201 
A_15_P193121 edn1 NM_131519 up 2.49 2.37 
A_15_P592857 wu:fj32b02 XM_683842 down 2.06 3.00 
A_15_P197261  BC154509 up 6.83 5.03 
A_15_P190501 thoc2 NM_001003847 down 2.22 4.25 
A_15_P136451 atp2b1b NM_001135631 down 2.35 2.72 
A_15_P351055  CT647711 down 4.18 5.49 
A_15_P243131 LOC100007935 XM_001346234 up 3.05 2.64 
A_15_P100991 zgc:55398 NM_201048 up 2.72 2.35 
A_15_P490392 LOC556882 XM_001919832 down 2.03 2.11 
A_15_P102120 foxq1 NM_212907 up 3.08 3.03 
A_15_P110501 tbcb NM_212775 up 8.27 7.43 
A_15_P552127 znf41 BC090732 down 2.99 3.00 
A_15_P167706  XM_001921641 down 3.63 4.48 
A_15_P173511 si:ch211-238n5.4 NM_001044347 up 2.71 2.49 
A_15_P238716 top2b NM_001045191 down 2.35 4.00 
A_15_P225386   down 3.82 2.16 
A_15_P441420   down 2.44 3.10 
A_15_P155176 ggct NM_213005 up 2.92 2.37 
A_15_P429435 DKEY-45K15.2 NM_001144794 down 2.34 2.12 
A_15_P120249 fgf13 NM_001007399 up 3.21 2.96 
A_15_P456985  EB973958 up 2.46 2.70 
A_15_P209466 slc35f2 NM_001076556 up 4.71 5.04 
A_15_P390035  CT619466 down 6.64 3.91 
A_15_P207781 gle1l NM_001003885 down 2.15 2.37 
A_15_P409440 zgc:162618 NM_001089331 up 2.72 7.93 
A_15_P440410  XM_001336957 down 2.45 4.09 
A_15_P407120 CH211-15B7.4 NM_001126472 up 3.45 4.89 
A_15_P339525   down 3.26 6.45 
A_15_P236606 mef2ca NM_131312 down 3.43 3.98 
A_15_P255401   down 3.66 2.59 
A_15_P554702   down 3.45 3.12 
A_15_P176881  BC096935 down 3.48 5.61 
A_15_P100747 zgc:103434 NM_001006037 down 2.85 3.04 
A_15_P229956  EB981970 up 8.42 3.59 
A_15_P309736 f3a BC154033 down 2.50 2.80 
A_15_P150711 itgav NM_001033721 up 2.85 2.21 
A_15_P266611  CK015994 up 2.07 2.15 
A_15_P184576 si:dkey-221h15.4 XM_687310 up 2.40 2.68 
A_15_P397815  EH433662 up 6.23 4.95 
A_15_P131516 hoxa13b NM_131194 up 2.13 2.32 
A_15_P105414 zgc:195155 NM_001128687 up 2.03 2.19 
A_15_P101233 si:dkey-103i16.2 NM_001044974 up 4.34 3.47 
A_15_P499802 LOC566173 BC152290 up 2.34 2.50 
Chapter 5 
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A_15_P416305 zgc:101867 NM_001008590 up 3.35 2.63 
A_15_P144361 tppp3 NM_201335 up 2.28 2.32 
A_15_P113187   up 2.16 2.12 
A_15_P102389 wu:fb70b03 EE319212 up 8.13 9.01 
A_15_P211851 vasn NM_001018131 up 5.21 5.82 
A_15_P287801 LOC558930 XM_682219 up 2.44 2.63 
A_15_P107010 sult1st1 NM_182941 up 2.01 2.41 
A_15_P186906  BC092801 down 2.94 2.54 
A_15_P164881 znf41 BC155766 down 4.04 4.38 
A_15_P441545 LOC566344 XM_689616 down 3.15 3.84 
A_15_P171941 zgc:163047 NM_001089564 down 2.59 2.37 
A_15_P241111 LOC797162 XM_001337584 down 3.07 4.36 
A_15_P134556 ptenb NM_001001822 down 2.51 3.07 
A_15_P182186 nfe2l3 NM_213231 down 2.11 2.21 
A_15_P227846   down 3.33 2.01 
A_15_P223676   up 2.63 2.06 
A_15_P288191   down 3.86 2.08 
A_15_P278901   down 4.75 2.88 
A_15_P179987 or137-5 NM_001130804 up 4.21 5.77 
A_15_P144141   down 3.38 2.32 
A_15_P423850  CT675248 down 3.19 2.15 
A_15_P567152 akap1b NM_001098179 down 2.23 2.64 
A_15_P152216 vox NM_131698 down 5.39 2.93 
A_15_P159721   down 2.12 3.46 
A_15_P305781   down 2.99 2.20 
A_15_P105319   down 3.23 2.38 
A_15_P272866   down 3.07 2.58 
A_15_P104528 stm NM_198817 up 2.86 2.83 
A_15_P134231 xpc NM_001045210 down 2.17 3.03 
A_15_P582987  BQ262605 down 4.59 3.82 
A_15_P535372   down 2.23 2.17 
A_15_P355255  CT707445 down 11.08 12.52 
A_15_P189811 si:ch211-218o21.2 NM_001123234 down 2.79 4.04 
A_15_P199851 wu:fc18f06 XM_687839 up 5.17 5.45 
A_15_P106063   down 3.04 2.20 
A_15_P162001 rnd3b NM_001002591 up 2.12 2.41 
A_15_P154431 LOC100004902 BC115073 up 4.45 3.97 
A_15_P144301 zgc:195027 NM_001130634 down 3.01 2.48 
A_15_P443450 DKEY-221J11.2 XM_688722 up 3.62 3.49 
A_15_P100039   up 4.02 4.33 
A_15_P205056 ftr72 NM_001007387 down 2.95 3.07 
A_15_P109375 LOC559157 XM_001919279 up 2.53 2.49 
A_15_P181246   up 2.89 3.79 
Appendix 3 
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A_15_P399015   down 3.91 2.54 
A_15_P239061   up 2.10 2.99 
A_15_P410955   down 3.42 2.11 
A_15_P130046  XM_690666 down 3.73 9.13 
A_15_P203161  XM_680029 up 3.05 4.08 
A_15_P400835 LOC556013 XM_678703 down 2.49 2.85 
A_15_P365850 ptgs2b NM_001025504 up 2.48 2.56 
A_15_P181026  XM_685788 down 2.14 2.11 
A_15_P346915   down 4.31 4.96 
A_15_P100735 hoxb6b NM_131538 up 3.57 3.48 
A_15_P141281 LOC100002334 NM_001098260 up 3.25 3.12 
A_15_P145796  BC100005 down 2.06 3.11 
A_15_P120256 btg4 BC053242 up 2.26 3.36 
A_15_P156841  EH585602 up 3.49 5.64 
A_15_P217661   down 2.01 2.23 
A_15_P176566 zgc:103736 NM_001013446 up 3.84 3.49 
A_15_P104449 npy8br NM_131436 down 3.16 3.09 
A_15_P190706 cxcl14 NM_131627 up 3.08 2.91 
A_15_P119543 rab3d NM_001145597 down 3.06 2.17 
A_15_P172886 zgc:66109 NM_200559 down 2.03 3.43 
A_15_P484810  XM_687344 down 2.28 2.51 
A_15_P597332  AI204746 down 3.02 2.16 
A_15_P200391 setdb2 NM_207058 up 4.30 2.30 
A_15_P141116 ctdsplb NM_001076615 down 2.31 3.15 
A_15_P568827  XM_685280 down 3.06 7.01 
A_15_P230116 wu:fc18f06 EB992434 up 2.47 2.62 
A_15_P135746 LOC571244 XM_001919024 up 3.50 5.71 
A_15_P558047  EH547031 down 4.73 2.03 
A_15_P147381 LOC560957 XM_684355 up 2.69 2.44 
A_15_P255941  CT725570 down 2.75 2.52 
A_15_P112432 nbas NM_001044807 down 3.61 3.05 
A_15_P121256 LOC798718 XM_001923006 down 2.82 2.55 
A_15_P133521 zgc:66125 NM_200823 down 4.08 3.95 
A_15_P368605 thbs1 XM_685303 up 2.03 2.53 
A_15_P172876 lbx2 NM_001007134 up 3.98 2.92 
A_15_P108326   down 2.58 2.22 
A_15_P417790   down 4.95 5.03 
A_15_P179011 hamp1 NM_205583 up 8.25 5.24 
A_15_P190576 LOC556714 XM_679585 up 2.95 3.82 
A_15_P134521 frap1 NM_001077211 down 2.99 3.91 
A_15_P105833 znf143 BC124735 down 3.13 2.98 
A_15_P283261   up 5.41 3.85 
A_15_P130591 fgfr1a NM_152962 down 3.02 4.62 
Chapter 5 
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A_15_P166066 LOC100150979 XR_044871 down 4.47 6.08 
A_15_P309586 LOC573743 XM_001922667 down 2.30 2.25 
A_15_P121123 mitfa NM_130923 up 2.22 2.02 
A_15_P134781 plp1a NM_175576 down 2.58 3.69 
A_15_P161296 sp8 NM_213241 up 4.17 3.68 
A_15_P118368   down 4.20 2.22 
A_15_P211753 LOC571647 NM_001109718 up 5.95 5.55 
A_15_P178051  BC129436 down 2.74 2.09 
A_15_P591527  CO925666 down 2.32 2.54 
A_15_P310471 sgca XM_680178 up 2.22 2.58 
A_15_P568757   down 3.15 6.82 
A_15_P410745 LOC565583 CO934890 up 2.37 2.54 
A_15_P162446 usp22 NM_001045248 down 5.68 3.40 
A_15_P448415  EH447279 down 3.35 6.73 
A_15_P144841   down 3.15 5.85 
A_15_P538917   down 4.67 6.38 
A_15_P182231 si:dkey-151c10.1 NM_001100032 down 2.97 3.33 
A_15_P514017   down 3.71 2.69 
A_15_P103134 zgc:110540 NM_001014352 up 2.47 2.68 
A_15_P208991 il17rd NM_153660 up 2.45 2.55 
A_15_P184876 si:ch211-57i17.5 XM_688399 up 4.45 2.76 
A_15_P106551 nucks1 NM_001004601 down 2.44 4.24 
A_15_P166541 im:7138263 AB247648 up 4.27 5.09 
A_15_P378340 im:6894757 BC115086 up 2.59 2.41 
A_15_P238121 skp2 NM_001082837 up 3.56 3.04 
A_15_P207326 zgc:153637 NM_001077457 down 4.59 3.46 
A_15_P119909 tln2 BC055166 down 2.33 2.81 
A_15_P178271 rexo1 NM_001126416 down 2.17 3.24 
A_15_P532767   up 3.80 3.77 
A_15_P329226  CT665069 down 3.83 2.36 
A_15_P103667 si:busm1-136d19.2 NM_001005312 up 2.82 4.12 
A_15_P540367 bbs7 NM_001077145 down 2.40 2.40 
A_15_P103392 LOC100148098 XM_001923612 up 3.16 2.86 
A_15_P111238 nitr3a NM_001007203 up 2.85 4.08 
A_15_P100416 LOC100001774 BC076251 up 3.31 2.04 
A_15_P152291 LOC561381 NM_001044958 up 10.68 6.74 
A_15_P101461 si:ch211-240l19.7 NM_001082929 up 4.78 13.16 
A_15_P208376 g12 NM_131335 up 2.36 2.46 
A_15_P102830 hspb7 NM_001006040 up 2.36 2.24 
A_15_P159361 LOC567778 XM_691079 up 2.62 2.86 
A_15_P201486 si:ch211-219a4.6 BC129404 down 2.01 3.70 
A_15_P116585  AL717593 down 3.78 4.75 
A_15_P445490 usp22 NM_001045248 down 3.52 2.57 
Appendix 3 
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A_15_P102850 glra4a NM_131782 up 3.75 4.23 
A_15_P181131   up 3.22 3.35 
A_15_P187676 LOC100001520 XM_001341462 up 4.86 3.09 
A_15_P107437 synpr NM_001004532 up 7.14 3.90 
A_15_P224541   up 2.31 2.27 
A_15_P275231 lrrc15 NM_001080682 up 3.33 2.67 
A_15_P389740  CT701002 down 19.85 10.17 
A_15_P565842 dhx37 NM_001083004 down 3.02 3.36 
A_15_P134261 ttnb BC090540 down 5.59 4.27 
A_15_P227186   down 3.03 8.80 
A_15_P421875   down 3.31 2.07 
A_15_P216876   down 2.76 2.36 
A_15_P178381  BC135030 down 2.49 4.84 
A_15_P399615 zgc:162150 NM_001110481 up 4.03 4.81 
A_15_P145596 ppm1f AB113301 down 32.28 8.17 
A_15_P210881 zgc:101848 NM_001005966 down 2.14 2.25 
A_15_P364890 mybl2 NM_001003867 up 2.45 2.54 
A_15_P395230 id:ibd2611 EE704940 up 3.15 2.69 
A_15_P355430   down 4.09 2.34 
A_15_P294351   down 10.82 6.90 
A_15_P120601 nos2a NM_001104937 up 3.24 3.08 
A_15_P469530   up 9.08 7.46 
A_15_P201191 itga6 NM_001144781 up 2.04 2.34 
A_15_P190496 thoc2 NM_001003847 down 3.16 3.11 
A_15_P491602 ercc1 NM_001103138 up 2.22 2.21 
A_15_P106487 zgc:162523 NM_001089561 down 3.83 5.26 
A_15_P178481 sart3 NM_001030118 down 2.74 3.51 
A_15_P104409 pcna NM_131404 up 2.06 2.18 
A_15_P134026 uba52 BC076111 down 2.52 2.52 
A_15_P115140  BM026700 down 3.64 2.76 
A_15_P167751 ctcf NM_001001844 down 2.04 4.91 
A_15_P118928  XM_001340479 down 4.76 2.88 
A_15_P321711   up 10.40 6.92 
A_15_P362840 LOC100149042 XM_001923904 up 9.05 3.52 
A_15_P101051 tchp NM_001040343 down 2.37 2.76 
A_15_P192406  BC090414 down 4.03 7.31 
A_15_P117168  XM_692864 down 2.48 2.75 
DCP_1_4    down 2.43 2.74 
A_15_P119243 mafba NM_131015 down 2.11 2.30 
A_15_P173461 zgc:153239 NM_001075112 down 2.07 2.39 
A_15_P382680   down 3.60 2.22 
A_15_P390845   down 2.92 3.00 
A_15_P162161 lmo2 NM_131111 up 2.49 2.10 
Chapter 5 
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A_15_P431930   down 2.97 2.91 
A_15_P187641  BC115093 down 2.73 3.75 
A_15_P331171 anxa1a NM_181758 up 3.93 3.30 
A_15_P582292 foxq1 NM_212907 up 2.98 2.76 
A_15_P266951 zgc:110727 NM_214782 up 2.65 2.28 
A_15_P184551 si:dkey-221h15.2 NM_001045025 up 3.50 2.75 
A_15_P203477  BC154745 up 2.50 2.07 
A_15_P110557 epn1 NM_213362 down 2.63 2.63 
A_15_P153656 dgat2 NM_001030196 down 2.11 2.25 
A_15_P446835   up 7.32 6.00 
A_15_P138971   up 6.51 4.67 
A_15_P133001 freqb NM_001020514 up 2.37 2.05 
A_15_P117390 LOC100007076 XM_001345596 down 3.18 4.76 
A_15_P473640 zgc:158364 NM_001089409 up 4.09 4.80 
A_15_P290831 sema4g XM_001921388 down 2.00 4.55 
A_15_P552892 zgc:174896 NM_001110412 up 2.85 2.14 
A_15_P134366 taf2 NM_001003835 down 2.05 3.05 
A_15_P256551 crb3b NM_001045323 up 2.51 2.40 
A_15_P158448 LOC100150616 XM_001921334 up 9.93 4.01 
A_15_P571112 LOC557544 DT876649 up 5.27 5.33 
A_15_P227811   down 17.25 6.25 
A_15_P203731 zgc:66117 NM_199560 up 2.45 2.12 
A_15_P120815  BC065887 up 7.59 6.96 
A_15_P225991   up 5.13 4.01 
A_15_P117301 LOC553499 BC077098 down 3.08 3.21 
A_15_P158571 tln1 NM_001009560 down 2.57 2.16 
A_15_P107284 si:dkey-69h6.7 NM_001100015 down 3.72 2.97 
A_15_P188626 LOC100149222 BC151959 down 2.02 2.27 
A_15_P481815  CT610756 down 4.18 2.14 
A_15_P277851  XM_001343661 up 2.43 3.16 
A_15_P190721 ppargc1b XM_678566 down 2.05 2.40 
A_15_P278586   up 2.43 2.88 
A_15_P161656 itgb3b NM_001082948 up 4.66 3.82 
A_15_P131747 foxb1.1 NM_131283 up 2.08 3.30 
A_15_P113732 LOC564883 XM_688207 up 3.40 3.89 
A_15_P107408 acpl2 NM_001002430 down 2.63 4.75 
A_15_P222111   down 3.95 3.36 
A_15_P347895 top1l NM_001044324 down 2.26 4.09 
A_15_P590552 wu:fa56c05 AA658707 down 7.05 5.91 
A_15_P108387 baz1a BC081390 down 2.06 2.60 
A_15_P119002 pcdh10a NM_212571 up 2.03 2.38 
A_15_P182446  BC134117 down 3.56 4.38 
A_15_P245696  EH433136 down 5.18 2.62 
Appendix 3 
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A_15_P104390 sp8l NM_205550 up 3.49 3.31 
A_15_P542267 myom1a NM_001161340 down 2.10 2.21 
A_15_P463155  AI522379 down 2.34 3.96 
A_15_P117331 srrm2 BC071371 down 2.68 3.87 
A_15_P329166  CT708252 down 9.71 8.90 
A_15_P293056   up 2.20 2.71 
A_15_P578427 ccdc25 NM_200388 up 2.73 2.02 
A_15_P120199  CA472755 up 2.18 2.36 
A_15_P308321 LOC795147 XM_001335221 up 2.59 2.49 
A_15_P101193 mxi1 NM_131237 down 3.12 4.10 
A_15_P178601  BC142784 down 5.18 4.04 
A_15_P339545   down 2.28 2.01 
A_15_P160161 LOC571171 XM_694737 up 5.37 4.68 
A_15_P498172 LOC100006752 BC154669 up 4.25 2.24 
A_15_P550422 jmjd5 NM_001109869 up 3.32 2.28 
A_15_P150471 defbl2 NM_001081554 up 4.01 3.19 
A_15_P193756 fzd8b NM_131553 up 2.53 2.18 
A_15_P114909 zfand5b NM_200949 up 4.64 2.19 
A_15_P596927  XM_680992 down 2.26 2.13 
A_15_P185551 lepr NM_001113376 down 3.70 4.64 
A_15_P271926   up 2.90 2.88 
A_15_P102241 LOC100002224 XM_001922426 down 2.72 3.12 
A_15_P120214  XM_001341599 down 3.40 4.29 
A_15_P109915 aqp4 NM_001003749 down 2.30 4.67 
A_15_P137333   down 2.99 4.41 
A_15_P245326   down 4.25 11.41 
A_15_P181996   down 2.67 2.79 
A_15_P180711 LOC564655 XM_001921843 up 3.08 3.79 
A_15_P385965   down 3.80 2.26 
A_15_P109098 zgc:66286 AF434191 up 2.28 2.00 
A_15_P104923   down 3.69 2.68 
A_15_P161366 zgc:101810 NM_001007772 up 2.24 2.41 
A_15_P145076 si:busm1-112p11.1 NM_001030081 down 2.18 2.68 
A_15_P313936  CT650977 down 2.90 2.25 
A_15_P353410  CT673553 down 4.78 2.87 
A_15_P289901   down 3.38 5.84 
A_15_P177736 ubr5 NM_001164394 down 2.25 2.48 
A_15_P103192 foxi1 NM_181735 up 3.85 3.61 
A_15_P451615 LOC100008030 XM_001346311 up 4.29 4.10 
A_15_P118474 LOC556422 XM_679236 up 2.88 2.02 
A_15_P166866 ttll6 NM_001105524 down 3.00 3.10 
A_15_P543067   down 2.97 2.93 
A_15_P115391 zgc:165343 NM_001080178 up 3.52 2.59 
Chapter 5 
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A_15_P105740  BI880356 down 2.13 2.23 
A_15_P119120 sh3gl1b NM_201497 down 2.17 2.17 
A_15_P192346 si:ch211-244p18.3 NM_001045119 down 2.87 3.64 
A_15_P110858 zgc:100942 NM_001003626 down 2.19 2.02 
A_15_P286426   down 2.76 3.87 
A_15_P204216   up 2.20 2.11 
A_15_P291636  XM_001333200 down 2.33 4.37 
A_15_P103929 zgc:92480 NM_001003485 up 2.60 2.20 
A_15_P185721 rhcg2a NM_001102618 up 3.29 2.31 
A_15_P117430   up 2.74 3.54 
A_15_P489717 alx4 XM_001340930 up 4.61 3.67 
A_15_P166516 LOC561765 BC155848 up 4.45 2.79 
A_15_P420305   down 2.39 4.31 
A_15_P534667   up 2.07 2.01 
A_15_P197596 LOC799375 XM_001339703 up 5.81 5.02 
A_15_P461055 LOC796235 XM_001336503 up 4.26 9.34 
A_15_P410375 mxra8a NM_001080582 down 2.14 3.33 
A_15_P185706   down 4.43 2.34 
A_15_P414300 pcsk5b NM_001083829 down 2.61 2.86 
A_15_P106187 zgc:92074 NM_205743 down 2.47 2.36 
A_15_P101148   down 2.44 3.59 
A_15_P217756  EB839799 down 5.07 12.93 
A_15_P120947   up 3.50 3.28 
A_15_P170381 ism2 NM_001020509 down 2.61 3.98 
A_15_P179471 LOC100001772 BC152007 down 2.07 2.61 
A_15_P441185   up 2.69 2.52 
A_15_P105231 LOC795659 BC095223 up 3.02 3.23 
A_15_P158421 LOC100001854 BC092865 up 16.76 5.07 
A_15_P600452   down 8.65 8.73 
A_15_P192226 jag2 NM_131665 down 2.49 2.20 
A_15_P302331 wu:fe05a04 XM_001345774 down 3.36 4.73 
A_15_P197391 vrk2 NM_201170 down 3.25 2.50 
A_15_P212351  BC094972 down 3.12 3.28 
A_15_P166006   down 4.63 4.14 
A_15_P259416   up 3.17 2.50 
A_15_P238176   up 6.23 6.46 
A_15_P152346 atp2a2a NM_200965 up 3.28 2.20 
A_15_P315396  CT618869 up 3.26 4.19 
A_15_P189876 si:dkey-220o5.4 BC093315 up 3.46 2.42 
A_15_P109217  BC122103 up 2.29 2.23 
A_15_P167701  XM_001921641 down 2.20 2.38 
A_15_P133346 cryabb NM_001002670 up 6.86 3.08 
A_15_P105778 igfbp1a NM_173283 up 2.76 2.26 
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A_15_P145431 ca4a NM_001114407 down 2.64 6.08 
A_15_P115912   down 2.01 2.37 
A_15_P101034 snn NM_213046 down 2.37 3.52 
A_15_P106750  CT668573 down 2.36 2.48 
A_15_P388595  CT617386 down 4.85 2.48 
A_15_P541757   up 2.31 2.27 
A_15_P166661 zgc:172248 NM_001113599 up 2.76 2.44 
A_15_P218851 efnb1 CU638799 down 2.82 8.32 
A_15_P150026 rbm25 NM_199790 down 5.51 19.53 
A_15_P130831 hoxa10b NM_131155 up 2.28 2.04 
A_15_P101168 t2gtl56 AB175329 down 4.70 7.27 
A_15_P161406 zgc:194556 NM_001023572 down 2.26 2.02 
A_15_P119205 igf2bp3 NM_131491 down 2.27 2.51 
A_15_P186641 LOC570897 NM_001114441 up 3.49 2.89 
A_15_P105544 smyd1b NM_001039636 up 2.13 2.25 
A_15_P195951 si:ch211-196l7.3 NM_001083096 down 2.39 2.68 
A_15_P370975  CT612918 down 3.90 2.27 
A_15_P430940   up 4.24 3.60 
A_15_P335334 si:dkey-85n7.4 XM_691298 up 3.72 3.02 
A_15_P514827 anxa1b NM_181759 up 3.66 3.34 
A_15_P113289 jph1b NM_001044348 down 4.78 6.65 
A_15_P539282   down 3.77 2.66 
A_15_P113646   down 3.53 4.82 
A_15_P138231 si:dkey-121a9.3 NM_001099256 up 2.84 3.08 
A_15_P268831 CH211-259K16.3 XM_684103 down 3.37 6.58 
A_15_P443355   down 3.86 2.98 
A_15_P104637   up 2.84 2.00 
A_15_P101217 acta1 AI964279 down 2.92 2.22 
A_15_P109872  DQ869310 down 2.88 2.64 
A_15_P189576   down 2.53 3.11 
A_15_P308616 sb:cb69 CB333781 up 3.17 2.25 
A_15_P303071 LOC570082 XM_693515 down 4.23 5.48 
A_15_P197751 nin BC135044 down 2.22 3.39 
A_15_P100200  BC083467 down 5.80 4.06 
A_15_P184081  BC090739 down 2.02 4.17 
A_15_P107314 hoxb6a NM_131119 down 2.14 2.12 
A_15_P239316 LOC566775 XM_001922115 up 2.27 2.91 
A_15_P157041  BC091815 down 2.79 3.33 
A_15_P110740   down 57.61 9.62 
A_15_P176766 zgc:165650 NM_001100149 down 2.92 3.00 
A_15_P275951   up 2.05 2.27 
A_15_P113217 orai1 NM_205600 down 3.31 3.25 
A_15_P176941 ktn1 NM_200081 down 3.72 3.44 
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A_15_P137336   down 2.45 3.13 
A_15_P341850 lin37 NM_001017888 up 2.22 2.17 
A_15_P113584   up 2.65 2.15 
A_15_P375100 si:ch211-240l19.7 NM_001082929 up 2.36 4.01 
A_15_P112482   up 2.35 2.01 
A_15_P119038 myf6 NM_001003982 up 7.70 4.58 
A_15_P170951 zgc:163000 NM_001082864 up 6.91 6.66 
A_15_P110719 slc4a4b XM_685028 down 3.24 4.27 
A_15_P450585   down 2.38 2.32 
A_15_P110061   up 2.97 3.90 
A_15_P597232 wu:fk57a03 EH995454 down 3.77 2.13 
A_15_P141581 zgc:136571 NM_001045263 down 4.08 3.65 
A_15_P302581   down 6.70 4.73 
A_15_P146401 LOC568671 XM_692016 up 4.15 3.45 
A_15_P219476 slc2a15b NM_001020494 up 3.00 3.43 
A_15_P354645  CT693264 down 2.45 2.44 
A_15_P147096 zfr NM_199558 down 3.09 4.87 
A_15_P603772   down 2.44 2.16 
A_15_P177306 taf3 NM_001042744 down 2.07 2.72 
A_15_P206906 wnt7a NM_001025540 up 4.36 5.38 
A_15_P221496 foxq1 NM_212907 up 3.83 3.86 
A_15_P134221 kiaa0261 BC090473 down 3.62 3.18 
A_15_P475655   up 3.21 2.58 
A_15_P272306 cpb1 NM_001110021 up 8.79 8.35 
A_15_P379795 fancl NM_212982 up 2.04 2.79 
A_15_P113865 grid2 NM_001004123 down 2.59 4.27 
A_15_P208301 atf7a NM_001030205 down 2.62 4.61 
A_15_P197381 LOC557043 XM_680019 up 3.51 2.47 
A_15_P134551 thoc2 NM_001003847 down 3.24 3.18 
A_15_P140511 gnptab BC133107 down 2.72 2.91 
A_15_P199896  BC057484 down 2.23 3.72 
A_15_P179111 LOC792773 BC151895 down 2.36 2.67 
A_15_P172146 si:dkey-121a9.3 NM_001099256 up 3.04 2.75 
A_15_P155686 zgc:172197 NM_001114925 down 2.63 2.41 
A_15_P115524 LOC559981 XM_683371 down 2.29 3.35 
A_15_P141721 zgc:113363 NM_001123302 down 2.38 2.32 
A_15_P601437   down 2.22 4.84 
A_15_P221646   down 6.72 6.68 
A_15_P115933 unk NM_200236 down 3.43 2.12 
A_15_P322176   down 2.45 2.15 
A_15_P134501 arl13b NM_173272 down 2.73 3.67 
A_15_P441355   down 4.85 2.37 
A_15_P520792   up 2.77 3.39 
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A_15_P350655   down 3.07 2.93 
A_15_P162651 tmem54 NM_001044716 down 3.64 7.54 
A_15_P118446 zgc:123203 NM_001037580 up 6.97 3.55 
A_15_P352405  CT677687 down 3.86 2.16 
A_15_P185481 LOC100148397 BC134195 down 3.85 3.58 
A_15_P119760 LOC100149829 BC091928 up 3.31 2.76 
A_15_P374845   up 2.12 2.42 
A_15_P161051 zgc:153278 NM_001045434 down 2.11 2.77 
A_15_P131656 cel.2 AF003943 up 2.06 3.37 
A_15_P495822   up 8.70 4.66 
A_15_P490582 LOC793282 XM_001332970 down 3.83 4.71 
A_15_P472310   down 2.00 2.18 
A_15_P579977   down 2.24 2.10 
A_15_P144621  XM_001919509 down 5.02 11.58 
A_15_P137721  XM_692723 down 2.76 3.31 
A_15_P167016 LOC799514 BC124167 down 2.10 4.92 
A_15_P205136 cldnb NM_131763 up 2.46 2.78 
A_15_P211841 gadd45b NM_213031 up 6.98 3.06 
A_15_P232456   down 3.16 2.14 
A_15_P109820 si:ch211-51m24.3 NM_001044858 down 2.04 3.29 
A_15_P117020 tcf12 NM_214816 down 2.63 2.77 
A_15_P111428 traf7  up 2.32 2.36 
A_15_P157371 LOC553505 BC092720 down 2.15 3.07 
A_15_P119804 zgc:136894 NM_001045303 down 2.06 2.86 
A_15_P102042  CF266409 down 2.55 4.31 
A_15_P255186  CT594166 down 2.16 2.32 
A_15_P401760   down 3.23 2.43 
A_15_P103720   up 4.04 2.94 
A_15_P186911 LOC556557 XM_679384 up 8.24 5.43 
A_15_P198746  BC090523 down 3.09 3.29 
A_15_P154551 LOC100148585 XM_001921436 down 2.12 3.27 
A_15_P237781 zgc:163064 NM_001089510 down 2.82 3.77 
A_15_P530182   up 2.33 2.81 
A_15_P312580   down 2.78 2.51 
A_15_P198841 myom1a NM_001161340 down 2.11 4.73 
A_15_P112737   up 3.24 2.15 
A_15_P512792 im:7158733 XM_001922324 up 2.10 2.02 
A_15_P106284 wasla NM_001083006 down 2.40 2.22 
A_15_P384995  CT625844 down 3.20 2.09 
A_15_P157636  XM_687425 up 3.72 2.13 
A_15_P306181   up 2.79 2.39 
A_15_P469045   down 7.06 5.21 
A_15_P311906 marveld2b NM_001126406 up 2.18 2.58 
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A_15_P104834 zgc:162825 NM_001089526 up 2.98 3.96 
A_15_P104962   down 2.95 3.03 
A_15_P452665  EB974833 up 5.37 5.82 
A_15_P188116 zgc:66419 NM_201111 down 3.44 4.64 
A_15_P179656 zgc:174938 NM_001105700 up 2.90 4.15 
A_15_P329971  CT694479 up 4.22 4.09 
A_15_P316916 slc38a4 NM_001005944 down 6.37 5.68 
A_15_P286291 si:ch211-196f5.2 NM_001044802 up 4.48 4.19 
A_15_P213161 zgc:153663 BC122368 down 11.76 36.04 
A_15_P102457 LOC565839 XM_689101 down 2.05 2.95 
A_15_P562167 LOC100149829 BC091928 up 7.26 6.44 
A_15_P176046 zgc:112303 NM_001030159 down 2.43 2.24 
A_15_P336340 zgc:66117 NM_199560 up 2.60 2.25 
A_15_P206781 p2rx3b NM_198986 up 2.29 2.82 
A_15_P310341 LOC100006622 XM_001345278 up 2.74 3.04 
A_15_P114825 zgc:112450 NM_001020700 down 2.80 2.06 
A_15_P422405   down 5.56 6.81 
A_15_P203556 ezrl NM_001020490 down 2.36 6.08 
A_15_P340035   down 4.75 2.23 
A_15_P597172 LOC100149324 XM_001920205 up 3.25 3.38 
A_15_P101232 slc31a1 NM_205717 down 2.00 2.28 
A_15_P171671 slc1a4 NM_001002513 up 3.66 4.69 
A_15_P180531 zgc:101080 NM_001003568 up 2.11 2.38 
A_15_P177431  BC122132 down 2.99 3.99 
A_15_P176771 cx30.9 NM_001007288 up 2.83 2.56 
A_15_P289331   up 2.71 2.70 
A_15_P201081 LOC100005060 XM_001344175 up 2.42 2.23 
A_15_P243556 LOC100000365 XM_001340547 down 2.13 3.43 
A_15_P113167 zgc:110243 NM_001017629 up 4.14 3.00 
A_15_P331599 pdxdc1 NM_001004552 down 2.74 4.56 
A_15_P102501 rbmx2 NM_001025166 down 2.20 3.10 
A_15_P440935   up 5.67 4.14 
A_15_P577242   down 2.66 2.08 
A_15_P162786 rab11fip4a NM_001002533 up 4.55 2.68 
A_15_P150916 zgc:112062 NM_001020648 up 2.68 2.63 
A_15_P564217  BC124727 up 2.41 2.17 
A_15_P139796 kcnj1 NM_201035 up 2.17 2.41 
A_15_P116658 zgc:154064 NM_001077726 down 3.14 3.25 
A_15_P160521 zgc:73328 NM_199686 down 2.75 3.45 
A_15_P111884 exorh NM_131212 up 2.70 2.66 
A_15_P442195  EG579885 down 4.63 3.97 
A_15_P103952 atad1a NM_001007112 up 2.33 3.65 
A_15_P100336  CT679047 down 5.07 2.95 
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A_15_P325921  CT697531 down 3.19 2.98 
A_15_P186821 LOC795768 XM_001335992 up 7.33 8.53 
A_15_P115509   up 3.14 2.96 
A_15_P178796 zgc:165467 NM_001103113 down 2.18 4.74 
A_15_P120563 cacna2d1a NM_001044960 down 3.94 3.77 
A_15_P119415 socs3a NM_199950 up 2.80 2.28 
A_15_P228476 LOC100150267 XM_001921702 down 2.23 3.06 
A_15_P168206   down 3.65 2.00 
A_15_P193936 zgc:162897 NM_001098195 down 2.40 2.10 
A_15_P338920   down 2.36 2.25 
A_15_P321971 ubtfl NM_201003 down 2.68 2.33 
A_15_P207846 si:dkey-19f23.2 NM_001044907 up 2.17 2.40 
A_15_P108976 zgc:174574 NM_001115070 up 3.86 3.02 
A_15_P164201 slc39a1 NM_212583 up 3.54 4.55 
A_15_P312831  CT613529 down 6.65 4.21 
A_15_P599207 ela3l NM_001024408 up 2.19 2.20 
A_15_P146986 flot2a NM_213075 down 2.03 3.89 
A_15_P141146 zgc:158773 NM_001082411 up 2.85 3.79 
A_15_P168596  BC090480 down 3.09 4.21 
A_15_P203526 LOC557381 XM_680435 up 2.87 2.14 
A_15_P350610  XM_689701 down 2.34 2.00 
A_15_P168231 cd82 NM_212663 up 2.10 2.39 
A_15_P112922  BC059615 down 3.09 3.63 
A_15_P120851 c6ast3 NM_001013526 up 2.02 2.84 
A_15_P259631 zgc:65997 NM_200553 up 2.45 2.11 
A_15_P104211 sh3glb2 NM_201119 up 2.60 2.32 
A_15_P333284 si:ch211-199c19.3 XM_686942 down 3.89 4.50 
A_15_P180446 CH211-233A1.7 NM_001161350 up 2.01 4.26 
A_15_P383965   down 2.06 2.74 
A_15_P192211   down 3.23 3.17 
A_15_P472535 zgc:163064 NM_001089510 down 2.52 3.16 
A_15_P109891   down 4.20 3.47 
A_15_P110159 ela2l AY179345 up 4.66 3.93 
A_15_P116155 krt15 NM_213523 up 2.91 2.68 
A_15_P101150 zgc:77306 NM_213228 up 2.91 2.04 
A_15_P560767  CT588033 down 5.35 12.73 
A_15_P548707   down 2.23 4.04 
A_15_P153756 snai3 NM_001077385 up 2.54 2.13 
A_15_P175206 anxa1b NM_181759 up 2.29 2.37 
A_15_P351880  CT692096 up 2.87 3.17 
A_15_P407970 LOC794711 XM_001334684 up 2.73 4.12 
A_15_P184621  BC083371 down 3.31 5.55 
A_15_P102966 zgc:64012 NM_214761 down 2.55 2.13 
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A_15_P111240  BC083288 down 2.25 2.81 
A_15_P366150 dgat2 NM_001030196 down 2.02 2.27 
A_15_P114940 zgc:163073 NM_001089511 up 5.19 3.53 
A_15_P159131 si:dkey-108d22.2 NM_001126110 up 4.49 2.85 
A_15_P120310   up 2.22 2.36 
A_15_P474630 letm2 BC154838 down 2.50 3.23 
A_15_P104132 zgc:112165 NM_001020656 up 4.01 4.09 
A_15_P114316 si:dkey-86e18.1 NM_001025491 up 2.09 2.28 
A_15_P119580 zgc:174342 NM_001110288 up 3.34 5.28 
A_15_P132526 klf4 NM_131723 up 4.92 4.26 
A_15_P578332 LOC557353 XM_001335696 down 2.77 4.36 
A_15_P110703   up 2.76 3.98 
A_15_P222826  BC135030 down 2.20 2.82 
A_15_P448290 ddx5 NM_212612 down 2.14 3.13 
A_15_P321361   down 2.62 2.11 
A_15_P150506 zgc:158393 NM_001080016 up 4.05 2.13 
A_15_P589482  EB971273 up 4.26 3.48 
A_15_P221436 LOC100151124 XM_001921076 down 2.79 9.61 
A_15_P309491 LOC558375 XM_681577 down 3.12 3.27 
A_15_P184246  EB930870 down 2.80 3.18 
A_15_P521517 zgc:163000 NM_001082864 up 4.01 3.94 
A_15_P565127   up 3.60 3.49 
A_15_P506462 LOC563316 BC155650 down 2.07 2.78 
A_15_P335519 si:ch211-251j10.4 NM_001123232 down 10.11 16.65 
A_15_P274421   up 5.82 2.48 
A_15_P177096 spef2 NM_001128232 down 2.34 2.37 
A_15_P180186   down 3.06 3.03 
A_15_P180171 LOC561649 XM_685063 down 2.49 4.54 
A_15_P117786 zgc:110045 NM_001039984 down 2.70 2.05 
A_15_P457045  XM_001923765 down 3.21 3.47 
A_15_P167123 LOC100148026 XM_001919814 up 2.82 3.95 
A_15_P221461 snapc1a NM_200263 up 3.62 3.01 
A_15_P106753   up 3.23 2.57 
A_15_P146841  XM_691963 up 3.45 3.06 
A_15_P160541 LOC562928 XM_686293 up 4.65 3.61 
A_15_P110814 nos2a NM_001104937 up 3.81 3.45 
A_15_P288711   up 2.93 2.89 
A_15_P309521   up 3.23 2.63 
A_15_P112683 cdca8 NM_001007456 up 3.38 3.64 
A_15_P197131 socs5b NM_001113797 down 6.46 6.51 
A_15_P196681   up 5.41 4.98 
A_15_P138376 LOC565670 XM_688937 down 2.66 4.78 
A_15_P201066  AY648770 down 3.47 3.28 
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A_15_P252566  CR929752 down 3.62 3.73 
A_15_P494522 acin1b BC045312 down 2.32 3.12 
A_15_P212121 tln1 NM_001009560 down 2.49 2.15 
A_15_P116696   down 2.56 2.32 
A_15_P261491 LOC100004986 XM_001344114 up 3.49 2.24 
A_15_P104101 cbln2a NM_001128688 up 4.92 4.72 
A_15_P505967  XM_001921567 down 2.81 5.15 
A_15_P155191 LOC798730 XM_001339126 up 7.38 6.33 
A_15_P200761  CK015821 up 5.03 6.70 
A_15_P510572  XM_680968 down 2.85 7.20 
A_15_P104006   down 2.71 2.48 
A_15_P119855 prkcb1l NM_201029 up 3.58 4.62 
A_15_P373835 eif2ak4 XR_044737 down 2.98 3.08 
A_15_P392800 fstb NM_001109831 up 2.07 2.92 
A_15_P224261   down 2.11 2.19 
A_15_P112944 map2k1 NM_213419 down 2.05 2.03 
A_15_P160046 LOC100149074 XM_001919536 down 2.77 2.70 
A_15_P579427 zgc:91908 NM_001002179 up 5.87 3.00 
A_15_P419550 gch2 NM_131667 up 4.68 3.79 
A_15_P471315   down 7.63 6.98 
A_15_P100412 tbx1 NM_183339 up 2.57 2.22 
A_15_P208351 zgc:113263 NM_001013331 down 2.38 4.65 
A_15_P135191  XM_001334548 down 3.14 2.71 
A_15_P327981  CT730864 down 3.38 2.46 
A_15_P153666 klf4 NM_131723 up 2.32 2.09 
A_15_P260731  CA474667 up 2.45 2.06 
A_15_P110458 jph1a NM_001166256 down 3.34 2.77 
A_15_P591092 wu:fb53f04 EH580949 up 2.49 2.25 
A_15_P547357  CO924904 up 5.86 6.12 
A_15_P104403 pawrl NM_001006015 down 2.56 3.73 
A_15_P190396   up 2.44 2.66 
A_15_P118636 sf3a1 NM_200094 down 3.56 6.41 
A_15_P588067  CK703328 down 5.71 2.75 
A_15_P113973   up 3.64 2.17 
A_15_P512452   down 2.46 2.24 
A_15_P177561 si:ch211-274p22.2 BC122423 down 2.90 4.67 
A_15_P111401 zgc:153154 NM_001045413 up 3.38 5.49 
A_15_P541997 LOC100150319 EH581399 down 2.75 2.01 
A_15_P119822 oclnb NM_001008618 up 2.51 2.32 
A_15_P472735 si:dkey-274c14.3 XM_682770 down 3.22 2.93 
A_15_P184096 ppat NM_001082877 up 2.65 2.30 
A_15_P142331 myf6 NM_001003982 up 3.43 2.76 
A_15_P113127 grhl1 XM_001923728 up 2.19 2.01 
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A_15_P435980  CA787485 down 3.32 3.38 
A_15_P557417 LOC100150225 XM_001921222 down 3.25 2.41 
A_15_P115666 zgc:153764 NM_001077318 up 3.36 2.21 
A_15_P109666 zgc:136396 NM_001040291 up 2.01 3.27 
A_15_P104423 dctn1a NM_001077212 down 3.11 4.15 
A_15_P121130   down 2.25 4.82 
A_15_P529307 zgc:162611 NM_001089517 up 3.76 3.13 
A_15_P201106  DQ812123 down 2.97 3.27 
A_15_P155871  XM_001345293 up 2.14 2.38 
A_15_P177246 LOC560667 BC115075 down 2.01 2.50 
A_15_P241836 LOC799182 XM_001339531 up 2.43 2.15 
A_15_P407150 wu:fb98b04 CT597797 down 2.62 4.46 
A_15_P112191 cx35.4 NM_001017685 up 4.08 4.43 
A_15_P190611 LOC559763 XM_001922074 up 3.91 2.93 
A_15_P249136   up 2.75 2.77 
A_15_P178211 si:ch211-218c6.1 NM_001044339 down 3.10 4.31 
A_15_P103991 zgc:112426 NM_001017793 up 5.42 6.07 
A_15_P191386   up 3.67 4.66 
A_15_P178181 zgc:153452 NM_001077569 down 2.06 3.53 
A_15_P321036   up 3.43 4.25 
A_15_P366130 rnf24 NM_001007352 down 2.55 2.36 
A_15_P115079 rcor2 NM_205638 down 2.58 2.41 
A_15_P199886 prkag3 BC090443 up 2.44 — 
A_15_P407165  AI601465 down 9.59 — 
A_15_P518272   down 2.69 
— 
A_15_P225241   up 2.03 
— 
A_15_P313636  CT628855 down 3.24 
— 
A_15_P508722   down 2.37 
— 
A_15_P563252  CT602888 down 2.29 
— 
A_15_P350070 mcat NM_001045043 up 2.26 
— 
A_15_P102647 zgc:158393 NM_001080016 up 3.21 
— 
A_15_P114781 mstn NM_131019 up 2.25 
— 
A_15_P334054   down 2.63 
— 
A_15_P101674 si:dkeyp-73d8.6 NM_001130644 down 2591.71 
— 
A_15_P282306 bmpr1ab NM_001004585 up 2.19 
— 
A_15_P530997   down 2.71 
— 
A_15_P199126 zgc:195172 NM_001128817 up 2.94 
— 
A_15_P341740   down 2.54 
— 
A_15_P166841   up 2.39 
— 
A_15_P198881 puf60a NM_001105588 up 2.38 
— 
A_15_P103560 zgc:77082 NM_212870 down 2.42 
— 
A_15_P590117  CT686697 down 2.04 
— 
A_15_P239856 zgc:65827 NM_213155 up 2.43 
— 
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A_15_P109797 zgc:85975 NM_213265 up 2.02 
— 
A_15_P286856   down 2.39 
— 
A_15_P110111   down 4.32 
— 
A_15_P160286  XM_001921251 down 2.07 
— 
A_15_P114160 lmnb1 NM_152972 down 2.16 
— 
A_15_P362945   up 2.04 
— 
A_15_P225216   down 2.28 
— 
A_15_P566942   up 3.01 
— 
A_15_P119390   down 4.35 
— 
A_15_P100437   down 9.74 
— 
A_15_P139291 LOC100002779 XM_001342445 down 4.45 
— 
A_15_P426445  CT585723 down 2.40 
— 
A_15_P353120   down 2.16 
— 
A_15_P393105  CT696504 up 2.33 
— 
A_15_P515372   up 2.02 
— 
A_15_P486250   down 2.26 
— 
A_15_P141421 si:dkey-173l11.4 NM_001077575 up 2.90 
— 
A_15_P435485 im:7145045 XM_687130 down 2.03 
— 
A_15_P479160  CT724746 down 2.60 
— 
A_15_P163896 LOC556956 NM_001034972 up 2.87 
— 
A_15_P212286 LOC100004140 BC091954 down 4.14 
— 
A_15_P250021  CT635404 down 2.62 
— 
A_15_P531307 zgc:162600 NM_001089486 up 2.08 
— 
A_15_P377775 LOC553259 BC121769 up 4.76 
— 
A_15_P590177  CT676876 down 2.09 
— 
A_15_P366600 gosr2 NM_199688 up 2.17 
— 
A_15_P172931 cx41.8 NM_001034988 down 2.02 
— 
A_15_P505992   down 2.38 
— 
A_15_P592467   down 2.25 
— 
A_15_P301966   down 2.44 
— 
A_15_P183381 tpd52l2b NM_199582 up 2.70 
— 
A_15_P119121  BQ109731 down 2.43 
— 
A_15_P487450   down 2.10 
— 
A_15_P176021 dync1li1 NM_001102428 up 2.31 
— 
A_15_P243881   down 2.26 
— 
A_15_P100253  BC071301 down 2.28 
— 
A_15_P116856 taf1 NM_001044785 down 2.08 
— 
A_15_P225096 si:dkey-7b17.2 BC134873 up 2.00 
— 
A_15_P148176 CH211-157C24.2 NM_001128329 down 2.39 
— 
A_15_P193921 wdr92 NM_001017621 down 3.51 
— 
A_15_P105276  BC068437 up 2.01 
— 
A_15_P264946  AW059303 down 3.19 
— 
A_15_P285036 LOC100150476  down 2.15 
— 
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A_15_P163011 foxp3 NM_001082874 down 2.02 
— 
A_15_P252436  CR928168 down 9.03 
— 
A_15_P105113  CK360741 down 2.72 
— 
A_15_P172551 optn NM_001100066 up 2.02 
— 
A_15_P358615  CT685142 down 2.30 
— 
A_15_P576277   down 2.48 
— 
A_15_P458110 tmem176l.4 NR_023331 down 3.55 
— 
A_15_P180916 zgc:110610 BC095333 down 2.38 
— 
A_15_P275856   down 2.76 
— 
A_15_P192311 slain2 BC125960 down 2.29 
— 
A_15_P423950  CT708980 down 2.16 
— 
A_15_P103460 arl4cb NM_213248 up 2.60 
— 
A_15_P552352   down 2.90 
— 
A_15_P533267   down 2.43 
— 
A_15_P512892   up 3.49 
— 
A_15_P315136  CT604282 down 2.63 
— 
A_15_P104563  XM_693146 up 2.44 
— 
A_15_P121481   up 2.06 
— 
A_15_P185556 raver2 XM_001338047 up 2.96 
— 
A_15_P387680   down 3.10 
— 
A_15_P109920   up 2.98 
— 
A_15_P224431 si:ch211-67e16.9 NM_001104938 up 2.42 
— 
A_15_P533157   down 2.04 
— 
A_15_P179241 zgc:103624 BC152157 down 2.26 
— 
A_15_P121072 mcat NM_001045043 up 2.31 
— 
A_15_P373380  CT721059 down 2.01 
— 
A_15_P179696  BC152020 down 3.16 
— 
A_15_P137784   up 2.14 
— 
A_15_P188256 LOC571064 XM_694618 down 2.64 
— 
A_15_P410615 LOC566978 EE691164 up 2.20 
— 
A_15_P184651 zgc:114082 NM_001039977 down 4.38 
— 
A_15_P134146 cdk5 BC085381 down 2.00 
— 
A_15_P439700   down 2.23 
— 
A_15_P349040   down 2.51 
— 
A_15_P193791 bbc3 NM_001045472 up 2.38 
— 
A_15_P594182 si:dkey-242k1.6 XM_001337567 down 2.02 
— 
A_15_P158041 LOC567806 BC146707 up 2.86 
— 
A_15_P162181 zgc:153288 NM_001077321 down 255.83 
— 
A_15_P593682   up 2.60 
— 
A_15_P495807   up 2.30 
— 
A_15_P244181 hhatlb NM_001077390 up 3.73 
— 
A_15_P197426 ap3m1 NM_201292 up 2.07 
— 
A_15_P533684   down 2.05 
— 
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A_15_P110005 zgc:110380 NM_001017660 up 2.46 
— 
A_15_P416150   up 2.20 
— 
A_15_P598182  BM070936 down 2.69 
— 
A_15_P165651 LOC563339 XM_686703 down 2.04 
— 
A_15_P277051   down 2.05 
— 
A_15_P106768 mrpl3 NM_200007 up 2.29 
— 
A_15_P509662 puf60a NM_001105588 up 2.43 
— 
A_15_P104220 DKEY-30O19.2 NM_001123236 up 2.66 
— 
A_15_P522977  CT716541 down 3.23 
— 
A_15_P387300  CT615859 down 2.18 
— 
A_15_P105487   down 2.17 
— 
A_15_P225846   down 2.16 
— 
A_15_P288781   down 2.14 
— 
A_15_P391965 blcap NM_131493 up 2.16 
— 
A_15_P117149   down 2.12 
— 
A_15_P242031 LOC563377 XM_686740 down 2.09 
— 
A_15_P130541 fgf1 NM_200760 up 2.15 
— 
A_15_P107392 zgc:153615 NM_001077791 up 2.26 
— 
A_15_P167336 polr3e NM_212754 up 7.57 
— 
A_15_P147146 DKEY-19F4.1 XM_001919526 down 2.15 
— 
A_15_P139951 nrxn1b NM_001079959 down 2.23 
— 
A_15_P164901   up 2.01 
— 
A_15_P203136  XM_692343 down 3.13 
— 
A_15_P152026 her7 NM_131609 down 2.36 
— 
A_15_P239846   up 2.48 
— 
A_15_P423075 eif6 NM_200944 up 2.02 
— 
A_15_P298926  EB980707 down 2.26 
— 
A_15_P423170   down 2.14 
— 
A_15_P265881 LOC566587 XM_689863 up 2.13 
— 
A_15_P101660 zgc:153218 NM_001077155 up 2.54 
— 
A_15_P110003 cradd NM_001006066 up 2.01 
— 
A_15_P214871   down 2.15 
— 
A_15_P143181 zgc:66430 NM_200055 up 2.56 
— 
A_15_P470595 ube2i2 NM_131833 up 2.01 
— 
A_15_P121322 ndrg3b NM_199797 up 2.16 
— 
A_15_P184116 moxd1 NM_001045206 up 2.21 
— 
A_15_P107760 si:dkey-39n1.2 NM_001128364 up 2.58 
— 
A_15_P203401   down 3.21 
— 
A_15_P492102  XM_691455 up 2.05 
— 
A_15_P110105   up 2.44 
— 
A_15_P181011 LOC100004941 XM_001344083 up 2.52 
— 
A_15_P291611  BC054690 up 3.32 
— 
A_15_P326876   down 2.01 
— 
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A_15_P196411 ndrg1l NM_200692 up 2.75 
— 
A_15_P116417 rbm41 NM_001007405 down 2.40 
— 
A_15_P118948 rsad1 NM_001083557 down 2.35 
— 
A_15_P152571 map4k2l NM_001040358 down 2.15 
— 
A_15_P180741 htr1ab NM_001145766 up 2.12 
— 
A_15_P360905  CT643967 down 2.48 
— 
A_15_P349625   up 2.23 
— 
A_15_P176546  BC134078 down 2.70 
— 
A_15_P119061 fgl2 NM_001025539 down 2.67 
— 
A_15_P516297 ube2i2 NM_131833 up 2.10 
— 
A_15_P217176 ndor1 NM_200648 up 2.19 
— 
A_15_P183421 LOC567047 FJ469678 up 2.48 
— 
A_15_P574827  EH552365 down 2.87 
— 
A_15_P545722 thoc5 NM_212692 up 2.09 
— 
A_15_P161711 zgc:158706 NM_001080201 up 2.04 
— 
A_15_P182891 LOC571066 XR_044837 down 2.25 
— 
A_15_P198631 si:dkey-218h11.4 NM_001044972 up 2.02 
— 
A_15_P160826 zgc:153654 NM_001077169 up 2.36 
— 
A_15_P105018 LOC564564 XM_685001 up 2.47 
— 
A_15_P399890   up 2.91 
— 
A_15_P131351 ndel1a NM_201344 up 2.05 
— 
A_15_P289551   down 4.17 
— 
A_15_P187236  XM_678984 down 3.42 
— 
A_15_P114935 wu:fb78c02 XM_001923468 up 2.12 
— 
A_15_P115764 ampd3 NM_199848 up 2.00 
— 
A_15_P393170  BE016846 down 2.12 
— 
A_15_P192116 rxfp3 XM_001346785 up 4.93 
— 
A_15_P544722   down 2.02 
— 
A_15_P100713  BC154050 up 4.93 
— 
A_15_P113091 ntn1b NM_130998 down 2.10 
— 
A_15_P131901 rnf2 NM_131213 up 2.43 
— 
A_15_P241431 LOC100007939 XM_001346237 down 2.71 
— 
A_15_P189111 DKEY-190G11.2 XM_690282 down 4.81 
— 
A_15_P113984 rfc5 NM_001003862 up 2.20 
— 
A_15_P154371 tspan7b NM_001130818 up 4.52 
— 
A_15_P542567   down 4.50 
— 
A_15_P192521 hspb6  down 2.33 
— 
A_15_P141101 ndufv1 NM_001003747 up 2.01 
— 
A_15_P105389 zgc:152779 NM_001077535 up 2.12 
— 
A_15_P284621 wu:fb94b04 XM_685394 down 2.10 
— 
A_15_P186301 LOC559303 XR_028989 down 2.10 
— 
A_15_P418925   down 2.19 
— 
A_15_P157906 zgc:86773 NM_001002129 up 2.33 
— 
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A_15_P201911 mstn BC094979 up 2.67 
— 
A_15_P100837 aldoc NM_194384 up 2.34 
— 
A_15_P113621  XM_694722 down 3.66 
— 
A_15_P106129 epd NM_131005 up 2.24 
— 
A_15_P120069   up 2.02 
— 
A_15_P103583  BM532658 down 5.02 
— 
A_15_P581627   up 2.64 
— 
A_15_P482580  EH454068 down 2.12 
— 
A_15_P538407   up 2.31 
— 
A_15_P113678 zgc:175088 NM_001113798 up 2.57 
— 
A_15_P117176 brf1 NM_199898 down 6.79 
— 
A_15_P187026 tmem86b NM_001045368 up 2.23 
— 
A_15_P280866 trnau1apl NM_001029966 down 2.10 
— 
A_15_P383370   up 2.07 
— 
A_15_P142136 mcfd2 NM_001005939 up 2.10 
— 
A_15_P345595 cct5 NM_212613 up 2.03 
— 
A_15_P109893 pik3ip1 NM_198374 up 2.06 
— 
A_15_P203796 zgc:175182 NM_001114410 up 2.48 
— 
A_15_P183581 klhl21 NM_207081 up 2.10 
— 
A_15_P403710 LOC565111 XM_001921567 up 2.47 
— 
A_15_P441080 LOC100149852 XM_001923886 down 4.80 
— 
A_15_P141291 si:dkeyp-31e2.1 NM_001082925 up 2.80 
— 
A_15_P481535  CT671392 down 4.77 
— 
A_15_P179416 zgc:171763 NM_001105696 down 2.12 
— 
A_15_P502402 got2a NM_213379 up 2.43 
— 
A_15_P580012   down 2.53 
— 
A_15_P234801  EH582738 down 2.45 
— 
A_15_P110781   down 2.15 
— 
A_15_P360885  CT729768 down 2.40 
— 
A_15_P111326 rapsn NM_178305 up 2.38 
— 
A_15_P120217 mut NM_001099226 up 2.26 
— 
A_15_P112682  BC154795 up 2.63 
— 
A_15_P158911 CH211-136G2.1 BC154645 up 2.11 
— 
A_15_P100918 LOC407614 NM_001161351 down 2.64 
— 
A_15_P104186 zgc:112161 NM_001020655 up 2.95 
— 
A_15_P502977   down 2.71 
— 
A_15_P356670   down 12.33 
— 
A_15_P148711 zgc:153648 NM_001045446 down 2.06 
— 
A_15_P418670   down 2.18 
— 
A_15_P106404 si:ch211-14a17.7 NM_001007180 down 5.30 
— 
A_15_P115872   down 3.49 
— 
A_15_P210401  CT631366 down 4.46 
— 
A_15_P467840   up 2.36 
— 
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A_15_P329236  CT653105 down 2.26 
— 
A_15_P303966 LOC796927 CK238742 down 2.03 
— 
A_15_P131921 rds2 NM_131566 up 2.36 
— 
A_15_P323881   up 4.04 
— 
A_15_P119305 si:ch211-67n3.4 NM_001144785 down 2.56 
— 
A_15_P117867   down 2.70 
— 
A_15_P500387   down 2.70 
— 
A_15_P188876 DKEY-83K24.4 NM_001130073 up 2.12 
— 
A_15_P137201 LOC559395 XM_682733 up 2.69 
— 
A_15_P179061 zgc:113377 BC152494 down 2.86 
— 
A_15_P140701 zgc:112437 NM_001017771 up 2.03 
— 
A_15_P567227 zgc:158345 NM_001083013 down 2.03 
— 
A_15_P106150 oxa1l NM_001105130 up 3.73 
— 
A_15_P488015   down 2.58 
— 
A_15_P229696  EB960943 up 2.04 
— 
A_15_P360015  CT687338 down 3.86 
— 
A_15_P100729 lrrn1 NM_001130694 up 2.38 
— 
A_15_P113774 depdc6 NM_001077320 down 2.22 
— 
A_15_P306646   down 4.29 
— 
A_15_P434725 pgam5 NM_001007323 up 2.53 
— 
A_15_P175501 si:ch211-191d15.2 NM_001003632 up 2.07 
— 
A_15_P134654 zgc:162640 NM_001082814 up 2.16 
— 
A_15_P117269 atp2a1l NM_001077533 up 2.33 
— 
A_15_P130206  BC154459 down 2.00 
— 
A_15_P594622  XM_001919953 down 2.11 
— 
A_15_P162256 kcnj11 NM_001039827 up 2.36 
— 
A_15_P179876 LOC100001767 CN177292 up 3.43 
— 
A_15_P325396  CT701933 down 2.12 
— 
A_15_P185506 erm NM_131205 up 3.98 
— 
A_15_P114594 nrp1b NM_205674 up 2.24 
— 
A_15_P154346   down 2.08 
— 
A_15_P100368 zgc:91968 NM_001002167 up 2.41 
— 
A_15_P104191   down 2.80 
— 
A_15_P111559 notch3 NM_131549 down 6.43 
— 
A_15_P177441  BC122152 up 3.16 
— 
A_15_P415805   up 3.08 
— 
A_15_P107868 zgc:73337 BC059655 up 84.37 
— 
A_15_P103567  BM035544 down 2.08 
— 
A_15_P404775  DN902661 down 2.48 
— 
A_15_P102168  AI545556 down 2.75 
— 
A_15_P119994 gpd1l NM_001005934 down 2.67 
— 
A_15_P154736 ND3 CV489513 down 2.48 
— 
A_15_P193171 zgc:101644 NM_001008643 down 2.72 
— 
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A_15_P120907 si:ch211-212d10.3 NM_001044843 up 2.22 
— 
A_15_P121335   down 2.07 
— 
A_15_P197036  XM_681566 up 2.41 
— 
A_15_P223521 LOC100150644 XM_001920798 down 3.11 
— 
A_15_P331101   up 3.86 
— 
A_15_P275301 casq2 NM_001002682 up 2.79 
— 
A_15_P146741 slc12a9 NM_001128548 up 2.33 
— 
A_15_P372115 pufa XM_690488 up 2.05 
— 
A_15_P382560   down 2.18 
— 
A_15_P118680 gdf8l NM_001004122 up 2.38 
— 
A_15_P111048 si:dkeyp-93c5.1 XM_681322 down 2.02 
— 
A_15_P193626 zgc:77051 NM_212866 up 2.07 
— 
A_15_P443465 LOC100004831 XM_001343998 down 2.50 
— 
A_15_P108830 cab39l1 NM_213501 down 2.51 
— 
A_15_P106128   down 2.22 
— 
A_15_P195161 zgc:158700 NM_001083031 up 2.12 
— 
A_15_P137806 LOC100008036  down 2.01 
— 
A_15_P170131 foxd3 NM_131290 up 2.08 
— 
A_15_P495617   down 2.29 
— 
A_15_P150381 capn2l NM_001017807 up 2.07 
— 
A_15_P584722  BU710225 down 2.98 
— 
A_15_P560997  EH442032 down 2.22 
— 
A_15_P203336  BC129415 down 36.91 
— 
A_15_P117981 slc5a11 NM_001007300 down 3.09 
— 
A_15_P456500  BI846484 down 2.21 
— 
A_15_P212906 zgc:136827 NM_001040245 up 2.22 
— 
A_15_P110300 arglu1a NM_213216 down 2.45 
— 
A_15_P185561 LOC794807 XM_001334793 down 2.93 
— 
A_15_P141256 zgc:109926 NM_001030076 up 2.85 
— 
A_15_P116098 golga5 NM_213411 up 2.25 
— 
A_15_P162226 zgc:113317 NM_001033725 down 212.56 
— 
A_15_P115904 zgc:77057 NM_214705 up 2.36 
— 
A_15_P503052   down 2.90 
— 
A_15_P120206 zgc:92034 NM_001004605 up 2.60 
— 
A_15_P120839 zgc:112221 NM_001020763 up 3.45 
— 
A_15_P347285   down 3.09 
— 
A_15_P531102   down 2.01 
— 
A_15_P314511  CT588715 down 2.21 
— 
A_15_P515327 zgc:92201 NM_001002640 up 2.15 
— 
A_15_P152307 eif2s1l NM_199569 up 2.37 
— 
A_15_P361625  CT636357 down 2.43 
— 
A_15_P140386 zgc:154037 NM_001076584 up 2.08 
— 
A_15_P473805   down 2.39 
— 
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A_15_P131666 gad1 NM_194419 up 2.31 
— 
A_15_P204026 sp8l AY457141 up 2.03 
— 
A_15_P449250   down 4.01 
— 
A_15_P464860  AW059471 down 2.32 
— 
A_15_P509412 DKEY-20I10.7 XM_001336739 up 2.05 
— 
A_15_P114411 hars NM_001004586 up 2.57 
— 
A_15_P114719 stc2 BC129138 up 2.12 
— 
A_15_P139481 prickle1b NM_001030098 up 2.02 
— 
A_15_P109826   up 2.00 
— 
A_15_P106877 hsp47 NM_131204 down 2.63 
— 
A_15_P581397   up 2.24 
— 
A_15_P522742   down 2.39 
— 
A_15_P161486 si:dkey-24l11.4 NM_001025538 up 2.09 
— 
A_15_P111247 tp73 NM_183340 up 2.00 
— 
A_15_P526572   down 2.42 
— 
A_15_P107776   down 2.27 
— 
A_15_P112485 tyw3 NM_001002611 up 2.06 
— 
A_15_P481520  CT671245 down 2.79 
— 
A_15_P160661 cebpd NM_131887 up 3.57 
— 
A_15_P554497  CO353902 down 2.44 
— 
A_15_P288581  BC163356 down 2.40 
— 
A_15_P111554 srfl NM_200631 up 2.13 
— 
A_15_P551007 LOC100150557 EV756135 up 2.13 
— 
A_15_P552287 LOC556985 XM_679939 up 2.11 
— 
A_15_P292731 DKEY-219C10.5 NM_001115139 down 2.21 
— 
A_15_P243141   down 2.08 
— 
A_15_P105352 hoxc6b NM_131530 down 2.22 
— 
A_15_P194741 ndrg4 NM_001045173 up 2.47 
— 
A_15_P376140 uros NM_212828 up 2.64 
— 
A_15_P533307 zgc:66117 NM_199560 up 2.18 
— 
A_15_P520137 wu:fe48e11 BI889407 up 2.11 
— 
A_15_P166026 mpzl3 NM_213169 up 2.34 
— 
A_15_P153831 zgc:153919 NM_001045415 up 2.26 
— 
A_15_P178726  BC142921 down 2.16 
— 
A_15_P299287 minpp1 NM_201100 up 2.00 
— 
A_15_P168856 efr3a NM_200827 down 2.41 
— 
A_15_P373490 LOC560275 XM_683672 up 2.03 
— 
A_15_P184141 aig1 XM_685654 up 2.64 
— 
A_15_P202191  BC095271 down 3.13 
— 
A_15_P362350   down 2.41 
— 
A_15_P302596   down 2.83 
— 
A_15_P577552 cebpd NM_131887 up 3.32 
— 
A_15_P569897   down 2.20 
— 
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A_15_P565902 eif6 NM_200944 up 2.43 
— 
A_15_P446290 rlbp1b NM_205690 up 2.32 
— 
A_15_P198486 atp1b3a NM_131221 up 2.24 
— 
A_15_P173636 zgc:165666 NM_001099242 down 2.10 
— 
A_15_P176986 si:dkey-162b3.6 NM_001161361 up 2.59 
— 
A_15_P152986 bnip3l2 NM_001012242 up 2.46 
— 
A_15_P473465   up 2.22 
— 
A_15_P107295  CT683426 down 2.20 
— 
A_15_P424295  CT675511 down 2.31 
— 
A_15_P191961 si:ch211-13n20.2 XM_693914 down 2.51 
— 
A_15_P102313   up 2.05 
— 
A_15_P312721  CT612545 down 2.38 
— 
A_15_P162141 prmt2 NM_001080175 down 2.22 
— 
A_15_P119403  BI845607 down 3.65 
— 
A_15_P154391 capzb NM_199935 up 2.64 
— 
A_15_P493942 im:7149356 BC091903 down 2.13 
— 
A_15_P362575   down 2.94 
— 
A_15_P532367   down 51.69 
— 
A_15_P437545 smek1 NM_001044809 down 2.86 
— 
A_15_P370540 LOC100151593 CT735115 down 2.06 
— 
A_15_P119945   down 2.96 
— 
A_15_P167076 kif19 BC135048 down 
— 
6.26 
A_15_P396485   down 
— 
2.91 
A_15_P169926 zgc:158867 NM_001080611 down 
— 
2.65 
A_15_P172961 zgc:163030 NM_001089413 up 
— 
7.09 
A_15_P539822 flii XM_683678 down 
— 
3.12 
A_15_P140241 si:ch211-199m3.8 NM_001044849 down 
— 
2.28 
A_15_P105293 zgc:91835 NM_001002201 down 
— 
3.30 
A_15_P113120 serinc5 NM_213514 up 
— 
2.06 
A_15_P119334 pdzk1ip1l NM_001007760 down 
— 
2.55 
A_15_P177991  BC129313 down 
— 
3.61 
A_15_P394650  CK024856 down 
— 
2.39 
A_15_P494432  BC151829 down 
— 
3.54 
A_15_P105702 ubtf NM_001005395 down 
— 
2.81 
A_15_P111530 pdc2 NM_001025464 down 
— 
5.33 
A_15_P109020 zgc:158446 NM_001083858 down 
— 
2.74 
A_15_P111624 zgc:158803 NM_001089547 down 
— 
2.84 
A_15_P500557   up 
— 
5.36 
A_15_P270601 LOC795978 EH448452 up 
— 
2.21 
A_15_P497057 DKEYP-20E4.6 NM_001164812 down 
— 
2.51 
A_15_P164596 si:ch211-146f4.5 NM_001044998 down 
— 
4.02 
A_15_P364875 cbl NM_001007330 down 
— 
2.01 
A_15_P306491   up 
— 
2.27 
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A_15_P186561 LOC556380 XM_679169 down 
— 
3.38 
A_15_P503892 zgc:112104 NM_001017745 down 
— 
2.65 
A_15_P527632  CT659012 down 
— 
2.42 
A_15_P176976 pomgnt1 BC097123 up 
— 
2.05 
A_15_P104848 tppp3 NM_201335 up 
— 
2.28 
A_15_P205611 suv420h2 NM_001098186 down 
— 
2.02 
A_15_P418090 si:ch211-173p18.3 NM_001044320 down 
— 
3.68 
A_15_P189851 zgc:63688 NM_200838 down 
— 
2.31 
A_15_P582052 LOC100004401 XM_001343682 down 
— 
28.95 
A_15_P185251  XM_001919989 down 
— 
3.30 
A_15_P196501 slc5a11 NM_001007300 down 
— 
2.22 
A_15_P202781 ecd NM_199891 down 
— 
2.36 
A_15_P188771  XM_695839 down 
— 
2.89 
A_15_P199021 zgc:100957 NM_001003620 down 
— 
2.47 
A_15_P365320 cpne3 NM_200167 up 
— 
2.35 
A_15_P100832  BM573563 up 
— 
2.20 
A_15_P138091   up 
— 
2.00 
A_15_P155861 sema6d NM_212999 down 
— 
2.25 
A_15_P234821  DR714895 down 
— 
2.23 
A_15_P297801   up 
— 
2.12 
A_15_P160076 zgc:194470 NM_001128765 down 
— 
2.34 
A_15_P437720   up 
— 
2.28 
A_15_P107489 top2b NM_001045191 down 
— 
2.16 
A_15_P443380   down 
— 
4.36 
A_15_P173126 zgc:56095 NM_213013 up 
— 
2.20 
A_15_P204612 zgc:136346 NM_001045276 down 
— 
3.08 
A_15_P397760 atrxl BC057486 down 
— 
2.67 
A_15_P111171  XM_683165 down 
— 
4.96 
A_15_P184941 mia3 NM_001105525 down 
— 
2.63 
A_15_P145766 LOC561911 XM_685313 down 
— 
3.27 
A_15_P550017 zgc:194294 NM_001128812 down 
— 
3.05 
A_15_P178591  BC142767 down 
— 
2.36 
A_15_P501087 DKEY-215K6.1 XM_679464 up 
— 
2.13 
A_15_P380925   down 
— 
2.89 
A_15_P156816 LOC100000778 XM_001337711 down 
— 
2.05 
A_15_P188846 si:ch211-145m1.1 NM_001130781 down 
— 
2.01 
A_15_P168911 zgc:152955 NM_001076613 down 
— 
2.23 
A_15_P134141 taf5 NM_001037431 down 
— 
3.65 
A_15_P201496 si:ch211-219a4.7 NM_001123233 down 
— 
2.66 
A_15_P239436 phf8 XM_689807 down 
— 
2.69 
A_15_P363695 zgc:153990 NM_001077271 up 
— 
2.27 
A_15_P356510   down 
— 
3.19 
A_15_P339915   down 
— 
2.61 
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A_15_P178171  BC134067 down 
— 
2.57 
A_15_P446435 hic1l NM_131483 down 
— 
2.05 
A_15_P147446  XM_691602 down 
— 
2.63 
A_15_P120887 zgc:56231 NM_213188 up 
— 
2.23 
A_15_P181991  XM_684255 down 
— 
2.19 
A_15_P235391 zgc:113259 NM_001014314 down 
— 
2.35 
A_15_P110900 zgc:63528 NM_201032 down 
— 
2.05 
A_15_P133611 ezrl NM_001020490 down 
— 
3.87 
A_15_P188781 si:dkey-49h9.6 BC091950 down 
— 
5.22 
A_15_P170506 zgc:64187 NM_200417 down 
— 
2.40 
A_15_P200271 LOC556634 XM_679483 up 
— 
2.31 
A_15_P166806 dclre1a NM_001020549 up 
— 
2.35 
A_15_P444760 prtfdc1 NM_199518 up 
— 
2.06 
A_15_P273176   up 
— 
2.09 
A_15_P107158 usp40 BC054934 down 
— 
2.44 
A_15_P192661 zgc:113418 NM_001012491 up 
— 
2.39 
A_15_P204566 mtdhb BC121767 down 
— 
2.12 
A_15_P116413 zgc:171476 NM_001114886 down 
— 
2.12 
A_15_P101831  BC076069 up 
— 
2.25 
A_15_P208871 ptpra NM_131888 down 
— 
2.19 
A_15_P133426 smc4 NM_173253 down 
— 
2.38 
A_15_P170016 aldh1a3 NM_001044745 up 
— 
2.46 
A_15_P254326  DT868229 up 
— 
2.27 
A_15_P413775   up 
— 
2.14 
A_15_P160571 top1l NM_001044324 down 
— 
3.62 
A_15_P116538 ppm1g NM_201488 down 
— 
3.18 
A_15_P503787  XM_690528 down 
— 
2.26 
A_15_P512832   up 
— 
2.02 
A_15_P197796 si:dkey-188i13.1 BC090712 down 
— 
2.37 
A_15_P102642 si:ch211-59d15.8 NM_001164029 down 
— 
2.26 
A_15_P207256 otx1l NM_131215 up 
— 
2.08 
A_15_P513977   up 
— 
2.02 
A_15_P184566 cad NM_001009884 up 
— 
2.43 
A_15_P164431 zgc:136892 NM_001040360 up 
— 
2.19 
A_15_P114320   up 
— 
2.09 
A_15_P446420 zgc:136689 NM_001045312 down 
— 
2.10 
A_15_P204133  XM_001344601 up 
— 
5.96 
A_15_P156966 LOC562675 XM_686050 down 
— 
4.11 
A_15_P539272   down 
— 
2.13 
A_15_P178551  BC142739 down 
— 
2.59 
A_15_P103593 mgll NM_200297 down 
— 
4.31 
A_15_P484495  XM_692771 down 
— 
5.30 
A_15_P284371 upp1 NM_001013301 down 
— 
2.38 
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A_15_P339060   up 
— 
2.01 
A_15_P105601 zgc:152816 NM_001077760 down 
— 
2.58 
A_15_P532737   up 
— 
3.22 
A_15_P192806 zgc:100856 NM_001003536 up 
— 
2.21 
A_15_P410650  AY968596 up 
— 
2.16 
A_15_P116045 zgc:136689 NM_001045312 down 
— 
2.30 
A_15_P535082   down 
— 
4.89 
A_15_P382895   down 
— 
2.25 
A_15_P152486 zgc:152896 NM_001077534 down 
— 
5.36 
A_15_P198006 LOC100004967 XM_001340075 down 
— 
2.16 
A_15_P309786   up 
— 
2.84 
A_15_P199016 zgc:100957 NM_001003620 down 
— 
2.68 
A_15_P570517 ihha NM_001034993 down 
— 
2.04 
A_15_P298691 LOC564478 XM_687812 down 
— 
3.38 
A_15_P281316 zgc:153154 NM_001045413 up 
— 
2.42 
A_15_P104030 lect1 NM_001126448 up 
— 
2.12 
A_15_P186201 LOC562296 XM_685694 up 
— 
2.54 
A_15_P118927 gpr177 NM_213146 up 
— 
2.01 
A_15_P158326 nipbl NM_001161447 down 
— 
2.65 
A_15_P558247 LOC566967 XM_690250 up 
— 
2.00 
A_15_P474340   up 
— 
2.40 
A_15_P120021 upf3b NM_200954 down 
— 
2.74 
A_15_P116455 jag1b NM_131863 down 
— 
2.31 
A_15_P189646 LOC553504 BC091795 down 
— 
2.62 
A_15_P184581 zgc:85746 NM_214819 down 
— 
2.47 
A_15_P134976  BC098606 down 
— 
3.73 
A_15_P198711 si:dkey-223d7.5 NM_001163298 down 
— 
3.34 
A_15_P407915 si:ch211-145m1.1 NM_001130781 down 
— 
2.08 
A_15_P562577   down 
— 
2.04 
A_15_P167196   up 
— 
2.08 
A_15_P175571 syntaxin1b NM_131523 down 
— 
3.88 
A_15_P116024  BC091977 down 
— 
3.03 
A_15_P412395 zgc:163030 NM_001089413 up 
— 
6.14 
A_15_P202106 LOC570106 XM_693543 down 
— 
5.16 
A_15_P190141 zgc:85787 NM_213167 down 
— 
3.50 
A_15_P188616  XM_001338077 down 
— 
10.43 
A_15_P185121 im:7140055 XM_679746 up 
— 
2.26 
A_15_P461090   down 
— 
2.36 
A_15_P190771 ahnak BC124733 down 
— 
4.24 
A_15_P435990   down 
— 
5.16 
A_15_P156036 zgc:152774 NM_001075109 down 
— 
2.78 
A_15_P154156 zgc:113362 NM_001014310 down 
— 
3.51 
A_15_P108891 zgc:100896 NM_001003524 down 
— 
2.53 
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A_15_P161851 zgc:158707 NM_001080638 down 
— 
4.74 
A_15_P186781 LOC100150828 XM_001919699 down 
— 
7.53 
A_15_P190786 hmmr NM_199580 down 
— 
2.64 
A_15_P499637 csf2rb NM_001113733 down 
— 
2.55 
A_15_P101060 hic1l NM_131483 down 
— 
2.80 
A_15_P237121 ppp1r12a NM_001003870 down 
— 
3.88 
DCP_1_1    
— 
— 2.11 
A_15_P216631   down 
— 
2.11 
A_15_P109100 ncf1 NM_001030071 down 
— 
2.58 
A_15_P320701 fam160b2 NM_001077766 down 
— 
3.25 
A_15_P117714  BC059206 down 
— 
2.59 
A_15_P180981 cadm1a NM_001113551 down 
— 
6.55 
A_15_P117002 zgc:112994 NM_001020707 down 
— 
2.71 
A_15_P191206   down 
— 
4.60 
A_15_P121073 im:6896251 XM_685145 down 
— 
2.80 
A_15_P212191 cpsf1 NM_001114681 down 
— 
3.06 
A_15_P198456 DKEY-87L9.2 XM_677653 down 
— 
5.13 
A_15_P194161 zgc:112431 NM_001017782 down 
— 
2.22 
A_15_P178246  BC134197 down 
— 
2.76 
A_15_P145086 neo1 NM_173218 down 
— 
2.73 
A_15_P434245 antxr2a NM_001044709 down 
— 
2.22 
A_15_P180526 LOC553309 BC090800 down 
— 
2.58 
A_15_P114476 im:7141573 CK680095 down 
— 
2.42 
A_15_P202551 baz1a BC096971 down 
— 
4.43 
A_15_P104868 LOC100003999 XM_001343386 up 
— 
2.11 
A_15_P133296 rhoaa NM_213137 down 
— 
2.03 
A_15_P106003   down 
— 
2.79 
A_15_P241696  CT711882 up 
— 
2.29 
A_15_P298146 LOC797886 XM_001338312 down 
— 
11.51 
A_15_P102338 trmt5 NM_001145583 up 
— 
2.17 
A_15_P110542 tbx3b NM_001101670 down 
— 
2.19 
A_15_P172646 cldng NM_180965 up 
— 
2.17 
A_15_P118326 efna1a NM_200597 down 
— 
2.80 
A_15_P130496  AB119258 up 
— 
2.35 
A_15_P178761 wu:fi14a03 BC146727 down 
— 
2.09 
A_15_P592027 wu:fb30e12 CN323290 down 
— 
2.19 
A_15_P186851  DQ017638 down 
— 
2.47 
A_15_P384325 haus6 NM_001079974 up 
— 
2.05 
A_15_P157431 LOC100002543 XM_001342265 down 
— 
3.65 
A_15_P141871  BC091840 down 
— 
3.63 
A_15_P134441 pdcd11 NM_001089368 down 
— 
2.83 
A_15_P178041  BC129399 down 
— 
2.68 
A_15_P102964 ppl NM_001137666 down 
— 
2.90 
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A_15_P592157 mgll NM_200297 down 
— 
3.06 
A_15_P118745   up 
— 
6.21 
A_15_P196916  XR_044976 down 
— 
4.33 
A_15_P443590   down 
— 
5.64 
A_15_P396625   up 
— 
2.72 
A_15_P186026 shq1 NM_001080600 down 
— 
3.02 
A_15_P121196 LOC561766  down 
— 
4.40 
A_15_P563677 zgc:55443 NM_213502 down 
— 
2.02 
A_15_P173771 prkcq NM_001089370 down 
— 
2.72 
A_15_P337395   up 
— 
5.83 
A_15_P261276   down 
— 
4.31 
A_15_P200651 LOC565975 EH436377 up 
— 
2.05 
A_15_P178222  BC134122 down 
— 
2.48 
A_15_P173676 daam1l NM_001030136 down 
— 
2.01 
A_15_P163151 zgc:162265 NM_001089326 up 
— 
2.06 
A_15_P572142 zgc:100960  up 
— 
2.64 
A_15_P200091 rbpja BC092918 down 
— 
2.13 
A_15_P136341  BC090794 down 
— 
2.28 
A_15_P161821 zgc:162874 NM_001099252 down 
— 
3.10 
A_15_P113913  XM_001339115 down 
— 
8.62 
A_15_P179951 col6a2 BC134051 down 
— 
2.11 
A_15_P206491 ihha NM_001034993 down 
— 
2.17 
A_15_P156676 zgc:175268 NM_001114462 down 
— 
3.15 
A_15_P206001 zgc:101621 NM_001006093 up 
— 
2.69 
A_15_P134746  BC095094 down 
— 
2.10 
A_15_P181371 LOC100005116 XM_001338974 down 
— 
2.14 
A_15_P181261 lars XM_693187 up 
— 
2.20 
A_15_P105183  BC064299 up 
— 
2.01 
A_15_P262346   down 
— 
2.68 
A_15_P177106 si:dkey-67c22.2 NM_001130400 down 
— 
2.43 
A_15_P439010 gldc NM_199554 down 
— 
4.03 
A_15_P141921 zgc:77593 NM_200880 down 
— 
2.11 
A_15_P114066 hoxa13b NM_131194 up 
— 
2.08 
A_15_P177066  BC107512 down 
— 
3.33 
A_15_P267626   down 
— 
2.35 
A_15_P196051 grk1a NM_001034181 down 
— 
2.44 
A_15_P100675   down 
— 
2.43 
A_15_P185441 xirp2 BC133989 down 
— 
2.56 
A_15_P178331 tpr NM_001030123 down 
— 
4.47 
A_15_P118608 mpdu1a NM_001004545 up 
— 
2.11 
A_15_P200796  XM_695597 down 
— 
2.72 
A_15_P156022 nrxn3b NM_001080047 down 
— 
2.35 
A_15_P274441 anp32a NM_199986 down 
— 
2.44 
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A_15_P115483 LOC558832 BC154646 up 
— 
2.73 
A_15_P108194 pak2a NM_001002717 down 
— 
2.28 
A_15_P206521 si:dkey-218n20.1 NM_001045026 down 
— 
2.45 
A_15_P348510   up 
— 
2.01 
A_15_P119540 wu:fj84d10 CK015579 down 
— 
3.13 
A_15_P107240 LOC100001225 XM_001337395 up 
— 
2.91 
A_15_P137356   up 
— 
2.11 
A_15_P121294 zgc:123105 NM_001039994 down 
— 
2.01 
A_15_P183181 zgc:171857 NM_001122628 down 
— 
2.62 
A_15_P285701 ptgs2a NM_153657 up 
— 
2.32 
A_15_P190971  XM_681489 down 
— 
2.69 
A_15_P184286 si:ch211-199m3.9 NM_001110519 down 
— 
3.33 
A_15_P184510   up 
— 
20.30 
A_15_P513912 CH211-279L9.6 XM_678293 down 
— 
2.17 
A_15_P134426  BC091912 down 
— 
2.07 
A_15_P401090 zgc:92599 NM_001004607 up 
— 
2.32 
A_15_P190816 slc7a2 NM_001008584 up 
— 
2.06 
A_15_P541427 dnl2 NM_200099 down 
— 
3.67 
A_15_P106441 si:dkey-151c10.1 NM_001100032 up 
— 
2.10 
A_15_P212091  BC076069 up 
— 
2.14 
A_15_P142841 osr2 NM_001017694 down 
— 
2.73 
A_15_P173176 zgc:152774 NM_001075109 down 
— 
2.92 
A_15_P210961 rrm2 NM_131450 up 
— 
2.27 
A_15_P130356 tpr NM_001030123 down 
— 
2.61 
A_15_P101546 crim1 NM_212821 down 
— 
2.23 
A_15_P202116 im:6906849 BC076425 down 
— 
2.97 
A_15_P509447   down 
— 
4.31 
A_15_P237456 wu:fi27h03 XM_679489 down 
— 
3.03 
A_15_P384760   down 
— 
4.23 
A_15_P277031   up 
— 
4.31 
A_15_P133501 sema6d NM_212999 down 
— 
2.45 
A_15_P220766   down 
— 
3.65 
A_15_P180541 LOC100004739 XM_001343932 up 
— 
2.35 
A_15_P165321 LOC565839 XM_689101 down 
— 
2.12 
A_15_P139211  XM_680821 down 
— 
2.68 
A_15_P110224  CT698302 down 
— 
5.68 
A_15_P105630 fancl NM_212982 up 
— 
2.45 
A_15_P104047   down 
— 
2.93 
A_15_P156131 tbx3b NM_001101670 down 
— 
2.54 
A_15_P114064 insig2 NM_212804 down 
— 
2.01 
A_15_P201836 si:dkey-67c22.2 NM_001130400 down 
— 
2.58 
A_15_P346585   up 
— 
2.58 
A_15_P133966 tlk1b NM_001024951 down 
— 
2.12 
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A_15_P139556 cdc14b NM_200179 down 
— 
2.06 
A_15_P191581 LOC571401 XR_029888 down 
— 
3.69 
A_15_P120089 sgcg NM_001003748 down 
— 
3.11 
A_15_P164976 LOC795748 XM_001335976 down 
— 
2.34 
A_15_P131941  AF210648 down 
— 
2.19 
A_15_P112284 ppp4cb NM_001111168 up 
— 
2.56 
A_15_P349585 ahnak XM_682604 down 
— 
2.31 
A_15_P328911  CT652973 down 
— 
5.70 
A_15_P146341 LOC566287 XM_689556 down 
— 
2.61 
A_15_P506652 myom1a NM_001161340 down 
— 
3.45 
A_15_P178821 mnta BC150240 down 
— 
2.03 
A_15_P413905 LOC793098 XM_001332041 down 
— 
2.12 
A_15_P169326 ccdc146 BC124200 down 
— 
2.38 
A_15_P106465 adam10a NM_001159314 down 
— 
2.05 
A_15_P112892  BC091988 down 
— 
2.46 
A_15_P537412 strn3 BC142862 down 
— 
3.96 
A_15_P121285 ptrf NM_001114549 down 
— 
4.15 
A_15_P163311 ncapg2 NM_001089492 up 
— 
2.01 
A_15_P209986 dhdhl NM_214735 down 
— 
2.35 
A_15_P162596 zgc:152864 NM_001077764 down 
— 
2.55 
A_15_P219486   down 
— 
2.04 
A_15_P177111 lyricl NM_001007135 down 
— 
2.65 
A_15_P440970 gclc NM_199277 down 
— 
2.54 
A_15_P182016 iffo1 XM_685073 down 
— 
4.62 
A_15_P391300   down 
— 
2.53 
A_15_P186404  BC079480 down 
— 
2.03 
A_15_P183476 LOC100002572 BC095146 down 
— 
4.25 
A_15_P105198 ddx42 NM_001037805 down 
— 
2.65 
A_15_P120760 si:dkey-231l1.6 NM_001080992 down 
— 
2.37 
A_15_P112816 LOC100147996 XM_001921128 up 
— 
2.00 
A_15_P456865  CK028289 up 
— 
2.01 
A_15_P112719 zgc:92428 NM_001003732 up 
— 
2.14 
A_15_P106837 zgc:114180 NM_001030248 down 
— 
2.49 
A_15_P107840 marveld2b NM_001126406 up 
— 
2.55 
A_15_P102278  EH605325 up 
— 
2.23 
A_15_P107652 ptgs2a NM_153657 up 
— 
2.20 
A_15_P449880   up 
— 
2.19 
A_15_P113818 sb:cb627 BC115332 down 
— 
2.63 
A_15_P181981 setdb1a NM_001044767 down 
— 
2.57 
A_15_P115680   up 
— 
2.30 
A_15_P198576 zgc:152779 NM_001077535 down 
— 
2.04 
A_15_P500157   up 
— 
3.30 
A_15_P101624 phf8 XM_689807 down 
— 
2.34 
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A_15_P263811  AW128375 down 
— 
2.03 
A_15_P430090  EB842738 down 
— 
2.60 
A_15_P106434   down 
— 
4.99 
A_15_P345745   up 
— 
2.57 
A_15_P108524 prph NM_131054 up 
— 
2.31 
A_15_P194836 shox NM_001126411 down 
— 
2.71 
A_15_P198901 klhl20 NM_213001 down 
— 
2.08 
A_15_P239116 ap4b1l NM_200338 down 
— 
2.15 
A_15_P162441 smc1al NM_212810 down 
— 
2.74 
A_15_P178891 myhb BC150415 down 
— 
3.22 
A_15_P287161   down 
— 
3.79 
A_15_P178791 hectd1 NM_001002504 down 
— 
2.86 
A_15_P434305   up 
— 
2.36 
A_15_P178801 si:dkey-147f20.5 NM_001161377 up 
— 
2.23 
A_15_P136751 LOC558640 XM_681870 down 
— 
2.01 
A_15_P173826 unc119.2 NM_001040394 down 
— 
2.03 
A_15_P437055  BC107512 down 
— 
2.70 
A_15_P197716  XR_044895 down 
— 
2.62 
A_15_P146976  BC152291 down 
— 
2.07 
A_15_P181786 daxx NM_001044949 down 
— 
2.26 
A_15_P536237 wu:fc07e08 XM_680061 down 
— 
5.47 
A_15_P162901 zgc:153738 NM_001079968 down 
— 
2.95 
A_15_P114529 si:ch211-129c21.6 NM_001045015 down 
— 
2.02 
A_15_P390725  CT607160 up 
— 
2.39 
A_15_P322966 pcna NM_131404 up 
— 
2.08 
A_15_P178981 cxxc1l NM_200599 down 
— 
3.64 
A_15_P244746 LOC560644 XM_684039 up 
— 
5.90 
A_15_P481085  CT700592 up 
— 
2.67 
A_15_P112851 fpgs NM_213437 down 
— 
2.46 
A_15_P144161 LOC568230 XM_691549 down 
— 
2.59 
A_15_P188826 CH73-250D21.2 NM_001126386 down 
— 
2.78 
A_15_P186036 rbm19 NM_198915 down 
— 
3.25 
A_15_P301341 LOC571620 XM_701503 down 
— 
2.12 
A_15_P144656 LOC100000576 XM_001337087 down 
— 
2.22 
A_15_P211181 zgc:114180 NM_001030248 down 
— 
2.66 
A_15_P104664 arr3l NM_001002405 down 
— 
2.12 
A_15_P168076   up 
— 
2.74 
A_15_P198981   down 
— 
5.16 
A_15_P402910  DN894231 down 
— 
2.30 
A_15_P111768 adra2b NM_207638 down 
— 
2.86 
A_15_P105540 zgc:66483 NM_199825 up 
— 
2.02 
A_15_P102124 adhfe1 NM_207086 up 
— 
2.15 
A_15_P513617 ahnak BC124733 down 
— 
2.42 
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A_15_P119425 cbl NM_001007330 down 
— 
2.01 
A_15_P270516  XM_001344147 down 
— 
2.39 
A_15_P146061 zgc:165373 XM_685461 down 
— 
3.07 
A_15_P263296  EV558642 down 
— 
3.17 
A_15_P261926   down 
— 
2.32 
A_15_P101440   up 
— 
3.22 
A_15_P267381   down 
— 
2.97 
A_15_P598767 irx1b NM_131823 up 
— 
2.38 
A_15_P446335 LOC558416 XM_681621 down 
— 
3.13 
A_15_P170136 zgc:56231 NM_213188 up 
— 
2.24 
A_15_P560357 ccrl1a XM_001342755 up 
— 
2.03 
A_15_P495672   up 
— 
2.30 
A_15_P258606 LOC100007727 XM_001346072 down 
— 
2.67 
A_15_P408265 zgc:162197 NM_001110454 down 
— 
2.02 
A_15_P134241  BC090500 down 
— 
2.15 
A_15_P109612 cldna NM_131762 up 
— 
2.09 
A_15_P106950  BC079483 down 
— 
2.84 
A_15_P319641   down 
— 
3.05 
A_15_P295321   up 
— 
2.02 
A_15_P100058 zgc:152845 NM_001077572 down 
— 
3.99 
A_15_P318656   up 
— 
3.23 
A_15_P185746 zranb2  down 
— 
3.13 
A_15_P114416 fancl NM_212982 up 
— 
2.13 
A_15_P153811 zgc:153018 NM_001076639 down 
— 
2.05 
A_15_P101297   down 
— 
2.40 
A_15_P445565  XM_001345940 down 
— 
3.72 
A_15_P599387 wu:fb94h07 CK693674 up 
— 
2.07 
A_15_P567452 cdx1a NM_212836 down 
— 
2.15 
A_15_P117061   down 
— 
3.76 
A_15_P433260 si:dkey-8l13.4 NM_001044986 down 
— 
2.57 
A_15_P181226   down 
— 
2.19 
A_15_P355380   down 
— 
2.37 
A_15_P117909 fzd9 NM_131511 up 
— 
2.00 
A_15_P282511   up 
— 
2.19 
A_15_P264796   down 
— 
2.28 
A_15_P113852 ftr76 BC155657 down 
— 
7.57 
A_15_P493732 rock2b NM_001093747 down 
— 
3.14 
A_15_P177056 si:ch211-284a13.1 BC107500 down 
— 
3.58 
A_15_P209371 zc3hdc1l BC085328 down 
— 
2.05 
A_15_P115330 LOC563198 XM_686560 up 
— 
2.51 
A_15_P109078 wu:fb81h03 XM_689244 down 
— 
3.22 
A_15_P106928 calcoco1 NM_001110166 down 
— 
4.16 
A_15_P115076 wu:fi25h02 BC055503 down 
— 
2.92 
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A_15_P182386 zgc:153912 NM_001079971 down 
— 
3.65 
A_15_P150961 zgc:162618 NM_001089331 up 
— 
2.36 
A_15_P261246   down 
— 
3.58 
A_15_P142396 LOC562205 NM_001044980 up 
— 
8.97 
A_15_P230191 zgc:112071 NM_001017646 up 
— 
2.17 
A_15_P473275 kri1l NM_001002041 down 
— 
2.11 
A_15_P106287 snapc1b NM_200254 up 
— 
2.30 
A_15_P106206 im:7159195 XM_684566 down 
— 
2.17 
A_15_P171411 tmprss4a NM_001077738 up 
— 
2.19 
A_15_P171571 zgc:113320 NM_001017910 down 
— 
3.15 
A_15_P600537 daam1 XM_702261 down 
— 
2.28 
A_15_P137061 LOC794759 XM_001922883 down 
— 
2.06 
A_15_P419440   down 
— 
2.30 
A_15_P106730 nudt4 NM_200110 up 
— 
2.55 
A_15_P597357 cfl1 NM_213639 up 
— 
2.40 
A_15_P420580 si:ch73-30n17.4 XM_696010 down 
— 
3.55 
A_15_P191566   down 
— 
2.51 
A_15_P197956 sfrp5 NM_131858 up 
— 
2.46 
A_15_P419955 rcc1 NM_213178 up 
— 
2.16 
A_15_P178356 LOC557176 BC135013 down 
— 
2.41 
 
 
Table 2  
50 top GO processes represented in MetaCore (FDR< 0.05. 
Process p-value 
cellular process 9.40e-17 
developmental process 5.82e-13 
system development 3.78e-13 
multicellular organismal development 2.42e-13 
anatomical structure development 1.94e-13 
muscle system process 3.62e-12 
muscle contraction 1.13e-11 
response to hormone stimulus 7.27e-10 
regulation of striated muscle cell differentiation 3.25e-10 
anatomical structure formation involved in morphogenesis 9.79e-09 
regulation of muscle cell differentiation 9.63e-09 
response to endogenous stimulus 7.79e-09 
regulation of multicellular organismal process 4.68e-09 
tissue development 4.65e-09 
muscle structure development 4.35e-09 
anatomical structure morphogenesis 3.74e-09 
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regulation of localization 3.45e-09 
organ development 3.13e-09 
vasculature development 2.97e-09 
cellular component organization 1.82e-09 
localization 1.66e-09 
blood vessel development 1.61e-09 
positive regulation of biological process 1.57e-09 
regulation of cell differentiation 9.54e-08 
cellular metabolic process 9.26e-08 
regulation of transport 8.17e-08 
multicellular organismal process 7.52e-08 
regulation of muscle contraction 7.52e-08 
positive regulation of muscle contraction 7.38e-08 
regulation of muscle system process 6.98e-08 
epithelium development 6.15e-08 
regulation of skeletal muscle tissue development 5.31e-08 
response to organic substance 4.68e-08 
regulation of vasoconstriction 4.61e-08 
cellular developmental process 4.13e-08 
macromolecule modification 3.92e-08 
muscle organ development 3.54e-08 
establishment of localization 3.35e-08 
response to steroid hormone stimulus 2.50e-08 
regulation of system process 2.01e-08 
cytoskeleton-dependent intracellular transport 1.93e-08 
transport 1.68e-08 
cell differentiation 1.40e-08 
nervous system development 2.17e-07 
organ morphogenesis 1.92e-07 
organelle organization 1.60e-07 
embryonic development 1.50e-07 
post-translational protein modification 1.42e-07 
regulation of developmental process 1.39e-07 
protein modification process 1.06e-07 
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Table 3 
15 top maps and pathways represented in MetaCore (FDR< 0.05).  
Pathway GeneGo Map Folders 
 
Cell Process p-Value 
 
Cytoskeleton remodeling_TGF, WNT and 
cytoskeletal remodelling 
Cell adhesion_Gap junctions 
Development_CNTF receptor signaling 
 
Tissue remodeling 
and wound repair 
Cell communication; 
Protein amino acid 
phosphorylation 
1.068e-7 
 
Immune response_IL-1 signaling pathway 
Immune response_IL-6 signaling pathway 
Development_Transcription regulation of 
granulocyte development 
Immune response Immunological synapse 
formation 
 
Immune system 
response 
Positive regulation of 
smooth muscle cell 
proliferation; 
JAK-STAT cascade 
involved in growth 
hormone signaling 
pathway 
2.344e-6 
 
Immune response_IL-1 signaling pathway 
Cell adhesion_Chemokines and adhesion 
Immune response_IL-6 signaling pathway 
 
Inflammatory 
response 
Positive regulation of 
smooth muscle cell 
proliferation; 
Cell migration 
9.541e-5 
 
Development_TGF-beta-dependent induction of 
EMT via MAPK 
Development_Regulation of epithelial-to-
mesenchymal transition (EMT) 
Development_CNTF receptor signalling 
 
Cell differentiation 
Positive regulation of 
apoptosis; 
Microtubule 
cytoskeleton 
organization 
1.099e-5 
 
DNA damage_Nucleotide excision repair 
DNA damage_Role of Brca1 and Brca2 in DNA 
repair 
Apoptosis and survival_Role of IAP-proteins in 
apoptosis 
 
DNA-damage 
response 
Response to DNA 
damage stimulus 8.560e-4 
 
Cell cycle_ESR1 regulation of G1/S transition 
DNA damage_ATM/ATR regulation of G1/S 
checkpoint 
Cell cycle_Role of SCF complex in cell cycle 
regulation 
 
Cell cycle and its 
regulation Cell cycle 2.612e-4 
 
Apoptosis and survival_Ceramides signaling 
pathway 
DNA damage_Role of SUMO in p53 regulation 
Development_EPO-induced Jak-STAT pathway 
 
Apoptosis Apoptosis and survival 7.757e-3 
 
Blood coagulation_GPIb-IX-V-dependent platelet 
activation 
Blood coagulation_GPVI-dependent platelet 
activation 
Blood coagulation_GPCRs in platelet aggregation 
 
Blood clotting Hemostasis 7.252e-3 
 
Translation_Non-genomic (rapid) action of 
Androgen Receptor 
Translation _Regulation of EIF2 activity 
Translation_Translation regulation by Alpha-1 
adrenergic receptors 
Translation_Insulin regulation of translation 
 
Protein Synthesis Translation 4.824e-3 
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Transcription_CREB pathway 
Development_Role of HDAC and 
calcium/calmodulin-dependent kinase (CaMK) in 
control of skeletal myogenesis 
Apoptosis and survival_NO synthesis and signaling 
 
Calcium signaling 
Protein amino acid 
phosphorylation; 
Insulin-like growth 
factor receptor 
signaling pathway 
4.721e-3 
 
Cell adhesion_Histamine H1 receptor signaling in 
the interruption of cell barrier integrity 
Cytoskeleton remodeling_Alpha-1A adrenergic 
receptor-dependent inhibition of PI3K 
Muscle contraction_ GPCRs in the regulation of 
smooth muscle tone 
 
Vasoconstriction 
Phosphoinositide 
phosphorylation; 
Cell adhesion 
 
1.661e-3 
 
Transcription_Receptor-mediated HIF regulation 
Development_FGFR signaling pathway 
Development_FGF-family signaling 
 
Vascular 
development 
(Angiogenesis) 
Cell proliferation 1.355e-3 
 
Signal transduction_PTEN pathway 
Development_IGF-1 receptor signaling 
Development_CNTF receptor signaling 
 
Mitogenic 
signaling Cell proliferation 1.184e-3 
 
Proteolysis_Putative SUMO-1 pathway 
Development_WNT signaling pathway. Part 1.  
Proteolysis_Putative ubiquitin pathway 
 
Protein 
degradation Proteolysis 4.080e-2 
 
Translation_Non-genomic (rapid) action of 
Androgen Receptor 
Transcription_Androgen Receptor nuclear signaling 
 
Androgen 
signaling 
Insulin-like growth 
factor receptor 
signaling pathway; 
Response to estrogen 
stimulus 
3.289e-2 
 
 
 
 
